<SEC-DOCUMENT>0002077096-26-000223.txt : 20260727
<SEC-HEADER>0002077096-26-000223.hdr.sgml : 20260727
<ACCEPTANCE-DATETIME>20260727083157
ACCESSION NUMBER:		0002077096-26-000223
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20260727
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20260727
DATE AS OF CHANGE:		20260727

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LUXFER HOLDINGS PLC
		CENTRAL INDEX KEY:			0001096056
		STANDARD INDUSTRIAL CLASSIFICATION:	INDUSTRIAL INORGANIC CHEMICALS [2810]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			X0
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35370
		FILM NUMBER:		261202918

	BUSINESS ADDRESS:	
		STREET 1:		LUMNS LANE
		CITY:			MANCHESTER
		STATE:			X0
		ZIP:			M27 8LN
		BUSINESS PHONE:		441615159620

	MAIL ADDRESS:	
		STREET 1:		LUMNS LANE
		CITY:			MANCHESTER
		STATE:			X0
		ZIP:			M27 8LN
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0299296-8k_luxfer.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:us-roles="http://fasb.org/us-roles/2026" xmlns:country="http://xbrl.sec.gov/country/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:LXFR="http://luxfer.com/20260727">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02F_US%2DGAAP%2D2026 -->
<!-- Field: Set; Name: xdx; ID: xdx_038_LXFR_luxfer.com_20260727 -->
<!-- Field: Set; Name: xdx; ID: xdx_049_20260727_20260727 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_052_edei%2D%2DEntityCentralIndexKey_0001096056 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000004" name="dei:EntityCentralIndexKey">0001096056</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2026-07-27" id="xdx2ixbrl0012" name="dei:EntityIncorporationStateCountryCode">X0</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="lxfr-20260727.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2026-07-27">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001096056</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2026-07-27</xbrli:startDate>
        <xbrli:endDate>2026-07-27</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 2pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>UNITED STATES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>SECURITIES AND EXCHANGE
COMMISSION</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Washington, D.C. 20549</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>FORM <span id="xdx_909_edei--DocumentType_c20260727__20260727_zHmXCBLpV3rj"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Pursuant to Section 13
or 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>Date of Report (Date of Earliest Event Reported)</b>:
<b><span id="xdx_907_edei--DocumentPeriodEndDate_c20260727__20260727_zTURVN2fW567"><ix:nonNumeric contextRef="AsOf2026-07-27" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">July 27, 2026</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b><span id="xdx_906_edei--EntityRegistrantName_c20260727__20260727_zpIPKnozsxdl"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000011" name="dei:EntityRegistrantName">LUXFER HOLDINGS PLC</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 25%"><div style="border-top: Black 1.5pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><b>(Name of Registrant as Specified in Charter)</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityIncorporationStateCountryCode_dxL_c20260727__20260727_z9G1bRGIg0nf" title="::XDX::X0"><span style="-sec-ix-hidden: xdx2ixbrl0012">England and Wales</span></span></b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--EntityFileNumber_c20260727__20260727_zAKz7rWxoQo5"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000013" name="dei:EntityFileNumber">001-35370</ix:nonNumeric></span></b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; text-align: center; width: 32%"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityTaxIdentificationNumber_c20260727__20260727_zOYnAYNvl4h3"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000014" name="dei:EntityTaxIdentificationNumber">98-1024030</ix:nonNumeric></span></b></span></td></tr>
  <tr style="vertical-align: bottom">
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(State or Other Jurisdiction<br/>
of Incorporation)</span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(Commission File Number)</span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt">(IRS Employer<br/>
Identification No.)</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_909_edei--EntityAddressAddressLine1_c20260727__20260727_zVKkW39wyWJ9"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000015" name="dei:EntityAddressAddressLine1">3016 Kansas Avenue</ix:nonNumeric></span>,</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b><span style="text-decoration: underline"><span id="xdx_90B_edei--EntityAddressCityOrTown_c20260727__20260727_zcT3GyUUNrZj"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000016" name="dei:EntityAddressCityOrTown">Riverside</ix:nonNumeric></span>, <span id="xdx_903_edei--EntityAddressStateOrProvince_c20260727__20260727_zyIp1xxzF5r"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000017" name="dei:EntityAddressStateOrProvince">CA</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressPostalZipCode_c20260727__20260727_zUVhvcTGlWF4"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000018" name="dei:EntityAddressPostalZipCode">92507</ix:nonNumeric></span></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">(Address and Zip Code of Principal Executive Offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Registrant&#8217;s Telephone Number, including
Area Code: +1 <span id="xdx_90A_edei--CityAreaCode_c20260727__20260727_zMGn4TqK556c"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000019" name="dei:CityAreaCode">414</ix:nonNumeric></span>-<span id="xdx_90C_edei--LocalPhoneNumber_c20260727__20260727_zps889vr6ph7"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000020" name="dei:LocalPhoneNumber">269-2419</ix:nonNumeric></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Title of each class</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Trading Symbol(s)</b></span></td>
    <td style="padding-bottom: 1.5pt; width: 2%">&#160;</td>
    <td style="border-bottom: Black 1.5pt solid; width: 32%; text-align: center"><span style="font-size: 10pt"><b>Name of each exchange on which registered</b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--Security12bTitle_c20260727__20260727_zpweNuKhcGV1"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000021" name="dei:Security12bTitle">Ordinary Shares, nominal value &#163;0.50 each</ix:nonNumeric></span></span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_909_edei--TradingSymbol_c20260727__20260727_zl0DkgGrOgt1"><ix:nonNumeric contextRef="AsOf2026-07-27" id="Fact000022" name="dei:TradingSymbol">LXFR</ix:nonNumeric></span></span></td>
    <td style="text-align: center; vertical-align: top">&#160;</td>
    <td style="vertical-align: top; text-align: center"><span style="font-size: 10pt"><span id="xdx_904_edei--SecurityExchangeName_c20260727__20260727_zaRV6H7mETag"><ix:nonNumeric contextRef="AsOf2026-07-27" format="ixt-sec:exchnameen" id="Fact000023" name="dei:SecurityExchangeName">New York Stock Exchange</ix:nonNumeric></span></span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr>
    <td style="vertical-align: top; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20260727__20260727_zIUIIsyqngyb"><ix:nonNumeric contextRef="AsOf2026-07-27" format="ixt:booleanfalse" id="Fact000024" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_edei--SolicitingMaterial_c20260727__20260727_zSebuBVxuzfj"><ix:nonNumeric contextRef="AsOf2026-07-27" format="ixt:booleantrue" id="Fact000025" name="dei:SolicitingMaterial">&#9746;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_edei--PreCommencementTenderOffer_c20260727__20260727_zXUSCbZbQsh9"><ix:nonNumeric contextRef="AsOf2026-07-27" format="ixt:booleanfalse" id="Fact000026" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Pre-commencement communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom">&#160;</td></tr>
  <tr>
    <td style="vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90C_edei--PreCommencementIssuerTenderOffer_c20260727__20260727_zRI9wnb1jIwf"><ix:nonNumeric contextRef="AsOf2026-07-27" format="ixt:booleanfalse" id="Fact000027" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="vertical-align: bottom"><span style="font-size: 10pt">Pre-commencement communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR &#167;230.405) or Rule 12b-2 of the Securities
Exchange Act of 1934 (17 CFR &#167;240.12b-2).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: left; width: 0.25in; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_905_edei--EntityEmergingGrowthCompany_c20260727__20260727_z5yHVdbLqo37"><ix:nonNumeric contextRef="AsOf2026-07-27" format="ixt:booleanfalse" id="Fact000028" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Emerging growth company</span></td></tr>
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 2pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Transaction Agreement</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">On July 26, 2026, Luxfer Holdings
PLC, a public limited company (the &#8220;<span style="text-decoration: underline">Company</span>&#8221;), entered into a Transaction Agreement (the &#8220;<span style="text-decoration: underline">Transaction Agreement</span>&#8221;)
with Double Eagle Acquisition Buyer, Inc., a Delaware corporation (&#8220;<span style="text-decoration: underline">Buyer</span>&#8221;). Buyer is a newly formed holding company
owned by funds managed by Wynnchurch Capital L.P. (&#8220;<span style="text-decoration: underline">Wynnchurch</span>&#8221;). Pursuant to the Transaction Agreement, upon the terms
and subject to the conditions set forth therein, Buyer will acquire the entire issued share capital of the Company (the &#8220;<span style="text-decoration: underline">Transaction</span>&#8221;),
pursuant to a court sanctioned English law scheme of arrangement under Part 26 of the Companies Act 2006 (the &#8220;<span style="text-decoration: underline">Scheme of Arrangement</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The board of directors of
the Company (the &#8220;<span style="text-decoration: underline">Company Board</span>&#8221;) (i) approved and declared the Transaction Agreement, and the transactions contemplated
thereby, including the Transaction, the Scheme of Arrangement and the other transactions contemplated thereby fair to and in the best
interests of the Company and its shareholders as a whole, (ii) declared that it is advisable and in the best interests of the Company&#8217;s
shareholders that the Company enter into the Transaction Agreement and consummate the Transaction, the Scheme of Arrangement and the other
transactions contemplated thereby, on the terms and subject to the conditions set forth therein, (iii) directed that an application be
made to the High Court of Justice in England and Wales (the &#8220;<span style="text-decoration: underline">Court</span>&#8221;) to seek directions relating to the Scheme of Arrangement
and (iv) resolved that it will, subject to the terms and conditions of the Transaction Agreement, recommend that the Company&#8217;s shareholders
vote in favor of all of the resolutions comprising the Company Shareholder Approval (as defined in the Transaction Agreement) at duly
held meetings of such shareholders for such purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Effect on Capital Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon the terms and subject
to the conditions set forth in the Transaction Agreement and the Scheme of Arrangement,&#160;at the effective time of the Transaction
(the &#8220;<span style="text-decoration: underline">Effective Time</span>&#8221;), all of the ordinary shares, with a par value of &#163;0.50 per share, of the Company (&#8220;<span style="text-decoration: underline">Company
Ordinary Shares</span>&#8221;), then outstanding will be transferred from the holders of Company Ordinary Shares (&#8220;<span style="text-decoration: underline">Company Shareholders</span>&#8221;)
to Buyer, and the Company Shareholders will be entitled, pursuant to and in accordance with the terms of the Scheme of Arrangement, to
receive $17.37 in cash per Company Ordinary Share (the &#8220;<span style="text-decoration: underline">Consideration</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Non-Solicitation; Superior
Proposal</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Subject to certain exceptions,
the Company has agreed not to solicit, initiate, knowingly induce, knowingly facilitate or knowingly encourage any inquiries, proposals
or offers that constitute, relate to or that could reasonably be expected to lead to, an Acquisition Proposal (as defined in the Transaction
Agreement), or take certain other restricted actions in connection therewith. Notwithstanding the foregoing, if prior to obtaining the
Company Shareholder Approval, the Company receives a bona fide, written Acquisition Proposal that did not result from a material breach
of the non-solicitation provisions of the Transaction Agreement that the Company Board determines in good faith, after consultation with
its financial advisor and outside legal counsel, constitutes or could reasonably be expected to lead to a Superior Proposal (as defined
in the Transaction Agreement), and, after consultation with the Company&#8217;s outside legal counsel, that the failure to take the following
actions would be inconsistent with its fiduciary duties, then the Company may take certain actions to participate in discussions and negotiations
and furnish information with respect to such Acquisition Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Closing Conditions</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Consummation of the Transaction
is subject to the satisfaction or waiver of certain customary closing conditions set forth in the Transaction Agreement, including (i)
obtaining the Company Shareholder Approval, (ii) the expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust
Improvements Act of 1976, as amended (the &#8220;<span style="text-decoration: underline">HSR Act</span>&#8221;), and approvals and clearance under the antitrust laws and foreign
investment laws of certain other jurisdictions, (iii) the absence of certain orders or laws prohibiting the consummation of the Transaction,
and (iv) the sanctioning of the Scheme of Arrangement by the Court and the delivery of the Court order to the Registrar of</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">Companies in
England and Wales. The obligation of each party to consummate the Transaction is also subject to other customary closing conditions, including
the absence of a material adverse effect with respect to the Company, the accuracy of the other party&#8217;s representations and warranties,
subject to certain materiality standards set forth in the Transaction Agreement, and compliance in all material respects with the other
party&#8217;s obligations under the Transaction Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Termination Rights and
Termination Fees</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transaction Agreement
contains certain customary termination rights for the Company and Buyer, including (i)&#160;by the mutual written consent of the parties,
(ii) if the closing does not occur by February 26, 2027 (the &#8220;<span style="text-decoration: underline">End Date</span>&#8221;), (iii) a court or governmental authority of
competent jurisdiction has issued a final and non-appealable order or taken any other action permanently enjoining, restraining or otherwise
prohibiting the consummation of the Transaction, (iv) if the Court affirmatively declines or refuses to sanction the Scheme of Arrangement,
(v) the meeting of the Company Shareholders to be held as the Court may direct in relation to the Scheme of Arrangement (the &#8220;<span style="text-decoration: underline">Scheme
Meeting</span>&#8221;) and the general meeting of the Company Shareholders to be convened in connection with the Scheme of Arrangement (the
&#8220;<span style="text-decoration: underline">Company GM</span>&#8221;) have been held and the Company Shareholder Approval has not been obtained, (vi) by Buyer, if the Company
Board effects an Adverse Recommendation Change (as defined in the Transaction Agreement) or if the Company materially or intentionally
breaches its non-solicitation obligations, (vii) by the Company, if the Company Board effects an Adverse Recommendation Change in respect
of a Superior Proposal in accordance with the Transaction Agreement, or (viii) if the other party breaches its representations, warranties
or covenants in a manner that would cause the conditions to the closing of the Transaction set forth in the Transaction Agreement to not
be satisfied, and such party fails to cure such breach.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Upon termination of the Transaction
Agreement in accordance with its terms, under specified circumstances, including (i) by the Company to accept a Superior Proposal or (ii)
by Buyer if the Company Board changes, withholds or withdraws its recommendation to the Company Shareholders or the Company materially
or intentionally breaches its non-solicitation obligations, in each case, prior to the receipt of the Company Shareholder Approval, the
Company will be required to pay Buyer a fee (the &#8220;<span style="text-decoration: underline">Company Termination Payment</span>&#8221;) of $18,000,000. The Company is also
required to pay the Company Termination Payment if Buyer terminates the Transaction Agreement due to the failure of the closing date to
occur by the End Date and at such time Buyer could have terminated pursuant to the foregoing clause (ii). The Company is also required
to pay the Company Termination Payment if (a)(I) the Company or Buyer terminates the Transaction Agreement due to (x) the failure of the
closing to occur by the End Date or (y) the failure to obtain the Company Shareholder Approval following the completion of the Scheme
Meeting and the Company GM, or (II) Buyer terminates the Transaction Agreement if the Company breaches its representations, warranties
or covenants in a manner that would cause the conditions to the closing of the Transaction to not be satisfied and fails to cure such
breach, (b) following the execution of the Transaction Agreement, an Acquisition Proposal is made directly to the Company Shareholders
or is otherwise publicly disclosed and, in each case of clause (a)(I)(y) or clause (a)(II), not withdrawn within five (5) Business Days
prior to any other termination, and (c) within twelve (12) months after the date of such termination, the Company enters into a definitive
agreement in respect of such Acquisition Proposal (whether or not such Acquisition Proposal is subsequently consummated), or an Acquisition
Proposal is consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Company terminates
the Transaction Agreement (i) due to Buyer breaching its representations, warranties or covenants in a manner that would cause the conditions
to the closing of the Transaction to not be satisfied and fails to cure such breach or (ii)&#160;if all conditions to the Transaction
have been and continue to be satisfied (subject to customary exceptions), and Buyer fails to consummate the Transaction after receiving
written notice from the Company, then Buyer will be required to pay the Company a fee (the &#8220;<span style="text-decoration: underline">Buyer Termination Payment</span>&#8221;)
equal to $32,250,000 in cash. Buyer is also required to pay the Buyer Termination Payment if Buyer terminates the Transaction Agreement
due to the failure of the closing date to occur by the End Date and at such time the Company could have terminated pursuant to the foregoing
clauses (i) or (ii).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Treatment of Company Equity
Awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the Transaction
Agreement, the following shall occur as of the Effective Time, contingent upon the occurrence of the Effective Time:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 3; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(1)</td><td style="text-align: justify">Each option to acquire Company Ordinary Shares granted pursuant to the Company&#8217;s Long-Term Umbrella
Incentive Plan (the &#8220;<span style="text-decoration: underline">Company LTIP</span>&#8221;) that is outstanding and unexercised immediately prior to the Effective Time (each,
a &#8220;<span style="text-decoration: underline">Company Share Option</span>&#8221;), whether vested or unvested, that is subject to only time-based vesting conditions shall
(i) become fully vested (to the extent unvested) and (ii) be cancelled and converted into the right to receive an amount in cash equal
to the sum of (a) the product of (I) the excess, if any, of the Consideration, over the applicable exercise price per Company Ordinary
Share of such Company Share Option, multiplied by (II) the total number of Company Ordinary Shares subject to such Company Share Option
immediately prior to the Effective Time and (b) any accrued but unpaid dividend equivalent payments granted in tandem with such Company
Share Option (without interest), subject to any applicable tax withholding.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(2)</td><td style="text-align: justify">Each Company Share Option underlying a Company PSU Award (as defined below), whether vested or unvested,
that is subject to performance-based vesting conditions shall (i) to the extent then unvested, become vested to the extent the performance
conditions applicable to such Company Share Option, as determined reasonably and in good faith by the Company Board or the Remuneration
Committee of the Company, are achieved based on actual performance results achieved as of the closing date, with the number of Company
Ordinary Shares deemed vested in accordance with the foregoing then multiplied by a fraction, (a) the numerator of which is the number
of days during the applicable performance period that have elapsed prior to and including the closing date and (b) the denominator of
which is the total number of days in such performance period, rounded down to the nearest whole number of shares (such resulting number
of shares, the &#8220;<span style="text-decoration: underline">Earned Shares</span>&#8221;), and (ii) be cancelled and converted into the right to receive an amount in cash equal
to the sum of (A) the product of (I) the excess, if any, of the Consideration, over the applicable exercise price per Company Ordinary
Share of such Company Share Option, multiplied by (II) the total number of Earned Shares and (B) any accrued but unpaid dividend equivalent
payments granted in tandem with such Company Share Option (without interest), subject to any applicable tax withholding. Each Company
Share Option that has a per-share exercise price that is greater than the Consideration shall be cancelled as of the Effective Time for
no consideration.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(3)</td><td style="text-align: justify">Pursuant to the Transaction Agreement, effective upon the Effective Time, each award of restricted share
units (&#8220;<span style="text-decoration: underline">RSUs</span>&#8221;) in respect of Company Ordinary Shares granted pursuant to the Company LTIP or the Company&#8217;s Amended
and Restated Non-Executive Directors Equity Incentive Plan that is outstanding immediately prior to the Effective Time that is subject
to only time-based vesting conditions (each, a &#8220;<span style="text-decoration: underline">Company RSU Award</span>&#8221;) shall (i) become fully vested and (ii) be cancelled
and converted into the right to receive an amount in cash equal to the sum of (a) the product of (I) the Consideration multiplied by (II)
the number of Company Ordinary Shares subject to such Company RSU Award immediately prior to the Effective Time and (b) any accrued but
unpaid dividend equivalent payments granted in tandem with such Company RSU Award (without interest), subject to any applicable tax withholding.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="width: 0.5in"/><td style="width: 0.25in">(4)</td><td style="text-align: justify">Each award of RSUs granted pursuant to the Company LTIP that is outstanding immediately prior to the Effective
Time and is subject to performance-based vesting conditions (each, a &#8220;<span style="text-decoration: underline">Company PSU Award</span>&#8221;) shall (i) become fully vested
based on performance conditions applicable to such Company PSU Award measured based on actual performance results achieved as of the closing
date, as determined reasonably and in good faith by the Company Board or the Remuneration Committee, with the number of Company Ordinary
Shares deemed earned in accordance with the foregoing then multiplied by a fraction, (a) the numerator of which is the number of days
during the applicable performance period that have elapsed prior to and including the closing date and (b) the denominator of which is
the total number of days in such performance period, rounded down to the nearest whole number of shares (such resulting number of shares,
the &#8220;<span style="text-decoration: underline">Earned PSUs</span>&#8221;), and (ii) be cancelled and converted into the right to receive an amount in cash equal to the sum
of (A) the product of (I) the Consideration multiplied by (II) the number of Earned PSUs and (B) any accrued but unpaid dividend equivalent
payments granted in tandem with such Company PSU Award (without interest), subject to any applicable tax withholding.</td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><i>Other Terms of the Transaction
Agreement</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and Buyer have
each made customary representations, warranties and covenants in the Transaction Agreement. Among other things, the Company has agreed,
subject to certain exceptions, from the date of</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 4; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">the Transaction Agreement until the earlier to occur of the termination of the Transaction
Agreement in accordance with its terms and the Effective Time, (i)&#160;to conduct its business in all material respects in the ordinary
course, and (ii)&#160;not to take certain actions prior to the Effective Time without the prior written consent of Buyer (not to be unreasonably
withheld, delayed or conditioned).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">If the Transaction is consummated,
the Company Ordinary Shares will be delisted from the New York Stock Exchange and deregistered under the&#160;Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The foregoing summary of
the Transaction Agreement and the transactions contemplated thereby, including the Transaction, does not purport to be complete and is
subject to, and qualified in its entirety by, the full text of the Transaction Agreement attached hereto as Exhibit 2.1, and incorporated
herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Transaction Agreement
has been attached as an exhibit hereto to provide investors with information regarding its terms. It is not intended to provide any other
factual information about the Company or Buyer or their respective businesses, or the actual conduct of their respective businesses during
the period prior to the consummation of the Transaction. The representations, warranties and covenants contained in the Transaction Agreement
were made only for purposes of the Transaction Agreement as of the specific dates therein, were made solely for the benefit of the parties
to the Transaction Agreement, and may be subject to limitations agreed upon by the contracting parties, including being qualified by confidential
disclosures made for the purposes of allocating contractual risk between the parties to the Transaction Agreement instead of establishing
these matters as facts, to standards of materiality applicable to the contracting parties that differ from those applicable to investors.
Accordingly, the representations and warranties may not describe the actual state of affairs as of the date they were made or at any other
time and investors should not rely on them as statements of fact. Moreover, information concerning the subject matter of representations
and warranties may change after the date of the Transaction Agreement, which subsequent information may or may not be reflected in the
Company&#8217;s public disclosures. The Transaction Agreement should not be read alone, but should instead be read in conjunction with
the other information regarding the Company and Buyer and the transactions contemplated by the Transaction Agreement that will be contained
in or attached as an annex to the proxy statement that the Company will file in connection with the transactions contemplated by the Transaction
Agreement and the Voting Agreement, as well as in the other filings that the Company will make with the Securities and Exchange Commission
(the &#8220;<span style="text-decoration: underline">SEC</span>&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Financing Commitments</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Buyer has obtained an equity
financing commitment from a fund managed by Wynnchurch and a debt financing commitment from funds managed by an institutional lender for
the Transaction, the aggregate proceeds of which will be sufficient for Buyer to pay the aggregate Consideration, any amounts required
to repay the Company&#8217;s existing indebtedness as set forth in the Transaction Agreement, and all related fees and expenses of Buyer
in connection with the transactions contemplated by the Transaction Agreement. The obligations of the equity investor to provide equity
financing under the equity commitment letter are subject to customary conditions and the obligations of the lenders to provide debt financing
under the debt commitment letter are subject to customary conditions. The consummation of the Transaction is not subject to any financing
condition.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The equity investor has also
provided a guarantee in favor of the Company, to guarantee, subject to certain limitations set forth therein (including the satisfaction
or waiver of certain of the conditions set forth in the Transaction Agreement), the payment by Buyer of the Buyer Termination Payment
and certain indemnity and reimbursement obligations of Buyer to the extent payable by Buyer in accordance with the terms of the Transaction
Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Voting Agreements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Concurrent with the execution
of the Transaction Agreement, Buyer entered into Voting Agreements with certain executive officers of the Company, solely in their capacity
as Company Shareholders providing that, among other things, subject to the terms and conditions set forth therein, such Company Shareholders
will support the Transaction and the transactions contemplated thereby, including by voting their Company Ordinary Shares in favor of
the Scheme of Arrangement at the Scheme Meeting and the shareholder resolution at the Company GM.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 5; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white"><b>Item 8.01.&#160;Other
Events.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">On July 27, 2026, the Company issued a press release announcing the entry into the Transaction Agreement. A copy of the press release
is attached as Exhibit 99.1 and is incorporated by reference herein. On July 27, 2026, Wynnchurch issued a press release announcing the
entry into the Transaction Agreement. A copy of the press release is attached as Exhibit 99.2 and is incorporated by reference herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Additional Information about the Transaction and Where to Find It
</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">In connection with the proposed
Transaction between the Company and Buyer, the Company will file with the SEC a proxy statement on Schedule 14A. Additionally, the Company
may file other relevant materials with the SEC in connection with the proposed Transaction. Investors and securityholders of the Company
are urged to read the proxy statement (which will include notices convening the Scheme Meeting and the Company GM and an explanatory statement
in respect of the Scheme of Arrangement of the Company, in accordance with the requirements of the U.K. Companies Act 2006) and any other
relevant materials filed or that will be filed with the SEC, as well as any amendments or supplements to these materials and documents
incorporated by reference therein, carefully and in their entirety when they become available because they contain or will contain important
information about the proposed Transaction and related matters. The definitive version of the proxy statement will be mailed or otherwise
made available to the Company&#8217;s securityholders. Investors and securityholders will be able to obtain a copy of the proxy statement (when
it is available) as well as other filings containing information about the proposed Transaction that are filed by the Company with the
SEC, free of charge on EDGAR at www.sec.gov, on the investor relations page of the Company&#8217;s website at https://www.luxfer.com/investors,
or by contacting the Company&#8217;s investor relations department at Investor.Relations@Luxfer.com.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Participants in the Solicitation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Company and its directors
and executive officers may be deemed to be participants in the solicitation of proxies from the Company Shareholders in respect of the
Transaction. Information about the Company&#8217;s directors and executive officers is set forth in the proxy statement for the Company&#8217;s
2026 Annual General Meeting, which was filed with the SEC on April 30, 2026. Other information regarding the participants in the proxy
solicitation and a description of their interests will be contained in the proxy statement and other relevant materials to be filed with
the SEC in respect of the proposed Transaction when they become available.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Cautionary Note Regarding Forward-Looking Statements</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This communication includes
&#8220;forward-looking statements&#8221; within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform
Act of 1995, including with respect to the proposed acquisition of the Company, and readers are cautioned not to place undue reliance
on such statements. Such forward-looking statements include, but are not limited to, the ability of Buyer and the Company to complete
the transactions contemplated by the Transaction Agreement, including statements about the Transaction, statements about the expected
timetable for completing the Transaction, the Company&#8217;s beliefs and expectations and statements about the benefits sought to be
achieved in the proposed acquisition, and the potential effects of the acquisition on the Company. These statements are based upon the
current beliefs and expectations of the Company&#8217;s management and are subject to significant risks and uncertainties. There can be no guarantees
that the conditions to the closing of the proposed Transaction will be satisfied on the expected timetable or at all. If underlying assumptions
prove inaccurate or risks or uncertainties materialize, actual results may differ materially from those set forth in the forward-looking
statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Risks and uncertainties include,
but are not limited to, uncertainties as to the timing of the proposed Transaction; the risk that competing offers or acquisition proposals
will be made; the possibility that various conditions to the consummation of the proposed Transaction contained in the Transaction Agreement
may not be satisfied or waived (including, but not limited to, the failure to obtain the Company Shareholder Approval and the failure
to obtain the sanction of the Court); the occurrence of any event, change or other circumstances that could give rise to the termination
of the Transaction Agreement; the effects of disruption from the transactions contemplated by the Transaction Agreement and the impact
of the announcement and pendency of the Transaction on the Company&#8217;s business, including its ability to retain and hire key personnel
and maintain relationships with customers; the risk that any announcements relating to the Transaction could have adverse effects on the
market price of the Company Ordinary Shares; the risk of any unexpected costs or expenses resulting from the Transaction; the risk that
shareholder</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></p>

<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0pt">litigation in connection with the Transaction may result in significant costs of defense, indemnification and liability; and
other risks related to the Company&#8217;s business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">The
Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events
or otherwise, except to the extent required by law. Additional factors that could cause results to differ materially from those described
in the forward-looking statements can be found in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2025
and the Company&#8217;s other filings with the SEC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(d) Exhibits:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1.5pt solid; width: 9%"><b><span style="text-decoration: none">Exhibit No.</span></b></td>
    <td style="width: 1%"><span style="text-decoration: none">&#160;</span></td>
    <td style="border-bottom: Black 1.5pt solid; width: 90%; text-align: center"><span style="font-size: 10pt"><b><span style="text-decoration: none">Description</span></b></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top"><span style="font-size: 10pt">2.1*</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><span style="font-size: 10pt"><a href="ea029929601ex2-1.htm">Transaction Agreement, dated as of July 26, 2026, by and between Luxfer Holdings PLC and Double Eagle Acquisition Buyer, Inc.</a></span></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">99.1</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><span style="font-size: 10pt"><a href="ea029929601ex99-1.htm">Press Release of Luxfer Holdings PLC, dated July 27, 2026.</a></span></td></tr>
  <tr style="background-color: rgb(204,238,255)">
    <td style="vertical-align: top">99.2</td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><a href="ea029929601ex99-2.htm">Press Release of Wynnchurch Capital, L.P., dated July 27, 2026.</a></td></tr>
  <tr style="background-color: White">
    <td style="vertical-align: top"><span style="font-size: 10pt">104</span></td>
    <td style="vertical-align: bottom">&#160;</td>
    <td style="text-align: justify; vertical-align: top"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr>
  </table>


<p style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify">
<td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">*</span></td><td style="text-align: justify"><span style="font-size: 10pt">Schedules and exhibits have
been omitted pursuant to Item 601(b)(2) and Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of
any omitted attachment to the SEC upon request.</span></td>
</tr></table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></p></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2"><b>LUXFER HOLDINGS PLC</b></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td colspan="2">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="width: 60%">Date: July 27, 2026</td>
    <td style="width: 5%">By:</td>
    <td style="border-bottom: black 1.5pt solid; width: 35%">/s/ Benjamin M. Coulson</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">Name:&#160;</td>
    <td style="vertical-align: top">Benjamin M. Coulson</td></tr>
  <tr>
    <td>&#160;</td>
    <td style="vertical-align: top">Title:</td>
    <td style="vertical-align: top">Corporate Controller &amp; Company Secretary</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></p>

<!-- Field: Page; Sequence: 8; Options: Last -->
    <div style="border-bottom: Black 1.5pt solid; margin-top: 12pt; margin-bottom: 6pt"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&#160;</p>

<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjdEKgkAQRb/Afxj2WUqFDHxMTCKLEIleFx1jSXdkdrP6pP6yTYmGC8PMvWdGCF/ktFUdMlw2ZQEV9kMnLUKJLTLqGl0i3e0TcL3EqzKWpbbT+ANTcgw6Jl6sarefkqMy2CQQrJdR7ARBlIQxnA7C+/op6VY1qK2SHUjdwIlpYIVW8mu+UMknaepf06czslGkEwgXwWy/IQrCCI40ygfxzUBRpMLzp/JEznQfXCp7WtRfErIOe/fOzPRf3gfR8kpm -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-2.1
<SEQUENCE>2
<FILENAME>ea029929601ex2-1.htm
<DESCRIPTION>TRANSACTION AGREEMENT, DATED AS OF JULY 26, 2026, BY AND BETWEEN LUXFER HOLDINGS PLC AND DOUBLE EAGLE ACQUISITION BUYER, INC
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 2.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>EXECUTION VERSION<BR>
CONFIDENTIAL</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TRANSACTION AGREEMENT<BR>
<BR>
by and between<BR>
<BR>
LUXFER HOLDINGS PLC<BR>
<BR>
and<BR>
<BR>
DOUBLE EAGLE ACQUISITION BUYER, INC.<BR>
<BR>
July 26</B>, <B>2026</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>





<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center"><U>TABLE OF CONTENTS</U></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</P>



<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif">
    <TD COLSPAN="2" STYLE="padding-bottom: 1.5pt; text-align: left"><U></U></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid; text-align: center"><P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><U STYLE="text-decoration: none">Page</U></P>

</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 1 THE TRANSACTION</TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left; width: 15%">Section 1.01</TD>
    <TD STYLE="text-align: left; width: 75%">The Transaction</TD>
    <TD STYLE="text-align: center; width: 10%">2</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 1.02</TD>
    <TD STYLE="text-align: left">Closing</TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 1.03</TD>
    <TD STYLE="text-align: left">Effective Time</TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 2 TRANSFER OF COMPANY ORDINARY SHARES; EXCHANGE PROCEDURES</TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 2.01</TD>
    <TD STYLE="text-align: left">Transfer of Company Ordinary Shares</TD>
    <TD STYLE="text-align: center">2</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 2.02</TD>
    <TD STYLE="text-align: left">Exchange Procedures</TD>
    <TD STYLE="text-align: center">3</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 2.03</TD>
    <TD STYLE="text-align: left">Company Equity Awards; Company ESPP; Company SIP</TD>
    <TD STYLE="text-align: center">4</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 2.04</TD>
    <TD STYLE="text-align: left">Company and Buyer Actions Prior to and at Closing</TD>
    <TD STYLE="text-align: center">7</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 2.05</TD>
    <TD STYLE="text-align: left">Withholding Rights</TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 2.06</TD>
    <TD STYLE="text-align: left">Further Assurances</TD>
    <TD STYLE="text-align: center">8</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 3 REPRESENTATIONS AND WARRANTIES OF THE COMPANY</TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.01</TD>
    <TD STYLE="text-align: left">Corporate Existence and Power</TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.02</TD>
    <TD STYLE="text-align: left">Corporate Authorization</TD>
    <TD STYLE="text-align: center">9</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.03</TD>
    <TD STYLE="text-align: left">Governmental Authorization</TD>
    <TD STYLE="text-align: center">10</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.04</TD>
    <TD STYLE="text-align: left">Non-contravention</TD>
    <TD STYLE="text-align: center">10</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.05</TD>
    <TD STYLE="text-align: left">Capitalization</TD>
    <TD STYLE="text-align: center">11</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.06</TD>
    <TD STYLE="text-align: left">Subsidiaries</TD>
    <TD STYLE="text-align: center">12</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.07</TD>
    <TD STYLE="text-align: left">SEC Filings and the Sarbanes-Oxley Act</TD>
    <TD STYLE="text-align: center">13</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.08</TD>
    <TD STYLE="text-align: left">Financial Statements; Internal Controls</TD>
    <TD STYLE="text-align: center">14</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.09</TD>
    <TD STYLE="text-align: left">Absence of Certain Changes</TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.10</TD>
    <TD STYLE="text-align: left">No Undisclosed Material Liabilities</TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.11</TD>
    <TD STYLE="text-align: left">Litigation</TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.12</TD>
    <TD STYLE="text-align: left">Compliance with Applicable Law</TD>
    <TD STYLE="text-align: center">15</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.13</TD>
    <TD STYLE="text-align: left">Certain Business Practices</TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.14</TD>
    <TD STYLE="text-align: left">Material Contracts</TD>
    <TD STYLE="text-align: center">16</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.15</TD>
    <TD STYLE="text-align: left">Taxes</TD>
    <TD STYLE="text-align: center">19</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.16</TD>
    <TD STYLE="text-align: left">Employee Benefit Plans</TD>
    <TD STYLE="text-align: center">21</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.17</TD>
    <TD STYLE="text-align: left">Labor and Employment Matters</TD>
    <TD STYLE="text-align: center">24</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.18</TD>
    <TD STYLE="text-align: left">Insurance</TD>
    <TD STYLE="text-align: center">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.19</TD>
    <TD STYLE="text-align: left">Environmental Matters</TD>
    <TD STYLE="text-align: center">25</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.20</TD>
    <TD STYLE="text-align: left">Intellectual Property; Data Protection</TD>
    <TD STYLE="text-align: center">26</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.21</TD>
    <TD STYLE="text-align: left">Properties</TD>
    <TD STYLE="text-align: center">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.22</TD>
    <TD STYLE="text-align: left">Takeover Statutes</TD>
    <TD STYLE="text-align: center">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.23</TD>
    <TD STYLE="text-align: left"> Brokers&rsquo; Fees</TD>
    <TD STYLE="text-align: center">28</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.24</TD>
    <TD STYLE="text-align: left">Information Supplied</TD>
    <TD STYLE="text-align: center">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.25</TD>
    <TD STYLE="text-align: left">Opinion of Financial Advisor</TD>
    <TD STYLE="text-align: center">29</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left; width: 15%">Section 3.26</TD>
    <TD STYLE="text-align: left; width: 75%">Interested Party Transactions</TD>
    <TD STYLE="text-align: center; width: 10%">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 3.27</TD>
    <TD STYLE="text-align: left">Government Contracts and Government Bids</TD>
    <TD STYLE="text-align: center">29</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 4 REPRESENTATIONS AND WARRANTIES OF BUYER</TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.01</TD>
    <TD STYLE="text-align: left">Corporate Existence and Power</TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.02</TD>
    <TD STYLE="text-align: left">Corporate Authorization</TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.03</TD>
    <TD STYLE="text-align: left"> Governmental Authorization</TD>
    <TD STYLE="text-align: center">30</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.04</TD>
    <TD STYLE="text-align: left">Prior Acquisitions</TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.05</TD>
    <TD STYLE="text-align: left"> Non-contravention</TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.06</TD>
    <TD STYLE="text-align: left">No Vote of Buyer Shareholders; Required Approval</TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.07</TD>
    <TD STYLE="text-align: left">Litigation</TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.08</TD>
    <TD STYLE="text-align: left">Available Funds</TD>
    <TD STYLE="text-align: center">31</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.09</TD>
    <TD STYLE="text-align: left">Solvency</TD>
    <TD STYLE="text-align: center">32</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.10</TD>
    <TD STYLE="text-align: left">Guarantee</TD>
    <TD STYLE="text-align: center">33</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.11</TD>
    <TD STYLE="text-align: left">Absence of Certain Agreements</TD>
    <TD STYLE="text-align: center">33</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.12</TD>
    <TD STYLE="text-align: left">Share Ownership</TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.13</TD>
    <TD STYLE="text-align: left">Information Supplied</TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.14</TD>
    <TD STYLE="text-align: left">Takeover Statutes</TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.15</TD>
    <TD STYLE="text-align: left">Compliance With Law</TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 4.16</TD>
    <TD STYLE="text-align: left"> Brokers&rsquo; Fees</TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 5 COVENANTS</TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.01</TD>
    <TD STYLE="text-align: left">Conduct of the Company</TD>
    <TD STYLE="text-align: center">34</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.02</TD>
    <TD STYLE="text-align: left">No Solicitation; Unsolicited Proposals</TD>
    <TD STYLE="text-align: center">38</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.03</TD>
    <TD STYLE="text-align: left">Company Recommendation</TD>
    <TD STYLE="text-align: center">40</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.04</TD>
    <TD STYLE="text-align: left">Responsibilities of the Parties in Respect of the Scheme of Arrangement</TD>
    <TD STYLE="text-align: center">43</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.05</TD>
    <TD STYLE="text-align: left">Access to Information</TD>
    <TD STYLE="text-align: center">48</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.06</TD>
    <TD STYLE="text-align: left">Notice of Certain Events</TD>
    <TD STYLE="text-align: center">50</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.07</TD>
    <TD STYLE="text-align: left"> Employee Matters</TD>
    <TD STYLE="text-align: center">50</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.08</TD>
    <TD STYLE="text-align: left">Takeover Laws</TD>
    <TD STYLE="text-align: center">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.09</TD>
    <TD STYLE="text-align: left">Voting of Shares</TD>
    <TD STYLE="text-align: center">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.10</TD>
    <TD STYLE="text-align: left"> Director and Officer Liability</TD>
    <TD STYLE="text-align: center">52</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.11</TD>
    <TD STYLE="text-align: left"> Best Efforts</TD>
    <TD STYLE="text-align: center">54</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.12</TD>
    <TD STYLE="text-align: left">Transaction Litigation</TD>
    <TD STYLE="text-align: center">57</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.13</TD>
    <TD STYLE="text-align: left">Public Announcements</TD>
    <TD STYLE="text-align: center">57</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.14</TD>
    <TD STYLE="text-align: left">Section 16 Matters</TD>
    <TD STYLE="text-align: center">58</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.15</TD>
    <TD STYLE="text-align: left">Financing</TD>
    <TD STYLE="text-align: center">58</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.16</TD>
    <TD STYLE="text-align: left">Confidentiality</TD>
    <TD STYLE="text-align: center">62</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.17</TD>
    <TD STYLE="text-align: left">Director Resignations</TD>
    <TD STYLE="text-align: center">63</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.18</TD>
    <TD STYLE="text-align: left">Listing Matters</TD>
    <TD STYLE="text-align: center">63</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.19</TD>
    <TD STYLE="text-align: left">Treatment of Company Debt</TD>
    <TD STYLE="text-align: center">63</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.20</TD>
    <TD STYLE="text-align: left">Control of Operations</TD>
    <TD STYLE="text-align: center">63</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 5.21</TD>
    <TD STYLE="text-align: left">Tax Cooperation and Assistance</TD>
    <TD STYLE="text-align: center">63</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 3; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->ii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%">
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 6 CONDITIONS TO THE TRANSACTION</TD>
    <TD STYLE="text-align: center">64</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left; width: 15%">Section 6.01</TD>
    <TD STYLE="text-align: left; width: 75%">Conditions to the Obligations of Each Party</TD>
    <TD STYLE="text-align: center; width: 10%">64</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 6.02</TD>
    <TD STYLE="text-align: left">Conditions to the Obligations of Buyer</TD>
    <TD STYLE="text-align: center">64</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 6.03</TD>
    <TD STYLE="text-align: left">Conditions to the Obligations of the Company</TD>
    <TD STYLE="text-align: center">65</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 7 TERMINATION</TD>
    <TD STYLE="text-align: center">66</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 7.01</TD>
    <TD STYLE="text-align: left">Termination</TD>
    <TD STYLE="text-align: center">66</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 7.02</TD>
    <TD STYLE="text-align: left">Effect of Termination</TD>
    <TD STYLE="text-align: center">67</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="text-align: left">ARTICLE 8 MISCELLANEOUS</TD>
    <TD STYLE="text-align: center">68</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD COLSPAN="2" STYLE="text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.01</TD>
    <TD STYLE="text-align: left">Notices</TD>
    <TD STYLE="text-align: center">68</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.02</TD>
    <TD STYLE="text-align: left">Survival of Representations and Warranties</TD>
    <TD STYLE="text-align: center">69</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.03</TD>
    <TD STYLE="text-align: left">Amendments and Waivers</TD>
    <TD STYLE="text-align: center">69</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.04</TD>
    <TD STYLE="text-align: left"> Fees and Expenses</TD>
    <TD STYLE="text-align: center">70</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.05</TD>
    <TD STYLE="text-align: left">VAT and Transfer Taxes</TD>
    <TD STYLE="text-align: center">72</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.06</TD>
    <TD STYLE="text-align: left">Assignment; Benefit</TD>
    <TD STYLE="text-align: center">73</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.07</TD>
    <TD STYLE="text-align: left">Governing Law</TD>
    <TD STYLE="text-align: center">74</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.08</TD>
    <TD STYLE="text-align: left">Jurisdiction</TD>
    <TD STYLE="text-align: center">74</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.09</TD>
    <TD STYLE="text-align: left">Waiver of Jury Trial</TD>
    <TD STYLE="text-align: center">74</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.10</TD>
    <TD STYLE="text-align: left">Specific Performance</TD>
    <TD STYLE="text-align: center">75</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.11</TD>
    <TD STYLE="text-align: left">Severability</TD>
    <TD STYLE="text-align: center">77</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.12</TD>
    <TD STYLE="text-align: left">Entire Agreement; No Reliance; Access to Information</TD>
    <TD STYLE="text-align: center">78</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.13</TD>
    <TD STYLE="text-align: left">Rules of Construction</TD>
    <TD STYLE="text-align: center">79</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.14</TD>
    <TD STYLE="text-align: left">Counterparts; Effectiveness</TD>
    <TD STYLE="text-align: center">79</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.15</TD>
    <TD STYLE="text-align: left">Certain Definitions</TD>
    <TD STYLE="text-align: center">79</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.16</TD>
    <TD STYLE="text-align: left">Other Definitional and Interpretative Provisions</TD>
    <TD STYLE="text-align: center">95</TD></TR>
  <TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD STYLE="padding-left: 0.25in; text-align: left">Section 8.17</TD>
    <TD STYLE="text-align: left">Debt Financing Sources</TD>
    <TD STYLE="text-align: center">96</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="padding-left: 0.25in; text-align: left">&nbsp;</TD>
    <TD STYLE="text-align: center">&nbsp;</TD></TR>
<TR STYLE="text-align: left; vertical-align: bottom; font: 10pt Times New Roman, Times, Serif; background-color: White">
    <TD COLSPAN="2" STYLE="padding-left: 0in; text-align: left">Exhibit A &ndash; Form of Scheme of Arrangement</TD>
    <TD STYLE="text-align: center"></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: LowerRoman; Name: PageNo -->iii<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">TRANSACTION AGREEMENT</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">This TRANSACTION AGREEMENT
(this &ldquo;<B>Agreement</B>&rdquo;), dated as of July 26, 2026, is by and between Double Eagle Acquisition Buyer, Inc., a Delaware corporation
(&ldquo;<B>Buyer</B>&rdquo;), and Luxfer Holdings PLC, a public limited company registered in England and Wales (the &ldquo;<B>Company</B>&rdquo;
and, together with Buyer, the &ldquo;<B>Parties</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Parties intend
that the Company Ordinary Shares be acquired by Buyer on the terms and subject to the conditions set out in this Agreement with the effect
that Buyer will acquire the entire issued share capital of the Company (the &ldquo;<B>Transaction</B>&rdquo;), pursuant to the Scheme
of Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company Board
has, by resolutions duly adopted unanimously by the directors in attendance at a meeting of the directors of the Company duly called and
held, (i) determined that this Agreement, the Scheme of Arrangement and the transactions contemplated hereby and thereby, including the
Transaction, are fair to and in the best interests of the Company and the Company Shareholders as a whole, and declared it advisable to
enter into this Agreement, (ii) approved the execution, delivery and performance of this Agreement and the consummation of the transactions
contemplated hereby, including the Transaction and the Scheme of Arrangement on the terms and subject to the conditions set forth herein,
(iii) determined that an application be made to the Court to seek directions relating to the Scheme of Arrangement and (iv) resolved to
recommend the approval of the Scheme of Arrangement at the Scheme Meeting and the passing of the Company Shareholder Resolutions by the
Company Shareholders;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, concurrently with
the execution and delivery of this Agreement, and as an inducement to each Party&rsquo;s willingness to enter into this Agreement, (i)
Wynnchurch Capital Partners VI, L.P. (the &ldquo;<B>Equity Investor</B>&rdquo;) is entering into an equity financing commitment letter
in favor of Buyer (the &ldquo;<B>Equity Commitment Letter</B>&rdquo;), pursuant to which the Equity Investor has committed, subject to
the terms and conditions therein, to invest, directly or indirectly, in Buyer the amounts set forth therein, and (ii) Wynnchurch Capital
Partners VI, L.P. (the &ldquo;<B>Guarantor</B>&rdquo;) is entering into a guarantee in favor of the Company (the &ldquo;<B>Guarantee</B>&rdquo;)
with respect to certain obligations of Buyer under this Agreement in an aggregate amount up to the maximum amount of the Buyer Liability
Limit, subject to the terms and conditions therein;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the board of directors
of Buyer has approved the execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
hereby, including the Transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, concurrently with
the execution and delivery of this Agreement, and as an inducement to Buyer&rsquo;s willingness to enter into this Agreement, certain
of the Company Shareholders, solely in their capacity as Company Shareholders, have entered into a support agreement with Buyer (collectively,
the &ldquo;<B>Voting Agreements</B>&rdquo;), pursuant to which, among other things, such Company Shareholders have agreed to vote their
Company Ordinary Shares in favor of the Scheme of Arrangement at the Scheme Meeting and the Company Shareholder Resolutions at the Company
GM, subject to the terms and conditions therein, and</P>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">WHEREAS, the Company and Buyer
desire to make certain representations, warranties, covenants and agreements specified herein in connection with this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">NOW, THEREFORE, in consideration
of the foregoing and the representations, warranties, covenants and agreements contained herein, and intending to be legally bound hereby,
the Company and Buyer agree as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
1 </FONT><BR>
THE TRANSACTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
1.01</FONT> <I>The Transaction</I>. At the Effective Time, upon the terms and subject to the conditions set forth in this Agreement and
in accordance with the Laws of England and Wales, the Companies Act, and the terms of the Scheme of Arrangement: (i) all of the Company
Ordinary Shares then outstanding shall be transferred from the Company Shareholders to Buyer (or an Affiliate of Buyer designated by
Buyer in accordance with the terms of the Scheme of Arrangement); and (ii) the Company Shareholders shall be entitled in accordance with
the terms of the Scheme of Arrangement to receive an amount in cash, without interest, equal to $17.37 per Company Ordinary Share that
is outstanding immediately prior to the Effective Time (the &ldquo;<B>Consideration</B>&rdquo;). No interest shall accumulate on any
cash payable in connection with the Transaction except in accordance with the terms of the Scheme of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.02 <I>Closing</I>.
The closing of the Transaction (the &ldquo;<B>Closing</B>&rdquo;) shall take place on a date to be agreed upon by Buyer and the Company
that is no later than the third (3<SUP>rd</SUP>) Business Day or, if earlier, the End Date, following the date on which the satisfaction
or waiver (to the extent permitted hereunder) of the conditions set forth in <U>&#8206;Article 6</U> (other than those conditions that
by their nature are to be satisfied at the Closing, but subject to the satisfaction or waiver of such conditions at the Closing) occurs,
or at such other place, date and time as the Company and Buyer may agree in writing. The date on which the Closing actually occurs is
referred to as the &ldquo;<B>Closing Date</B>.&rdquo; The Closing shall be deemed to have occurred as of 12:01 a.m., Eastern Time on
the Closing Date. To the extent that documents and signatures are required to be executed or provided at closing, such matters shall
be dealt with by way of a virtual closing through electronic exchange of documents and signatures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 1.03 <I>Effective
Time</I>. On the Closing Date, the Scheme of Arrangement shall become effective at such time as an order of the High Court of Justice
in England and Wales (the &ldquo;<B>Court</B>&rdquo;) sanctioning the Scheme of Arrangement (such order, the &ldquo;<B>Court Order</B>&rdquo;)
has been delivered to the Registrar of Companies in England and Wales (such date and time is hereinafter referred to as the &ldquo;<B>Effective
Time</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
2 </FONT><BR>
TRANSFER OF COMPANY ORDINARY SHARES; EXCHANGE PROCEDURES</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.01 <I>Transfer of
Company Ordinary Shares</I>. At the Effective Time, all Company Ordinary Shares then outstanding shall be transferred from the Company
Shareholders in accordance with the provisions of the Scheme of Arrangement, <U>&#8206;Section 1.01</U>, this <U>&#8206;Section 2.01</U>
and <U>&#8206;Section 2.02</U>, and the Company Shareholders shall cease to have any rights with respect to the Company Ordinary Shares,
except their rights under the Scheme of Arrangement, including the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 6; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">right to receive the Consideration. As soon as practicable
following the Effective Time (subject to any mandatory stamping of relevant instruments of transfer for the Company Ordinary Shares),
the Company&rsquo;s Register of Members will be updated in accordance with the provisions of the Scheme of Arrangement to reflect the
transfer of the Company Ordinary Shares to Buyer (or an Affiliate of Buyer designated by Buyer prior to the filing of the Scheme of Arrangement
with the Court), following which the Company shall be a wholly owned subsidiary of Buyer or such Affiliate of Buyer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.02 <I>Exchange Procedures</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a) &nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Prior to the Closing, Buyer shall (A) select a nationally recognized bank or trust company reasonably acceptable to the Company
to act as exchange agent for the payment of the Consideration (&ldquo;<B>Exchange Agent</B>&rdquo;) and (B) enter into an agreement with
the Exchange Agent (the &ldquo;<B>Exchange Agent Agreement</B>&rdquo;), in form and substance reasonably acceptable to the Company, with
such Exchange Agent. On the Closing Date, Buyer shall deposit, or cause to be deposited, with the Exchange Agent, for the benefit of the
Company Shareholders, cash in an amount equal to the aggregate Consideration. All cash deposited with the Exchange Agent pursuant to the
preceding sentence shall hereinafter be referred to as the &ldquo;<B>Exchange Fund</B>&rdquo;.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As promptly as reasonably practicable after the Effective Time, and in any event within three (3) Business Days after the Effective
Time, Buyer shall cause the Exchange Agent to mail to each holder of record of a certificate or certificates which immediately prior to
the Effective Time represented outstanding Company Ordinary Shares (the &ldquo;<B>Certificates</B>&rdquo;) or non-certificated Company
Ordinary Shares represented by book-entry (the &ldquo;<B>Book-Entry Shares</B>&rdquo;) that is entitled to receive the Consideration pursuant
to <B><I><U>&#8206;</U></I></B><U>Section 1.01</U> a letter of transmittal, which shall be in such form and have such other provisions
as Buyer and the Exchange Agent may reasonably specify. The Exchange Agent Agreement shall require that each holder of Company Ordinary
Shares that have been converted into the right to receive the Consideration shall be entitled to receive the Consideration in respect
of the Company Ordinary Shares represented by a Certificate, within two (2) Business Days following delivery to the Exchange Agent of
a duly completed and validly executed letter of transmittal, or receipt of an &ldquo;agent&rsquo;s message&rdquo; by the Exchange Agent
in the case of Book-Entry Shares, and, in each case, delivery to the Exchange Agent of such other documents as may be reasonably requested
by the Exchange Agent. The Exchange Agent shall accept such letters of transmittal, &ldquo;agent&rsquo;s message&rdquo; with respect to
Book-Entry Shares or other documents upon compliance with such reasonable terms and conditions as the Exchange Agent may impose to effect
orderly payments of the Consideration in accordance with normal exchange practices. If payment of the Consideration is to be made to a
person other than the person in whose name the Certificate is registered, it shall be a condition precedent to payment that the person
requesting such payment shall have paid (and provided all requested documentation thereof) any transfer, stamp and other similar Taxes
required by reason of the payment of the Consideration to a person other than the registered holder of the Certificate surrendered or
shall have established to the satisfaction of Buyer and the Exchange Agent that such Tax either has been paid or is not required to be
paid. Payment of the Consideration with respect to Book-Entry Shares shall only be made to the person in whose name such Book-Entry Shares
are registered. Each Certificate and Book-Entry Share shall be deemed at any time after the Effective Time to represent only the right</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 7; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">to receive the Consideration as contemplated by this <B><I><U>&#8206;</U></I></B><U>Article 2</U>, without interest thereon. Any portion
of the Exchange Fund which has not been transferred to the holders of Company Ordinary Shares within twelve (12) months of the Effective
Time shall be delivered to Buyer or its designee(s) promptly upon request by Buyer, it being understood that no such delivery shall affect
any legal right that a Company Shareholder may have to receive the Consideration. None of Buyer, the Company or the Exchange Agent or
any of their respective Affiliates or Representatives or agents shall be liable to any Person in respect of any Consideration (or dividends
or distributions with respect thereto) from the Exchange Fund delivered to a public official pursuant to any applicable abandoned property,
escheat or similar Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>At the Effective Time, the share transfer books of the Company shall be closed and thereafter (other than to record the transfer
of Company Ordinary Shares to Buyer or its designate in accordance with this Agreement) there shall be no further registration of transfers
of Company Ordinary Shares on the records of the Company until the Company Ordinary Shares have been transferred to Buyer on the terms
of the Scheme of Arrangement. From and after the Effective Time, the holders of Certificates or Book-Entry Shares outstanding immediately
prior to the Effective Time shall cease to have any rights with respect to the Company Ordinary Shares formerly represented thereby except
as otherwise provided for herein. If, after the Effective Time, Certificates or Book-Entry Shares are presented to the Buyer, the Company
or the Exchange Agent for any reason, they shall be cancelled and exchanged as provided in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the event that any Certificates shall have been lost, stolen or destroyed, the Exchange Agent shall issue in exchange for such
lost, stolen or destroyed Certificates, upon the making of an affidavit of that fact by the holder thereof (such affidavit to be in a
form reasonably satisfactory to Buyer and the Exchange Agent), the Consideration payable in respect thereof pursuant to <B><U>&#8206;</U></B><U>Section
1.01</U>; provided, however, that Buyer may, in its discretion and as a condition precedent to the issuance thereof, require the owner
of such lost, stolen or destroyed Certificate to deliver a bond in such reasonable and customary amount as Buyer may direct as indemnity
against any claim that may be made against Buyer and its Subsidiaries or the Exchange Agent with respect to the Certificate alleged to
have been lost, stolen or destroyed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.03 <I>Company Equity
Awards; Company ESPP; Company SIP</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><I>Company LTIP; Company EIP. </I>No later than immediately prior to the Effective Time, the Company Board or the applicable committee
thereof shall take all actions reasonable, necessary or advisable to cause the following to occur as of the Effective Time, contingent
upon the occurrence of the Effective Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each option to acquire Company Ordinary Shares granted pursuant to the Company LTIP set forth in <U>Section 3.05(b)(i)</U> of the
Company Disclosure Schedule that is outstanding and unexercised immediately prior to the Effective Time (each, a &ldquo;<B>Company Share
Option</B>&rdquo;), whether vested or unvested, that is subject to only time-based vesting conditions shall (x) become fully vested (to
the extent unvested) and (y) be cancelled and converted into the right to receive an amount in cash equal to the sum of (A) the <I>product
of </I>(I) the excess, if any, of the Consideration, <I>over </I>the applicable exercise price per Company Ordinary Share of such Company
Share Option, <I>multiplied by </I>(II) the total number of Company Ordinary Shares subject to such Company Share Option immediately prior
to the Effective Time and (B) any accrued but unpaid</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 8; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">dividend equivalent payments granted in tandem with such Company Share Option (without
interest) (such amounts, collectively, the &ldquo;<B>Time-Based Option Cash Amounts</B>&rdquo;), subject to any applicable Tax withholding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii) Each Company Share
Option underlying a Company PSU Award, whether vested or unvested, that is subject to performance-based vesting conditions shall (x)
to the extent then unvested, become vested to the extent the performance conditions applicable to such Company Share Option, as
determined reasonably and in good faith by the Company Board or the applicable committee, are achieved based on actual performance
results achieved as of the Closing Date, with the number of Company Ordinary Shares deemed vested in accordance with the foregoing
then multiplied by a fraction, (I) the numerator of which is the number of days during the applicable performance period that have
elapsed prior to and including the Closing Date and (II) the denominator of which is the total number of days in such performance
period, rounded down to the nearest whole number of shares (such resulting number of shares, the &ldquo;<B>Earned
Shares</B>&rdquo;), and (y) be cancelled and converted into the right to receive an amount in cash equal to the sum of (A) the
product of (I) the excess, if any, of the Consideration, <I>over </I>the applicable exercise price per Company Ordinary Share of
such Company Share Option, <I>multiplied by </I>(II) the total number of Earned Shares and (B) any accrued but unpaid dividend
equivalent payments granted in tandem with such Company Share Option (without interest) (such amounts, collectively with the
Time-Based Option Cash Amounts, the &ldquo;<B>Option Cash Amounts</B>&rdquo;), subject to any applicable Tax withholding. For the
avoidance of doubt, each Company Share Option, whether vested or unvested, that is outstanding immediately prior to the Effective
Time and has a per-share exercise price that is greater than the Consideration shall be cancelled as of the Effective Time for no
consideration.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each award of restricted share units (&ldquo;<B>RSUs</B>&rdquo;) in respect of Company Ordinary Shares granted pursuant to the
Company LTIP or the Company EIP set forth in <U>Section 3.05(b)(ii)</U> of the Company Disclosure Schedule that is outstanding immediately
prior to the Effective Time that is subject to only time-based vesting conditions (each, a &ldquo;<B>Company RSU Award</B>&rdquo;) shall
(x) become fully vested and (y) be cancelled and converted into the right to receive an amount in cash equal to the sum of (A) the product
of (I) the Consideration multiplied by (II) the number of Company Ordinary Shares subject to such Company RSU Award immediately prior
to the Effective Time and (B) any accrued but unpaid dividend equivalent payments granted in tandem with such Company RSU Award (without
interest) (such payments, collectively, the &ldquo;<B>RSU Award Payments</B>&rdquo;), subject to any applicable Tax withholding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv) Each award of RSUs granted
pursuant to the Company LTIP set forth in <U>Section 3.05(b)(iii)</U> of the Company Disclosure Schedule that is outstanding immediately
prior to the Effective Time and is subject to performance-based vesting conditions (each, a &ldquo;<B>Company PSU Award</B>&rdquo; and,
together with the Company Share Options and Company RSU Awards, the &ldquo;<B>Company Equity Awards</B>&rdquo;) shall (x) become fully
vested based on performance conditions applicable to such Company PSU Award measured based on actual performance results achieved as
of the Closing Date, as determined reasonably and in good faith by the Company Board or the applicable committee, with the number of
Company Ordinary Shares deemed earned in accordance with the foregoing then multiplied by a fraction, (I) the numerator of which is the
number of days during the applicable performance period that have elapsed prior to and including the Closing Date and (II) the denominator
of which is the total number of days in such performance period, rounded</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 9; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">down to the nearest whole number of shares
(such resulting number of shares, the &ldquo;<B>Earned RSUs</B>&rdquo;), and (y) be cancelled and converted into the right to receive
an amount in cash equal to the sum of (A) the product of (I) the Consideration multiplied by (II) the number of Earned RSUs and (B) any
accrued but unpaid dividend equivalent payments granted in tandem with such Company PSU Award (without interest) (such payments, collectively,
the &ldquo;<B>PSU Award Payments</B>&rdquo;), subject to any applicable Tax withholding.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Following the Effective Time, the Company shall pay the holders of Company Equity Awards, in each case with respect to holders
who are current or former employees of the Company or any of its Subsidiaries through the Company&rsquo;s payroll system in order to effectuate
all applicable Tax withholding obligations on such payments, the cash payments described in <B><U>&#8206;</U></B><U>Section 2.03(a)</U>,
on or as soon as reasonably practicable after the Closing Date, but in any event within ten (10) Business Days thereafter; <U>provided</U>,
<U>however</U>, that in the case of any such amounts that constitute non-qualified deferred compensation under Section 409A of the Code,
the Company shall pay such amounts at the earliest time permitted under the terms of the applicable agreement, plan or arrangement that
will not trigger a Tax or penalty under Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As soon as practicable following the date hereof (but in any event no later than fifteen (15) calendar days following the date
hereof), the Company shall take all actions with respect to the Company ESPP to provide that (i) with respect to any offering periods
in effect as of the date hereof under the Company ESPP (the &ldquo;<B>Current ESPP Offering Period</B>&rdquo;), (A) no employee who is
not a participant in the Company ESPP, as of the date hereof may become a participant in the Company ESPP, and (B) no participant in the
Company ESPP as of the date hereof may increase his or her rate of payroll deductions or contributions under the Company ESPP from the
rate in effect as of the date hereof or make separate nonpayroll contributions on or following the date hereof, (ii) subject to the consummation
of the transactions contemplated by this Agreement, the Company ESPP shall terminate immediately prior to the Effective Time, (iii) if
the Current ESPP Offering Period terminates prior to the Effective Time, then the Company ESPP shall be suspended and no new offering
period shall be commenced under the Company ESPP prior to the termination of this Agreement, (iv) if the Current ESPP Offering Period
is still in effect at the Effective Time, then the last day of such Current ESPP Offering Period shall be accelerated to a date before
the Closing Date as specified by the Company Board or its designated committee in consultation with Buyer and in accordance with the terms
of the Company ESPP, and (v) any Company Ordinary Shares purchased by or otherwise issued to participants in the Company ESPP pursuant
to the accelerated offering period under this <B><U>&#8206;</U></B><U>Section 2.03(c)</U> shall be treated as Company Ordinary Shares
issued and outstanding immediately prior to the Effective Time for purposes of <B><U>&#8206;</U></B><U>Section 2.01</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As soon as practicable following the date hereof, the Company shall take all actions with respect to the Company SIP to provide
that (i) no employee who is not a participant in the Company SIP as of the date hereof may become a participant in the Company SIP, (ii)
no participant in the Company SIP as of the date hereof may increase his or her rate of payroll deductions or contributions under the
Company SIP from the rate in effect as of the date hereof, (iii) the Company shall seek the consent of the trustee of the Company SIP
(the &ldquo;<U>SIP Trustee</U>&rdquo;) to terminate the Company SIP with effect immediately prior to the Effective Time without a clear
14 days&rsquo; notice of the actual date of the Effective Time (the &ldquo;<U>SIP Trustee Consent</U>&rdquo;), and (iv) (x) if the SIP
Trustee Consent is received, then with respect to any accumulation periods in effect as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 10; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">the date hereof as defined in the Company SIP
(the &ldquo;<B>Current SIP Accumulation Period</B>&rdquo;), and subject to the consummation of the transactions contemplated by this Agreement,
(A) if the Current SIP Accumulation Period terminates prior to the Effective Time, then the Company SIP shall be suspended and no new
accumulation period shall be commenced under the Company SIP prior to the termination of this Agreement, and (B) if the Current SIP Accumulation
Period is still in effect at the Effective Time, the Company SIP shall be terminated immediately prior to the Effective Time (thereby
terminating the Current SIP Accumulation Period), and any payroll deductions or contributions under the Company SIP taken in during the
Current SIP Accumulation Period shall be returned subject to any withholding as required to each participant in accordance with the Company
SIP, or (y) if the SIP Trustee Consent is not received then, with respect to the Current SIP Accumulation Period, and subject to the consummation
of the transactions contemplated by this Agreement, (I) if the Current SIP Accumulation Period terminates prior to the Effective Time,
then the Company SIP shall be suspended and no new accumulation period shall be commenced under the Company SIP prior to the termination
of this Agreement, (II) if the Current SIP Accumulation Period is still to be in effect at the Effective Time, then the Company SIP shall
be suspended with effect from a date before the Closing Date as specified by the Company Board in consultation with Buyer in accordance
with the terms of the Company SIP and participants shall be permitted to use any payroll deductions or contributions under the Company
SIP taken in during the Current SIP Accumulation Period to acquire Company Ordinary Shares, and (III) the Company SIP shall be terminated
as soon as practicable after the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Prior to the Effective Time, the Company Board or any authorized committee thereof shall adopt such resolutions as may reasonably
be appropriate or required in its discretion to effectuate the actions contemplated by this <B><U>&#8206;</U></B><U>Section 2.03</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
2.04</FONT> Company and Buyer Actions Prior to and at Closing.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or prior to the Closing Date, the Company shall procure that a meeting of the Company Board (or a duly authorized committee
thereof) is held at which resolutions are passed (conditional upon the delivery of the Court Order to the Registrar of Companies in England
and Wales and effective as of the Effective Time) approving:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the transfer to Buyer of the Company Ordinary Shares provided to be transferred on the terms of the Scheme of Arrangement and the
registration as a member of such person(s) in accordance with the Scheme of Arrangement in respect of such Company Ordinary Shares;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the removal or resignation of such directors of the Company as Buyer shall determine from (A) the Company Board and (B) the boards
of directors of any of the Company&rsquo;s Subsidiaries on which any such director also sits;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the removal or resignation of the company secretary and/or corporate administrator to the Company (as Buyer shall determine); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the appointment of such persons as Buyer shall determine as the directors of the Company (and, if required by Buyer, as company
secretary),</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 11; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">in each case, provided that Buyer provides
written notice to the Company identifying the persons who are to resign or be appointed not less than five (5) Business Days prior to
Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.1in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On or prior to the Closing Date, Buyer shall procure that a meeting of the Board of Directors or equivalent governing body (or
a duly authorized committee thereof) of Buyer is held at which resolutions are passed (conditional upon the delivery of the Court Order
to the Registrar of Companies in England and Wales and effective as of the Effective Time) approving the payment of the Consideration
to the Exchange Agent, for the benefit of the Company Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>On the Closing Date, the Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>deliver the Court Order to the Registrar of Companies in England and Wales with a copy to Buyer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>deliver to Buyer a certified copy of the resolutions referred to in <B><I><U>&#8206;</U></I></B><U>Section 2.04(a)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>deliver to Buyer a letter of resignation (or evidence of removal) in form and substance reasonably satisfactory to Buyer from each
director who resigns (or is removed) in accordance with <B><I><U>&#8206;</U></I></B><U>Section 2.04(a)(ii)</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>deliver to Buyer a letter of resignation (or evidence of removal) from each relevant person who resigns (or is removed) in form
and substance reasonably satisfactory to Buyer in accordance with <B><I><U>&#8206;</U></I></B><U>Section 2.04(a)(iii)</U>; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>deliver to Buyer all Certificates received by the Company in respect of the Company Ordinary Shares (if any) transferred to Buyer
in accordance with the Scheme of Arrangement; <U>provided</U> that to the extent any such Certificates are received by the Company after
the Closing Date, delivery to Buyer shall be made as promptly as reasonably practicable thereafter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.05 <I>Withholding
Rights</I>. Notwithstanding anything herein to the contrary, each of the Exchange Agent, Buyer, the Company and any other applicable
withholding agent shall be entitled to deduct and withhold from any amounts otherwise payable pursuant to this Agreement such amounts
as it is required to deduct and withhold with respect to the making of such payment under any Applicable Law. The applicable withholding
agent shall provide written notice to the applicable payee at least seven (7) Business Days prior to any such deduction or withholding,
and provide such payee with a reasonable opportunity to provide any certificates, forms or other documentation to reduce or eliminate
such deduction or withholding. To the extent that amounts are so deducted or withheld by an applicable withholding agent and timely remitted
by such withholding agent to the applicable Governmental Authority, such amounts shall be treated for all purposes of this Agreement
as having been paid to the Person in respect of which such deduction and withholding was made by such withholding agent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 2.06 <I>Further Assurances</I>.
If at any time before or after the Effective Time, Buyer or the Company reasonably believes that any further instruments, deeds, documents,
conveyances or assignments are reasonably necessary to consummate the Transaction, then Buyer and the Company and their respective officers
and directors shall execute and deliver all such proper</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 12; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">instruments, deeds or assignments reasonably necessary
to consummate the Transaction and to carry out the intent and purposes of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
3 </FONT><BR>
REPRESENTATIONS AND WARRANTIES OF THE COMPANY</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in; text-align: justify; text-indent: 0.5in">Except as set forth in
(a) any form, document or report publicly filed with or publicly furnished to the SEC by the Company (including any documents incorporated
by reference therein) since January 1, 2024 and at least one (1) Business Day prior to the date of this Agreement (excluding statements
in any &ldquo;Forward-Looking Statements&rdquo; or &ldquo;Risk Factors&rdquo; sections or any other disclosures contained therein to the
extent that such statements are cautionary, predictive or forward-looking in nature but, for the purpose of clarification, including and
giving effect to any factual or historical statements included in any such statements), which are deemed to have been Made Available to
Buyer (&ldquo;<B>Recent SEC Reports</B>&rdquo;); provided that nothing disclosed in the Recent SEC Reports will be deemed to modify or
qualify the representations and warranties set forth in <U>&#8206;Section 3.05</U>, <U>&#8206;Section 3.09(a)</U>, and <U>&#8206;Section
3.25</U>, or (b) as set forth in the Company Disclosure Schedule (it being acknowledged and agreed that (i) disclosure of any item in
any section or subsection of the Company Disclosure Schedule, whether or not an explicit cross reference appears, shall be deemed disclosed
with respect to any other section or subsection to which the relevance of such item is reasonably apparent on the face of such disclosure,
and (ii) the mere inclusion of an item in the Company Disclosure Schedule as an exception to a representation or warranty shall not be
deemed an admission that such item represents a material exception or material fact, event or circumstance or that such item is material
or constitutes a Company Material Adverse Effect or that the inclusion of such item in the Company Disclosure Schedule is required), the
Company hereby represents and warrants to Buyer as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.01 <I>Corporate
Existence and Power</I>. The Company is a public limited company duly incorporated, validly existing and in good standing under the Laws
of England and Wales and has all corporate powers required to carry on its business as now conducted. The Company is duly qualified to
do business as a foreign corporation and is in good standing in each jurisdiction where such qualification is necessary, except for those
jurisdictions where failure to be so qualified would not reasonably be expected to have, individually or in the aggregate, a Company
Material Adverse Effect. The Company has Made Available to Buyer complete and correct copies of the Company&rsquo;s memorandum and articles
of association, as amended (the &ldquo;<B>Company Articles of Association</B>&rdquo;). The Company Articles of Association are in full
force and effect and the Company is not in violation of the Company Articles of Association in any material respect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.02 <I>Corporate
Authorization</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company has the requisite corporate power and authority to execute and deliver this Agreement and each other document to be
entered into by the Company in connection with the transactions contemplated hereby (together with this Agreement, the &ldquo;<B>Company
Transaction Documents</B>&rdquo;) and, subject to <B><U>&#8206;</U></B><U>Section 3.03</U>, upon receipt of the Company Shareholder Approval
and the Court Order, will have the requisite corporate power and authority to consummate the transactions contemplated hereby and thereby,
including the Transaction. The execution, delivery and performance of this Agreement and the other Company Transaction</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 13; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Documents and the
consummation of the transactions contemplated hereby and thereby have been duly and validly authorized by the Company Board and, except
for the Company Shareholder Approval and the filing of the required documents and other actions in connection with the Scheme of Arrangement
with, and subject to receipt of the required sanctioning of the Scheme of Arrangement by, the Court, no other corporate action on the
part of the Company or vote of the Company Shareholders is necessary to authorize the execution and delivery by the Company of this Agreement
and the other Company Transaction Documents and the consummation of the Transaction. Each of the Company Transaction Documents has been
duly and validly executed and delivered by the Company and, assuming each such Company Transaction Document has been duly authorized,
executed and delivered by each other counterparty thereto, each of the Company Transaction Documents constitutes the legal, valid and
binding obligation of the Company, enforceable against the Company in accordance with its terms, except as such enforcement may be subject
to (A) the effect of bankruptcy, insolvency, reorganization, receivership, administration, arrangement, moratorium or other Laws affecting
or relating to creditors&rsquo; rights generally or (B) the rules governing the availability of specific performance, injunctive relief
or other equitable remedies and general principles of equity, regardless of whether considered in a proceeding in equity or at law (the
&ldquo;<B>Enforceability Exceptions</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company Board has, by resolutions duly adopted unanimously by the directors in attendance at a meeting of the directors of
the Company duly called and held, (i) approved and declared this Agreement, and the transactions contemplated hereby, including the Transaction,
the Scheme of Arrangement and the other transactions contemplated hereby fair to and in the best interests of the Company and the Company
Shareholders as a whole, (ii) declared that it is advisable and in the best interests of the Company Shareholders that the Company enter
into this Agreement and consummate the Transaction, the Scheme of Arrangement and the other transactions contemplated hereby and thereby,
on the terms and subject to the conditions set forth herein, and (iii) directed that an application be made to the Court to seek directions
relating to the Scheme of Arrangement. The Company Board has further resolved that it will, subject to the terms and conditions of this
Agreement, recommend that the Company Shareholders vote in favor of all of the resolutions comprising the Company Shareholder Approval
at a duly held meeting of such shareholders for such purposes (such recommendation referred to herein as the &ldquo;<B>Company Recommendation</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.03 <I>Governmental
Authorization</I>. Other than in connection with or in compliance with (i) the Companies Act, (ii) the U.S. Securities Exchange Act of
1934, and the rules and regulations promulgated thereunder (the &ldquo;<B>Exchange Act</B>&rdquo;), (iii) the U.S. Securities Act of
1933, and the rules and regulations promulgated thereunder (the &ldquo;<B>Securities Act</B>&rdquo;), (iv) the rules and regulations
of The New York Stock Exchange (&ldquo;<B>NYSE</B>&rdquo;), (v) the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended,
and the rules and regulations promulgated thereunder (the &ldquo;<B>HSR Act</B>&rdquo;), and (vi) the Foreign Investment Laws, and, subject
to the accuracy of the representations and warranties of Buyer in <U>&#8206;Section 4.03</U>, no authorization, consent, Order, license,
permit or approval of, or registration, declaration, notice or filing with, or notice to, any Governmental Authority is necessary, under
Applicable Law, for the execution, delivery and performance of this Agreement or the consummation by the Company of the transactions
contemplated hereby, except for such authorizations, consents, Orders, licenses, permits, approvals or filings that, if not obtained
or made, would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 14; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.04 <I>Non-contravention</I>.
The execution, delivery and performance by the Company of this Agreement do not, and the consummation of the transactions contemplated
hereby and compliance with the provisions hereof will not, (i) result in any violation of, or default (with or without notice or lapse
of time, or both) under, or give rise to any right of termination, cancellation, material modification, or acceleration of any right
or obligation, under any Material Contract or result in the creation of any liens, licenses, sublicenses, claims, mortgages, encumbrances,
pledges, security interests, equities or charges of any kind (each, a &ldquo;<B>Lien</B>&rdquo;) (other than Permitted Liens and any
Liens created in connection with any action taken by Buyer or its Affiliates) upon any of the properties or assets of the Company or
any of its Subsidiaries, (ii) conflict with or result in any violation of any provision of the Company Articles of Association or the
organizational documents of the Company&rsquo;s Subsidiaries or (iii) assuming compliance with the matters referred to in <U>&#8206;Section
3.03</U>, conflict with or violate any Applicable Law, except in each case of clauses (i) through (iii) for such violations, defaults,
terminations, cancellations, modifications, accelerations, conflicts, or Liens as would not reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.05 <I>Capitalization</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>At the close of business on July 22, 2026 (the &ldquo;<B>Capitalization Date</B>&rdquo;): (A) 28,944,000 ordinary shares with a
par value of &pound;0.50 per share, of the Company (the &ldquo;<B>Company Ordinary Shares</B>&rdquo;), were issued and outstanding; (B)
Company Share Options to purchase an aggregate of 239,267 Company Ordinary Shares were issued and outstanding; (C) an aggregate of 270,659
Company Ordinary Shares were subject to outstanding Company RSU Awards; (D) an aggregate of 371,519 Company Ordinary Shares were subject
to outstanding Company PSU Awards (of which 302,742 underlie RSUs and 68,777 underlie performance-based Company Share Options) (assuming
any applicable performance goals were achieved at the maximum level of performance); and (E) an aggregate of 1,950,796 Company Ordinary
Shares were held in the treasury of the Company. Since the Capitalization Date, the Company has not issued any securities (including derivative
or convertible securities) except for (A) Company Ordinary Shares issued upon exercise or settlement of Company Share Options or Company
RSU Awards or Company PSU Awards or (B) pursuant to the terms of any Company Employee Plan in accordance with <B><U>&#8206;</U></B><U>Section
5.01(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Section 3.05(b)</U> of the Company Disclosure Schedule sets forth, as of the close of business on the Capitalization Date, a
complete and correct list of (i) all outstanding Company Share Options, including the number of Company Ordinary Shares subject to such
award, the name of the holder, the grant date, the vesting schedule, the exercise or purchase price per Company Ordinary Share of each
such Company Share Option, and any dividends or dividend equivalent payments granted in tandem with such Company Share Option, (ii) all
outstanding Company RSU Awards, including the name of the holder, the grant date, the vesting schedule, the number of Company Ordinary
Shares subject to each Company RSU Award, and any dividends or dividend equivalent payments granted in tandem with such Company RSU Award,
and (iii) all outstanding Company PSU Awards, including the name of the holder, the grant date, the vesting schedule, the number of Company
Ordinary Shares subject to each Company PSU Award (assuming any applicable performance goals were achieved at the maximum level of performance).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 15; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as set forth in this <B><U>&#8206;</U></B><U>Section 3.05</U> and for changes since the Capitalization Date resulting from
(x) the exercise or settlement of Company Equity Awards outstanding on such date or granted thereafter as permitted under <B><U>&#8206;</U></B><U>Section
5.01(b)(iv)</U>, or (y) the purchase of Company Ordinary Shares under the Company ESPP and the Company SIP, as permitted hereunder, there
are no outstanding (i) capital shares or voting securities (including voting debt) of the Company or any of its Subsidiaries (whether
Company Ordinary Shares or otherwise), (ii) securities of the Company or any of its Subsidiaries convertible into or exchangeable for
capital shares or voting securities (including voting debt) of the Company or any of its Subsidiaries, (iii) options, warrants, other
equity or equity-based rights or other rights or arrangements to acquire from the Company or any of its Subsidiaries, or other obligations
or commitments of the Company or any of its Subsidiaries to issue, any share capital or other voting securities (including voting debt)
or ownership interests in, or any securities convertible into or exchangeable for, share capital or other voting securities (including
voting debt) or ownership interests in, the Company or any of its Subsidiaries, (iv) restricted shares, share appreciation rights, performance
shares, contingent value rights, &ldquo;phantom&rdquo; shares or similar securities or rights that are derivative of, or provide economic
benefits based, directly or indirectly, on the value or price of, any share capital of, or other voting securities (including voting debt)
or ownership interests in, the Company or any of its Subsidiaries (the items in <U>clauses (i)-(iv)</U>, whether in reference to the Company
or any of its Subsidiaries, being referred to collectively as the &ldquo;<B>Company Securities</B>&rdquo;), (v) voting trusts, proxies
or other similar agreements or understandings to which the Company or any of its Subsidiaries is a party or by which the Company or any
of its Subsidiaries is bound with respect to the voting of any share capital of the Company or any of its Subsidiaries or (vi) contractual
obligations or commitments of any character restricting the transfer of, or requiring the registration for sale of, any share capital
of the Company or any of its Subsidiaries. There are no outstanding obligations or commitments of the Company or any of its Subsidiaries
to repurchase, redeem or otherwise acquire any of the Company Securities. All Company Share Options, Company RSU Awards, Company PSU Awards,
and rights under the Company ESPP may, by their terms, be treated in accordance with <B><U>&#8206;</U></B><U>Section 2.03</U>. No Subsidiary
of the Company owns any Company Securities (other than an ownership interest in any other Subsidiary of the Company). As of the date hereof,
there are no accrued but unpaid dividends or dividend equivalent rights with respect to the Company Securities, other than the Company
Equity Awards.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>All outstanding Company Ordinary Shares have been, and all shares that may be issued pursuant to any Company Share Plan or the
Company ESPP or the Company SIP as permitted under <U>Section 5.01(b)(iv)</U> will be, when issued in accordance with the respective terms
thereof, duly authorized and validly issued and are (or, in the case of Company Ordinary Shares that have not yet been issued, will be)
fully paid, nonassessable and not subject to or issued in violation of any purchase option, call option, right of first refusal, preemptive
right, anti-dilutive right or any similar right pursuant to any provision of Applicable Law or any Contract to which the Company or any
of its Subsidiaries is a party or otherwise bound. None of the outstanding Company Ordinary Shares have been issued in violation of any
foreign, federal or state securities laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.06 <I>Subsidiaries</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Section 3.06(a)</U> of the Company Disclosure Schedule lists each of the Company&rsquo;s Subsidiaries. Neither the Company nor
any of its Subsidiaries owns, directly or indirectly, any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 16; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">share capital or voting securities of, or other equity interests in, or has
any direct or indirect equity participation or similar interest in, or any interest convertible into or exchangeable or exercisable for,
any share capital or voting securities of, or other equity interest in, any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, each Subsidiary
of the Company: (i) is duly organized, validly existing and in good standing (with respect to jurisdictions that recognize that concept)
under the laws of its respective jurisdiction of organization and (ii) has the requisite corporate or similar power and authority to own,
lease and operate its properties and assets and to carry on its business as presently conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>None of the Company&rsquo;s Subsidiaries is in violation of any of its articles of association, certificate of incorporation, bylaws,
limited partnership agreement, limited liability company agreement or comparable constituent or organizational documents, in each case
as amended to and in effect as of the date hereof, except for any such violation that would not reasonably be expected to have, individually
or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.07 <I>SEC Filings
and the Sarbanes-Oxley Act</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Since January 1, 2024 through the date hereof, the Company has filed with or furnished to the SEC each report, statement, schedule,
form or other document or filing required by the Securities Act or the Exchange Act to be filed or furnished to the SEC by the Company
at or prior to the time so required (the &ldquo;<B>Company SEC Documents</B>&rdquo;) and has Made Available the Company SEC Documents
to Buyer. As of the date hereof, no Subsidiary of the Company is required to file any report, statement, schedule, form or other document
with the SEC pursuant to the Exchange Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As of its filing date (or, if amended or superseded by a filing prior to the date hereof, on the date of such filing or, as of
the date each such filing became effective), and in the case of registration statements and proxy statements, as of the dates of effectiveness
and the dates of mailing, respectively, (i) each Company SEC Document complied in all material respects with the applicable requirements
of the Securities Act, the Exchange Act and the Sarbanes-Oxley Act as the case may be, each as in effect on the date so filed (or amended),
and (ii) no Company SEC Document at the time it was filed (or, if amended or superseded by a filing prior to the date of this Agreement,
as of the date of the last such filing) contained any untrue statement of a material fact or omitted to state any material fact necessary
in order to make the statements made therein, in light of the circumstances under which they were made, not misleading. As of the date
hereof, to the Knowledge of the Company, none of the Company SEC Documents is the subject of any ongoing review by the SEC and there are
no outstanding or unresolved comments in comment letters received from the SEC with respect to the Company SEC Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each applicable Company SEC Document containing financial statements that has been filed with the SEC by the Company since January
1, 2024 through the date hereof was accompanied by the certifications required to be filed by the Company&rsquo;s principal executive
officer and principal financial officer, as applicable, pursuant to the Sarbanes-Oxley Act and, at the time of filing of each such certification,
such certification was true and accurate and complied with the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 17; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">Sarbanes-Oxley Act. As of the date hereof, to the Knowledge of the Company,
neither the Company, nor any current or former executive officer of the Company, has received written notice from any Governmental Authority
challenging or questioning the accuracy, completeness, form or manner of filing of such certifications made with respect to the Company
SEC Documents filed prior to the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Since January 1, 2024, the Company has complied in all material respects with the applicable listing and corporate governance rules
and regulations of the NYSE.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.08 <I>Financial
Statements; Internal Controls</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The audited consolidated financial statements and unaudited consolidated interim financial statements (in each case, including
the related notes and schedules thereto) of the Company included or incorporated by reference in the Company SEC Documents (i) have complied
as to form, as of their respective filing dates with the SEC, in all material respects with the then-applicable accounting requirements
and the published rules and regulations of the SEC with respect thereto except to the extent disclosed in any such Company SEC Document,
(ii) have been prepared in accordance with GAAP (except, in the case of the unaudited statements or any foreign Subsidiaries, as permitted
by the SEC) applied on a consistent basis during the periods involved (except as may be indicated therein or in the notes thereto), and
(iii) on that basis, fairly presented (except as may be indicated therein or in the notes thereto) in all material respects the consolidated
financial position of the Company and its consolidated Subsidiaries as of the dates thereof and their consolidated results of operations
and cash flows for the periods presented therein (subject to normal recurring adjustments including the notes thereto, in the case of
any unaudited interim financial statements).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company&rsquo;s system of internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the
Exchange Act) (&ldquo;<B>Internal Controls</B>&rdquo;) is reasonably sufficient to provide reasonable assurance that (i) transactions
are recorded as necessary to permit preparation of financial statements in accordance with GAAP, (ii) receipts and expenditures are being
made only in accordance with authorizations of the Company&rsquo;s management and directors, and (iii) any unauthorized use, acquisition
or disposition of the Company&rsquo;s assets that would materially affect the Company&rsquo;s financial statements would be prevented
or detected in a timely manner. There were no material weaknesses, or significant deficiencies that in the aggregate would amount to a
material weakness, identified in the management of the Company&rsquo;s assessment of internal controls as of and for the year ended December
31, 2025 (nor has any such material weakness been identified since such date through the date hereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company&rsquo;s &ldquo;disclosure controls and procedures&rdquo; (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange
Act) are reasonably designed and established to ensure, that (i) material information (both financial and non-financial) required to be
disclosed by the Company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported
to the individuals responsible for preparing such reports within the time periods specified in the rules and forms of the SEC and (ii)
such material information is accumulated and communicated to the Company&rsquo;s management as appropriate to allow timely decisions regarding
required disclosure and to make the certifications of the principal executive</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 18; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">officer and principal financial officer of the Company required
under the Exchange Act with respect to such reports.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.09 <I>Absence of
Certain Changes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Since the Company Balance Sheet Date through the date hereof, none of the Company or any of its Subsidiaries has taken any action
that would require the consent of Buyer pursuant to <U>Section 5.01(b)(i)</U>, <U>(ii)</U>, <U>(iii)</U>, <U>(v)</U>, <U>(vii)</U>, <U>(xi)</U>,
<U>(xii)</U>, <U>(xiv)</U>, and <U>(xix)</U> if taken after the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Since the Company Balance Sheet Date through the date hereof (except for actions taken in connection with the transactions contemplated
by this Agreement), (i) the Company and its Subsidiaries have conducted their business in the ordinary course consistent with past practice
and (ii) there has not been any event, change, occurrence, development or state of circumstances that has had or would reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.10 <I>No Undisclosed
Material Liabilities</I>. There are no liabilities or obligations of the Company or any of its Subsidiaries of any kind whatsoever, whether
accrued, contingent, absolute, determined, determinable or otherwise, other than: (a) liabilities or obligations disclosed or reflected
and adequately reserved against in the Company Balance Sheet, (b) liabilities or obligations incurred since the Company Balance Sheet
Date and in the ordinary course of business (none of which relates to a material breach of Contract, tort, misappropriation, infringement,
or violation of Applicable Laws), (c) liabilities or obligations arising under Contracts to which the Company or any of its Subsidiaries
is a party (none of which relates to a material breach of Contract, tort, misappropriation, infringement, or violation of Applicable
Laws) and which are Made Available to Buyer, (d) liabilities or obligations pursuant to the terms of this Agreement; and (e) liabilities
or obligations that would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries,
taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.11 <I>Litigation</I>.
Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries, taken
as a whole, (i) there is, and since January 1, 2025 has been, no Proceeding pending against or to the Knowledge of the Company, threatened,
against the Company or any of its Subsidiaries, and (ii) neither the Company nor any of its Subsidiaries is subject to any outstanding
Order or settlement agreement. To the Knowledge of the Company, there is no pending or threatened in writing Proceeding or outstanding
Order or settlement agreement that would not reasonably be expected to be, individually or in the aggregate, material to the Company
and its Subsidiaries, taken as a whole.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.12 <I>Compliance
with Applicable Law</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as has not and would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect,
each of the Company and its Subsidiaries is, and, for the past two (2) years, has been, in compliance with all Applicable Laws. Neither
the Company nor any of its Subsidiaries has received any written notice for the past two (2) years through the date hereof that remains
unresolved (i) of any administrative, civil or criminal investigation or material audit by any Governmental Authority relating to the
Company or any of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 19; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">its Subsidiaries or (ii) from any Governmental Authority alleging that the Company or any of its Subsidiaries is not
in compliance with any Applicable Law, except for such notices described in clauses (i) and (ii) that would not reasonably be expected
to have, individually or in the aggregate, a Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b) Except as would
not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) each of the Company and
its Subsidiaries has in effect all Governmental Authorizations necessary for it to own, lease or otherwise hold and operate its properties
and assets and to carry on its businesses and operations as now conducted and (ii) there have occurred no defaults (with or without notice
or lapse of time or both) under, violations of, or events giving rise to any right of termination, material amendment or cancellation
of, any such Governmental Authorizations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.13 <I>Certain Business
Practices</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and its Subsidiaries are, and for the past five (5) years have been, in compliance in all material respects with the
provisions of the Foreign Corrupt Practices Act of 1977, 15 U.S.C. &sect;&sect; 78dd-1, et seq., and each other anti-corruption or anti-bribery
law binding on any of them (collectively, &ldquo;<B>Anti-Corruption Laws</B>&rdquo;). The Company, its Subsidiaries, and their respective
directors, officers, and employees, and to the Knowledge of the Company, or any agents thereof (in their capacity as such) have not paid,
offered or promised to pay, or authorized payment of, any monies or any other thing of value to any government official or employee (including
employees of government-owned or controlled entities) or any political party or candidate for political office (collectively, a &ldquo;<B>Proscribed
Recipient</B>&rdquo;) for the purpose of, (i) influencing any act or decision of such Proscribed Recipient, (ii) inducing such Proscribed
Recipient to do or omit to do any act in violation of the lawful duty of such Proscribed Recipient, or to use his, her, or its influence
with a Governmental Authority to affect or influence any act or decision of such Governmental Authority, or (iii) assisting in obtaining
or retaining business for or with, or directing business to, any Person, in each case, in violation of Anti-Corruption Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and its Subsidiaries are in compliance with applicable Sanctions and Ex-Im Laws. None of the Company, any Subsidiaries
thereof, nor any of their respective directors, officers, nor to the Knowledge of the Company, employees or agents (in their capacity
as such) (i) is or has been a Sanctioned Person; (ii) since April 24, 2019, has violated applicable Sanctions; (iii)&nbsp;since April
24, 2019, has engaged in any dealings with a Sanctioned Person or in a Sanctioned Country in violation of Sanctions; or (iv) in the last
five (5) years, committed a violation of any applicable Ex-Im Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>None of the Company, nor any of its Subsidiaries have been, in the last five (5) years (and, in the case of Sanctions, since April
24, 2019), the subject of any voluntary disclosure, investigation, prosecution or enforcement action related to compliance with any Anti-Corruption
Laws, Sanctions or Ex-Im Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.14 <I>Material Contracts</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except (x) this Agreement and the other Transaction Documents, (y) the Company Employee Plans, and (z) as set forth in <U>Section
3.14(a)</U> of the Company Disclosure Schedule, as of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 20; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">the date hereof, neither the Company nor any of its Subsidiaries is a party to or
is bound by any Contract:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>that is a &ldquo;material contract&rdquo; (as such term is defined in Item 601(b)(10) of Regulation S-K of the Exchange Act);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>that is with the ten (10) largest customers of the Company (as determined based on annual recurring revenue for the fiscal year
ended December 31, 2025) (other than, solely for listing purposes in the case of this <U>Section 3.14(a)(ii)</U>, (x) individual purchase
orders with a value of $1,000,000 or less entered into in the ordinary course of business consistent with past practice and that contain
terms primarily related to quantity, price or similar terms or (y) with respect to Government Contracts individual purchase orders with
a value of $1,000,000 or less or (z) any task, purchase, or delivery order, in each case, issued under a Government Contract);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>that is with the top ten (10) suppliers/vendors of the Company (as determined by total payments for the fiscal year ended December
31, 2025) (other than, solely for listing purposes in the case of this <U>Section 3.14(a)(iii)</U>, individual purchase orders with a
value of $1,000,000 or less entered into in the ordinary course of business consistent with past practice and that contain terms primarily
related to quantity, price or similar terms);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>evidencing a capital expenditure for which aggregate future payments are required in excess of $2,000,000 during any twelve (12)
month period;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(A) containing a covenant limiting in any material respect the ability of the Company or any of its Subsidiaries to compete or
engage in any line of business or to compete with any Person in any geographic area or (B) containing any provision described in <U>clause
(A)</U> that would bind Buyer or any of its Affiliates (without giving effect to the proviso in the definition of &ldquo;Affiliate&rdquo;)
after the Closing, that in each case are material to the Company or any of its Subsidiaries taken as a whole;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(A) that is a derivative Contract of the Company or its Subsidiaries and (B) relating to or evidencing Indebtedness of the Company
or any of its Subsidiaries (excluding, for the avoidance of doubt, intercompany loans between or among the Company and its Subsidiaries)
or the mortgaging, pledging or otherwise granting of a Lien (other than Permitted Liens) on any material asset or group of assets of the
Company or its Subsidiaries, in each case, in excess of $1,500,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>that (A) contains &ldquo;most favored nation&rdquo; pricing provisions from the Company or any of its Subsidiaries in favor of,
(B) grants exclusive rights, rights of first refusal, rights of first negotiation or offer or similar rights to, any customer or (C) contains
any provision described in clause (A) or (B) that would bind Buyer or any of its Affiliates (without giving effect to the proviso in the
definition of &ldquo;Affiliate&rdquo;) after the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>that is material to the operation of the business of the Company or any of its Subsidiaries (including with respect to the Intellectual
Property that is the subject thereof) and (A) pursuant to which the Company or any of its Subsidiaries licenses or sublicenses Intellectual
Property to or from third parties other than Incidental Licenses, (B) relates to the acquisition, or development of Intellectual Property
(excluding Contracts with employees and, to the extent</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 21; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">entered into in the ordinary course of business, independent contractors of the
Company or any of its Subsidiaries) or (C) arises out of any Intellectual Property-related dispute (including concurrent use agreements,
settlement agreements, covenant not to sue agreements and consent to use agreements);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(A) under which the Company or any of its Subsidiaries has any indemnification obligations (excluding indemnification obligations
in respect of representations and warranties and covenants that survive indefinitely or for periods equal to a statute of limitations
and excluding obligations to indemnify directors and officers pursuant to acquisition agreements) which have not been satisfied or performed,
(B) pursuant to which any earn-out, deferred or contingent payment remain outstanding or (C) under which any other obligation remains
to be performed or liabilities continuing after the date of this Agreement of more than $1,000,000, in each case, relating to the acquisition
or disposition of all or any portion of any business or the assets or properties of any business (whether by merger, sale of shares, sale
of assets or otherwise) for consideration in excess of $1,500,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>relating to a partnership, joint venture or other similar arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>between the Company or any of its Subsidiaries, on the one hand, and (A) any current director or officer of the Company, (B) any
record or beneficial owner owning five (5) percent or more of the Company Ordinary Shares or (C) to the Knowledge of the Company, any
affiliate of any such director, officer or owner (other than the Company or any of its Subsidiaries), on the other hand, except for any
commercial Contracts entered into on arm&rsquo;s length terms in the ordinary course of business and Company Employee Plans (each such
transaction among such Persons, an &ldquo;<B>Interested Party Transaction</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>entered into for the settlement or other resolution of any litigation, suit, or Proceeding under which the Company or any of its
Subsidiaries have any outstanding or unsatisfied obligations requiring the Company or any such Subsidiary to pay more than $1,500,000
(net of any amount covered by insurance or indemnification) or that imposes any material non-monetary obligations on the Company or any
such Subsidiary;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>that is a Government Contract involving aggregate payments during calendar year 2025 or any subsequent 12-month period of at least
$1,500,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>involving aggregate payments by the Company during calendar year 2025 or any subsequent 12-month period of at least $2,000,000
and which is not terminable by either party on less than 60 days&rsquo; written notice without penalty; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>committing the Company or any of its Subsidiaries to enter into any Contracts of the types described in the foregoing <U>clauses
(i)</U> through <U>(xiv)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each Contract of the type described above in <B><U>&#8206;</U></B><U>Section 3.14(a)</U>, whether or not set forth in <U>Section
3.14(a)</U> of the Company Disclosure Schedule, is referred to herein as a &ldquo;<B>Material Contract</B>.&rdquo; Except for Material
Contracts that have expired or terminated by their terms, as of the date hereof, all of the Material Contracts are (i) legal, valid and
binding agreements of the Company or its applicable Subsidiary, as the case may be, and, to the Knowledge of the Company, each other party
thereto, and (ii) in full force and effect, except for such failures as would not,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 22; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">individually or in the aggregate, reasonably be expected
to be material to the Company and its Subsidiaries, taken as a whole, subject to the Enforceability Exceptions. Neither the Company nor
any of its Subsidiaries has, and, to the Knowledge of the Company, none of the other parties thereto have, violated any provision of,
or committed or failed to perform any act under, and no event or condition exists, which (with or without notice, lapse of time or both)
would constitute a default under, the provisions of any Material Contract, except in each case for those violations, acts (or failures
to act) and defaults which, individually or in the aggregate, would not reasonably be expected to be material to the Company and its Subsidiaries,
taken as a whole, and, as of the date hereof, neither the Company nor any of its Subsidiaries has received written notice of any of the
foregoing. As of the date hereof, except as has not been and would not, individually or in the aggregate, be material to the Company and
its Subsidiaries, taken as a whole, neither the Company nor any of its Subsidiaries has (x) received any notice in writing, or to the
Knowledge of the Company, orally, from any Person that such Person intends to terminate, not renew, renegotiate, or claim a material breach
under, any Material Contract or (y) waived, or failed to enforce, any of its material rights or benefits under any Material Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.15 <I>Taxes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0in; text-align: justify; text-indent: 0.45in">Except as
would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in 0pt 0.1in; text-align: justify; text-indent: 0.45in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>all Tax Returns required to be filed by the Company or any of its Subsidiaries with any Taxing Authority have been filed when due
(taking into account any extensions of time within which to file) in accordance with all Applicable Laws, and each such Tax Return is
true, correct, and complete in all respects;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company and each of its Subsidiaries have timely paid all Taxes that have become due and payable by them;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company and each of its Subsidiaries have timely withheld and paid all Taxes required to have been withheld and paid by each
of them in connection with amounts paid or owing to any employee, independent contractor, creditor, shareholder, or other third party;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>no Tax liabilities of the Company or any of its Subsidiaries are the subject of any on-going Proceeding with a Taxing Authority
and, to the Knowledge of the Company, there is no Proceeding pending or threatened against the Company or any of its Subsidiaries in respect
of any Tax;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>since January 1, 2023, neither the Company nor any of its Subsidiaries has received any written notice from any Taxing Authority
in a jurisdiction in which the Company or such Subsidiary does not file Tax Returns asserting that the Company or such Subsidiary is subject
to Tax, or required to file a Tax Return, in such jurisdiction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries has waived any statute of limitations applicable to, or consented to extend, the
time in which any Tax may be assessed or collected by any Governmental Authority which waiver or extension is still in effect (other than
pursuant to automatic extensions of time to file Tax Returns);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 23; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries was a &ldquo;distributing corporation&rdquo; or a &ldquo;controlled corporation&rdquo;
in a transaction intended to be governed by Section 355 of the Code (or any corresponding provision of Applicable Law) in the two (2)
years prior to the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries (A) is or has been a member of an affiliated group of companies for any Tax purposes,
that has filed a combined, consolidated or unitary Tax Return (other than in each case such a group containing only members of the group
of which the Company or one of its Subsidiaries is or was the common parent) or (B) to the Knowledge of the Company, has any liability
for Taxes that are directly or primarily chargeable against any Person (other than the Company, any of its Subsidiaries or any member
of an affiliated group of which the Company or one of its Subsidiaries is or was the common parent) under Applicable Laws, including pursuant
to Treasury Regulations Section 1.1502-6 (or any corresponding provision of Applicable Law), or as a transferee or successor, by Contract
(other than any customary commercial Contract not primarily related to Taxes and entered into in the ordinary course of business), or
otherwise by operation of Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any Subsidiary has participated in, or is currently participating in, any &ldquo;listed transaction&rdquo;
within the meaning of Section 6707A(c) of the Code or Treasury Regulation Section 1.6011-4(b) (or any corresponding provision of Applicable
Law);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries is a party to or bound by any &ldquo;closing agreement&rdquo; described in Section
7121 of the Code (or any corresponding provision of Applicable Law) or other written agreement or ruling with a Taxing Authority regarding
Taxes or Tax matters;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries will be required to include any material item of income in, or exclude any material
item of deduction from, taxable income for any taxable period (or portion thereof) beginning after the Closing Date as a result of any:
(i) change in method of accounting, or use of an improper method of accounting, in each case, prior to the Closing Date, (ii) installment
sale or other transaction on or prior to the Closing Date, (iii) prepaid amount received, or paid, on or prior to the Closing Date (other
than prepaid amounts received or paid in the ordinary course of business), (iv) any material Tax sharing agreement, Tax allocation agreement
or Tax indemnity agreement (other than any customary commercial Contract not primarily related to Taxes among or between only the Company
or any of its Subsidiaries) or (v) election pursuant to Section 965(h) of the Code made by any U.S. Subsidiary prior to the Closing Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company and each of its Subsidiaries have complied with all Applicable Laws related to VAT and transfer pricing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>there are no material Liens on any of the assets of the Company or any of its Subsidiaries that arose in connection with any failure
(or alleged failure) to pay any Taxes, other than Permitted Liens;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries is or has ever been resident, for all Tax purposes, in any jurisdiction other than
its jurisdiction of incorporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 24; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries has engaged in, or been a party to, any transaction, series of transactions, scheme
or arrangement which (i) were abusive tax arrangements within the meaning of Part 5 of the Finance Act 2013 of the United Kingdom (<I>General
Anti-Abuse Rule</I>), (ii) have been the subject of a notice of counteraction issued by a Taxing Authority under any targeted anti-avoidance
provision of Applicable Law, (iii) were required to be disclosed as a notifiable arrangement within the meaning of Part 7 of the Finance
Act 2004 (<I>Disclosure of Tax Avoidance Schemes</I>) of the United Kingdom, or (iv) the Company or any of its Subsidiaries was advised
or knew had as its or their main purpose, or one of its or their main purposes, the avoidance of Tax or the improper obtaining of a Tax
advantage; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>all documents which establish or are necessary to establish the title of the Company or any of its Subsidiaries to any material
asset have been duly stamped and any applicable stamp duties in respect of such documents have been duly paid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 3.16 <I>Employee Benefit
Plans</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Section 3.16(a)</U> of the Company Disclosure Schedule contains a correct and complete list identifying each material U.S. Employee
Plan and each material Foreign Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>With respect to each Company Employee Plan, the Company has delivered or made available to Buyer true and complete copies, to the
extent applicable, of (i) the current plan document (or, to the extent that the Company Employee Plan is not written, a written description),
any related adoption agreement, the most recent summary annual report, annuity contracts, service provider contracts, insurance contracts,
policies and certificates of coverage, and any trust agreements, in each case together with all amendments thereto; (ii) the most recent
summary plan description and any summary of material modifications thereto; (iii) for the most recent plan year, (A) the Form 5500 and
attached schedules, (B) the audited financial statements, (C) the most recent triennial actuarial valuation of the UK DB Plan; and (D)
nondiscrimination testing results; (iv) in the case of any plan that is intended to be qualified under Code Section 401(a), the most recent
determination, advisory or opinion letter from the Internal Revenue Service; and (v) any material and non-routine correspondence with,
and all filings, records and notices concerning audits or investigations by, any Governmental Authority during the past three (3) years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>None of the Company Employee Plans are, and neither the Company nor any of its Subsidiaries nor any ERISA Affiliate of the Company
or any of its Subsidiaries has sponsored, maintained or contributed to, or has been obligated to contribute to, or has any liability or
obligation (contingent or otherwise) with respect to, (i) an employee benefit plan that is or was subject to Title IV of ERISA or Section
302 of ERISA or Section 412 of the Code, (ii) a multiemployer plan within the meaning of Section 3(37) of ERISA, (iii) a &ldquo;multiple
employer plan&rdquo; as defined in Section 210 of ERISA or Section 413 of the Code, (iv) a &ldquo;multiple employer welfare arrangement&rdquo;
(within the meaning of Section 3(40) of ERISA), or (v) a plan providing for or promising retiree medical or life insurance or other welfare
benefits to any current or former employee or other service provider of the Company, any of its Subsidiaries or any ERISA Affiliate, except
to the extent required by Section 4980B of the Code or other similar U.S. state Applicable Law. Neither the Company nor any of its Subsidiaries
has incurred (whether or not assessed) any material Tax or penalty under Sections 4980B, 4980D, 4980H, 6721 or 6722 of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 25; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each U.S. Employee Plan that is intended to be qualified under Section 401(a) of the Code has received or is permitted to rely
upon a favorable determination or an opinion letter to that effect, or has pending or has time remaining in which to file, an application
for such determination from the Internal Revenue Service, and nothing has occurred that could reasonably be expected to cause the loss
of or adversely affect such qualification.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) Each U.S. Employee Plan has been established, funded, operated, administered, and maintained in all material respects in compliance
with its terms and with the requirements prescribed by Applicable Laws, including ERISA and the Code, and (ii) all material contributions,
premiums and other payments due or required to be paid to (or with respect to) any U.S. Employee Plan have been timely paid in accordance
with the terms of such U.S. Employee Plan and Applicable Law or, if not yet due, have been properly accrued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) No material litigation, Proceeding or claim is pending with respect to any Company Employee Plan (other than routine claims
for benefits) and, to the Knowledge of the Company, no such litigation, Proceeding or claim is threatened, and (ii) there have not previously
been, and there are not currently, any governmental audits or investigations pending or conducted in connection with any Company Employee
Plan, or, to the Knowledge of the Company, threatened in connection with any Company Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not, individually or in the aggregate, reasonably be expected to have a Company Material Adverse Effect, each Foreign
Employee Plan and related trust, if any, complies with and has been established, administered, and maintained in compliance in all material
respects with (i) the requirements of all Applicable Laws, including but not limited to any applicable provisions of the United Kingdom
Pensions Act 2008, and (ii) its terms (including the governing documentation relating to the UK DB Plan) and the terms of any industrial
instruments, collective bargaining, collective labor or works council agreements. Each Foreign Employee Plan that, under the Applicable
Laws of the subject foreign country, is required to be registered or approved by any Governmental Authority has been so registered or
approved and maintained in good standing with applicable regulatory authorities, and all employer and employee contributions to each Foreign
Employee Plan required to be made by Applicable Law or by the terms of such plan and any other plan or arrangement to which contributions
are mandated by any Governmental Authority have been timely made. No Foreign Employee Plan (other than the UK DB Plan) is a defined benefit
plan, and there are no unfunded or underfunded liabilities with respect to any Foreign Employee Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as provided in this Agreement or as required under Applicable Law, the consummation of the transactions contemplated by
this Agreement will not (either alone or together with any other event, other than actions taken by or at the direction of Buyer) (i)
entitle any current or former employee, officer, director or independent contractor of the Company or any of its Subsidiaries to additional
payments or benefits, (ii) accelerate the time of payment or vesting of any compensation or equity-based award, or other benefit, (iii)
trigger any payment, increase the amount payable or trigger any other obligation pursuant to any Company Employee Plan or Foreign Employee
Plan, or (iv) result in the forgiveness of any employee or service provider loan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated by this Agreement would
reasonably be expected to (either alone or in</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 26; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">conjunction with any other event) trigger any payment or entitlement (whether in cash, property
or the vesting of property) that constitutes, or cause any payment or entitlement that was previously paid or provided to constitute,
a &ldquo;parachute payment&rdquo; within the meaning of Section 280G of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No Person is entitled to receive any additional payment (including any tax gross-up or other payment) from the Company or any of
its Subsidiaries as a result of the imposition of the excise Taxes by Section 4999 of the Code or any Taxes imposed by Section 409A of
the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(k)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No prohibited transaction within the meaning of Section 406 or 407 of ERISA or Section 4975 of the Code or breach of fiduciary
duty under ERISA has occurred with respect to any U.S. Employee Plan or any other plan maintained by the Company or any of its Subsidiaries
with respect to which there has been a liability de-risking transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(l)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the Company nor any of its Subsidiaries has any current or contingent liability or obligation on account of at any time
being considered a single employer under Section 414 of the Code with any other Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(m)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>With respect to any U.S. Employee Plan that is or was subject to Section 412 of the Code or Section 302 or Title IV of ERISA: (i)
the minimum funding standards under Section 430 of the Code have been satisfied and all contributions required under Section 302 of ERISA
have been timely made, whether or not waived; (ii) no reportable event within the meaning of Section 4043 of ERISA for which the 30-day
notice requirement has not been waived has occurred and no such reportable event is expected to occur in connection with the transactions
contemplated by this Agreement; (iii) all premiums due to the Pension Benefit Guaranty Corporation (&ldquo;<B>PBGC</B>&rdquo;) have been
timely paid in full; (iv) the PBGC has not instituted or threatened to institute proceedings to terminate any such U.S. Employee Plan;
and (v) all applicable requirements of Section 204(h) of ERISA have been complied with.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(n)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each Company Employee Plan that constitutes in any part a &ldquo;nonqualified deferred compensation plan&rdquo; (as defined under
Section 409A(d)(1) of the Code) subject to Section 409A of the Code has been operated and administered in all material respects in operational
compliance with, and is in all material respects in documentary compliance with, Section 409A of the Code and all IRS guidance promulgated
thereunder, and no amount under any such plan, agreement or arrangement is or would reasonably be expected to be subject to any additional
Tax, interest or penalties under Section 409A of the Code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(o)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Save in respect of the UK DB Plan, neither the Company nor any of its Subsidiaries have ever been an &ldquo;employer&rdquo; nor
are, nor have in the last six years been, an &ldquo;associate&rdquo; of or &ldquo;connected&rdquo; with an &ldquo;employer&rdquo; (within
the meaning of the United Kingdom Pensions Act 2004) of an &ldquo;occupational pension scheme&rdquo; which is not a &ldquo;money purchase
scheme&rdquo; (as such terms are defined in the United Kingdom Pension Schemes Act 1993).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(p)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No United Kingdom-based employee or officer, and no former United Kingdom-based employee or officer, of the Company or any of its
Subsidiaries has any entitlement (whether actual or contingent) to enhanced pension rights on early retirement and/or redundancy arising
as a result of a transfer of their employment to the Company or any of its Subsidiaries under either</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 27; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">the United Kingdom Transfer of Undertakings
(Protection of Employment) Regulations 2006 (as amended) or its predecessor legislation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.17</FONT> Labor and Employment Matters.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>To the Company&rsquo;s Knowledge, the Company and its Subsidiaries are, and for the past three years have been, in compliance in
all material respects with all federal, state, and foreign Applicable Laws respecting labor, employment and employment practices and terms
and conditions of employment, including but not limited to Applicable Laws related to wages and hours, workplace safety and health, workers&rsquo;
compensation, and immigration (including the completion of Forms I-9 for all U.S. employees and the proper confirmation of employee visas),
Title VII of the Civil Rights Act of 1964, as amended, the Equal Pay Act of 1963, as amended, the Age Discrimination in Employment Act
of 1967, as amended, the Americans with Disabilities Act, as amended, and state and local anti-discrimination laws. Except as would not
result in material liability for the Company and its Subsidiaries taken as a whole, (i) the Company has not received written notice of
any audits or investigations pending or scheduled by any Governmental Authority pertaining to the labor or employment practices of the
Company, and (ii) to the Knowledge of the Company, no written complaints relating to employment practices of the Company have been made
to any Governmental Authority or submitted to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to be, individually or in the aggregate, material to the Company and its Subsidiaries,
taken as a whole, neither the Company nor any of its Subsidiaries is a party to, or otherwise bound by, any collective bargaining agreement,
contract or other agreement or understanding with a labor union, works council, employee representative, or labor organization (each,
a &ldquo;<B>Labor Agreement</B>&rdquo;); there are no Labor Agreements that cover any of the employees of the Company or any of its Subsidiaries
in respect of such employment, and except as set forth on Schedule 3.17(b), none are currently being negotiated; and no employees of the
Company or any of its Subsidiaries in respect of such employment are represented by any labor union, labor organization, works council,
or other employee representative or a group of employees with respect to their employment with the Company or any of its Subsidiaries.
To the Knowledge of the Company, neither the Company nor any of its Subsidiaries is subject to any charge, demand, petition or representation
Proceeding seeking to compel, require or demand it to bargain with any labor union, works council or labor organization. To the Knowledge
of the Company, in the past three years, there have been no labor organizing activities with respect to any employees of the Company or
any of its Subsidiaries. In the past three years, there has been no actual, or, to the Knowledge of the Company, pending or threatened,
unfair labor practice charges, material labor grievances, material labor arbitrations, strikes, lockouts, work stoppages, slowdowns, picketing,
hand billing, or other material labor disputes against or involving the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>None of the Company or any of its Subsidiaries has any legal or contractual requirement to provide notice or information to, bargain
with, enter into any consultation procedure with, or obtain consent from any labor union, works council, labor organization, or employee
representative, or any applicable labor tribunal, in connection with the execution of this Agreement or the transactions contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 28; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>To the Knowledge of the Company, the Company has reasonably investigated all sexual harassment or other harassment, discrimination,
or retaliation allegations against officers or directors of the Company and its Subsidiaries that have been reported to the Company or
any of its Subsidiaries in writing. With respect to each such allegation (that the Company or its applicable Subsidiary reasonably deemed
to have merit), the Company and its Subsidiaries have taken prompt corrective action reasonably calculated to prevent further improper
action. The Company and its Subsidiaries do not reasonably expect any material liability with respect to such allegations, and to the
Knowledge of the Company, there are no such allegations of harassment or discrimination that, if known to the public, would bring the
Company or any of its Subsidiaries into material disrepute.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.18</FONT> <I>Insurance</I>. Except as would not, individually or in the aggregate, reasonably be expected to have a Company Material
Adverse Effect: (a) the Company and its Subsidiaries maintain insurance for which the Company or any of its Subsidiaries is a policyholder
or which cover the business, operations, employees, officers, directors or assets of the Company or any of its Subsidiaries in such amounts
and against such risks as are usually insured against by similarly situated companies in the same or similar businesses and trades, (b)
all insurance policies maintained by the Company and its Subsidiaries are in full force and effect and all premiums due and payable thereon
have been paid; (c) neither the Company nor any of its Subsidiaries is in breach of or default under any of such insurance policies;
and (d) since January 1, 2024, the Company has not received any written notice of termination or cancellation or denial of coverage with
respect to any insurance policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.19</FONT> <I>Environmental Matters</I>. Except as would not, individually or in the aggregate, reasonably be expected to have a Company
Material Adverse Effect:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company and its Subsidiaries are, and since January 1, 2023 have been, in compliance with all Environmental Laws applicable
to the operation of the business of the Company and its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company and its Subsidiaries hold, and since January 1, 2023 have held, all Environmental Permits required for the operation
of the business of the Company and its Subsidiaries and are, and since January 1, 2023 have been, in compliance with the terms and conditions
of such Environmental Permits;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>neither the Company nor any of its Subsidiaries is, or since January 1, 2023 has been, the subject of any outstanding Order arising
under Environmental Law, and there is no Proceeding arising under or written notice alleging violation of or liability pursuant to Environmental
Law that is, or since January 1, 2023 has been, pending or, to the Knowledge of the Company, threatened against the Company or its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>there has been no release, disposal or arrangement for disposal of, or exposure of any person to, or, to the Knowledge of the Company,
operation of any real property contaminated by, any Hazardous Substance by the Company or any of its Subsidiaries, including as a result
of the operation of the business of the Company and its Subsidiaries, in each case, which release, disposal or arrangement for disposal,
exposure or contamination is in a manner requiring remediation by the Company or any of its Subsidiaries pursuant to Environmental Law
or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 29; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">otherwise is reasonably likely to give rise to liability of the Company or any of its Subsidiaries pursuant to Environmental Law; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and its Subsidiaries have not entered into any written agreement with outstanding obligations to expressly assume and
indemnify any known and currently existing material liabilities of any other Person arising under Environmental Laws, which, for the avoidance
of doubt, shall not include ordinary course indemnification provisions in customer and vendor Contracts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>To the Knowledge of the Company, neither this Agreement nor the consummation of the transactions that are the subject of this Agreement
will result in any obligations for notification to, filings with, or consent of the New Jersey Department of Environmental Protection,
pursuant to the New Jersey Industrial Site Recovery Act, N.J.S.A. 13:1K-6 et seq., and the regulations promulgated pursuant thereto, N.J.A.C.
7:26B 1.1 et seq., as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.20</FONT> <I>Intellectual Property; Data Protection</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Section 3.20(a)</U> of the Company Disclosure Schedule contains a complete list as of the date hereof of all patents and patent
applications, trademark registrations and applications, copyright registrations and applications, and domain names, in each case, that
are owned by the Company or any of its Subsidiaries. Except as would not reasonably be expected to have, individually or in the aggregate,
a Company Material Adverse Effect, the items identified on <U>Section 3.20(a)</U> of the Company Disclosure Schedule are (i) subsisting
and in good standing with the Governmental Authorities or the applicable internet domain name registrar with which such items are registered
or pending, and (ii) as well as the other Company Intellectual Property, to the Knowledge of the Company, are valid and enforceable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company
and its Subsidiaries (i) exclusively own all Company Intellectual Property and (ii) have valid, enforceable, and sufficient rights to
all Intellectual Property used in or necessary for the operation of the business of the Company and its Subsidiaries, in each case of
(i) and (ii), free and clear of all Liens, other than (x) Permitted Liens and, (y) in the case of <U>clause (ii)</U>, Liens granted by
Third Parties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, to the
Knowledge of the Company, (i) neither the Company or any of its Subsidiaries nor the operation of the business of the Company and its
Subsidiaries as currently conducted, or in the past three (3) years, is or has been infringing or misappropriating any Third Party right,
and (ii) there is and has not been in the last three (3) years any infringement or misappropriation by any Person of any of the Company
Intellectual Property. Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse
Effect, there are no (and have not in the last three (3) years been any) Proceedings or claims pending, or, to the Knowledge of the Company,
threatened in writing, by or against the Company or any of its Subsidiaries, concerning the foregoing <U>clauses (i)</U> and <U>(ii)</U>
or otherwise challenging the ownership, enforceability or validity of any Company Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 30; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) the
Company and its Subsidiaries have taken reasonable measures to protect the confidentiality of trade secrets included in the Company Intellectual
Property and (ii) no such trade secrets or other confidential information of the Company or any of its Subsidiaries have been disclosed
to any Person other than in the ordinary course of business pursuant to a reasonable, written confidentiality and non-disclosure agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, all current
employees and consultants of the Company and its Subsidiaries and other Persons who have developed for the Company or any of its Subsidiaries
any material Intellectual Property that would not otherwise be owned by the Company or a Subsidiary as a matter of law, have assigned
to the Company or such Subsidiary ownership of such Intellectual Property to the extent that the Company or such Subsidiary intended such
Intellectual Property be owned by the Company or such Subsidiary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, no funding,
facilities or personnel of any Governmental Authority were used to develop, in whole or in part, any material Company Intellectual Property
in a manner that grants to the applicable Governmental Authority any ownership interest in such Company Intellectual Property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, (i) the
software, computer systems, servers, network equipment and other computer hardware and IT assets owned, licensed, sublicensed, used or
controlled by or for the Company or any of its Subsidiaries (&ldquo;<B>IT Systems</B>&rdquo;) are adequate and sufficient for the operation
of the business of the Company and its Subsidiaries as currently conducted, (ii) the Company and its Subsidiaries have implemented commercially
reasonable technical and physical safeguards designed to protect the IT Systems against unauthorized use, access, modification, or corruption
and (iii) to the Knowledge of the Company, during the past three (3) years (including January 1, 2024 through the date hereof), there
has been no security breach of, unauthorized access to, or unauthorized use of, any of the IT Systems (or the Personal Information stored
therein) or other confidential information or trade secret of the Company or any of its Subsidiaries, or any successful phishing incident
or ransomware or malware attack, and (iv) to the Knowledge of the Company, no software included in the IT Systems contains any &ldquo;virus&rdquo;,
&ldquo;back door,&rdquo; &ldquo;time bomb&rdquo;, &ldquo;Trojan horse&rdquo; or other malicious code.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As of the date hereof, except as would not reasonably be expected to have, individually or in the aggregate, a Company Material
Adverse Effect, the Company and its Subsidiaries comply and during the past three (3) years (including since January 1, 2024) have complied
with all applicable laws concerning the privacy and security and Processing of Personal Information and other Privacy Requirements. <FONT STYLE="font-size: 10pt">Neither
</FONT>the Company nor any of its Subsidiaries are, or during the past three (3) years have, to the Knowledge of the Company, (i) been
subject to or received any notice of any investigation, complaint or other Proceeding by any Person, or (ii) sent or been required to
send to any Person any notice, concerning, in the case of either <U>clauses (i)</U> or <U>(ii)</U>, above or any actual or potential violation
of any Privacy Requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.21</FONT> <I>Properties</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 31; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Section 3.21(a)</U> of the Company Disclosure Schedule sets forth a complete and correct list as of the date of this Agreement
of the street address and fee owner of each real property owned by the Company or any of its Subsidiaries (collectively, the &ldquo;<B>Owned
Real Property</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT><U>Section 3.21(b)</U> of the Company Disclosure Schedule sets forth a true and complete list of all real property leased, subleased
or otherwise occupied by the Company or any of its Subsidiaries (collectively, the &ldquo;<B>Company Leased Real Property</B>&rdquo;)
and the address for each Company Leased Real Property. Each lease agreement pursuant to which such Company Leased Real Property is occupied
by the Company or a Subsidiary is valid and in full force and effect and is enforceable in accordance with its terms and, to the Knowledge
of the Company, no party thereto is in material violation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company
and its Subsidiaries have good and valid title to the Owned Real Property or a valid leasehold interest in the Company Leased Real Property
as necessary to permit the Company and its Subsidiaries to conduct their business in the ordinary course as currently conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as would not reasonably be expected to have, individually or in the aggregate, a Company Material Adverse Effect, the Company
and its Subsidiaries have good and valid title to, or a valid leasehold interest in or enforceable rights to use, all material tangible
personal property as necessary to permit the Company and its Subsidiaries to conduct their business in the ordinary course as currently
conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.22</FONT> <I>Takeover Statutes</I>. There are no &ldquo;moratorium,&rdquo; &ldquo;fair price,&rdquo; &ldquo;supermajority,&rdquo; &ldquo;affiliate
transactions,&rdquo; &ldquo;control share acquisition&rdquo; or &ldquo;business combination statute or regulation&rdquo; or other similar
state or other anti-takeover Laws and regulations applicable to the Company, the Company Ordinary Shares, the Transaction or any other
transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.23</FONT> <I>Brokers&rsquo; Fees</I>. Except for Deutsche Bank pursuant to an engagement letter, there are no investment bankers, brokers,
finders or agents that have been retained by or are authorized to act on behalf of the Company or any of its Subsidiaries who are entitled
to any banking, broker&rsquo;s, finder&rsquo;s or similar fee or commission in connection with the Transaction. The Company has Made
Available to Buyer a good faith estimate as of the date hereof of the aggregate fee due to Deutsche Bank at the Closing and a true and
correct unredacted copy of the fee and provisions of the engagement letter with Deutsche Bank. Promptly following the execution of this
Agreement, the Company will make available a true and correct copy of the engagement letter with Deutsche Bank and each other investment
banker, broker, finder and agent that has been retained by the Company and its Subsidiaries and the Company Board in connection with
the Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.24</FONT> <I>Information Supplied</I>. The information supplied or to be supplied by the Company for inclusion in the Proxy Statement
(including, for the avoidance of any doubt, the Scheme Document) will not, at the time the Proxy Statement is first mailed to the Company
Shareholders and at the time of the Scheme Meeting and the Company GM to be held in connection with the Transaction, contain any untrue
statement of a material fact or omit to state any material</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 32; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they are made, not misleading, except that no representation or warranty is made by the Company
with respect to statements made or incorporated by reference therein based on information supplied by Buyer in writing expressly for inclusion
therein. The Company shall use its reasonable best efforts to cause the Proxy Statement (excluding any portion thereof based on information
supplied by Buyer in writing expressly for inclusion therein, with respect to which no representation or warranty is made by the Company)
to comply as to form in all material respects with the provisions of the Securities Act and the Exchange Act and the rules and regulations
promulgated thereunder and any applicable provisions of the Companies Act, and the Scheme of Arrangement to comply in all material respects
with the provisions of the Companies Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.25</FONT> <I>Opinion of Financial Advisor</I>. The Company Board has received an opinion from Deutsche Bank substantially to the effect
that, as of the date thereof and based upon and subject to the assumptions, limitations, qualifications and conditions set forth therein,
the Consideration was fair, from a financial point of view, to the holders of Company Ordinary Shares (other than Buyer and its Affiliates).
It is agreed and understood that such opinion is for the benefit of the Company Board, in its capacity as such, and may not be relied
on by Buyer or its Affiliates. A true, correct and complete copy of the signed written version of the opinion referenced in the first
sentence of this <U>&#8206;Section 3.25</U> will be made available to Buyer for informational purposes only on a non-reliance basis promptly
following receipt by the Company Board (and, in any event, within two (2) Business Days of the date of the Agreement).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.26</FONT> <I>Interested Party Transactions</I>. As of the date hereof, except as disclosed in the Company&rsquo;s definitive proxy statements
included in the Recent SEC Reports, there are no Interested Party Transactions and no event has occurred and no relationship exists that
would be required to be disclosed under Item 404 of Regulation S-K promulgated by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
3.27</FONT> <I>Government Contracts and Government Bids</I>. Since January 1, 2024: (i) neither the Company nor any of its Subsidiaries
nor any Principal (as defined in 48 C.F.R. &sect; 52.209-5) of the Company or any of its Subsidiaries has been debarred or suspended
from doing business with any Governmental Authority, and no suspension or debarment action has been commenced or, to the Knowledge of
the Company, threatened against the Company or any of its Subsidiaries or any Principal of the Company or any of its Subsidiaries; (ii)
no Governmental Authority or higher-tier contractor has notified the Company or any of its Subsidiaries in writing of any material breach
or violation of any applicable Law or of any certification, representation, clause, provision, or requirement of any Government Contract
that in each case remains unresolved; (iii) neither the Company nor any of its Subsidiaries has received any written notice of any termination
for default, cure notice, or show cause notice pertaining to any Government Contract that in each case remains unresolved; (iv) neither
the Company nor any of its Subsidiaries has received any written notice of any audit or investigation by any Governmental Authority or
higher-tier contractor with respect to any Government Contract or Government Bid that in each case remains unresolved (other than in
the ordinary course of business); and (v) neither the Company nor any of its Subsidiaries has made any voluntary or mandatory disclosure
to any Governmental Authority or higher-tier contractor with respect to any material irregularity, misstatement, significant overpayment,
or violation of applicable Law arising under or relating to any Government Contract or Government Bid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 33; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
4 </FONT><BR>
REPRESENTATIONS AND WARRANTIES OF BUYER</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">Buyer hereby represents and warrants to the Company that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.55in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.01</FONT> <I>Corporate Existence and Power</I>. Buyer is a corporation duly organized, validly existing and in good standing under the
Laws of Delaware and has all corporate or similar powers required to carry on its business as now conducted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.02</FONT> <I>Corporate Authorization</I>. Buyer has the requisite corporate power and authority to execute and deliver this Agreement
and each other document to be entered into by Buyer in connection with the transactions contemplated hereby (together with this Agreement,
the &ldquo;<B>Buyer Transaction Documents</B>&rdquo; and, together with the Company Transaction Documents, the &ldquo;<B>Transaction
Documents</B>&rdquo;) and, subject to <U>&#8206;Section 4.03</U>, upon receipt of the Court Order, will have the requisite corporate
power and authority to consummate the transactions contemplated hereby and thereby, including the Transaction. The execution, delivery
and performance of this Agreement and the other Buyer Transaction Documents and the consummation of the transactions contemplated hereby
and thereby have been duly and validly authorized by the board of directors of Buyer and, except for the filing of the required documents
and other actions in connection with the Scheme of Arrangement with, and subject to receipt of the required sanctioning of the Scheme
of Arrangement by, the Court, no other corporate action on the part of Buyer is necessary to authorize the execution and delivery by
Buyer of this Agreement and the other Buyer Transaction Documents and the consummation of the Transaction. This Agreement has been duly
and validly executed and delivered by Buyer and, assuming each such Buyer Transaction Document has been duly authorized, executed and
delivered by each other counterparty thereto, this Agreement constitutes the legal, valid and binding obligation of Buyer, enforceable
against Buyer in accordance with its terms, except as such enforcement may be subject to the Enforceability Exceptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.03</FONT> <I>Governmental Authorization</I>. Other than in connection with or in compliance with (i) the Companies Act, (ii) the Exchange
Act, (iii) the Securities Act, (iv) the HSR Act, and (v) the Foreign Investment Laws and, subject to the accuracy of the representations
and warranties of the Company in <U>&#8206;Section 3.03</U>, no authorization, consent, Order, license, permit or approval of, or registration,
declaration, notice or filing with, or notice to, any Governmental Authority is necessary, under Applicable Law, for the execution, delivery
and performance of this Agreement or the consummation by Buyer of the transactions contemplated hereby, except for such authorizations,
consents, Orders, licenses, permits, approvals or filings that, if not obtained or made, would not reasonably be expected to have, individually
or in the aggregate, a Buyer Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.04</FONT> <I>Prior Acquisitions</I>. Neither Buyer nor any of its Subsidiaries or Affiliates has, within six (6) months prior to the
date of this Agreement, acquired, or agreed to acquire, any entity, business or assets or interests in any entity, business or assets
(a) that is engaged in any line of business in which the Company or any of its Subsidiaries or Affiliates is engaged or (b) where such
acquisition or contemplated acquisition would reasonably be expected to (i) impose any material delay in the obtaining of, or materially
increase the risk of not obtaining, any consents or approvals from any Governmental Authority necessary to consummate the Transaction
or the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 34; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">expiration
or termination of any applicable waiting period, (ii) materially increase the risk of any Governmental Authority entering an Order prohibiting
the consummation of the Transaction or (iii) otherwise materially delay the consummation of the Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.05</FONT> <I>Non-contravention</I>. The execution, delivery and performance by Buyer of this Agreement do not, and the consummation
of the transactions contemplated hereby and compliance with the provisions hereof will not, (i) result in any violation of, or default
(with or without notice or lapse of time, or both) under, or give rise to any right of termination, cancellation, material modification,
acceleration of any right or obligation, under any material Contract of Buyer or result in the creation of any Liens (other than Permitted
Liens and any Liens created in connection with any action taken by the Company or its Affiliates) upon any of the properties or assets
of Buyer or any of its Subsidiaries, (ii) conflict with or result in any violation of any provision of the organizational documents of
Buyer and its Subsidiaries or (iii) assuming compliance with the matters referred to in <U>&#8206;Section 4.03</U>, conflict with or
violate any Applicable Law, except for such losses, suspensions, limitations, impairments, conflicts, violations, defaults, terminations,
cancellations, accelerations or Liens as would not reasonably be expected to have, individually or in the aggregate, a Buyer Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.06</FONT> <I>No Vote of Buyer Shareholders; Required Approval</I>. No vote or consent of the holders of any class or series of capital
stock of Buyer or the holders of any other securities of Buyer (equity or otherwise) is necessary to adopt this Agreement or to approve
the Transaction or the other transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.07</FONT> <I>Litigation</I>. As of the date hereof, there is no Proceeding pending, or, to the Knowledge of Buyer, threatened, that
would reasonably be expected to have, individually or in the aggregate, a Buyer Material Adverse Effect. As of the date hereof, neither
Buyer nor any of its Subsidiaries is subject to any Order that would reasonably be expected to have, individually or in the aggregate,
a Buyer Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.08</FONT> <I>Available Funds</I>. Buyer has delivered to the Company true, correct and complete copies, as of the date hereof, of (i)
the fully executed Equity Commitment Letter (the financing provided for therein being referred to as the &ldquo;<B>Equity Financing</B>&rdquo;)
and (ii) a fully executed commitment letter (together with all exhibits, schedules, annexes, supplements, and term sheets thereto) and
(subject to customary redactions of the fee information, market &ldquo;flex&rdquo; information and other economic or commercially sensitive
information, which redacted terms do not adversely affect the conditionality or availability of the Debt Financing) fee letter(s) from
the Debt Financing Sources identified therein (collectively, as each of the foregoing may be amended, supplemented, replaced, substituted,
terminated or otherwise modified or waived from time to time after the date hereof in compliance with <U>Section 5.15</U>, the &ldquo;<B>Debt
Commitment Letter</B>&rdquo; and, together with the Equity Commitment Letter, the &ldquo;<B>Financing Commitment Letters</B>&rdquo;)
to provide, on the terms and subject only to the conditions expressly stated therein, debt financing in the amounts set forth therein
(being collectively referred to as the &ldquo;<B>Debt Financing</B>&rdquo; and, together with the Equity Financing, the &ldquo;<B>Financing</B>&rdquo;).
As of the date hereof, none of the Financing Commitment Letters has been withdrawn, terminated, repudiated, rescinded, amended or modified,
no terms thereunder have been waived, and, to Buyer&rsquo;s knowledge, no such withdrawal, termination, repudiation, rescission, amendment,
modification or waiver is contemplated. Buyer has fully paid, or caused to be paid, any and all commitment fees, other fees and other
amounts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 35; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">earned and due on or prior to the date hereof in connection with the Financing Commitment Letters. Assuming the Financing is funded
in accordance with the Equity Commitment Letter and the Debt Commitment Letter, as applicable, the net cash proceeds contemplated by the
Equity Commitment Letter and the Debt Commitment Letter (both before and after giving effect to any &ldquo;flex&rdquo; provisions contained
in the Debt Commitment Letter) will, in the aggregate, be sufficient for Buyer to pay the amounts required to be paid in connection with
the Transaction and the other transactions contemplated hereby on the Closing Date, including payment of the Aggregate Transaction Consideration,
to make any repayment, repurchase or refinancing of debt contemplated by this Agreement (including the Company Credit Facilities) or the
Debt Commitment Letter, to pay any other amounts required to be paid in connection with the consummation of the transactions contemplated
by this Agreement and to pay all related fees and expenses, in each case, required to be paid at the Closing (such amounts, collectively,
and after giving effect to all other available sources of cash, the &ldquo;<B>Financing Amounts</B>&rdquo;). As of the date hereof, the
Financing Commitment Letters are, as to Buyer and, to Buyer&rsquo;s knowledge, the other parties thereto, enforceable against such Persons
in accordance with their terms, in each case, except as such enforcement may be subject to the Enforceability Exceptions. As of the date
hereof, the Financing Commitment Letters are in full force and effect and no event has occurred which, with or without notice, lapse of
time or both, would or would reasonably be expected to constitute a default or breach on the part of Buyer or, to the Knowledge of Buyer,
any other parties thereto, under any of the Financing Commitment Letters. As of the date hereof, assuming satisfaction of the conditions
to Buyer&rsquo;s obligations to consummate the transactions contemplated by this Agreement, Buyer does not have any reason to believe
that any of the conditions to the funding of the Financing will not be satisfied on a timely basis or that the Financing will be available
to Buyer on the date of the Closing in an amount less than the Financing Amounts (after giving effect to other sources of cash available).
The Financing Commitment Letters contain all of the conditions precedent to the obligations of the Debt Financing Sources party thereto
to make the Financing available to Buyer on the Closing Date in an amount not less than the Financing Amounts (after giving effect to
other sources of cash available) on the terms therein. As of the date hereof, there are no side letters or other agreements or binding
arrangements to which Buyer or any of its Affiliates is a party related to the funding or investing, as applicable, of the full amount
of the Financing. The Equity Commitment Letter provides, and will continue to provide, that the Company is a third-party beneficiary thereof
as set forth therein. The obligations of Buyer under this Agreement are not subject to any conditions regarding Buyer&rsquo;s, its Affiliates&rsquo;
or any other Person&rsquo;s (including, for the avoidance of doubt, the Company&rsquo;s or any of its Subsidiaries&rsquo;) ability to
obtain the Financing or any other financing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.09</FONT> <I>Solvency</I>. Assuming (x) the accuracy of the representations and warranties in <U>&#8206;Article 3</U>, (y) compliance
and performance by the Company with its covenants and agreements hereunder and (z) the satisfaction of the conditions set forth in <U>&#8206;Section
6.01</U> and <U>&#8206;Section 6.02</U>, Buyer and its Subsidiaries (including, at the Effective Time, the Company and its Subsidiaries)
will be Solvent as of the Effective Time and immediately after the consummation of the transactions contemplated by this Agreement and
any debt financing (including, without limitation, any Debt Financing) occurring in connection therewith. Buyer is not entering into
the Transaction with the actual intent to hinder, delay or defraud either present or future creditors of the Company, Buyer or any of
their respective Subsidiaries. For purposes of this <U>&#8206;Section 4.09</U>, the term &ldquo;<B>Solvent</B>&rdquo;, or any derivation
thereof, when used with respect to any Person, means that, as of any date of determination (x) the amount of the &ldquo;fair saleable
value&rdquo; of the assets and property of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 36; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">such Person, in each case, will, as of such date, exceed (i) the value of all &ldquo;liabilities of such Person,
including contingent and other liabilities,&rdquo; as of such date, as such quoted terms are generally determined in accordance with Applicable
Laws governing determinations of the insolvency of debtors, and (ii) the amount that will be required to pay the probable liabilities
of such Person on its existing debts (including contingent and other liabilities) as such debts become absolute and mature, (y) such Person
will not have, as of such date, an unreasonably small amount of capital for the operation of the businesses in which it is engaged or
proposed as of such date to be engaged following such date and (z) such Person will be able to pay its liabilities, including contingent
(it being understood that the amount of contingent liabilities at any time shall be computed as the amount that, in light of all the facts
and circumstances existing at such time, represents the amount that can reasonably be expected to become an actual or matured liability),
subordinated and other liabilities, as they mature.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.10</FONT> <I>Guarantee</I>. Concurrently with the execution of this Agreement, Buyer has delivered to the Company a duly executed, true,
complete and correct copy of the Guarantee. As of the date hereof, the Guarantee is in full force and effect. The Guarantee is (i) a
legal, valid and binding obligation of the Guarantor and (ii) enforceable in accordance with its respective terms against such Guarantor,
except as may be limited by the Enforceability Exceptions. As of the date hereof, there is no breach or default under the Guarantee by
the Guarantor, and no event has occurred that would constitute a breach or default (or with notice or lapse of time or both would constitute
a breach or default) thereunder by the Guarantor.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.11</FONT> <I>Absence of Certain Agreements</I>. As of the date hereof, neither Buyer nor any of its Affiliates has entered into any
agreement, arrangement or understanding (in each case, whether oral or written), or authorized, committed or agreed to enter into any
agreement, arrangement or understanding (in each case, whether oral or written), (i) pursuant to which any Person known to Buyer or its
Affiliates to be a beneficial owner (as defined in Rule 13d-3 under the Exchange Act) of five percent (5%) or more of the outstanding
share capital of the Company (other than any existing limited partner or equity financing source of the Equity Investor or any of its
Affiliates) would be entitled to receive consideration of a different amount or nature than the Consideration or pursuant to which any
Company Shareholder has agreed to vote to adopt this Agreement or has agreed to vote against any Superior Proposal other than the Voting
Agreements or (ii) pursuant to which any such beneficial owner has agreed to make an investment in, or contribution to, Buyer in connection
with the transactions contemplated by this Agreement. As of the date hereof, there are no agreements, arrangements or understandings
(in each case, whether oral or written) between Buyer, the Equity Investor, the Guarantor or any of their respective Affiliates, on the
one hand, and any member of the Company&rsquo;s management or directors, on the other hand, that relate in any way to the transactions
contemplated by this Agreement or operation of the Company following the Closing other than this Agreement and the other Transaction
Documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.12</FONT> <I>Share Ownership</I>. Buyer does not own any capital shares of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.13</FONT> <I>Information Supplied</I>. The information supplied or to be supplied by Buyer in writing for inclusion in the Proxy Statement
(including, for the avoidance of any doubt, the Scheme Document) will not, at the time the Proxy Statement is first mailed to the Company
Shareholders and at the time of the Scheme Meeting and the Company GM to be held in connection</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 37; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">with the Transaction, contain any untrue statement of
a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein,
in light of the circumstances under which they are made, not misleading, except that no representation or warranty is made by Buyer with
respect to statements made or incorporated by reference therein based on information supplied by the Company or any of its Subsidiaries
in writing expressly for inclusion therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.14</FONT> <I>Takeover Statutes</I>. There are no &ldquo;moratorium,&rdquo; &ldquo;control share acquisition,&rdquo; &ldquo;fair price,&rdquo;
&ldquo;supermajority,&rdquo; &ldquo;affiliate transactions,&rdquo; or &ldquo;business combination statute or regulation&rdquo; or other
similar state or other anti-takeover Laws and regulations applicable to Buyer, the Transaction or any other transactions contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.15</FONT> <I>Compliance With Law</I>. None of Buyer or any Subsidiaries thereof, is a Sanctioned Person. Buyer is not a &ldquo;foreign
person,&rdquo; as that term is defined in 31 C.F.R. &sect; 800.224, nor subject to &ldquo;foreign ownership&rdquo; or &ldquo;foreign
control,&rdquo; as those terms are defined in 22 C.F.R. &sect; 120.65.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
4.16</FONT> <I>Brokers&rsquo; Fees</I>. There is no investment banker, broker, finder or other agent or intermediary that has been retained
by or is authorized to act on behalf of Buyer or any of its Subsidiaries, Affiliates, or any of their respective officers or directors
in their capacities as officers or directors, who is entitled to any advisory, banking, broker&rsquo;s, finder&rsquo;s or similar fee
or commission payable by the Company or any of its Subsidiaries in connection with the Transaction and the other transactions contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
5 </FONT><BR>
COVENANTS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.01</FONT> <I>Conduct of the Company</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except for matters (i) required or expressly permitted by the terms of this Agreement, (ii) set forth in <U>Section 5.01(a)</U>
of the Company Disclosure Schedule, (iii) required by Applicable Law or the rules or regulations of NYSE, or (iv) undertaken with the
prior written consent of Buyer (which consent shall not be unreasonably withheld, conditioned or delayed), from the date hereof until
the Effective Time, the Company shall, and shall cause each of its Subsidiaries to, (A) maintain its existence in good standing pursuant
to Applicable Law and (B) use its reasonable best efforts to (x) conduct its business in all material respects in the ordinary course,
and (y) preserve substantially intact in all material respects its business organization, goodwill, assets and material business relationships;
<U>provided</U>, that no inaction by the Company or any of its Subsidiaries with respect to matters prohibited by any provision of <B><U>&#8206;</U></B><U>Section
5.01(b)</U> may be taken into consideration in determining whether a breach of this <B><U>&#8206;</U></B><U>Section 5.01(a)</U> has occurred
unless such inaction would constitute a breach of such other provision.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Without limiting the generality of the foregoing, except for matters (i) required or expressly permitted by the terms of this Agreement,
(ii) set forth in <U>Section 5.01(b)</U> of the Company Disclosure Schedule, (iii) required by Applicable Law or the rules or regulations
of NYSE, or (iv) undertaken with the prior written consent of Buyer (which consent shall not be unreasonably withheld, conditioned or
delayed, other than with respect to <B><U>&#8206;</U></B><U>Section 5.01(b)(ii)</U>, as to which no</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 38; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">consent of Buyer shall be required
and which shall be exercised at the Company&rsquo;s sole discretion), from the date hereof until the Effective Time, the Company shall
not, and shall not permit any of its Subsidiaries to:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>amend the Company Articles of Association, or amend in any material respect any organizational documents of the Company&rsquo;s
Subsidiaries or adopt, amend, extend or waive a shareholder rights plan or enter into any agreement with respect to the voting of its
equity interests;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>establish a record date for, declare, set aside or pay any dividends on, or make any other distributions (whether in cash, share
capital, property or otherwise) in respect of, or enter into any agreement with respect to the voting of, any Company Securities, other
than dividends and distributions by a direct or indirect wholly-owned Subsidiary of the Company to its parent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(A) split, combine, subdivide or reclassify any Company Securities, (B) except as otherwise provided in <B><I><U>&#8206;</U></I></B><U>Section
5.01(b)(iv)</U>, issue or authorize the issuance of any other securities in respect of, in lieu of or in substitution for, any Company
Securities, or (C) purchase, redeem or otherwise acquire or offer to repurchase, redeem or otherwise acquire any Company Securities, except
for acquisitions of Company Ordinary Shares by the Company in satisfaction by holders of Company Equity Awards as in effect as of the
date hereof of the applicable exercise price and/or withholding taxes or in accordance with the terms of the Company ESPP;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>issue, deliver, sell or grant any Company Securities or any equity or equity-based awards, options, warrants or rights of any kind
to acquire any shares of, or securities convertible into, or exchangeable for any shares of, Company Ordinary Shares, or other securities
in respect of, in lieu of, or in substitution for any class of its capital stock outstanding as of the Capitalization Date, other than
the issuance of Company Ordinary Shares upon the exercise of Company Share Options or the delivery of Company Ordinary Shares pursuant
to the terms of Company RSU Awards or Company PSU Awards that are outstanding on the date hereof and set forth on <U>Section 3.05(b)</U>
of the Company Disclosure Schedule, in each case in accordance with the applicable terms of such Company Equity Award and the terms of
this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>adopt a plan or agreement of, or resolutions providing for or authorizing, complete or partial liquidation, dissolution, restructuring
or recapitalization or other reorganization, each with respect to the Company or any of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(A) increase the salary, wages, benefits, bonuses or other compensation payable or to become payable to the Company&rsquo;s directors,
officers, employees or other individual service providers, except (i) as required under any Company Employee Plan as in effect on the
date hereof, (ii) increases in salaries, wages, or short-term incentive opportunities in the ordinary course of business that do not exceed
ten percent (10%) individually or three percent (3%) in the aggregate relative to the prior fiscal year of the Company, or (iii) pursuant
to any actions taken with the prior written consent of Buyer (not to be unreasonably withheld, conditioned or delayed) to mitigate any
issues resulting from applications of Sections 280G and 4999 of the Code; or (B) terminate, adopt, amend or modify any benefit or compensation
plan, program, contract,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 39; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">agreement, policy or arrangement, other than in the ordinary course of business and with a cost to the Company
and its Subsidiaries of less than $750,000 in the aggregate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) adopt, enter into, engage in negotiations for, terminate or amend any Labor Agreement, except as required by Applicable Law
or the terms thereof, or (ii) recognize or certify any labor union, labor organization, works council or group of employees as the bargaining
representative of any employees of the Company or any of its Subsidiaries, except as required by Applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>acquire, directly or indirectly, any business, assets or capital stock of any Person or division thereof, whether in whole or in
part (and whether by purchase of stock, purchase of assets, merger, amalgamation, plan of arrangement, consolidation, or otherwise), other
than one or more acquisitions in the ordinary course of business that, individually or in the aggregate, involve a purchase price of not
more than $1,000,000;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>sell, lease, license, sublicense, assign, pledge, transfer, subject to any Lien or otherwise encumber or dispose of any material
Company Intellectual Property, material assets or material properties except (i) pursuant to contracts or commitments existing as of the
date hereof that have been disclosed in <U>Section 5.01(b)(ix)</U> of the Company Disclosure Schedule, (ii) for Permitted Liens, (iii)
sales of inventory or used equipment in the ordinary course of business consistent with past practice or (iv) the lapse or expiration
of any registration of Company Intellectual Property at the end of its maximum statutory term;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>agree to any covenant limiting, in any material respect, the ability of the Company or any of its Subsidiaries to compete or engage
in any line of business or to compete with any Person in any geographic area, or pursuant to which any material benefit or right would
be required to be given or lost as a result of so competing or engaging, or which would have any such effect on Buyer or any of its Affiliates
after the Effective Time;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>change any of the accounting principles, methods or practices used by the Company materially affecting its assets, liabilities
or business, except for such changes that are required by GAAP or Regulation S-X promulgated under the Exchange Act or as otherwise specifically
disclosed in the Company&rsquo;s reports filed with the SEC;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>except for borrowings under the Company Credit Facilities, and except for intercompany loans between the Company and any of its
wholly-owned Subsidiaries or between any wholly-owned Subsidiaries of the Company, in each case in the ordinary course of business, (i)
incur, issue, or otherwise become liable for additional Indebtedness, provided that the Company and its Subsidiaries may incur any such
additional Indebtedness pursuant to this <B><I><U>&#8206;</U></I></B><U>Section 5.01(b)(xii)</U> so long as such additional Indebtedness
is less than $2,000,000 in the aggregate and shall reasonably be expected to be fully refinanced at the Closing and would not reasonably
be expected to prevent or materially delay the availability of the Debt Financing, (ii) modify in a manner adverse, in any material respect,
to the Company or its Subsidiaries the terms of any material Indebtedness existing as of the date hereof, or (iii) assume, guarantee or
endorse the obligations of any Person (other than a wholly-owned Subsidiary of the Company);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 40; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>make, change or revoke any material Tax election, amend any material Tax Return, change any Tax accounting period, adopt or change
any method of Tax accounting, settle or compromise any Proceeding relating to Taxes for an amount materially in excess of the amount accrued
or reserved therefor in the Company&rsquo;s, or the applicable Subsidiary&rsquo;s, financial statements, agree to an extension or waiver
of the statute of limitations with respect to the assessment or determination of material Taxes (other than automatically granted extensions
and extensions granted in the normal course of Tax audit management), enter into any &ldquo;closing agreement&rdquo; described in Section
7121 of the Code (or any corresponding provision of Applicable Law) or other ruling or written agreement with a Tax authority, surrender
any right to claim a refund of material Taxes, or take any action (or fail to take any action) that could reasonably be expected to result
in the Company or any of its Subsidiaries ceasing to be resident for Tax purposes in its jurisdiction of incorporation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>incur any capital expenditures on an annualized basis in excess of the amounts budgeted for such expenditures in the Company&rsquo;s
annual budget adopted by the Company Board prior to the date of this Agreement and Made Available to Buyer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>enter into any Contract between the Company or any of its Subsidiaries, on the one hand, and any current director or officer of
the Company or any Person (or any of their Affiliates) beneficially owning five (5) percent or more of the Company Securities, on the
other hand, except for any commercial Contracts entered into on arm&rsquo;s length terms in the ordinary course of business;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xvi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(A) enter into any Contract or propose to enter into any Contract that would have been a Material Contract if it had been entered
into prior to the date of this Agreement, or (B) amend or modify in any material respect, waive any material rights under, terminate (other
than any termination in accordance with the terms of an existing Material Contract (or any Contract described in the foregoing clause
(A)) and any termination as a result of a counterparty&rsquo;s material breach), replace or release any Material Contract (or any Contract
described in the foregoing clause (A)) in a manner materially adverse to the Company, except for any such actions taken in the ordinary
course of business with respect to any such Contracts with customers or suppliers that require by their terms the payment or delivery
of cash or other consideration by or to the Company or any of its Subsidiaries in an amount having an expected value less than $1,500,000
in the aggregate over the life of such Contracts;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xvii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(A) except in connection with Transaction Litigation settled in accordance with the terms of this Agreement, enter into any settlement
or other resolution of any pending or threatened Proceeding, other than any settlement or resolution that would solely involve payment
(or an obligation to make a payment) by the Company or any of its Subsidiaries of less than $2,000,000 individually or $5,000,000 in the
aggregate (net of insurance coverage) and that do not impose any material restrictions on the business or operations of the Company and
its Subsidiaries taken as a whole, following the Closing or (B) enter into any settlement or other resolution of any pending or threatened
Proceeding related to the matters set forth on <U>Section 5.01(a)(xvii)</U> of the Company Disclosure Schedule;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xviii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>cancel, materially reduce or terminate or fail to use commercially reasonable efforts to (A) keep in force material insurance policies
and (B) in the event of a</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 41; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">termination, cancellation or lapse of any material insurance policies, obtain replacement policies (which may
be via self-insurance) providing insurance coverage with respect to the material assets, operations and activities of the Company and
the Company Subsidiaries that&nbsp;is&nbsp;not materially less advantageous than the insurance coverage&nbsp;currently in effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>implement or announce any employee layoffs, furloughs, reductions in force, plant closings, reductions in compensation or other
similar actions that trigger notice obligations under the WARN Act;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xx)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>waive or release any non-competition, non-solicitation, non-disclosure or other restrictive covenant obligations of any current
or former employee or independent contractor of the Company or any of its Subsidiaries;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xxi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>disclose to any Person any trade secrets of the Company or any of its Subsidiaries (other than in the ordinary course of business
pursuant to a reasonable, written confidentiality and non-disclosure agreement); or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xxii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>authorize, commit or agree to take any of the foregoing actions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Notwithstanding the foregoing, nothing contained
in this Agreement shall give to Buyer, directly or indirectly, rights to control or direct the operations of the Company and its Subsidiaries
prior to the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.02</FONT> <I>No Solicitation; Unsolicited Proposals</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subject to <B><U>&#8206;</U></B><U>Section 5.03(b)</U> and <B><U>&#8206;</U></B><U>Section 5.03(c)</U> and except as permitted
by this <B><U>&#8206;</U></B><U>Section 5.02</U>, until the earlier to occur of the Effective Time or the termination of this Agreement
pursuant to <B><U>&#8206;</U></B><U>Section 7.01</U>:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company shall not, nor shall the Company permit any of its Subsidiaries to, and nor shall the Company authorize or permit any
of its Representatives or any of its Subsidiaries&rsquo; Representatives to, and shall use reasonable efforts to cause its Representatives
or any of its Subsidiaries&rsquo; Representatives not to, directly or indirectly (other than with respect to Buyer), (A) solicit, initiate,
knowingly induce, knowingly facilitate or knowingly encourage any inquiries, proposals or offers that constitute, relate to or that could
reasonably be expected to lead to, an Acquisition Proposal, (B) engage in, continue or otherwise participate in any discussions or negotiations
with any Third Party regarding or relating to an Acquisition Proposal, or furnish to any Third Party information or provide to any Third
Party access to the businesses, properties, assets or personnel of the Company or any of its Subsidiaries, in each case for the purpose
of encouraging or facilitating or in circumstances which could reasonably be expected to lead to an Acquisition Proposal or (C) enter
into any letter of intent, merger agreement, acquisition agreement, or other agreement (other than an Acceptable Confidentiality Agreement)
with respect to or relating to an Acquisition Proposal or enter into any agreement requiring the Company to abandon, terminate or fail
to consummate the transactions contemplated by this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company shall, and shall cause its Subsidiaries to, and shall direct the Company&rsquo;s and its Subsidiaries&rsquo; Representatives
to, (A) immediately cease and terminate any existing solicitation, encouragement, facilitation, discussions or negotiations with any Third
Party,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 42; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">theretofore conducted by the Company, its Subsidiaries or their respective Representatives with respect to an Acquisition Proposal,
(B) immediately (but no later than twenty-four (24) hours after the date of this Agreement) cease providing any such Third Party access
to nonpublic information of the Company and its Subsidiaries with respect to or relating to an Acquisition Proposal, and promptly (but
no later than forty-eight (48) hours after the date of this Agreement) request that all non-public information with respect to or relating
to an Acquisition Proposal previously provided by or on behalf of the Company or any of its Subsidiaries to any such Third Party be returned
or destroyed in accordance with the applicable Acceptable Confidentiality Agreement and (C) immediately (but no later than twenty-four
(24) hours after the date of this Agreement) terminate all access granted to any such Third Party to any physical or electronic data room
or information (including access to the business, properties, assets, books, records or other non-public information or to personnel of
the Company or any of its Subsidiaries).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding anything to the contrary in this <B><U>&#8206;</U></B><U>Section 5.02</U> or in <B><U>&#8206;</U></B><U>Section
5.03</U>, if, prior to obtaining the Company Shareholder Approval, (i) the Company receives a bona fide written Acquisition Proposal from
a Third Party, (ii) such Acquisition Proposal did not result from a material breach of this <B><U>&#8206;</U></B><U>Section 5.02</U> or
<B><U>&#8206;</U></B><U>Section 5.03</U> and (iii) the Company Board or any duly authorized committee thereof determines in good faith,
after consultation with the Company&rsquo;s financial advisor and outside legal counsel, that such Acquisition Proposal constitutes, or
could reasonably be expected to lead to, a Superior Proposal and, after consultation with the Company&rsquo;s outside legal counsel, that
the failure to take the following actions would be inconsistent with its fiduciary duties pursuant to Applicable Law, then the Company
may (A) furnish information and data with respect to the Company and its Subsidiaries to the Third Party making such Acquisition Proposal
(and its representatives, prospective debt and equity financing sources and/or their respective representatives) and afford such Third
Party (and its representatives, prospective debt and equity financing sources and/or their respective representatives) access to the businesses,
properties, assets and personnel of the Company and its Subsidiaries and (B) enter into, maintain and participate in discussions or negotiations
with the Third Party making such Acquisition Proposal (and its representatives) regarding such Acquisition Proposal or otherwise cooperate
with or assist or participate in, or facilitate, any such discussions or negotiations (including by entering into an Acceptable Confidentiality
Agreement with such Third Party for the purpose of receiving nonpublic information relating to such Third Party); <U>provided</U>, <U>however</U>,
that the Company (1) will not, and will not permit its Subsidiaries to, and direct its or their Representatives not to, furnish any non-public
information except pursuant to an Acceptable Confidentiality Agreement and (2) will promptly (and in any event within twenty-four (24)
hours) provide to Buyer any non-public information concerning the Company or its Subsidiaries provided to such Third Party that was not
previously provided to Buyer. Subject to the requirements of <U>clauses (i)</U> through <U>(iii)</U> of this <B><U>&#8206;</U></B><U>Section
5.02(b)</U>, the Company and its Representatives may direct any Persons to this Agreement, including the specific provisions of this <B><U>&#8206;</U></B><U>Section
5.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From and after the date hereof, the Company shall as promptly as practicable (and in any event within twenty-four (24) hours) notify
Buyer of the Company&rsquo;s receipt of any Acquisition Proposal, which notification shall include a copy of the applicable written Acquisition
Proposal (or, if oral, the material terms and conditions of such Acquisition Proposal) and the identity of the Third Party making such
Acquisition Proposal. The Company shall thereafter keep Buyer reasonably informed on a reasonably current basis of the status of any material
developments, discussions or negotiations regarding any such Acquisition Proposal, and the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 43; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: justify">material terms and conditions thereof (including
any change in price or form of consideration or other material amendment thereto), including by providing a copy of all material documentation
relating thereto that is exchanged between the Third Party (or its Representatives) making such Acquisition Proposal and the Company (or
its Representatives) within twenty-four (24) hours after receipt thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company agrees not to release or permit the release of any Person from, or to waive or permit the waiver or termination of
any provision of, any standstill or similar agreement to which any of the Company or any of its Subsidiaries is a party, other than to
the extent that the Company Board or any duly authorized committee thereof determines in good faith, after consultation with the Company&rsquo;s
outside legal counsel, that failure to provide such waiver, release or termination would reasonably be expected to be inconsistent with
its fiduciary duties under Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company agrees that any action taken by (i) a director or officer of the Company or any of its Subsidiaries or (ii) any other
Representative of the Company or any of its Subsidiaries, to the extent such Representative was acting at the direction of, in concert
with, or with the prior Knowledge of the Company, that, if taken by the Company, would constitute a material breach of this <U>Section
5.02</U> will be deemed to constitute a material breach by the Company of this <U>Section 5.02</U>. The Company will not authorize, direct
or knowingly permit any Representative of the Company to breach this <B><U>&#8206;</U></B><U>Section 5.02</U>, and upon becoming aware
of any breach or threatened breach of this <B><U>&#8206;</U></B><U>Section 5.02</U> by a Representative of the Company, shall use its
commercially reasonable efforts to stop such breach or threatened breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.03</FONT> <I>Company Recommendation</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Subject to <U>&#8206;Section 5.03(b)</U> and <U>&#8206;Section 5.03(c)</U>, neither the Company Board nor any committee thereof
shall (i) fail to make, withdraw, qualify, amend or modify, or publicly propose to withhold, withdraw, qualify, amend or modify, in any
manner adverse to Buyer, the Company Recommendation or take any action, or make any public statement, filing or release inconsistent with
the Company Recommendation, (ii) adopt, approve, endorse, authorize or recommend, or publicly propose to adopt, approve, endorse, authorize
or recommend, an Acquisition Proposal, (iii) fail to recommend against acceptance of any Third Party tender offer or exchange offer for
Company Ordinary Shares within ten (10) Business Days after commencement of such offer or submit any Acquisition Proposal to a vote of
the Company Shareholders, (iv) submit to a vote of the Company Shareholders, approve or recommend, or publicly propose to approve or recommend,
or cause or permit the Company or any of its Subsidiaries to execute or enter into, any letter of intent, merger agreement, acquisition
agreement, or other agreement with respect to an Acquisition Proposal (other than an Acceptable Confidentiality Agreement), (v) fail to
issue a press release publicly reaffirming the Company Recommendation within ten (10) Business Days after the Company&rsquo;s receipt
of Buyer&rsquo;s written request to do so; provided that the press release may state, if accurate, that the Company is in negotiations
at the time of such press release (and such statement shall not be deemed an Adverse Recommendation Change), (vi) fail to include the
Company Recommendation in the Proxy Statement or any shareholder circulars in relation to the Transaction, or (vii) resolve or publicly
propose to take any action described in the foregoing <U>clauses (i)</U> through <U>(vi)</U> (each of the foregoing actions described
in <U>clauses (i)</U> through <U>(vii)</U> being referred to as an &ldquo;<B>Adverse Recommendation Change</B>&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 44; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding anything in this Agreement to the contrary, including <B><I><U>&#8206;</U></I></B><U>Section 5.03(a)</U>, at any
time prior to obtaining the Company Shareholder Approval, the Company Board or any duly authorized committee thereof may, if it determines
in good faith (after consultation with the Company&rsquo;s financial advisor and outside legal counsel) that the failure to do so would
reasonably be expected to be inconsistent with its fiduciary duties under Applicable Law, (A) make an Adverse Recommendation Change (x)
in response to either (1) a bona fide Superior Proposal that the Company has received that did not result from a material breach of this
<B><I><U>&#8206;</U></I></B><U>Section 5.03</U> (after taking into account the terms of any proposals, amendments or modifications made
or agreed to by Buyer pursuant to this <B><I><U>&#8206;</U></I></B><U>Section 5.03(b)</U>) or (2) any fact, event, material change, development
or circumstance with respect to the Company (other than any fact, event, material change, development or circumstance resulting from a
material breach of this Agreement by the Company) that (a) was not known or reasonably foreseeable by the Company Board as of the date
hereof (or, if known, the consequences of which were not known nor reasonably foreseeable) and becomes known by the Company Board after
the date hereof and (b) does not relate to (I) an Acquisition Proposal or a Superior Proposal or any inquiry or communications or matters
relating directly thereto; (II) the mere fact, in and of itself, that the Company meets or exceeds any internal or published or third-party
projections, forecasts, estimates or predictions of revenue, earnings or other financial or operating metrics for any period ending on
or after the date of this Agreement, or changes after the date of this Agreement in the market price or trading volume of the Company
Ordinary Shares or the credit rating of the Company (it being understood that the underlying cause of any of the foregoing in this <U>clause
(II)</U> may be considered and taken into account); (III) the public announcement, pendency and consummation of this Agreement or the
Transaction or any actions required to be taken or to be refrained from being taken pursuant to this Agreement or (IV) the internal affairs
of Buyer or any of its Affiliates; (such fact, event, change, development, circumstance or consequences thereof, an &ldquo;<B>Intervening
Event</B>&rdquo;) and/or (B) if the Company has received a bona fide Superior Proposal that did not result from a material breach of this
<B><I><U>&#8206;</U></I></B><U>Section 5.03</U> (after taking into account the terms of any proposals, amendments or modifications made
or agreed to by Buyer pursuant to this <B><I><U>&#8206;</U></I></B><U>Section 5.03(b)</U>), cause the Company to terminate this Agreement
pursuant to <B><I><U>&#8206;</U></I></B><U>Section 7.01(i)</U> and authorize the Company to enter into a definitive agreement concerning
a transaction that constitutes a Superior Proposal (which agreement shall be entered into concurrently with such termination), subject
in each case to compliance with the terms of paragraph (ii) or (iii) below, as applicable.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the case of a Superior Proposal, (x) no Adverse Recommendation Change pursuant to this <U>Section 5.03(b)</U> may be made and
(y) no termination of this Agreement pursuant to <B><I><U>&#8206;</U></I></B><U>Section 7.01(i)</U> may be made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>until after the fourth (4<SUP>th</SUP>) Business Day following written notice from the Company (x) advising Buyer that the Company
Board or any duly authorized committee thereof (I) has received a Superior Proposal that did not result from a material breach of this
<U>&#8206;Section 5.03</U> (after taking into account the terms of any proposals, amendments or modifications made or agreed to by Buyer
pursuant to this <U>&#8206;Section 5.03(b)</U>) and (II) intends to make an Adverse Recommendation Change and/or terminate this Agreement
pursuant to <U>&#8206;Section 7.01(i)</U> (a &ldquo;<B>Notice of Superior Proposal</B>&rdquo;) and (y) specifying the reasons therefor,
including, if applicable, the material terms and conditions</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 45; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 0in">of, and the identity of the Third Party making such Superior Proposal, and
a copy of any relevant transaction documents (it being understood and agreed that any amendment to the financial terms or any other material
term of such Superior Proposal shall require a new Notice of Superior Proposal, which shall require a new notice period of three (3) Business
Days, and compliance with this <U>&#8206;Section 5.03(b)</U> with respect to such new notice);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>unless during such four (4) Business Day period (or three (3) Business Day period following an amended proposal), the Company shall,
and shall direct its Representatives to, to the extent requested by Buyer, make itself available to engage in good faith negotiations
with Buyer to make such adjustments to the terms and conditions of this Agreement, the Guarantee and the Financing Commitment Letters
as would enable the Company Board or a duly authorized committee thereof to maintain the Company Recommendation and not make an Adverse
Recommendation Change or terminate this Agreement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>unless, prior to the expiration of such four (4) Business Day period (or three (3) Business Day period following an amended proposal),
the Company Board or a duly authorized committee thereof determines in good faith (after consultation with the Company&rsquo;s financial
advisor and outside legal counsel and giving effect to any proposals, amendments or modifications made or agreed to by Buyer, if any)
that the failure to make an Adverse Recommendation Change or terminate this Agreement pursuant to <U>&#8206;Section 7.01(i)</U>, as applicable,
would reasonably be expected to be inconsistent with its fiduciary duties under Applicable Law and the Superior Proposal remains a Superior
Proposal; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(D)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>solely in the event of a termination of this Agreement pursuant to <U>&#8206;Section 7.01(i)</U>, the Company pays the Company
Termination Payment to Buyer concurrently with the termination of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the case of an Intervening Event, no Adverse Recommendation Change pursuant to this <B><I><U>&#8206;</U></I></B><U>Section 5.03(b)</U>
may be made:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>until after the fourth (4<SUP>th</SUP>) Business Day following written notice from the Company advising Buyer that the Company
Board or any duly authorized committee thereof intends to make an Adverse Recommendation Change, the material facts underlying the determination
by the Company Board or a duly authorized committee thereof that an Intervening Event has occurred, including the material facts of the
Intervening Event, and the reason for the Adverse Recommendation Change, in reasonable detail (a &ldquo;<B>Notice of Intervening Event</B>&rdquo;);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>unless during such four (4) Business Day period, the Company shall, and shall direct its Representatives to, to the extent requested
by Buyer, make itself available to engage in good faith negotiations with Buyer to make such adjustments to the terms and conditions of
this Agreement, the Guarantee and the Financing Commitment Letters as would enable the Company Board or a duly authorized committee thereof
to maintain the Company Recommendation and not make an Adverse Recommendation Change or terminate this Agreement; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 46; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>unless, prior to the expiration of such four (4) Business Day period, the Company Board or a duly authorized committee thereof
determines in good faith, taking into consideration any amendments to this Agreement, the Guarantee and the Financing Commitment Letters
proposed in writing by Buyer (after consultation with the Company&rsquo;s financial advisor and outside legal counsel) that the failure
to effect an Adverse Recommendation Change would reasonably be expected to be inconsistent with its fiduciary duties under Applicable
Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Nothing contained in <B><U>&#8206;</U></B><U>Section 5.02</U> or this <B><U>&#8206;</U></B><U>Section 5.03</U> or elsewhere in
this Agreement shall prohibit the Company from (i) taking and disclosing a position required by Rule 14d-9, Rule 14e-2(a) or Item 1012(a)
of Regulation M-A promulgated under the Exchange Act, (ii) making any disclosure to the Company&rsquo;s shareholders if, in the good faith
judgment of the Company Board or any duly authorized committee thereof, after consultation with the Company&rsquo;s outside legal counsel,
the failure to do so would reasonably be expected to be inconsistent with its fiduciary duties under Applicable Law or any disclosure
requirements under Applicable Law, (iii) making any disclosure that constitutes a &ldquo;stop, look and listen&rdquo; communication or
similar communication of the type contemplated by Section 14d-9(f) promulgated under the Exchange Act or (iv) making honest and complete
disclosure to the Court at the hearing to sanction the Scheme of Arrangement as required by Applicable Law; <U>provided</U> that, in all
cases, including in the cases of the preceding <U>clauses (i)-(iv)</U>, the Company shall not effect an Adverse Recommendation Change
other than in accordance with <B><U>&#8206;</U></B><U>Section 5.03(b)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.04</FONT> Responsibilities of the Parties in Respect of the Scheme of Arrangement.</P>

<P STYLE="font: italic 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Company shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>prepare as promptly as reasonably practicable following the date hereof and prior to the Court hearing at which an order will be
sought in relation to the convening of the Scheme Meeting, the shareholder document incorporating the Scheme of Arrangement (the &ldquo;<B>Scheme
Document</B>&rdquo;), which may be included in the Proxy Statement, in accordance with Applicable Law, and all other documentation reasonably
necessary to effect the Scheme of Arrangement and to convene the Scheme Meeting and the Company GM, and publish and post such Scheme Document
to the Company Shareholders in accordance with the directions given at the Court meeting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>consult with Buyer as to the form and content of the Scheme Document and solely to the extent the Scheme Document reflects <STRIKE></STRIKE>(A)
terms that are inconsistent with the terms of this Agreement (including any obligations of Buyer) or <STRIKE></STRIKE>(B) disclosures
about Buyer (including communications or other actions by Buyer) leading to execution of this Agreement, seek and obtain the approval
of Buyer (<U>provided</U> that the terms of the Scheme of Arrangement shall be in all material respects in the form set out in <U>Exhibit
A</U>, subject to any amendment that the Parties agree to in accordance with <B><I><U>&#8206;</U></I></B><U>Section 5.04(d)</U>); <U>provided
further</U>, that in no event shall the Company&rsquo;s obligations pursuant to this <B><I><U>&#8206;</U></I></B><U>Section 5.04(a)(ii)</U>
prevent the Company from complying with Applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 47; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>afford Buyer (or its nominated advisers) a period of not less than five (5) Business Days to review the Scheme Document in order
to provide comments and take into consideration in good faith all comments reasonably proposed by Buyer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>not finalize or post the Scheme Document to the Company Shareholders on not less than five (5) Business Days&rsquo; advance written
notice to Buyer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>provide Buyer with drafts of the forms of proxy for use by the Company Shareholders at the Company GM and the Scheme Meeting (the
&ldquo;<B>Forms of Proxy</B>&rdquo;), all the necessary evidence and pleadings in relation to the Scheme of Arrangement (the &ldquo;<B>Court
Documentation</B>&rdquo;) and any supplemental circular or document required to be published or submitted to the Court in connection with
the Scheme of Arrangement or any variation or amendment to the Scheme of Arrangement (a &ldquo;<B>Scheme Supplemental Document</B>&rdquo;),
in each case prepared in accordance with Applicable Laws and customary practice;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>afford Buyer (or its nominated advisers) a period of not less than five (5) Business Days to review each draft of all such documents
detailed in <U>clause (v)</U> above and take into consideration in good faith all comments reasonably proposed by Buyer;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>as promptly as reasonably practicable, notify Buyer of any matter of which it becomes aware that would reasonably be expected to
materially delay or prevent filing of the Scheme Document or the Court Documentation; provided that any failure to comply with this Section
5.04(a)(vii) shall not constitute a breach or failure to perform by the Company with respect to the conditions set forth in <U>Article
6</U>, or give rise to any right of termination under <U>Article 7</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(viii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>as promptly as reasonably practicable, in each case after prior consultation with, and having taken into account the reasonable
comments of the Buyer, make all necessary applications to the Court in connection with the implementation of the Scheme of Arrangement
(including applying to the Court for leave to convene the Scheme Meeting and settling with the Court the Scheme Document, the Forms of
Proxy and any Scheme Supplemental Document and taking such other steps as may be required or desirable in connection with such applications,
in each case as promptly as reasonably practicable), and use its reasonable best efforts so as to ensure that the hearing of such proceedings
occurs as promptly as practicable in order to facilitate the dispatch of the Scheme Document and any Scheme Supplemental Document and
seek such directions of the Court as it considers necessary or desirable in connection with the Scheme Meeting;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>if deemed reasonably necessary by the Company Board in consultation with its outside legal counsel in order to assist with the
satisfaction of the &ldquo;head-count test&rdquo; described in section 899 of the Companies Act, procure that certain beneficial holders
of Company Ordinary Shares transfer some or all of their beneficially held Company Ordinary Shares from Cede &amp; Co. to themselves and
cause each such beneficial holders of Company Ordinary Shares to enter into an irrevocable undertaking;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(x)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>for the purpose of implementing the Scheme of Arrangement, instruct a King&rsquo;s Counsel from Erskine Chambers;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 48; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>procure the publication of any advertisements required by Applicable Law and dispatch of the Scheme Document, the Forms of Proxy
and any Scheme Supplemental Document to Company Shareholders on the Register of Members of the Company on the record date as agreed with
the Court (in accordance with Applicable Law and, in respect of the Scheme Meeting, with the consent of the Court), as promptly as reasonably
practicable after the approval of the Court to dispatch the documents being obtained, and thereafter publish and/or post such other documents
and information (the form of which shall be agreed between the Parties) as the Court may approve or direct from time to time in connection
with the implementation of the Scheme of Arrangement in accordance with Applicable Law;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>unless the Company Board has effected an Adverse Recommendation Change pursuant to and in accordance with <B><I><U>&#8206;</U></I></B><U>Section
5.03</U>, procure that the Scheme Document includes the Company Recommendation;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xiii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>include in the Scheme Document a notice convening the Company GM to be held immediately following the Scheme Meeting to consider
and, if thought fit, approve the Company Shareholder Resolutions and convene the Scheme Meeting and the Company GM, subject to the approval
of the Court, for the date that is at least twenty-one (21) and no more than forty-five (45) calendar days after the dispatch of the Scheme
Document (not counting the day notice of the Scheme Meeting is deemed received and the day of the Scheme Meeting itself);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xiv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>call, convene, hold and conduct the Scheme Meeting and the Company GM in compliance with this Agreement, the Company Articles of
Association and Applicable Law and permit a reasonable number of representatives of Buyer and/or its financial and legal advisers to attend
and observe the Scheme Meeting and the Company GM;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>prior to the Scheme Meeting, keep Buyer informed on a regular basis prior to the Scheme Meeting of the number of valid proxy votes
received in respect of resolutions to be proposed at the Scheme Meeting and/or the Company GM (with the number of valid proxy votes for
and against being separately identified in respect of each resolution), and in any event provide such number as promptly as reasonably
practicable following a request by Buyer or its Representatives, but not more than one time per Business Day;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xvi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>except as required by Applicable Law or the Court, not postpone or adjourn the Scheme Meeting and/or the Company GM; <U>provided</U>,
<U>however</U>, that the Company may, without the consent of Buyer and only in accordance with the Company Articles of Association and
Applicable Law, adjourn or postpone the Scheme Meeting and/or the Company GM (A) in the case of adjournment, if requested by the Company
Shareholders (on a poll) to do so, <U>provided</U> that the adjournment resolution was not proposed or instigated by or on behalf of the
Company, (B) in the case of adjournment by the chairman of the Scheme Meeting or Company GM where the chairman considers, acting reasonably,
that to do so is necessary to ensure the orderly conduct of the meeting, (C) to the extent reasonably necessary to ensure that any required
supplement or amendment to the Scheme Document is provided to the Company Shareholders, (D) if, as of the time for which the Scheme Meeting
or the Company GM is scheduled (as set forth in the Scheme Document), there are insufficient Company Ordinary Shares or Company Shareholders
represented (either in person or by proxy) (x) to constitute a quorum necessary to conduct the business of the Scheme Meeting or the Company
GM, but only until a meeting can be held at</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 49; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">which there is a sufficient number of Company Ordinary Shares or Company Shareholders represented
to constitute a quorum or (y) to obtain the Company Shareholder Approval, but only until a meeting can be held at which there is a sufficient
number of votes of the Company Shareholders to obtain the Company Shareholder Approval, or (E) in the event the Company Board has effected
an Adverse Recommendation Change;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xvii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>following the Scheme Meeting and Company GM, assuming the Scheme of Arrangement and Company Shareholder Resolutions are duly passed
(including by the requisite majorities required under section 899(1) of the Companies Act in the case of the Scheme Meeting) and all other
conditions are satisfied or waived where applicable (with the exception of the condition set out in <B><I><U>&#8206;</U></I></B><U>Section
6.01(b)</U>), take all necessary steps on the part of the Company to prepare and issue, serve and lodge all such court documents as are
required to seek the sanction of the Court to the Scheme of Arrangement as promptly as reasonably practicable thereafter;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xviii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>give such undertakings as are required by the Court in connection with the Scheme of Arrangement as are reasonably and commercially
necessary or desirable to implement the Scheme of Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xix)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>on the Closing Date, deliver the Court Order, together with any confirmation received by the Company pursuant to <B><I><U>&#8206;</U></I></B><U>Section
5.04(b)(vi)</U>, to the Registrar of Companies in England and Wales;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xx)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>promptly provide Buyer with a copy of the resolutions passed at the Scheme Meeting, the Company Shareholder Resolutions and of
each order of the Court (including the Court Order) once obtained, in each case no later than two (2) Business Days following the passing
of such resolutions or the making of such order; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(xxi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>subject to the foregoing, take any other action reasonably necessary to make the Scheme of Arrangement effective as provided for
or contemplated by this Agreement, provided that the Company shall, at all times, keep Buyer reasonably informed of the progress of the
Scheme of Arrangement process and the expected timetable for the implementation thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Buyer shall:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>either (A) instruct counsel to appear on its behalf at the Court hearing to sanction the Scheme of Arrangement and undertake to
the Court to be bound by the terms of the Scheme of Arrangement insofar as it relates to Buyer; or (B) notify the Company that it agrees
to be represented by the Company&rsquo;s counsel and undertake to the Court to be bound by the Scheme of Arrangement and provide such
documentation or information as may reasonably be required by the Company&rsquo;s counsel or the Court in relation to such undertaking,
provided that neither <U>clause (A)</U> nor <U>(B)</U> shall oblige Buyer to waive any of the Conditions or treat them as satisfied;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>subject to the terms of this Agreement, afford all such reasonable cooperation and assistance as may reasonably be requested of
it by the Company in respect of the preparation and verification of any document required for the implementation of the Scheme of Arrangement
or any other matter set forth in <B><I><U>&#8206;</U></I></B><U>Section 5.04(a)</U>, including the provision to the Company of such information
and confirmations relating to it, its Subsidiaries and any of its or their respective directors or employees as Company may reasonably
request (including for the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 50; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">purposes of preparing the Scheme Document or any Scheme Supplemental Document) and to do so in a timely manner;
provided that this <B><I><U>&#8206;</U></I></B><U>Section 5.04(b)(ii)</U> shall not require Buyer to provide any information that is commercially
or competitively sensitive or that would result in the loss of any legal privilege, and in such circumstances Buyer shall, to the extent
permitted by Applicable Law, provide such information on an outside counsel only basis;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>review and provide comments (if any) in a reasonably timely manner on all such documentation submitted to it;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iv)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>as promptly as reasonably practicable, notify the Company of any matter of which it becomes actually aware that would reasonably
be expected to materially delay, materially impair or prevent filing of the Scheme Document or the Court Documentation; provided that
any failure to comply with this <U>Section 5.04(b)(iv)</U> shall not constitute a breach or failure to perform by Buyer with respect to
the conditions set forth in <U>Article 6</U>, or give rise to any right of termination under <U>Article 7</U>;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(v)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>as soon as reasonably practicable after the date thereof, apply to His Majesty&rsquo;s Revenue &amp; Customs for confirmation that
the Court Order is not subject to United Kingdom stamp duty or stamp duty reserve tax and include in such application an undertaking to
present the relevant instrument(s) of transfer to His Majesty&rsquo;s Revenue &amp; Customs, together with payment of any applicable stamp
duty, for stamping; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(vi)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>as soon as reasonably practicable following receipt of confirmation from His Majesty&rsquo;s Revenue &amp; Customs referred to
in <B><I><U>&#8206;</U></I></B><U>Section 5.04(b)(v)</U>, deliver a copy of such confirmation to the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding anything to the contrary in this Agreement, Buyer and the Company shall cooperate to schedule and convene the Scheme
Meeting and Company GM for the same date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If either Buyer or the Company (each acting reasonably) considers that an amendment should be made to the provisions of the Scheme
of Arrangement or the Scheme Document in order to implement the Transaction in as efficient a manner as practicable either prior to or
after consideration by the Court (including in respect of any amendment imposed by the Court), it may notify the other Party and the Parties
shall be obliged to consider and negotiate, acting reasonably and in good faith, such amendment; <U>provided</U> that (<U>i)</U> no Party
shall be required to consider and negotiate in good faith any amendment that would materially and adversely affect it, its shareholders
or the likelihood of consummation of the Transaction and (ii) each Party recognizes that any amendments may require the recommencement
of the Court approval process and/or a new notice of the Scheme Meeting or other shareholder circular to be sent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As promptly as reasonably practicable following the date of this Agreement (and in any event within thirty (30) days following
the date hereof), the Company shall (with the participation, assistance and cooperation of Buyer as reasonably requested by the Company)
take all action reasonably necessary to prepare and file with the SEC, in accordance with Applicable Law and the organizational documents
of the Company and its Subsidiaries, as applicable, proxy materials which shall constitute the Scheme Document and the preliminary proxy
statement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 51; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">relating to the Scheme Meeting and the Company GM for the purpose of passing the Company Shareholder Resolutions (such proxy
materials and proxy statement, as amended or supplemented from time to time, the &ldquo;<B>Proxy Statement</B>&rdquo;). The Company shall
use reasonable best efforts to have the Proxy Statement cleared by the SEC as promptly as reasonably practicable after filing. Buyer shall,
upon the Company&rsquo;s request, promptly furnish to the Company all information concerning itself, its Subsidiaries, directors and officers
and (to the extent reasonably available to Buyer or its Subsidiaries) such other information concerning Buyer as may be reasonably necessary
or advisable in connection with any statement, filing, notice or application made to the SEC or NYSE in connection with the Proxy Statement.
Other than in the case of an Adverse Recommendation Change pursuant to <B><U>&#8206;</U></B><U>Section 5.03</U>, no filing of, or amendment
or supplement to, the Proxy Statement will be made by the Company without providing Buyer and its counsel a reasonable opportunity to
review and comment thereon (which comments shall be considered by the Company in good faith). The Company will advise Buyer promptly after
it receives any oral or written request by the SEC for amendment of the Proxy Statement or comments thereon and responses thereto or requests
by the SEC for additional information, and will promptly provide Buyer with copies of any written communication from the SEC or any state
securities commission with respect thereto. Each of the Company and Buyer shall ensure that the information provided by it for inclusion
in the Proxy Statement (and any supplement required thereto) at the time of mailing thereof and at the time of the Scheme Meeting and
the Company GM will not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading, and the Company
will ensure that the Proxy Statement (and any supplement required thereto) at the time of mailing thereof and at the time of the Scheme
Meeting and the Company GM will (with the assistance and cooperation of Buyer as reasonably requested by Company) comply as to form in
all material respects with the provisions of the Securities Act and the Exchange Act and the rules and regulations promulgated thereunder
and any applicable provisions of the Companies Act. If at any time prior to the receipt of the Company Shareholder Approval, any information
relating to the Company, Buyer, or any of their respective Affiliates, officers or directors, should be discovered by the Company or Buyer
that should be set forth in an amendment or supplement to the Proxy Statement, so that it would not include any misstatement of a material
fact or omit to state any material fact necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading, the Party which discovers such information shall promptly notify the other Parties and an appropriate amendment
or supplement describing such information shall promptly be prepared and filed with the SEC and, to the extent required under Applicable
Law, disseminated to the Company Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>For the avoidance of doubt, Buyer may not elect to implement the acquisition of the entire issued share capital of the Company
as contemplated by this Agreement by means of a takeover offer within the meaning of section 974 of the Companies Act, or otherwise announce
any such takeover offer in respect of the Company, at any time without the Company&rsquo;s prior written consent (to be granted in the
Company&rsquo;s sole discretion).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 5.05 <I>Access to
Information</I>. Subject to Applicable Law, <U>&#8206;Section 5.11</U> and <U>&#8206;Section 5.16</U>, upon reasonable notice, throughout
the period starting on the date hereof and ending on the earlier to occur of (x) the Effective Time or (y) the date this Agreement is
terminated in accordance with its terms, the Company shall (and shall cause its Subsidiaries to) afford Buyer and its Representatives
reasonable access during normal business hours to its books, officers, properties,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 52; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Contracts and records, in each case
solely for purposes of effectuating or consummating the transactions contemplated hereby or integration and transition planning relating
thereto. The foregoing shall not require the Company or its Subsidiaries to (a) provide access to any inspection or information that would
violate any of its obligations with respect to confidentiality in effect as of the date hereof (provided that the Company shall use its
commercially reasonable efforts to obtain the required consent of any such counterparty to such access or disclosure, but in no event
shall the Company be obligated to pay any amount of money to any Person to obtain the required consent of such counterparty to such access
or disclosure or otherwise provide), (b) provide access to or otherwise make available or furnish any information if and to the extent
that the provision of such information in the good faith judgment of the Company based on advice of counsel would reasonably be expected
to give rise to the waiver of any attorney-client, work product or other legal privilege or trade secret protection (it being agreed that
the Company shall give notice to Buyer of the fact that it is withholding such information or documents and thereafter the Company and
Buyer shall use their respective commercially reasonable efforts to cause such information (or as much of it as possible) to be provided
in a manner that would not reasonably be expected to violate such restriction or waive the applicable privilege or trade secret protection),
(c) provide access to or otherwise make available or furnish any information relating to the process conducted by the Company, including
negotiations, that led to the execution of this Agreement and the transactions contemplated hereby (other than as required by this Agreement)<FONT STYLE="background-color: white">,
(d)</FONT> provide access to such documents or information that are reasonably pertinent to any adverse Proceeding between the Company
and its Affiliates, on the one hand, and Buyer and its Affiliates, on the other hand<FONT STYLE="background-color: white">, </FONT>(e)
to provide access to or otherwise make available or furnish any information if and to the extent that the provision of such information
could in the judgment of the Company, based on advice of counsel, violate any Applicable Law or would result in a breach of a Contract
to which the Company or any of its Subsidiaries are bound as of the date hereof, or (f) without limiting the obligations of the Company
pursuant to <U>Section 5.02</U>, <U>&#8206;Section 5.03</U> and <U>Section 5.04(e)</U>, any information related to the negotiation and
transactions potentially competing with or alternative to the transactions contemplated by this Agreement or proposals from other third
parties relating to any competing or alternative transactions (including Acquisition Proposals) and the actions of the Company Board (or
any committee thereof) with respect to any of the foregoing (including an Adverse Recommendation Change), whether prior to or after execution
of this Agreement (it being agreed that, in the case of&nbsp;<U>clauses&nbsp;(a)</U>,&nbsp;<U>(b)</U>, <U>(d)</U> and <U>(e)</U>, the
Company shall give notice to Buyer of the fact that it is withholding such information or documents and thereafter the Company and Buyer
shall use their respective commercially reasonable efforts to cause such information to be provided in a manner that would not reasonably
be expected to violate such restriction, policy or Applicable Law or waive the applicable privilege or protection). Notwithstanding anything
herein to the contrary, (i) Buyer shall not, and shall cause its Representatives not to, contact any employee of the Company not involved
in the negotiation of the transactions contemplated by this Agreement or any customer, technology or other partner, vendor or supplier
of the Company in connection with the Transaction or any of the other transactions contemplated by this Agreement, in each case without
the Company&rsquo;s prior written consent, and Buyer acknowledges and agrees that any such contact shall be arranged and supervised by
Representatives of the Company, (ii) any such access shall be conducted in such a manner as not to interfere with the normal business
or operations of the Company or its Subsidiaries and (iii) in no event shall Buyer or any of its representatives be permitted to conduct
any sampling of soil, sediment, ground water, surface water or building material in connection with any access pursuant to this <U>&#8206;Section
5.05</U> and (iv) no inspection or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 53; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">investigation pursuant to this <U>Section 5.05</U> shall affect or be deemed to modify any representation
or warranty made by the Company herein. Each of Buyer and the Company, as it deems advisable and necessary, may reasonably designate commercially
sensitive material provided to the other as &ldquo;Outside Counsel Only Material&rdquo; or with similar restrictions, and such materials
and the information contained therein shall be given only to the outside counsel of the recipient, or otherwise as the restriction indicates,
and be subject to any additional confidentiality or joint defense agreement between the parties. Nothing in this <U>&#8206;Section 5.05</U>
will be construed to require the Company, any of its Subsidiaries or any of their respective Representatives to prepare any reports, analyses,
appraisals, opinions or other information. Any access to the properties of the Company and its Subsidiaries will be subject to the Company&rsquo;s
reasonable security measures, policies and insurance requirements. All requests for information made pursuant to this <U>&#8206;Section
5.05</U> shall be directed to the General Counsel or other Person designated by the Company. All such information shall be deemed Confidential
Information (as defined in the Confidentiality Agreement) under and be governed by the terms of the Confidentiality Agreement. Notwithstanding
anything to the contrary in the Confidentiality Agreement, from and after the date hereof, no consent of the Company or any of its Affiliates
shall be required for any Person who is a potential source of, or may provide equity, debt or any other type of financing, in each case,
to become a Representative (as defined in the Confidentiality Agreement) of Wynnchurch thereunder; provided that Wynnchurch shall provide
reasonable prior written notice to the Company identifying such Person and such Person shall be subject to the terms as a Representative
(as defined in the Confidentiality Agreement) thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.06</FONT> <I>Notice of Certain Events</I>. Each of the Company and Buyer will give prompt notice to the other (and will subsequently
keep the other informed on a reasonably current basis of any material developments related to such notice) upon its becoming aware of
the occurrence or existence of any fact, event or circumstance that (a) with respect to the Company, has had or would reasonably be expected
to have a Company Material Adverse Effect, (b) with respect to Buyer, has had or would reasonably be expected to have a Buyer Material
Adverse Effect and/or (c) is reasonably likely to result in any of the conditions set forth in <U>&#8206;Article 6</U> not being able
to be satisfied prior to the End Date. No notification given by any party pursuant to this <U>&#8206;Section 5.06</U> shall limit or
otherwise affect any of the representations, warranties, covenants, obligations or conditions contained in this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.07</FONT> <I>Employee Matters</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>For a period of not less than twelve (12) months after the Closing Date (or until the termination of employment of the relevant
Continuing Employee, if sooner), Buyer shall, or shall cause one of its Subsidiaries (including the Company following the Closing Date)
to, provide each employee of the Company or its Subsidiaries immediately before the Effective Time who continues employment with Buyer
or any Subsidiary of Buyer following the Closing Date (each a &ldquo;<B>Continuing Employee</B>&rdquo;) with (i) at least the same base
salary or base hourly rate as was provided to each such Continuing Employee immediately prior to the Closing Date, (ii) short-term incentive
compensation opportunities (including, annual target cash bonus and commission opportunities, but excluding long-term compensation opportunities
and equity or equity-based compensation) that are at least as favorable, in the aggregate, as the short-term incentive compensation opportunities
that were provided to each such Continuing Employee immediately prior to the Closing Date, (iii) severance entitlements that are no less
favorable to each such Continuing</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 54; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Employee&rsquo;s entitlements as in effect as of immediately prior to the Closing Date, and (iv) other
employee benefits, (excluding, for this <U>clause (iv)</U>, long-term incentive compensation opportunities (including equity and equity-based
compensation), severance, nonqualified deferred compensation, defined benefit pension, and post-termination or retiree welfare benefits
(together, the &ldquo;<B>Excluded Benefits</B>&rdquo;)) that are substantially comparable in the aggregate to those provided under a Company
Employee Plan to each such Continuing Employee immediately prior to the Closing Date (subject to the same exclusions).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From and after the Closing Date, Buyer shall, or shall cause one of its Subsidiaries (including the Company following the Closing
Date) to, cause the service of each Continuing Employee to be recognized for purposes of eligibility to participate and vesting, levels
of paid time off benefits (but not for benefit accruals under any defined benefit pension plan or for any purpose under any Excluded Benefit)
and vesting under each compensation, severance, retirement, vacation, paid time off, fringe or other welfare benefit plan, program or
arrangement of Buyer, the Company or any of their Subsidiaries (collectively, the &ldquo;<B>Buyer Benefit Plans</B>&rdquo;), but not including
any equity compensation plans, programs, agreements or arrangements or any nonqualified deferred compensation, defined benefit pension,
and post-termination or retiree welfare benefits or other Excluded Benefit, in which any Continuing Employee is or becomes eligible to
participate, but solely to the extent service was credited to such employee for such purposes under a comparable Company Employee Plan
immediately prior to the Closing Date and only to the extent such credit would not result in a duplication of benefits or compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From and after the Closing Date, with respect to each Buyer Benefit Plan that is an &ldquo;employee welfare benefit plan&rdquo;
as defined in Section 3(1) of ERISA that is a group health plan in which any Continuing Employee is or becomes eligible to participate
in the plan year in which the Closing occurs, Buyer shall, or shall cause one of its Subsidiaries (including the Company following the
Closing Date) to, use commercially reasonable efforts to cause each such Buyer Benefit Plan that is a group health plan to, for the plan
year in which the Closing occurs, (i) waive all limitations as to pre-existing conditions, waiting periods, required physical examinations
and exclusions with respect to participation and coverage requirements applicable under such Buyer Benefit Plan for such Continuing Employees
and their eligible dependents to the same extent that such pre-existing conditions, waiting periods, required physical examinations and
exclusions would not have applied or would have been waived under the corresponding Company Employee Plan in which such Continuing Employee
was a participant immediately prior to his or her commencement of participation in such Buyer Benefit Plan; <U>provided</U>, <U>however</U>,
that for purposes of clarity, to the extent such benefit coverage includes eligibility conditions based on periods of employment, <B><U>&#8206;</U></B><U>Section
5.07(a)</U> shall control; and (ii) provide each Continuing Employee and their eligible dependents with credit for any co-payments and
deductibles paid in the calendar year that, and prior to the date that, such Continuing Employee commences participation in such Buyer
Benefit Plan in satisfying any applicable co-payment, deductible or out-of-pocket maximum requirements under such Buyer Benefit Plan for
the applicable calendar year, to the extent that such expenses were recognized for such purposes under the comparable Company Employee
Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Nothing in this <B><U>&#8206;</U></B><U>Section 5.07</U> or this Agreement shall be deemed to: (i) guarantee employment for any
period of time or preclude the ability of Buyer, the Company or their respective Subsidiaries to terminate the employment of any Continuing
Employee; (ii) establish, terminate or amend any Buyer Benefit Plan or Company Employee Plan, or limit the ability of</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 55; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Buyer or any of
its Affiliates (including following the Closing the Company or any of its Subsidiaries) to modify, amend or terminate any benefit or compensation
plan, program, contract, policy, agreement or arrangement; or (iii) require Buyer, the Company or any of their Affiliates to continue
or amend any particular benefit plan before or after the consummation of the transactions contemplated in this Agreement, and any such
plan may be amended or terminated in accordance with its terms and Applicable Law. Nothing in this <U>Section 5.07</U> shall create any
rights or remedies (including any third-party beneficiary rights) in any Person not a Party. Notwithstanding anything in this Agreement
to the contrary, the terms and conditions of employment for any Continuing Employees covered by a Labor Agreement shall be governed by
the applicable Labor Agreement until the expiration, modification or termination of such Labor Agreement in accordance with its terms
or applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.08</FONT> <I>Takeover Laws</I>. If any &ldquo;control share acquisition,&rdquo; &ldquo;fair price,&rdquo; &ldquo;moratorium&rdquo; or
other anti-takeover Applicable Law becomes or is deemed to be applicable to the Company, Buyer or the Transaction or any other transaction
contemplated by this Agreement, then each of the Company, Buyer and their respective Boards of Directors shall grant such approvals and
take such actions within their respective authority as are necessary so that the transactions contemplated by this Agreement may be consummated
as promptly as practicable on the terms contemplated by this Agreement and otherwise act to render such anti-takeover Applicable Law
inapplicable to the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.09</FONT> <I>Voting of Shares</I>. Buyer shall vote, or cause to be voted, any Company Ordinary Shares beneficially owned by it or any
of its Affiliates in favor of approving the Scheme of Arrangement and passing the Company Shareholder Resolutions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.10</FONT> <I>Director and Officer Liability</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>For six (6) years after the Effective Time, Buyer shall cause to be maintained officers&rsquo; and directors&rsquo; liability insurance
in respect of acts, errors or omissions occurring prior to the Effective Time covering each such person currently covered by the Company&rsquo;s
officers&rsquo; and directors&rsquo; liability insurance policy on terms with respect to coverage and amount no less favorable than those
of such policy in effect as of the date of this Agreement; <U>provided</U>, <U>however</U>, that in satisfying its obligation under this
<B><U>&#8206;</U></B><U>Section 5.10(a)</U>, Buyer shall not be obligated to pay annual premiums in excess of 300% of the amount paid
by the Company for coverage in its last full fiscal year for such insurance (the &ldquo;<B>Current Premium</B>&rdquo;) and if such premiums
for such insurance would at any time exceed 300% of the Current Premium, then Buyer shall cause to be maintained policies of insurance
that, in Buyer&rsquo;s good faith judgment, provide the maximum coverage available at an annual premium equal to 300% of the Current Premium.
The provisions of the immediately preceding sentence shall be deemed to have been satisfied if prepaid &ldquo;tail&rdquo; or &ldquo;runoff&rdquo;
policies have been obtained by the Company prior to or after the Effective Time, which policies provide such persons currently covered
by such policies with coverage for an aggregate period of up to six (6) years with respect to claims arising from acts, errors or omissions
that occurred on or before the Effective Time, including in respect of the transactions contemplated by this Agreement; <U>provided</U>
that such premiums for such insurance do not exceed 300% of the Current Premium with respect to each such coverage. The Company may also
purchase prepaid &ldquo;tail&rdquo; or &ldquo;runoff&rdquo; policies for any other &ldquo;claims-made&rdquo; liability insurance coverage,
including employment practices liability, professional liability and cyber and data security liability coverages; <U>provided</U> that
such</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 56; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">premiums for such insurance do not exceed 300% of the amount paid by the Company for coverage in its last full fiscal year for such
insurance (&ldquo;<B>Other Tail Premium</B>&rdquo;), and if such premiums for such insurance exceed 300% of the Other Tail Premium with
respect to each such coverage, then the Company may procure prepaid &ldquo;tail&rdquo; or &ldquo;runoff&rdquo; policies that, in the Company&rsquo;s
good faith judgment (following consultation with and the prior written approval of Buyer (which consent shall not be unreasonably withheld,
conditioned or delayed)), provide the maximum coverage available with such limit. If any such prepaid policies described in this <B><U>&#8206;</U></B><U>Section
5.10(a)</U> have been obtained by the Company prior to the Effective Time, then Buyer shall make reasonable best efforts to cause to be
maintained any and all such policies in full force and effect for their full term, and continue to honor the obligations thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From and after the Effective Time, each of Buyer and the Company shall cause the Company to: (i) indemnify (including advancement
of expenses) and hold harmless each individual who at the Effective Time is, or at any time prior to the Effective Time was, a director
or officer of the Company or any of its Subsidiaries or otherwise (each an &ldquo;<B>Indemnified Party</B>&rdquo;) for any and all costs
and expenses (including reasonable and documented out-of-pocket fees and expenses of legal counsel, which shall be advanced as they are
incurred; <U>provided</U> that the Indemnified Party shall have made a sufficient undertaking to repay such expenses if it is ultimately
determined that such Indemnified Party was not entitled to indemnification), judgments, fines, penalties or liabilities (including amounts
paid in settlement or compromise) imposed upon or incurred by such Indemnified Party in connection with or arising out of any action,
suit or other Proceeding (whether civil or criminal) in which such Indemnified Party may be involved or with which he or she may be threatened
(regardless of whether as a named party or as a participant other than as a named party, including as a witness) (an &ldquo;<B>Indemnified
Party Proceeding</B>&rdquo;) (A) by reason of such Indemnified Party&rsquo;s being or having been such director, officer or employee of
the Company or any of its Subsidiaries or otherwise in connection with any action taken or not taken at the request of the Company or
any of its Subsidiaries or (B) arising out of such Indemnified Party&rsquo;s service in connection with any other corporation or organization
for which he or she serves or has served as a director, officer, employee, agent, trustee or fiduciary at the request of the Company (including
in any capacity with respect to any employee benefit plan), in each of (A) or (B), whether or not the Indemnified Party continues in such
position at the time such Indemnified Party Proceeding is brought or threatened and at, or at any time prior to, the Effective Time (including
any Indemnified Party Proceeding relating in whole or in part to the transactions contemplated by this Agreement or relating to the enforcement
of this provision or any other indemnification or advancement right of any Indemnified Party), to the fullest extent permitted under Applicable
Law; and (ii) fulfill and honor in all respects the obligations of the Company pursuant to: (x) each indemnification provision set forth
in any Contract in effect as of the date hereof between the Company or any of its Subsidiaries and any Indemnified Party; and (y) any
indemnification provision (including advancement of expenses) and any exculpation provision set forth in the articles of association,
certificate of incorporation, bylaws or similar organizational documents of the Company or any of its Subsidiaries as in effect on the
date hereof. Buyer&rsquo;s obligations under the foregoing <U>clauses (i)</U> and <U>(ii)</U> shall continue in full force and effect
for a period of six (6) years from the Effective Time; <U>provided</U>, <U>however</U>, that all rights to indemnification, exculpation
and advancement of expenses in respect of any claim asserted or made within such period shall continue until the final disposition of
such claim. From and after the Effective Time, Buyer shall guarantee the prompt payment of its obligations under this <B><U>&#8206;</U></B><U>Section
5.10</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 57; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>During the period commencing at the Effective Time and ending on the sixth (6th) anniversary of the Effective Time, Buyer shall
cause the organizational documents of the Company and any of its successors or assigns to contain provisions with respect to indemnification,
exculpation and the advancement of expenses that are at least as favorable to those subject to those provisions as the indemnification,
exculpation and advancement of expenses provisions set forth in the organizational documents of the Company as of the date hereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If Buyer, the Company or any of their respective successors or assigns (i) consolidates with or merges into any other Person and
shall not be the continuing or surviving corporation or entity of such consolidation or merger or (ii) transfers or conveys all or substantially
all of its properties and assets to any Person, then, in each such case proper provision shall be made so that the successors and assigns
of Buyer or the Company, as the case may be, shall assume the obligations set forth in this <B><U>&#8206;</U></B><U>Section 5.10</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The provisions of this <B><U>&#8206;</U></B><U>Section 5.10</U> are (i) intended to be for the benefit of, and shall be enforceable
by, each Indemnified Party, his or her heirs and (ii) in addition to, and not in substitution for, any other rights to indemnification
or contribution that any such individual may have under any certificate of incorporation or bylaws, by contract or otherwise. The obligations
of Buyer under this <B><U>&#8206;</U></B><U>Section 5.10</U> shall not be terminated or modified in such a manner as to adversely affect
the rights of any Indemnified Party unless (x) such termination or modification is required by Applicable Law or (y) the affected Indemnified
Party shall have consented in writing to such termination or modification (it being expressly agreed that the Indemnified Parties shall
be third party beneficiaries of this <B><U>&#8206;</U></B><U>Section 5.10</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.11</FONT> <I>Best Efforts</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company and Buyer shall use, and shall cause their Subsidiaries to use, their best efforts to consummate and make effective
the Transaction and the other transactions contemplated by this Agreement as promptly as possible after the date hereof, including the
obtaining of all necessary actions or non-actions, waivers, consents approvals, and confirmations of non-jurisdiction from Governmental
Authorities and the making of all necessary registrations and filings (including filings with Governmental Authorities, if any) and the
taking of all steps as may be necessary or advisable to obtain such approval or waiver from, or to avoid a Proceeding by, any Governmental
Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In furtherance and not in limitation of the foregoing, each of the Company and Buyer (and their respective Subsidiaries, if applicable)
shall: (i) promptly, but in no event later than ten (10) Business Days after the date hereof, file any and all notices, reports and other
documents required to be filed by such party under the HSR Act with respect to the Transaction and the other transactions contemplated
by this Agreement and shall use best efforts to promptly secure the expiration or termination of any applicable waiting periods under
the HSR Act, and the Parties agree the filings shall not include a request for early termination of the waiting period; (ii) as promptly
as reasonably practical make all filings, and use best efforts to timely obtain all consents, permits, authorizations, waivers, clearances,
approvals and confirmations of non-jurisdiction, as applicable, and use best efforts to cause the expiration or termination of any applicable
waiting periods, as may be required under any Foreign Investment Laws as set forth in <U>Section 3.03</U> of the Company Disclosure Schedule;
(iii) as promptly as reasonably practicable</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 58; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">provide such information as may reasonably be requested by the U.S. Department of Justice
(the &ldquo;<B>DOJ</B>&rdquo;) or the Federal Trade Commission (the &ldquo;<B>FTC</B>&rdquo;) under the HSR Act or by any other Governmental
Authority, including under any Antitrust Laws or Foreign Investment Laws in connection with the Transaction and the other transactions
contemplated by this Agreement, as well as any information required to be submitted to comply with a request for additional information
in order to commence or end a statutory waiting period; and (iv) promptly take any and all actions and steps requested or required by
any Governmental Authority as a condition to granting any consent, permit, authorization, waiver, clearance, approvals, and confirmations
of non-jurisdiction and to cause the prompt expiration or termination of any applicable waiting period and to resolve such objections,
if any, as the FTC and the DOJ, or other Governmental Authorities of any other jurisdiction for which consents, permits, authorizations,
waivers, clearances, approvals and expirations or terminations of waiting periods are required with respect to the Transaction and the
other transactions contemplated by this Agreement; <U>provided</U> that the Company and its Subsidiaries will only be required to take
or commit to take any such action, or agree to any such condition or restriction, if such action, commitment, agreement, condition or
restriction is binding on the Company or its Subsidiaries only in the event the Closing occurs. Buyer shall pay all filing fees under
the HSR Act and the Foreign Investment Laws, and the Company shall not be required to pay any fees or other payments to any Governmental
Authority in connection with any filings under the HSR Act and the Foreign Investment Laws, in connection with the Transaction or the
other transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Without limiting the generality of anything contained in this <B><U>&#8206;</U></B><U>Section 5.11</U>, each Party shall: (i) give
the other Party prompt notice of the making or commencement of any request, inquiry or Proceeding by any Governmental Authority with respect
to the Transaction and the other transactions contemplated by this Agreement; (ii) keep the other Party reasonably informed as to the
status of any such request, inquiry or Proceeding; (iii) promptly inform the other Party of any communication to or from the FTC, DOJ
or any other Governmental Authority to the extent regarding the Transaction and the other transactions contemplated by this Agreement,
or regarding any such request, inquiry or Proceeding, and provide a copy of all written communications; and (iv) pull and re-file any
notice under the HSR Act, extend any waiting period, or enter into an agreement not to consummate the Transaction for a period of time
only with the prior written consent of the other Party. Subject to Applicable Law, in advance and to the extent practicable, each of Buyer
or the Company, as the case may be, will consult the other on all the information relating to Buyer or the Company, as the case may be,
and any of their respective Subsidiaries that appear in any filing made with, or written materials submitted to, any third party and/or
any Governmental Authority in connection with the Transaction and the other transactions contemplated by this Agreement and shall incorporate
all comments reasonably proposed by the other Party, as the case may be. In addition, except as may be prohibited by any Governmental
Authority or by any Applicable Law, in connection with any such request, inquiry or Proceeding in respect of the Transaction and the other
transactions contemplated by this Agreement, each Party will permit authorized Representatives of the other Party to be present at each
meeting or conference relating to such request, inquiry or Proceeding and to have access to and be consulted in connection with any document,
opinion or proposal made or submitted to any Governmental Authority in connection with such request, inquiry or Proceeding. The Parties
shall jointly develop, consult and cooperate with one another regarding the strategy for obtaining any necessary approval of, or responding
to any request from, inquiry by, or investigation by (including directing the timing, nature and substance of all such responses) any
third party and/or Governmental Authority</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 59; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">in connection with this Agreement and the other transactions contemplated by this Agreement,
including determining the timing and content of any registrations, filings, agreements, forms, notices, petitions, statements, submissions
of information, applications and other documents, communications and correspondence contemplated by, made in accordance with, or subject
to this <B><U>&#8206;</U></B><U>Section 5.11</U>, provided that Buyer shall have final decision making authority with respect to all such
strategy. Notwithstanding anything to the contrary in this <B><U>&#8206;</U></B><U>Section 5.11</U>, each Party may redact materials provided
to the other party: (i) to remove competitively sensitive information or information concerning valuation, (ii) as necessary to comply
with legal or contractual arrangements and (iii) as necessary to address reasonable attorney-client privilege or other privilege or confidentiality
concerns (provided that, subject to applicable legal requirements, such material shall be provided to the other party&rsquo;s counsel
on an &ldquo;external counsel&rdquo; basis); <U>provided further</U> that the Parties shall not be required to share filings made under
the HSR Act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In furtherance and not in limitation of the foregoing, Buyer agrees to promptly take, and to cause its Subsidiaries to take, any
and all steps necessary or advisable to avoid, eliminate or resolve each and every impediment and obtain all clearances, consents, approvals,
confirmations of non-jurisdiction and waivers under Antitrust Laws and Foreign Investment Laws, so as to enable the Parties to consummate
the Transaction and the other transactions contemplated by this Agreement as soon as practicable (and in any event no later than the End
Date), including committing to or effecting, by consent decree, hold separate order, trust, or otherwise, the sale, divestiture, license,
transfer, assignment or other disposition of, and agreeing to any behavioral undertaking, conditions, obligations, commitments, mitigations
or restrictions with respect to, assets or businesses of the Company or its Subsidiaries, and stipulate to the entry of an Order or file
appropriate applications with any Governmental Authority in connection with any of the foregoing (each action contemplated, a &ldquo;<B>Divestiture
Action</B>&rdquo;), in each case, as may be necessary or required, to avoid the entry of, or to effect the dissolution of or vacate or
lift, any Order or Proceeding that would otherwise have the effect of preventing consummation of the Transaction and the other transactions
contemplated by this Agreement, and to ensure that no Governmental Authority with the authority to clear, authorize or otherwise approve
consummation of the Transaction or the other transactions contemplated by this Agreement, fails to do so as promptly as practicable and
in any event no later than the End Date, provided that nothing in this Agreement shall require Buyer to take any action pursuant to this
<U>Section 5.11(d)</U> that would, individually or in the aggregate, materially impair Buyer&rsquo;s expected financial benefits of the
Transaction or result in a Company Material Adverse Effect. Buyer and the Company shall cooperate in any proposal, negotiation, or offer
to commit and to effect, by consent decree, hold separate order or otherwise, any and all Divestiture Actions or otherwise to offer to
take or offer to commit (and if such offer is accepted, commit to and effect) to take any Divestiture Action as may be required to resolve
any Governmental Authority&rsquo;s objections to the Transaction and the other transactions contemplated by this Agreement; <U>provided</U>,
<U>however</U>, that the Company shall not be required to take any Divestiture Action that is not conditioned upon consummation of the
Transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Buyer shall not, nor shall it permit its Subsidiaries to, acquire, whether by merging with or into, consolidating with, purchasing
all or a portion of the assets of or all or a portion of the equity in, or otherwise, any business or corporation, partnership, or other
business organization or division thereof or other Person (i) that owns, controls, or operates a business engaged in any line of business
in which the Company or any of its Subsidiaries is engaged, or (ii) if such acquisition would reasonably be expected to, (A) impose any
material delay in the obtaining of, or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 60; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">materially increase the risk of not obtaining, the expiration, termination or waiver of any applicable
waiting period or any consent, approval, permit, ruling, authorization, clearance or other approval pursuant to the Antitrust Laws and
Foreign Investment Laws necessary to consummate the transactions contemplated hereby by the End Date, (B) materially increase the risk
of any Governmental Authority entering an Order prohibiting the consummation of the transactions contemplated hereby, including the Transaction
by the End Date, (C) materially increase the risk of not being able to remove any such Order on appeal or otherwise by the End Date, (D)
delay, impair, impede, hinder, adversely affect or prevent the consummation of the transactions contemplated hereby, including the Transaction,
by the End Date, or (E) cause any of the conditions set forth in <B><U>&#8206;</U></B><U>Article 6</U> to fail to be satisfied or delay,
impair, impede, hinder, adversely affect or prevent the ability of Buyer to consummate the transactions contemplated by this Agreement
by the End Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.12</FONT> <I>Transaction Litigation</I>. The Company shall as promptly as reasonably practicable (and in any event within forty-eight
(48) hours of learning of any Transaction Litigation) notify Buyer in writing of (including by providing copies of all pleadings with
respect thereto), and shall give Buyer a reasonable opportunity to participate in the defense and settlement of, any Transaction Litigation.
For purposes of this <U>&#8206;Section 5.12</U>, &ldquo;participate&rdquo; means that the Company shall keep Buyer reasonably apprised
of any material development and the proposed strategy and other significant decisions with respect to any Transaction Litigation and
provide Buyer with copies of any proposed litigation papers at least forty-eight (48) hours prior to the Company filing any such papers
(to the extent that the attorney-client privilege is not undermined or otherwise adversely affected), promptly provide Buyer with copies
of all litigation papers filed in any Transaction Litigation, provide the opportunity for Buyer to offer advice, comments or suggestions
with respect to such Transaction Litigation which the Company shall consider in good faith, provide Buyer and its counsel the opportunity
to participate with the Company in the defense, release, compromise, waiver or settlement of any Transaction Litigation, and jointly
cooperate with Buyer in the proposed strategy and any other significant decisions with respect to the Transaction Litigation by the Company,
with no such significant decisions being made without the prior written consent of the other. The Company shall not settle or agree to
settle any such Transaction Litigation without Buyer&rsquo;s prior written consent (which consent shall not be unreasonably withheld,
conditioned or delayed). Without otherwise limiting the Indemnified Parties&rsquo; indemnification rights, following the Effective Time,
any Indemnified Party that is made party to any Transaction Litigation shall be entitled to participate in, but not control, the defense
of such Transaction Litigation with counsel selected by such Indemnified Party that is acceptable to Buyer in its reasonable discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.13</FONT> <I>Public Announcements</I>. The initial press release relating to this Agreement shall be a joint press release issued by
the Company and Buyer, and thereafter, except with respect to any Adverse Recommendation Change or announcement made with respect to
any Acquisition Proposal, Superior Proposal or related matters in accordance with the terms of this Agreement (in the case of the Company,
in each case that complies with <U>Section 5.02</U> and <U>&#8206;Section 5.03</U>), the Company and Buyer shall consult with each other
before issuing any press release or making any other public announcements, or scheduling a press conference or conference call with investors
or analysts, with respect to this Agreement or the transactions contemplated by this Agreement and shall not issue any such press release
or make any such other public announcement without the prior consent of the other Party, which consent shall not be unreasonably withheld,
conditioned or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 61; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">delayed, except as such release or announcement may be required by Applicable Law or any listing agreement under which or rule of any
national securities exchange or association upon which the securities of the Company are listed, in which case the Party required to make
the release or announcement shall consult with the other Party about, and allow the other Party reasonable time (taking into account the
circumstances) to comment on, such release or announcement in advance of such issuance; provided, however, that notwithstanding the foregoing
and for the avoidance of doubt, the Company shall not be required to consult with Buyer before issuing any press release or making any
other public statement (x) solely to the extent expressly permitted under <U>&#8206;Section 5.03</U>, with respect to its receipt and
consideration of any Acquisition Proposal, Superior Proposal or &ldquo;stop-look-and-listen&rdquo; communication or similar communication
of the type contemplated by Rule 14d-9(f) under the Exchange Act, or (y) disseminating any communications principally directed to employees,
customers, partners or vendors so long as such communications are in compliance with this Agreement (including <U>&#8206;Section 5.05</U>)
or substantively consistent with (and do not add additional material information to) previous releases, public disclosures, public statements
or other communications made by the Parties not in violation of this Agreement. Notwithstanding anything to the contrary contained herein,
nothing in this <U>&#8206;Section 5.13</U> shall limit the ability of Buyer or the Equity Investor to make customary communications that
are principally directed to any existing or prospective general or limited partners, equity financing sources, equity holders, members
and investors of Buyer, the Equity Investor or any of their respective Affiliates with respect to fundraising, marketing, informational
or reporting activities, in each case, who are subject to confidentiality obligations to Buyer, the Equity Investor or their respective
Affiliates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.14</FONT> <I>Section 16 Matters</I>. Prior to the Effective Time, the Company shall take all such steps as may be reasonably required
to cause any dispositions of Company Ordinary Shares (including the disposition, cancellation or deemed disposition of the Company Equity
Awards) resulting from the transactions contemplated by this Agreement by each individual who is subject to the reporting requirements
of Section 16(a) of the Exchange Act with respect to the Company to be exempt under Rule 16b-3 promulgated under the Exchange Act, to
the extent permitted by Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.15</FONT> <I>Financing</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>From the date of this Agreement until the earlier of the date of the termination of this Agreement and the Closing Date, Buyer
shall use its reasonable best efforts to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary,
proper or advisable to obtain the proceeds of the Financing (after giving effect to all other available sources of cash) in an amount
sufficient to fund the Financing Amounts on the date on which the Closing is required to occur pursuant to the terms hereof, including
using its reasonable best efforts to (i) maintain in full force and effect the Financing Commitment Letters in accordance with the terms
thereof, (ii) negotiate and enter into the definitive documentation related to the Debt Financing (the &ldquo;<B>Debt Financing Documents</B>&rdquo;),
in each case, on terms and conditions not materially less favorable, in the aggregate, than those contained in the Debt Commitment Letter
(including any &ldquo;market flex&rdquo; provisions contained in any related fee letter), (iii) satisfy on a timely basis or obtain a
waiver of all conditions required to be satisfied by it in the Financing Commitment Letters and the Debt Financing Documents that are
within its control and comply with its obligations thereunder; and (iv) enforce its rights under the Financing Commitment Letters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 62; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->58<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Buyer shall keep the Company informed on a reasonable basis and in reasonable detail of the status of its efforts to arrange the
Financing. Buyer shall reasonably promptly notify the Company of any actual or threatened (in writing) material violation, material breach,
material default, termination, withdrawal or repudiation by any party to the Financing Commitment Letters of which Buyer becomes aware.
In the event that any portion of the Debt Financing required to pay the Financing Amounts becomes unavailable (or Buyer determines in
good faith that it will not be available) after taking into account the available portion of the Financing in an amount less than the
Financing Amounts (after giving effect to all other available sources of cash), Buyer shall promptly notify the Company and shall (i)
use its reasonable best efforts to arrange for alternative financing from the same or alternative sources (the &ldquo;<B>Alternative Financing</B>&rdquo;)
(x) on terms and conditions not materially less favorable, in the aggregate, to Buyer than those contained in the Debt Commitment Letter
(including any &ldquo;market flex&rdquo; provisions contained in any related fee letter) and (y) in an amount sufficient, when taken together
with the available portion of the Financing, to pay the Financing Amounts (after giving effect to all other available sources of cash)
and (ii) provide the Company with a true and complete copy of any new debt commitment letter that provides for such Alternative Financing
(it being understood that any fee letter in connection therewith may be redacted in a manner consistent with <B><U>&#8206;</U></B><U>Section
4.08</U>). Notwithstanding anything to the contrary contained in this Agreement, nothing contained in this <B><U>&#8206;</U></B><U>Section
5.15</U> shall require, and in no event shall the reasonable best efforts of Buyer be deemed or construed to require, Buyer to (i) seek
the Equity Financing from any source other than a counterparty (or an affiliate of a counterparty) to, or in any amount in excess of that
contemplated by, the Equity Commitment Letter, (ii) pay any fees or other amounts applicable to the Debt Financing in excess of those
contemplated by the Debt Commitment Letter (after giving effect to the &ldquo;market flex&rdquo; provisions in any related fee letter)
or (iii) agree to any terms less favorable to Buyer than as set forth in the Debt Commitment Letter as of the date of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Without prior written consent of the Company, Buyer shall not amend, modify, or waive any provision under, the Financing Commitment
Letters if such amendment, modification or waiver would (i) reduce the aggregate principal amount of the Financing below the amount necessary
to satisfy the Financing Amounts (after taking into consideration the amount of the remaining Financing and available cash of the Company
and its Subsidiaries), (ii) add new conditions precedent or otherwise adversely modify any of the conditions precedent to the funding
or investing of the Financing on the Closing Date as set forth in the Financing Commitment Letters on the date hereof, (iii) reasonably
be expected to materially delay, impede or prevent the availability of all or a portion of the Financing on the Closing Date in an amount
necessary to satisfy the Financing Amounts (after taking into consideration the amount of the remaining Financing and available cash of
the Company and its Subsidiaries) or the consummation of the Closing and the transactions contemplated hereby, or (iv) adversely affect
the ability of Buyer to enforce its rights against the other parties to the Financing Commitment Letters or the Debt Financing Documents;
<U>provided</U>, that Buyer may amend or otherwise modify the Debt Commitment Letter without the consent from the Company to (A) add (or
assign or reassign commitments and roles to) lenders, lead arrangers, bookrunners, syndication agents or similar entities that have not
executed the Debt Commitment Letter as of the date hereof or (B) correct typographical errors. Buyer shall reasonably promptly provide
the Company with a true and complete copy of any such amendment, modification or waiver (which may be redacted in a manner consistent
with <U>Section 4.08</U>).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 63; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->59<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>To the extent Buyer obtains Alternative Financing or amends, modifies or waives any of the Financing Commitment Letters, in each
case pursuant to this <B><U>&#8206;</U></B><U>Section 5.15</U>, references to the &ldquo;Financing,&rdquo; &ldquo;Debt Financing,&rdquo;
&ldquo;Equity Financing,&rdquo; &ldquo;Debt Financing Sources,&rdquo; &ldquo;Debt Financing Sources Related Parties,&rdquo; &ldquo;Debt
Commitment Letter,&rdquo; &ldquo;Equity Commitment Letter,&rdquo; and &ldquo;Financing Commitment Letters&rdquo; (and other like terms
in this Agreement) shall be deemed to refer to such Alternative Financing, the financing sources and/or their related parties in respect
thereof, the commitments thereunder and the agreements with respect thereto, or the Financing as so amended, modified or waived.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Prior to the Closing, the Company shall use its reasonable best efforts to, and cause its Subsidiaries and each of its and its
Subsidiaries&rsquo; respective Representatives to use their respective reasonable best efforts to, provide at Buyer&rsquo;s sole cost
and expense customary cooperation reasonably requested by Buyer in connection with arranging, obtaining and syndicating the Debt Financing,
including using reasonable best efforts to: (i) as promptly as practicable furnish Buyer with the Required Financial Information and other
information regarding the Company and its Subsidiaries and their respective businesses, (ii) assist Buyer and the Debt Financing Sources
in their preparation of customary syndication and marketing materials, bank information memoranda, rating agency presentations, lender
presentations and similar documents and any supplements thereto in connection with the Debt Financing, (iii) (A) cooperate with the marketing
efforts for the Debt Financing and (B) assist Buyer in obtaining ratings in connection with the Debt Financing, (iv) cause members of
senior management of the Company to participate in a reasonable number of meetings, conference calls, presentations, road shows, drafting
sessions, due diligence sessions and sessions with rating agencies, at reasonable times and with reasonable advance notice, (v) facilitate
the pledging of collateral and granting of guarantees for the Debt Financing, including using reasonable best efforts to deliver any original
stock certificates and appropriate instruments of transfer and any original promissory notes and appropriate instruments of transfer that
are intended to constitute collateral for the Debt Financing and to obtain releases of existing Liens; it being understood, in each case,
that the effectiveness of such pledges and guarantees shall be conditioned upon the occurrence of, and are only effective as of or after,
the Closing, (vi) furnish Buyer and the Debt Financing Sources at least five (5) Business Days prior to the Closing Date (solely to the
extent requested by Buyer in writing at least eight (8) Business Days prior to the Closing Date) with all documentation and other information
related to the Company and its Subsidiaries required by applicable &ldquo;know your customer&rdquo; and anti-money laundering rules and
regulations, including without limitation the USA Patriot Act and a beneficial ownership certificate for any entity that qualifies as
a &ldquo;legal entity customer&rdquo; under the Beneficial Ownership Regulation (31 C.F.R. &sect; 1010.230), (vii) facilitate the taking
of customary corporate approvals reasonably requested by Buyer to permit the consummation of the Debt Financing on the Closing Date (it
being understood that no such corporate or other action will take effect prior to the occurrence of, and are only effective as of or after,
the Closing), (viii) assist Buyer in its preparation of, and facilitate execution and delivery as of but not prior to the Closing of,
definitive financing documents (including any guarantee, pledge and security documents, currency or interest rate hedging arrangement,
other definitive financing documents or other certificates or documents as may be reasonably requested by Buyer or the Debt Financing
Sources, including insurance deliverables) and the schedules and exhibits thereto, it being understood that the effectiveness of such
documents shall be conditioned upon the occurrence of, and are only effective as of or after, the Closing, (ix) execute customary authorization
letters authorizing the distribution of information regarding the Company and its Subsidiaries to prospective lenders in connection with
the Debt</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 64; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->60<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Financing and containing a customary representation that the public side versions of such documents do not include material non-public
information about the Company or its Subsidiaries or their securities, and a customary representation as to the accuracy of the information
contained in the disclosure and marketing materials related to the Debt Financing, subject to customary confidentiality provisions (which
may include customary &ldquo;click through&rdquo; confidentiality arrangements or other confidentiality arrangements customary for syndication
and arrangement procedures), and (x) otherwise reasonably cooperate with Buyer in its efforts to obtain the Debt Financing; <U>provided</U>,
however, that (A) nothing herein shall require such cooperation to the extent it would (x) materially and unreasonably disrupt or interfere
with the business or operations of the Company and/or its Subsidiaries or (y) reasonably be expected to (I) cause any condition to the
Closing set forth in <B><U>&#8206;</U></B><U>Article 6</U> to not be satisfied or otherwise cause any breach of this Agreement, (II) conflict
with, violate, breach or otherwise contravene any Applicable Law, and (III) subject any of the Company&rsquo;s or its Subsidiaries&rsquo;
respective directors, managers, officers or employees to any actual or potential personal liability with respect to matters related to
the Debt Financing, (B) unless the Buyer and such directors, officers and managers have agreed that such directors, officers and managers
are to remain as directors, officers and managers of the Company or such Subsidiary, as applicable, on and after the Closing Date, none
of the pre-Closing directors, officers or managers of the Company, acting in such capacity, shall be required to execute, deliver or enter
into or perform any agreement, document or instrument, including any Debt Financing Document, with respect to the Debt Financing or adopt
any resolutions approving the agreements, documents and instruments pursuant to which the Debt Financing is obtained, (C) none of the
Company, the Company&rsquo;s Subsidiaries or their respective Representatives shall be required to execute, deliver or enter into, or
perform any agreement, document or instrument, including any Debt Financing Document, with respect to the Debt Financing that is not contingent
upon the Closing or that would be effective prior to the Closing Date (in each case, other than any authorization letter referred to in
<U>clause (ix)</U> above), (D) the Company shall not be required to deliver or obtain opinions of internal or external counsel, (E) nothing
herein shall obligate the Company to provide or prepare any projections, pro forma financial statements or other forward-looking financial
information, or to provide any financial information that is not readily available to the Company (other than the Required Financial Information)
and (F) nothing herein shall obligate the Company to provide any information that would violate any binding third party obligation of
confidentiality or result in a loss of attorney-client privilege or other similar privilege of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Neither the Company nor any of its Subsidiaries nor any of their respective equityholders or Representatives shall be required
to bear any cost or expense or to pay any commitment or other similar fee or make any other payment or incur or assume any other liability
or provide or agree to provide any indemnity, in each case, prior to the Closing in connection with the Debt Financing or their performance
of their respective obligations under this <B><U>&#8206;</U></B><U>Section 5.15</U> (except to the extent the effectiveness of any such
cost, expense, fee, payment, liability or indemnity is subject to and conditioned upon the occurrence of the Closing or otherwise promptly
reimbursed by Buyer or with respect to the preparation of audited and other historical financial statements). Buyer shall indemnify, defend
and hold harmless the Company, its Subsidiaries and their respective Representatives from and against any and all liabilities, losses,
damages, claims, costs, expenses, interest, awards, judgments and penalties suffered or incurred by them in connection with their cooperation
or efforts pursuant to this <B><U>&#8206;</U></B><U>Section 5.15</U>, the arrangement of the Debt Financing, the performance of their
obligations under this <B><U>&#8206;</U></B><U>Section 5.15</U> and any information utilized in connection therewith (other than (x) to
the extent any of the foregoing was suffered or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 65; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->61<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">incurred as a result of the fraud, bad faith, gross negligence or willful misconduct of
the Company, its Subsidiaries or any of its or their respective Representatives, in each case, as determined by a court of competent jurisdiction
in a final and non-appealable decision or (y) with respect to the preparation of audited and other historical financial statements). Buyer
shall, promptly upon written request by the Company, reimburse the Company for all reasonable and documented out-of-pocket costs incurred
by the Company in connection with the cooperation contemplated by this <B><U>&#8206;</U></B><U>Section 5.15</U>. Notwithstanding anything
to the contrary contained herein, Buyer&rsquo;s obligation to reimburse any such out-of-pocket costs contemplated by this <B><U>&#8206;</U></B><U>Section
5.15</U> shall not exceed $1,000,000 in the aggregate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company hereby consents to the reasonable use of the logos and trademarks of the Company and its Subsidiaries in connection
with the Debt Financing prior to the Closing; <U>provided</U>, that such logos and trademarks are used solely in a manner that is not
intended to nor reasonably likely to (i) harm or disparage the Company or the reputation or goodwill of the Company or (ii) otherwise
materially adversely affect the Company or any of its Subsidiaries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The parties hereto acknowledge and agree that the provisions contained in this <B><U>&#8206;</U></B><U>Section 5.15</U> represent
the sole obligation of the Company and its Subsidiaries with respect to cooperation in connection with the arrangement of any financing
(including the Debt Financing) to be obtained by Buyer with respect to the transactions contemplated by this Agreement (including the
Debt Commitment Letter), and no other provision of this Agreement (including any Exhibits hereto) or the Debt Commitment Letter shall
be deemed to expand or modify such obligations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>For the avoidance of doubt, without modifying any of the limitations set forth herein, Buyer may, to most effectively access the
financing markets, request the cooperation of the Company and its Subsidiaries under this <B><U>&#8206;</U></B><U>Section 5.15</U> at
any time, and from time to time and on multiple occasions, between the date of this Agreement and the Closing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.16</FONT> <I>Confidentiality</I>. Buyer and the Company hereby agree to continue to be bound by the non-disclosure agreement by and
between Wynnchurch Capital, LP (&ldquo;<B>Wynnchurch</B>&rdquo;) and the Company set forth on <U>Section 5.16</U> of the Company Disclosure
Schedule (the &ldquo;<B>Confidentiality Agreement</B>&rdquo;). All information provided by or on behalf of the Company or its Subsidiaries
pursuant to this Agreement (including in connection with the Debt Financing) will be kept confidential in accordance with the Confidentiality
Agreement; provided, however, that Buyer will be permitted to disclose such information on a need-to-know basis to any Debt Financing
Sources that may become parties to the documents evidencing the Debt Financing (and, in each case, to their respective counsel and auditors)
so long as each such Person (a) agrees for the benefit of the Company to be bound by the Confidentiality Agreement as if a party thereto
or (b) is subject to other confidentiality undertakings of which the Company is a third party beneficiary that are no less restrictive
than the undertakings set forth in the Confidentiality Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.17</FONT> <I>Director Resignations</I>. Prior to the Closing, the Company shall use its reasonable best efforts to deliver to Buyer
resignations executed by each director of the Company in office immediately prior to the Effective Time, which resignations shall be
effective at the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 66; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->62<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.18</FONT> <I>Listing Matters</I>. Each of the Company and Buyer agrees to cooperate with the other Party in taking, or causing to be
taken, all action necessary to delist the Company Ordinary Shares from NYSE and terminate its registration under the Exchange Act, provided
that such delisting and termination shall not be effective until the Effective Time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.19</FONT> <I>Treatment of Company Debt</I>. If requested by Buyer in writing no later than thirty (30) days prior to the Closing Date,
the Company shall, and shall cause its Subsidiaries to, deliver all notices and take all other actions that are required to facilitate
in accordance with the terms thereof the termination of all commitments outstanding under the Company Credit Facilities, the repayment
in full of all obligations, if any, outstanding thereunder, the release of all Liens, if any, securing such obligations, and the release
of any guarantees provided in connection therewith as of the Effective Time (collectively, the &ldquo;<B>Credit Facilities Termination</B>&rdquo;).
No less than (a) five (5) Business Days prior to the Closing Date, the Company shall obtain draft payoff letters and (b) one (1) Business
Day prior to the Closing Date, the Company shall obtain fully executed payoff letters, for the Company Credit Facilities in form and
substance reasonably satisfactory to the Buyer, which payoff letters shall acknowledge the aggregate principal amount and all accrued
but unpaid interest constituting such Indebtedness (the &ldquo;<B>Payoff Letters</B>&rdquo;). Notwithstanding anything herein to the
contrary, in no event shall this <U>&#8206;Section 5.19</U> require the Company or any of its Subsidiaries to cause the Credit Facilities
Termination to be effective unless and until the Effective Time has occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.20</FONT> <I>Control of Operations</I>. Without in any way limiting any Party&rsquo;s rights or obligations under this Agreement, the
Parties understand and agree that (a) nothing contained in this Agreement shall give the Company or Buyer, directly or indirectly, the
right to control or direct the other Party&rsquo;s operations prior to the Effective Time and (b) prior to the Effective Time, each of
the Company and Buyer shall exercise, consistent with the terms and conditions of this Agreement, complete control and supervision over
its operations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
5.21</FONT> <I>Tax Cooperation and Assistance</I>. The Company shall (and shall procure that its Subsidiaries and its and their Representatives
shall) provide such assistance and information as Buyer may reasonably request in order for Buyer to (a) discharge its obligations under
this Agreement, including pursuant to <I><U>&#8206;</U></I><U>Section 5.04(b)(v)</U> (relating to UK stamp duty and stamp duty reserve
tax) or (b) obtain any Tax clearance or consent which Buyer reasonably determines is required to be obtained by Buyer in order to give
effect to the transactions contemplated by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
6 </FONT><BR>
CONDITIONS TO THE TRANSACTION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
6.01</FONT> <I>Conditions to the Obligations of Each Party</I>. The obligation of each Party to consummate the Transaction and the other
transactions contemplated by this Agreement is subject to the satisfaction or, to the extent permitted by Applicable Law, waiver in writing
by each Party, at or prior to Closing, of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company Shareholder Approval shall have been obtained at the Scheme Meeting and the Company GM;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 67; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->63<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Scheme of Arrangement shall have been sanctioned by the Court with or without modification (but subject to any non-de <I>minimis
</I>modification being acceptable to both Parties acting reasonably and in good faith) and a copy of the Court Order shall have been delivered
to Registrar of Companies in England and Wales;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>no Governmental Authority having jurisdiction over any Party shall have issued any Order that is in effect (whether temporary,
preliminary or permanent) restraining, enjoining or otherwise prohibiting the consummation of the Transaction and no Applicable Law shall
have been adopted that makes consummation of the Transaction illegal or otherwise prohibited; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) the applicable waiting period applicable to the Transaction under the HSR Act shall have expired or been terminated, (ii) the
conditions set forth in Section 3.03 of the Company Disclosure Schedule, and (iii) all agreements between a Party and a Governmental Authority
to delay or not consummate the transactions contemplated hereby shall have been rescinded, expired, terminated or otherwise closed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
6.02</FONT> <I>Conditions to the Obligations of Buyer</I>. The obligation of Buyer to consummate the Transaction is subject to the satisfaction,
or waiver in writing by Buyer, at or prior to Closing, of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) the representations and warranties of the Company set forth in <B><U>&#8206;</U></B><U>Section 3.01</U>, <B><U>&#8206;</U></B><U>Section
3.02</U>, <B><U>&#8206;</U></B><U>Section 3.22</U>, <B><U>&#8206;</U></B><U>Section 3.23</U>, <U>Section 3.24</U> and <U>Section 3.25</U>
shall be true and correct in all material respects on the date of this Agreement and the Closing Date as if made on each such date (except
to the extent that any such representation and warranty expressly speaks as of an earlier date, in which case such representation and
warranty shall be true and correct in all material respects only as of such earlier date), (ii) the representations and warranties of
the Company set forth in <B><U>&#8206;</U></B><U>Section 3.05(a)</U> and the first sentence of <B><U>&#8206;</U></B><U>Section 3.05(c)</U>
shall be true and correct in all respects (other than <I>de minimis </I>inaccuracies) on the date of this Agreement and the Closing Date
as if made on each such date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in
which case such representation and warranty shall be true and correct in all material respects only as of such earlier date), (iii) the
representations and warranties of the Company set forth in <B><U>&#8206;</U></B><U>Section 3.09(b)(ii)</U> shall be true and correct in
all respects on the date of this Agreement and the Closing Date as if made on each such date, and (iv) the other representations and warranties
of the Company set forth in <B><U>&#8206;</U></B><U>Article 3</U> shall be true and correct on the date of this Agreement and the Closing
Date as if made on each such date (except to the extent that any such representation and warranty expressly speaks as of an earlier date,
in which case such representation and warranty shall be true and correct only as of such earlier date), except where the failure of such
representations and warranties to be so true and correct (disregarding all qualifications or limitations as to &ldquo;materiality,&rdquo;
&ldquo;Company Material Adverse Effect&rdquo; or words of similar import) would not, individually or in the aggregate, have a Company
Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company shall have performed or complied in all material respects with all obligations required to be performed or complied
with by it under this Agreement at or prior to the Closing;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 68; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->64<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Buyer shall have received at the Closing a certificate signed on behalf of the Company by the Chief Executive Officer or the Chief
Financial Officer of the Company certifying that the conditions set forth in <B><U>&#8206;</U></B><U>Section 6.02(a)</U>, <B><U>&#8206;</U></B><U>Section
6.02(b)</U> and <B><U>&#8206;</U></B><U>Section 6.02(d)</U> have been satisfied; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>since the date of this Agreement, there shall not have occurred any Company Material Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
6.03</FONT> <I>Conditions to the Obligations of the Company</I>. The obligation of the Company to consummate the Transaction is subject
to the satisfaction, or waiver in writing by the Company, at or prior to Closing, of the following conditions:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>(i) The representations and warranties of Buyer set forth in the first sentence in <B><U>&#8206;</U></B><U>Section 4.01</U>, <B><U>&#8206;</U></B><U>Section
4.02</U> and <U>Section 4.16</U> shall be true and correct in all material respects on the date of this Agreement and the Closing Date
as if made on each such date (except to the extent that any such representation and warranty expressly speaks as of an earlier date, in
which case such representation and warranty shall be true and correct in all material respects only as of such earlier date), and (ii)
the other representations and warranties contained in <B><U>&#8206;</U></B><U>Article 4</U> shall be true and correct on the date of this
Agreement and the Closing Date as if made on each such date (except to the extent that any such representation and warranty expressly
speaks as of an earlier date, in which case such representation and warranty shall be true and correct only as of such earlier date),
except where the failure of such representations and warranties to be so true and correct (disregarding all qualifications or limitations
as to &ldquo;materiality,&rdquo; &ldquo;Buyer Material Adverse Effect&rdquo; or words of similar import) would not, individually or in
the aggregate, have a Buyer Material Adverse Effect;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Buyer shall have performed or complied in all material respects with all obligations required to be performed or complied with
by it under this Agreement at or prior to the Closing; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the Company shall have received at the Closing a certificate signed on behalf of Buyer by an authorized officer of Buyer certifying
that the conditions set forth in <B><U>&#8206;</U></B><U>Section 6.03(a)</U> and <B><U>&#8206;</U></B><U>Section 6.03(b)</U> have been
satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
7 </FONT><BR>
TERMINATION</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
7.01</FONT> <I>Termination</I>. This Agreement may be terminated and the Transaction may be abandoned at any time prior to the Closing
only as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by mutual written agreement of the Company and Buyer (notwithstanding any approval of this Agreement by the Company Shareholders);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by either Buyer or the Company, upon written notice to the other party, if the Closing Date has not occurred on or before February
26, 2027 (the &ldquo;<B>End Date</B>&rdquo;) (notwithstanding any approval of this Agreement by the Company Shareholders); <U>provided</U>
that the right to terminate this Agreement under this <B><U>&#8206;</U></B><U>Section 7.01(b)</U> shall not be available to any Party
whose material breach</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 69; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->65<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">of any provision of this Agreement has been the primary cause of, or primarily resulted in, the failure of the Transaction
to be consummated by the End Date;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by either Buyer or the Company, upon written notice to the other party, if at any time prior to the Effective Time, any Governmental
Authority of competent jurisdiction shall have issued a final and non-appealable Order or taken any other action permanently enjoining,
restraining or otherwise prohibiting the consummation of the Transaction (notwithstanding any approval of this Agreement by the Company
Shareholders); <U>provided</U>, <U>however</U>, the right to terminate this Agreement under this <B><U>&#8206;</U></B><U>Section 7.01(c)</U>
shall not be available to any Party whose material breach of any provision of this Agreement has been the primary cause of, or primarily
resulted in, such final and non-appealable Order or action enjoining, restraining or otherwise prohibiting the consummation of the Transaction;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by either Buyer or the Company, upon written notice to the other Party, if the Court affirmatively declines or refuses to sanction
the Scheme of Arrangement, unless the Company or Buyer appeals the decision of the Court within any applicable time limits, in which case
such termination right pursuant to this <B><U>&#8206;</U></B><U>Section 7.01(d)</U> shall not be available until a final, non-appealable
Order is given declining the Scheme of Arrangement;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(e)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by either Buyer or the Company, upon written notice to the other Party, if the Scheme Meeting and the Company GM (including, in
each case, any postponements or adjournments thereof) shall have been completed and the Company Shareholder Approval shall not have been
obtained;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(f)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by Buyer, upon written notice to the Company, in the event of a breach by the Company of any representation, warranty, covenant
or other agreement contained herein that (i) would result in any condition set forth in <B><U>&#8206;</U></B><U>Section 6.02</U> not being
satisfied and (ii) (x) such breach is incapable of being cured or (y) if capable of being cured, has not been cured prior to the earlier
of the End Date or the thirtieth (30th) day following Buyer&rsquo;s delivery of written notice describing such breach to the Company;
<U>provided</U>, <U>however</U>, that Buyer shall not be entitled to terminate this Agreement pursuant to this <B><U>&#8206;</U></B><U>Section
7.01(f)</U> if Buyer&rsquo;s material breach of its obligations under this Agreement, directly or indirectly, is the primary cause of,
or primarily resulted in, the failure of the conditions set forth in <B><U>&#8206;</U></B><U>Section 6.03(a)</U> or <B><U>&#8206;</U></B><U>Section
6.03(b)</U> to be satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(g)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by the Company, upon written notice to Buyer, in the event of a breach by Buyer of any representation, warranty, covenant or other
agreement contained herein that (i) would result in any condition set forth in <B><U>&#8206;</U></B><U>Section 6.03</U> not being satisfied
and (ii) (x) such breach is incapable of being cured or (y) if capable of being cured, has not been cured prior to the earlier of the
End Date or the thirtieth (30th) day following the Company&rsquo;s delivery of written notice describing such breach to Buyer; <U>provided</U>,
<U>however</U>, that the Company shall not be entitled to terminate this Agreement pursuant to this <B><U>&#8206;</U></B><U>Section 7.01(g)</U>
if the Company&rsquo;s material breach of its obligations under this Agreement, directly or indirectly, is the primary cause of, or primarily
resulted in, the failure of the conditions set forth in <B><U>&#8206;</U></B><U>Section 6.02(a)</U> or <B><U>&#8206;</U></B><U>Section
6.02(b)</U> to be satisfied.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(h)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by Buyer, upon written notice to the Company, at any time prior to receipt of the Company Shareholder Approval, if (i) the Company
Board shall have effected an Adverse</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 70; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->66<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Recommendation Change or (ii) the Company has materially or intentionally breached its obligations
under <U>Section 5.02</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by the Company, upon written notice to Buyer, at any time prior to receipt of the Company Shareholder Approval, if the Company
Board shall have effected an Adverse Recommendation Change in respect of a Superior Proposal that did not result from a material breach
of <B><U>&#8206;</U></B><U>Section 5.02</U> and in accordance with <B><U>&#8206;</U></B><U>Section 5.03(b)</U>, and promptly following
such termination, the Company enters into a definitive agreement with respect to such Superior Proposal; provided that concurrently with
such termination, the Company pays the Company Termination Payment payable pursuant to <B><U>&#8206;</U></B><U>Section 8.04(b)</U>; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(j)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>by the Company, upon written notice to Buyer, if (A) the conditions set forth in <B><U>&#8206;</U></B><U>Section 6.01</U> and <B><U>&#8206;</U></B><U>Section
6.02</U> (other than those conditions that by their nature are to be satisfied at the Closing; <U>provided</U> that each such condition
is then capable of being satisfied at the Closing on such date or the failure of which to be satisfied is attributable primarily to a
breach by Buyer of its representations, warranties, covenants or agreements contained herein have been satisfied or waived, (B) Buyer
is required to consummate the Transaction pursuant to <B><U>&#8206;</U></B><U>Section 1.02</U>, (C) Buyer fails to consummate the Transaction
within three (3) Business Days after the date the Closing was required to occur pursuant to <B><U>&#8206;</U></B><U>Section 1.02</U>,
and (D) the Company stood ready, willing and able to consummate the transactions contemplated by this Agreement on that date and the Company
has irrevocably notified Buyer in writing at or prior to such date that (x) the Company stood ready, willing and able to consummate the
Transaction on that date, and (y) all of the conditions set forth in <B><U>&#8206;</U></B><U>Section 6.01</U> and <B><U>&#8206;</U></B><U>Section
6.02</U> (other than those conditions that by their nature are to be satisfied at the Closing); <U>provided</U> that each such condition
would have then been capable of being satisfied).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">The Party desiring to terminate this Agreement
pursuant to this <U>&#8206;Section 7.01</U> (other than pursuant to <U>&#8206;Section 7.01(a)</U>) shall give written notice of such termination
to the other Party setting forth in reasonable detail the provision of this <U>&#8206;Section 7.01</U> pursuant to which this Agreement
is being terminated.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.05in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
7.02</FONT> <I>Effect of Termination</I>. If this Agreement is terminated pursuant to <U>&#8206;Section 7.01</U>, this Agreement shall
become void and of no effect without liability of any Party (or any Representative of such Party) to the other Party; provided, however,
that the provisions of (a) this <U>&#8206;Section 7.02</U>, (b) the last sentence of <U>&#8206;Section 5.05</U>, (c) the last sentence
of <U>&#8206;Section 5.11(b)</U>, (d) <U>Section 5.13</U>, (e) <U>Section 5.15(f)</U>, (f) <U>Section 5.16</U>, and (g) <U>&#8206;Article
8</U> (other than <U>&#8206;Section 8.10(a)</U>, <U>&#8206;Section 8.10(b)</U> and <U>&#8206;Section 8.10(c)</U> except with respect
to specific enforcement of the provisions which expressly survive termination of this Agreement in accordance with <U>&#8206;Section
8.10(a)</U>) shall survive any termination hereof pursuant to <U>&#8206;Section 7.01</U>. Notwithstanding the foregoing or any other
provision of this Agreement to the contrary, the Company shall not be relieved or released from any liabilities or damages arising out
of its Willful and Material Breach of any provision of this Agreement or any other agreement delivered in connection herewith. Notwithstanding
anything in this Agreement to the contrary, under no circumstances will the amount payable by Buyer, Equity Investor, the Guarantor or
any of their respective Affiliates, whether pursuant to this Agreement or the Guarantee, in connection with or following any termination
of this Agreement exceed an amount equal to the sum of (x) the Buyer Termination Payment, <I>plus </I>(y) the Company Recovery Costs,
<I>plus</I> (z) the Buyer Expenses (such sum, the &ldquo;<B>Buyer Liability Limit</B>&rdquo;). For the avoidance of doubt, (A) the Confidentiality
Agreement shall survive the termination of this</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 71; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->67<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Agreement and shall remain in full force and effect in accordance with its terms and (B) the Guarantee (solely
to the extent provided for therein) shall survive the termination of this Agreement and shall remain in full force and effect in accordance
with its terms. Notwithstanding anything to the contrary provided in this Agreement, including the foregoing provision of this <U>Section
7.02</U>, nothing shall relieve the Company from liability for Fraud.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in"><FONT STYLE="text-transform: uppercase">Article
8 </FONT><BR>
MISCELLANEOUS</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.01</FONT> <I>Notices</I>. Any notices or other communications required or permitted under, or otherwise given in connection with, this
Agreement shall be in writing and shall be deemed to have been duly given (i) when delivered or sent if delivered in person, (ii) on
the fifth (5t<SUP>h</SUP>) Business Day after dispatch by registered or certified mail, (iii) on the next Business Day if transmitted
by national overnight courier or (iv) on the date sent if sent by e-mail (provided that no transmission failure message is generated),
in each case as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if to Buyer, to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Double Eagle Acquisition Buyer, Inc.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">c/o Wynnchurch Capital, L.P.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">6250 N. River Road, Suite 10-100</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rosemont, Illinois</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 0.5in; text-align: justify">&nbsp;</TD>
    <TD STYLE="width: 0.6in; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Greg Gleason, Brian Riordan and Dave Venker</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ggleason@wynnchurch.com; briordan@wynnchurch.com;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">dvenker@wynnchurch.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a copy to (which shall not constitute notice):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirkland &amp; Ellis LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">601 Lexington Avenue</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10022</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Joshua Kogan, P.C. and Marshall Shaffer, P.C.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">joshua.kogan@kirkland.com; marshall.shaffer@kirkland.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">and to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Kirkland &amp; Ellis LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">333 W Wolf Point Plaza</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Chicago, IL 60654</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Katherine B. Kennedy</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">kate.kennedy@kirkland.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">if to the Company, to:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Luxfer Holdings PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">3016 Kansas Avenue</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Riverside, CA 92507</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 72; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->68<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify; width: 0.5in">&nbsp;</TD>
    <TD STYLE="text-align: justify; width: 0.6in"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Janelle Ramos</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">janelle.ramos@luxfer.com</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a copy to (which shall not constitute notice):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fried, Frank, Harris, Shriver and Jacobson LLP</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">One New York Plaza</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">New York, NY 10004</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Christopher Ewan</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">David McDonald</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: justify">&nbsp;</TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email:</FONT></TD>
    <TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">christopher.ewan@friedfrank.com;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">david.mcdonald@friedfrank.com</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.02</FONT> <I>Survival of Representations and Warranties</I>. None of the representations, warranties or covenants in this Agreement
or in any certificate delivered pursuant to this Agreement shall survive the Effective Time, except that this <U>&#8206;Section 8.02</U>
shall not limit any covenant or agreement of the Parties which by its terms contemplates performance after the Effective Time, which
shall survive to the extent expressly provided for herein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.03</FONT> <I>Amendments and Waivers</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Any provision of this Agreement may be amended or waived prior to the Effective Time if, but only if, such amendment or waiver
is in writing and is signed, in the case of an amendment, by each Party or, in the case of a waiver, by each Party against whom the waiver
is to be effective; <U>provided</U>, <U>however</U>, that after receipt of the Company Shareholder Approval, if any such amendment or
waiver shall by Applicable Law or in accordance with the rules and regulations of NYSE require further approval of the Company Shareholders,
the effectiveness of such amendment or waiver shall be subject to the approval of the Company Shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>No failure or delay by any Party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall
any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege.
Except as otherwise expressly provided in this Agreement, the rights and remedies herein provided shall be cumulative and not exclusive
of any rights or remedies provided by Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.04</FONT> <I>Fees and Expenses</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Except as otherwise provided in this Agreement, all costs and expenses incurred in connection with this Agreement shall be paid
by the Party incurring such cost or expense.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the event that:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>this Agreement is terminated pursuant to <B><I><U>&#8206;</U></I></B><U>Section 7.01(h)</U> (or pursuant to <B><I><U>&#8206;</U></I></B><U>Section
7.01(b)</U> and at the time of such termination, Buyer could have terminated this Agreement pursuant to <B><I><U>&#8206;</U></I></B><U>Section
7.01(h)</U>);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>this Agreement is terminated pursuant to <B><I><U>&#8206;</U></I></B><U>Section 7.01(i)</U>; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 73; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->69<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(iii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>this Agreement is terminated by either Buyer or the Company pursuant to <U>&#8206;Section 7.01(b)</U> or <U>&#8206;Section 7.01(e)</U>,
or by Buyer pursuant to <U>&#8206;Section 7.01(f)</U> and (A) after the date hereof an Acquisition Proposal is made directly to the Company
Shareholders or is otherwise publicly disclosed and, in each case of <U>Section 7.01(e)</U> or <U>&#8206;Section 7.01(f)</U>, not withdrawn
within five (5) Business Days prior to any other termination pursuant to <U>Section 7.01</U>, and (B) within twelve (12) months after
the date of such termination, the Company enters into a definitive agreement in respect of such Acquisition Proposal (whether or not such
Acquisition Proposal is subsequently consummated) or an Acquisition Proposal is consummated (in each case, whether or not the Acquisition
Proposal referenced in clause (A)); provided, that for purposes of this <U>clause (iii)</U>, each reference to &ldquo;20% or more&rdquo;
or &ldquo;80% or less&rdquo; in the definition of Acquisition Proposal shall be deemed to be references to &ldquo;more than 50%&rdquo;
or &ldquo;50% or less&rdquo;, respectively; then the Company shall pay to Buyer the Company Termination Payment by wire transfer of same-day
funds (x) in the case of <U>&#8206;Section 8.04(b)(i)</U>, within two (2) Business Days after such termination, (y) in the case of <U>&#8206;Section
8.04(b)(ii)</U>, concurrently with the termination of this Agreement pursuant to <U>&#8206;Section 7.01(i)</U> (or no later than the next
Business Day if such termination occurs on a day that is not a Business Day) and (z) in the case of <U>&#8206;Section 8.04(b)(iii)</U>,
on the earlier of the date of such definitive Contract or such consummation of such Acquisition Proposal referenced in <U>&#8206;Section
8.04(b)(iii)(B)</U>. For the avoidance of doubt, any payment made by the Company under this <U>&#8206;Section 8.04(b)</U> shall be payable
only once with respect to <U>&#8206;Section 8.04(b)</U> and not in duplication, even though such payment may be payable under one or more
provisions hereof. In the event that Buyer shall receive full payment of the Company Termination Payment pursuant to this <U>&#8206;Section
8.04(b)</U>, the receipt of the Company Termination Payment and the Buyer Recovery Costs shall be deemed to be liquidated damages for
any and all losses or damages suffered or incurred by Buyer or any of its Affiliates or any other Person in connection with this Agreement
(and the termination hereof), the transactions contemplated by this Agreement (and the abandonment thereof) or any matter forming the
basis for such termination, and except for the obligations of the Company pursuant to this <U>&#8206;Section 8.04(b)</U> and Buyer&rsquo;s
right set forth in <U>&#8206;Section 8.10</U>, the Company shall have no further liability, whether pursuant to a claim at law or in equity,
to Buyer or any of its Affiliates or any other Person in connection with this Agreement (and the termination hereof), the transactions
contemplated by this Agreement (and the abandonment thereof) or any matter forming the basis for such termination (including for any Willful
and Material Breach), and none of Buyer or any of its Affiliates or any other Person shall be entitled to bring or maintain any Proceeding
against the Company or any of its Subsidiaries or Affiliates for damages or any equitable relief arising out of or in connection with
this Agreement (other than equitable relief to require payment of the Company Termination Payment and any expenses pursuant to this <U>&#8206;Section
8.04(b)</U>), any of the transactions contemplated by this Agreement or any matters forming the basis for such termination; <U>provided</U>
that if the Company fails to pay the Company Termination Payment when due and Buyer commences a suit which results in a final, non-appealable
judgment against the Company for the Company Termination Payment or any portion thereof, then the Company shall pay Buyer its costs and
expenses (including reasonable attorney&rsquo;s fees and disbursements) in connection with such suit, together with interest on the Company
Termination Payment at the &ldquo;prime rate&rdquo; as published in <I>The Wall Street Journal, </I>Eastern Edition, in effect on the
date such payment was required to be made through the date of payment (calculated daily on the basis of a year of 365 days and the actual
number of days elapsed, without compounding) (the &ldquo;<B>Buyer Recovery Costs</B>&rdquo;); <U>provided</U> that in no event shall such
cost, expenses and interest exceed $1,000,000 in the aggregate.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 74; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->70<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In the event that this Agreement is terminated (i) by the Company pursuant to <U>Section 7.01(g)</U> or <B><U>&#8206;</U></B><U>Section
7.01(j)</U> or (ii) by Buyer pursuant to <B><U>&#8206;</U></B><U>Section 7.01(b)</U> and at the time of such termination the Company could
have terminated this Agreement pursuant to <U>Section 7.01(g)</U> or <U>Section 7.01(j)</U>, then, in any such case, Buyer shall pay to
the Company the Buyer Termination Payment by wire transfer of same-day funds within three (3) Business Days after such termination. For
the avoidance of doubt, any payment made by Buyer under this <B><U>&#8206;</U></B><U>Section 8.04(c)</U> shall be payable only once with
respect to <B><U>&#8206;</U></B><U>Section 8.04(c)</U> and not in duplication, even though such payment may be payable under one or more
provisions hereof. In the event that the Company shall receive full payment of the Buyer Termination Payment pursuant to this <B><U>&#8206;</U></B><U>Section
8.04(c)</U>, the receipt of the Buyer Termination Payment shall be deemed to be liquidated damages and, other than with respect to Buyer&rsquo;s
reimbursement obligations with respect to Buyer Expenses, the sole and exclusive remedy for any and all losses or damages suffered or
incurred by the Company or any of its Affiliates or any other Person in connection with this Agreement (and the termination hereof), the
transactions contemplated by this Agreement (and the abandonment thereof) or any matter forming the basis for such termination (including
for any Willful and Material Breach), and except for the obligations of Buyer pursuant to <B><U>&#8206;</U></B><U>Section 5.15</U> and
this <B><U>&#8206;</U></B><U>Section 8.04(c)</U> (collectively, the &ldquo;<B>Buyer Expenses</B>&rdquo;), neither Buyer nor any of its
Affiliates, financing sources, or any of their respective former, current or future directors, officers, employees, partners, managers,
members, equityholders, Affiliates or Representatives (collectively, &ldquo;<B>Buyer Related Parties</B>&rdquo;) shall have any further
liability, whether pursuant to a claim at law or in equity, to the Company and each of its former, current or future Affiliates, controlling
persons, directors, officers, employees, equityholders, managers, agents, Representatives, successors and assigns (collectively, &ldquo;<B>Company
Related Parties</B>&rdquo;) or any other Person in connection with this Agreement (and the termination hereof), the transactions contemplated
by this Agreement (and the abandonment thereof) or any matter forming the basis for such termination, and none of the Company or any of
the Company Related Parties or any other Person shall be entitled to bring or maintain any Proceeding against any Buyer Related Party
for damages or any equitable relief arising out of or in connection with this Agreement, any of the transactions contemplated by this
Agreement or any matters forming the basis for such termination (other than equitable relief to require payment of the Buyer Termination
Payment and/or any Buyer Expenses); <U>provided</U> that if Buyer fails to pay the Buyer Termination Payment and/or any Buyer Expenses
and the Company commences a suit which results in a final, non-appealable judgment against Buyer for the Buyer Termination Payment and/or
any Buyer Expenses, or any portions thereof, then Buyer shall pay the Company its costs and expenses (including reasonable attorney&rsquo;s
fees and disbursements) in connection with such suit, together with interest on the Buyer Termination Payment and/or Buyer Expenses at
the &ldquo;prime rate&rdquo; as published in <I>The Wall Street Journal, </I>Eastern Edition, in effect on the date such payment was required
to be made through the date of payment (calculated daily on the basis of a year of 365 days and the actual number of days elapsed, without
compounding) (the &ldquo;<B>Company Recovery Costs</B>&rdquo;); <U>provided</U> that in no event shall such Company Recovery Costs exceed
$1,000,000 in the aggregate. Buyer acknowledges and agrees that the Company&rsquo;s right to receive the Buyer Termination Payment pursuant
to this Agreement shall not limit or otherwise affect the Company&rsquo;s right to seek specific performance solely to the extent provided
in <B><U>&#8206;</U></B><U>Section 8.10</U> prior to a termination of this Agreement. For the avoidance of doubt, while the Company may
pursue both a grant of specific performance prior to the termination of this Agreement, and the payment of the Buyer Termination Payment,
if applicable, following a termination of this Agreement, under no circumstances shall the Company be permitted or entitled to receive
both a grant of specific</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 75; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->71<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">performance to cause the Closing to occur and all or any portion of the Buyer Termination Payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>If Buyer fails to effect the Closing or otherwise breaches this Agreement or fails to perform hereunder, and in each case the Closing
has not occurred, in no event shall the Company or any Company Related Party seek, or permit to be sought, any monetary remedies from
any Buyer Related Party in connection with this Agreement or any of the transactions contemplated hereby (including the Financing), other
than (without duplication) (x) the obligation of Buyer to pay the Buyer Termination Payment (plus any Company Recovery Costs payable)
to the extent provided in <U>Section 8.04(c)</U>, (y) to the extent that the Buyer Termination Payment (plus any Company Recovery Costs
payable) has not been paid in full by Buyer in accordance with <U>Section 8.04(c)</U>, from the Guarantor in accordance with the Guarantee
(provided, that in such case, the aggregate amount payable under this Agreement or in connection with the transactions contemplated hereby
shall not exceed an amount equal to the portion of the Buyer Termination Payment (plus any Company Recovery Costs payable) that has not
already been paid, if any) and (z) any Buyer Expenses to the extent payable pursuant to <U>Section 5.15(f)</U>. Nothing in this <B><U>&#8206;</U></B><U>Section
8.04</U> shall in any way expand or be deemed to expand the circumstances in which Buyer or any Buyer Related Party may be liable under
this Agreement or any of the transactions contemplated hereby (including the Financing).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.05</FONT> <I>VAT and Transfer Taxes</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Where under the terms of this Agreement one party is liable to indemnify or reimburse another party in respect of costs, charges
or expenses, the payment shall include an amount equal to any VAT thereon not otherwise recoverable by the other party or the representative
member of any VAT group of which it forms part.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The parties anticipate and shall use reasonable commercial endeavours to secure that any Company Termination Payment or any Buyer
Termination Payment (each a &ldquo;<B>Termination Payment</B>&rdquo;) is not and will not be treated as consideration for a taxable supply
for VAT purposes. However, if a Taxing Authority successfully asserts that a Termination Payment is consideration in whole or in part
for a taxable supply for VAT purposes then:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(i)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>if a relevant Taxing Authority successfully asserts that the Termination Payment is consideration for a taxable supply in respect
of which the payee is liable to account for VAT then (A) if such VAT is not (or would not be) recoverable by the payer (if paid by the
payer) by deduction or refund of input VAT, no additional amount shall be paid by such payee in respect of VAT and the Termination Payment
shall be VAT inclusive; or (B) if and to the extent that such VAT is (or is reasonably expected to be) wholly or partly recoverable by
the payer by deduction or refund of input VAT, the amount of the Termination Payment shall be increased to take account of such recoverable
VAT (but not any irrecoverable VAT, with respect to which (A) shall apply); and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">(ii)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>if under a reverse charge mechanism the Termination Payment is determined by a relevant Taxing Authority to be consideration for
a taxable supply in respect of which the payer is liable to account for VAT then, to the extent that any VAT chargeable on the supply
is not recoverable by the payer by deduction or refund of input VAT, the amount of the</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in"></P>

<!-- Field: Page; Sequence: 76; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->72<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Termination Payment shall be reduced to take account
of such irrecoverable VAT, such that in either case after making any such adjustments the aggregate of (x) the total amount of the Termination
Payment paid to the payee, plus (y) any irrecoverable VAT incurred under a reverse charge mechanism by the payer shall be equal to the
amount that the Termination Payment would have been in the absence of any VAT.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Such adjusting payment or payments as may be required to give effect to <B><U>&#8206;</U></B><U>Section 8.05(b)</U> shall be made
ten (10) Business Days after the date on which the assertion by the relevant Taxing Authority which results in such payment being required
has been communicated to the party required to make the payment (together with such evidence of it as is reasonable in the circumstances
to provide and, where <B><U>&#8206;</U></B><U>Section 8.05(b)(i)</U> applies, together with the provision of a valid VAT invoice) or,
if later, (in the case of <B><U>&#8206;</U></B><U>Section 8.05(b)(i)</U>) ten (10) Business Days after the VAT is recovered or (in the
case of <B><U>&#8206;</U></B><U>Section 8.05(b)(ii)</U>), ten (10) Business Days before VAT is required to be accounted for. References
in this Section to the payer and the payee include, where applicable, references to a member of any group of which such entity is a member
for VAT purposes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>All transfer, documentary, sales, use, stamp, stamp duty reserve, registration, value-added and other similar Taxes, duties and
fees (the &ldquo;<B>Transfer Taxes</B>&rdquo;) arising as a result of the entry into or implementation of this Agreement or Scheme Document
or incurred in connection with the transactions contemplated by this Agreement (including the transfer of the Company Ordinary Shares,
or with respect to any instrument effecting such transfer) shall be timely paid by Buyer. Buyer shall timely prepare and file, at Buyer&rsquo;s
expense (i) all Tax Returns and other documentation with respect to such Transfer Taxes, and (ii) any Tax clearances or consents to mitigate
any United Kingdom stamp duty or stamp duty reserve tax in connection with the transactions contemplated by this Agreement (including
confirmation from His Majesty&rsquo;s Revenue &amp; Customs that the Court Order is not subject to United Kingdom stamp duty or stamp
duty reserve tax).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.06</FONT> <I>Assignment; Benefit</I>. This Agreement shall not be assigned by any of the Parties (whether by operation of law or otherwise)
without the prior written consent of the other Party; provided that the rights, interests and obligations of Buyer may be assigned as
collateral to any Persons providing the Debt Financing or any agent or collateral trustee for such Persons for the purpose of securing
the Debt Financing (or any subsequent financing sources). Notwithstanding anything contained in this Agreement to the contrary, nothing
in this Agreement, express or implied, is intended to confer on any Person other than the Parties or their respective heirs, successors,
executors, administrators and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except following
the Closing for the provisions of <U>&#8206;Article 2</U> concerning payment of the Aggregate Transaction Consideration, <U>&#8206;Section
5.10</U>, <U>&#8206;Section 5.15</U>, and <U>&#8206;Section 8.10(c)</U> which provisions shall inure to the benefit of the Persons or
entities benefiting therefrom who shall be third party beneficiaries thereof and who may enforce the covenants contained therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.07</FONT> <I>Governing Law</I>. This Agreement and all disputes or controversies arising out of or relating to this Agreement or the
transactions contemplated hereby (whether based in contract, tort, or otherwise), including the applicable statute of limitations, shall
be governed by and construed in accordance with the laws of the State of Delaware, without regard to the conflicts</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 77; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->73<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">of law rules of the State of Delaware;
provided that, notwithstanding the foregoing, any provisions in this Agreement (w) respecting the implementation, effect and consequence
of the Scheme of Arrangement, (x) which expressly reference the Laws of England and Wales or the Companies Act, or (y) which relate to
the fiduciary or other duties of any officer or director of the Company, in each case shall be interpreted, construed and governed by
and in accordance with the Laws of England and Wales without regard to the conflicts of law rules of England and Wales.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.08</FONT> <I>Jurisdiction</I>. The Parties agree that any Proceeding seeking to enforce any provision of, or based on any matter arising
out of or in connection with, this Agreement or the transactions contemplated by this Agreement shall be brought in the Delaware Court
of Chancery, New Castle County, or if that court does not have jurisdiction or declines to exercise jurisdiction, a federal court sitting
in the State of Delaware, or if that court does not have jurisdiction or declines to exercise jurisdiction, the Delaware Superior Court,
New Castle County, and any applicable appellate courts relating to any of the foregoing (the &ldquo;<B>Delaware Courts</B>&rdquo;). Each
Party hereby irrevocably submits to the exclusive jurisdiction of the Delaware Courts in respect of any legal or equitable Proceeding
arising out of or relating to this Agreement or the transactions contemplated by this Agreement, or relating to enforcement of any of
the terms of this Agreement, and hereby waives, and agrees not to assert, as a defense in any such Proceeding, any claim that it is not
subject personally to the jurisdiction of such court, that the Proceeding is brought in an inconvenient forum, that the venue of the
Proceeding is improper or that this Agreement or the transactions contemplated by this Agreement may not be enforced in or by such courts.
Each Party agrees that notice or the service of process in any Proceeding arising out of or relating to this Agreement or the transactions
contemplated by this Agreement shall be properly served or delivered if delivered in the manner contemplated by <U>&#8206;Section 8.01</U>
or in any other manner permitted by law. Notwithstanding the foregoing provisions of this <U>&#8206;Section 8.08</U>, nothing herein
shall prevent the implementation and enforcement of the Scheme of Arrangement before the Court and, to the extent required by Applicable
Law, the Court shall have exclusive jurisdiction with respect of such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.09</FONT> <I>Waiver of Jury Trial</I>. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY
LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT. EACH PARTY CERTIFIES
AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH
OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO ENFORCE THE FOREGOING WAIVER, (II) EACH PARTY UNDERSTANDS AND HAS CONSIDERED
THE IMPLICATIONS OF THIS WAIVER, (III) EACH PARTY MAKES THIS WAIVER VOLUNTARILY AND (IV) EACH PARTY HAS BEEN INDUCED TO ENTER INTO THIS
AGREEMENT (INCLUDING ANY EXHIBITS) BY, AMONG OTHER THINGS, THE MUTUAL WAIVERS AND CERTIFICATIONS IN THIS <U>&#8206;SECTION 8.09</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.10</FONT> <I>Specific Performance</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Parties agree that irreparable harm would occur in the event that any of the provisions of this Agreement were not performed
in accordance with their specific terms or were otherwise breached, and that monetary damages or other legal remedies would not be an
adequate</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 78; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->74<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">remedy for any such harm. Subject to the terms of this <B><U>&#8206;</U></B><U>Section 8.10(a)</U>, the Parties agree that unless
and until this Agreement is terminated in accordance with <B><U>&#8206;</U></B><U>Section 7.01</U>, (i) the Parties shall be entitled
to an injunction or injunctions from a court of competent jurisdiction as set forth in <B><U>&#8206;</U></B><U>Section 8.08</U> to prevent
breaches (or threatened breaches) of this Agreement and to enforce specifically the terms and provisions of this Agreement (other than
Buyer&rsquo;s obligation to effect the Transaction or the Closing, which shall be governed by the next sentence), without bond or other
security being required, and (ii) the right of specific enforcement is an integral part of the transactions contemplated by this Agreement,
and without that right, neither the Company nor Buyer would have entered into this Agreement. Notwithstanding anything to the contrary
in this Agreement, the Parties further agree that unless and until this Agreement is terminated in accordance with <B><U>&#8206;</U></B><U>Section
7.01</U>, the Company shall be entitled to an injunction, specific performance or other equitable remedy to specifically enforce Buyer&rsquo;s
obligations to effect the Closing on the terms and conditions set forth herein in the event that (A) the conditions set forth in <B><U>&#8206;</U></B><U>Section
6.01</U> and <B><U>&#8206;</U></B><U>Section 6.02</U> (other than those conditions that by their nature are to be satisfied at the Closing;
<U>provided</U> that each such condition is then capable of being satisfied at a Closing on such date) have been satisfied or waived,
(B) the Debt Financing is available to be funded at the Closing and has been funded or will be funded if the Equity Financing is funded
at the Closing, (C) Buyer is required to consummate the Closing pursuant to <U>Section 1.02</U>, (D) the Company stands ready, willing
and able to consummate the transactions contemplated by this Agreement on that date and the Company has irrevocably notified Buyer in
writing at or prior to such date that (x) the Company stands ready, willing and able to consummate the Transaction on that date, and if
specific performance is granted and the Financing is funded, the Closing will so occur on the terms and conditions set forth in this Agreement
and (y) all of the conditions set forth in <B><U>&#8206;</U></B><U>Section 6.01</U> and <B><U>&#8206;</U></B><U>Section 6.02</U> (other
than those conditions that by their nature are to be satisfied at the Closing; <U>provided</U> that each such condition would have then
been capable of being satisfied as of such date), and (E) Buyer fails to consummate the Closing within three (3) Business Days (or, if
earlier, the Business Day immediately preceding the End Date) of the date of delivery of the written notification by the Company contemplated
in <U>clause (D)</U> (such <U>clauses (A)</U>, <U>(B)</U>, <U>(C)</U>, <U>(D)</U> and <U>(E)</U>, together, the &ldquo;<B>Specific Performance
Conditions</B>&rdquo;). Each of the Parties agrees that it will not oppose the granting of an injunction, specific performance or other
equitable relief on the basis that the other Party has an adequate remedy at law or that any such injunction or award of specific performance
or other equitable relief is not an appropriate remedy for any reason; <U>provided</U> that solely with respect to the equitable remedy
to specifically enforce Buyer&rsquo;s obligation to effect the Closing, Buyer may oppose the granting of specific performance only on
the basis that one of the Specific Performance Conditions has not been satisfied. The Parties further agree that (x) following the Company&rsquo;s
termination of this Agreement in accordance with <B><U>&#8206;</U></B><U>Section 7.01</U>, the Company shall be entitled to an injunction
or injunctions from a court of competent jurisdiction as set forth in <B><U>&#8206;</U></B><U>Section 8.08</U> to enforce specifically
Buyer&rsquo;s surviving obligations herein, including with respect to the payment of monetary damages under <B><U>&#8206;</U></B><U>Section
7.02</U> or the payments to which the Company is entitled under <B><U>&#8206;</U></B><U>Section 8.04(c)</U>, and (y) following Buyer&rsquo;s
termination of this Agreement in accordance with <B><U>&#8206;</U></B><U>Section 7.01</U>, Buyer shall be entitled to an injunction or
injunctions from a court of competent jurisdiction as set forth in <B><U>&#8206;</U></B><U>Section 8.08</U> to enforce specifically the
Company&rsquo;s surviving obligations herein, including with respect to the payment of monetary damages under <B><U>&#8206;</U></B><U>Section
7.02</U> or the payments to which Buyer is entitled under <B><U>&#8206;</U></B><U>Section 8.04(b)</U>; <U>provided</U> that the Parties
acknowledge and agree that, while the Company may pursue a grant of specific performance prior to the termination of this Agreement, following
a termination of this Agreement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 79; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->75<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">and the Buyer Termination Payment has been paid or is payable pursuant to <B><U>&#8206;</U></B><U>Section
8.04(c)</U>, under no circumstances shall the Company be permitted or entitled to seek a grant of specific performance to cause the Closing
to occur.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Parties further agree that subject to the terms, limitations and conditions set forth in this Agreement (including <B><U>&#8206;</U></B><U>Section
8.04(c)</U>), (i) by seeking the remedies provided for in this <B><U>&#8206;</U></B><U>Section 8.10</U>, a party shall not in any respect
waive its right to seek any other form of relief that may be available to a party under this Agreement, including for breach of any of
the provisions of this Agreement or in connection with a termination of this Agreement or in the event that the remedies provided for
in this <B><U>&#8206;</U></B><U>Section 8.10</U> are not available or otherwise are not granted, and (ii) nothing set forth in this <B><U>&#8206;</U></B><U>Section
8.10</U> shall require any Party to institute any Proceeding for (or limit any party&rsquo;s right to institute any Proceeding for) specific
performance under this <B><U>&#8206;</U></B><U>Section 8.10</U> prior or as a condition to exercising any termination right under <B><U>&#8206;</U></B><U>Article
7</U> (and pursuing damages after such termination), nor shall the commencement of any Proceeding pursuant to this <B><U>&#8206;</U></B><U>Section
8.10</U> or anything set forth in this <B><U>&#8206;</U></B><U>Section 8.10</U> restrict or limit any Party&rsquo;s right to terminate
this Agreement in accordance with the terms of <B><U>&#8206;</U></B><U>Article 7</U> or pursue any other remedies under this Agreement
that may be available at any time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>In no event shall the Company seek or permit to be sought on behalf of the Company any monetary damages of any kind, including
consequential, indirect, or punitive damages, from any officer, director, agent or employee of Buyer, any direct or indirect holder of
any equity interests or securities of Buyer or any direct or indirect director, officer, employee, partner, Affiliate, member, controlling
Person or Representative of any of the foregoing, in connection with this Agreement or the transactions contemplated by this Agreement
(other than as expressly provided by and subject to the terms of the Equity Commitment Letter and the Guarantee, which the Company may
enforce directly in accordance with their respective terms). Except for the liabilities and obligations of the parties to the Equity Commitment
Letter, the Debt Commitment Letter, the Guarantee, the Company Transaction Documents and the other Buyer Transaction Documents under any
of the foregoing Contracts to which they are parties and except for claims for fraud, all claims, obligations, liabilities, or causes
of action (whether in contract or in tort, in law or in equity, or granted by statute) that may be based upon, in respect of, arise under,
out or by reason of, be connected with, or relate in any manner to this Agreement or the transactions contemplated by this Agreement,
or the negotiation, execution, or performance of this Agreement (including any representation or warranty made in, in connection with,
or as an inducement to, this Agreement), may be made only against (and such representations and warranties are those solely of) the Persons
that are expressly identified as the parties in the preamble to this Agreement (the &ldquo;<B>Contracting Parties</B>&rdquo;). No Person
who is not a Contracting Party, including any current, former or future director, officer, employee, incorporator, member, partner, manager,
stockholder, equityholder, Affiliate, agent, attorney, representative or assignee of, and any financial advisor or lender to, any Contracting
Party, or any current, former or future director, officer, employee, incorporator, member, partner, manager, stockholder, equityholder,
Affiliate, agent, attorney, representative or assignee of any of the foregoing and the Equity Investor and Debt Financing Sources (collectively,
the &ldquo;<B>Non-Recourse Party</B>&rdquo;), shall have any liability (whether in contract or in tort, in law or in equity, or granted
by statute) for any claims, causes of action, obligations, or liabilities arising under, out of, in connection with, or related in any
manner to this Agreement or the transactions contemplated by this Agreement or based on, in respect of, or by reason of this Agreement
or the transactions contemplated by this Agreement or the negotiation, execution,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 80; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->76<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">performance, or breach of this Agreement (other than,
in each case, the liabilities and obligations of the parties to the Equity Commitment Letter, the Debt Commitment Letter, the Guarantee,
the Company Transaction Documents and the other Buyer Transaction Documents under any of the foregoing Contracts to which they are expressly
identified as parties), and, to the maximum extent permitted by Applicable Law, each Contracting Party, on behalf of itself and its Affiliates,
hereby waives and releases all such liabilities, claims, causes of action, and obligations against any such Non-Recourse Party. Without
limiting the foregoing, to the maximum extent permitted by Applicable Law, except as provided in the Equity Commitment Letter, the Debt
Commitment Letter, the Guarantee, the Company Transaction Documents and the other Buyer Transaction Documents, (a) each Contracting Party
hereby waives and releases any and all rights, claims, demands, or causes of action that may otherwise be available at law or in equity,
or granted by statute, to avoid or disregard the entity form of a Contracting Party or otherwise impute or extend the liability of a Contracting
Party to any Non-Recourse Party, whether based on statute or based on theories of equity, agency, control, instrumentality, alter ego,
domination, sham, single business enterprise, piercing the veil, unfairness, undercapitalization, or otherwise; and (b) each Contracting
Party disclaims any reliance upon any Non-Recourse Party with respect to the performance of this Agreement or any representation or warranty
made in, in connection with, or as an inducement to this Agreement. Subject to the terms of the Equity Commitment Letter, in connection
with a valid Order requiring Buyer to specifically perform the Closing of the Transaction under this Agreement, only the Company may enforce
the terms of the Equity Commitment Letter in accordance with their terms. Notwithstanding the foregoing provisions of this <B><U>&#8206;</U></B><U>Section
8.10(c)</U> and any other provision of this Agreement to the contrary, only the Company may enforce the terms and conditions of the Guarantee
directly against the applicable Guarantor (without being required to cause or direct Buyer to do so).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Notwithstanding anything herein to the contrary and for the avoidance of doubt, nothing in this <B><U>&#8206;</U></B><U>Section
8.10</U> nor <B><U>&#8206;</U></B><U>Section 8.04</U> shall limit in any way any fraud remedies or the remedies of the parties under the
Confidentiality Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.11</FONT> <I>Severability</I>. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction
or other Governmental Authority to be invalid, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions
of this Agreement shall remain in full force and effect and shall in no way be affected, impaired or invalidated so long as the economic
or legal substance of the transactions contemplated by this Agreement is not affected in any manner materially adverse to any party.
Upon such a determination, the Parties agree to negotiate in good faith to modify this Agreement so as to effect the original intent
of the Parties as closely as possible in an acceptable manner, in order that the transactions contemplated by this Agreement be consummated
as originally contemplated to the fullest extent possible.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.12</FONT> <I>Entire Agreement; No Reliance; Access to Information</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>This Agreement, the Confidentiality Agreement, the exhibits and schedules to this Agreement, the Company Disclosure Schedule, the
Voting Agreements, the Financing Commitment Letters and the Guarantee constitute the entire agreement between the Parties with respect
to the subject matter hereof and supersede all prior agreements and understandings, both written and oral, between the Parties with respect
thereto. In the event of any inconsistency or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 81; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->77<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">conflict between the provisions of this Agreement and the Scheme of Arrangement, the provisions
of this Agreement shall prevail and govern.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Buyer agrees that, except for the representations and warranties contained in <B><U>&#8206;</U></B><U>Article 3</U> of this Agreement
and the representations and warranties of the Company contained in any Company Transaction Document, including the certificate contemplated
by <U>Section 6.02(c)</U>, the Company makes no other representations or warranties and hereby disclaims any other representations or
warranties made by itself or any of its Representatives, with respect to the execution and delivery of this Agreement or the transactions
contemplated by this Agreement, notwithstanding the delivery or disclosure to any other party or any other party&rsquo;s Representatives
of any document or other information with respect to any one or more of the foregoing. Without limiting the generality of the foregoing,
and notwithstanding any otherwise express representations and warranties made by the parties in this Agreement and the Company Transaction
Documents, Buyer agrees that none of the Company or any of its Subsidiaries makes or has made any representation or warranty with respect
to (i) any projections, forecasts, estimates, plans or budgets or future revenues, expenses or expenditures, future results of operations
(or any component thereof), future cash flows (or any component thereof) or future financial condition (or any component thereof) of the
Company or any of its Subsidiaries or the future business, operations or affairs of the Company or any of its Subsidiaries heretofore
or hereafter delivered to or made available to it, or (ii) any other information, statements or documents heretofore or hereafter delivered
to or made available to it, including the information in the electronic data room of the Company, with respect to the Company or any of
its Subsidiaries or the business, operations or affairs of the Company or any of its Subsidiaries, except to the extent and as expressly
covered by a representation and warranty made in <B><U>&#8206;</U></B><U>Article 3</U> of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(c)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Buyer acknowledges and agrees that it (i) has had an opportunity to discuss the business of the Company and its Subsidiaries with
the management of the Company, (ii) has had reasonable access to (A) the books and records of the Company and its Subsidiaries and (B)
the documents provided by the Company for purposes of the transactions contemplated by this Agreement, (iii) has been afforded the opportunity
to ask questions of and received answers from officers of the Company and (iv) has conducted its own investigation of the Company and
its Subsidiaries, their respective businesses and the transactions contemplated hereby, and has not relied on any representation, warranty
or other statement by any Person on behalf of the Company or any of its Subsidiaries, other than the representations and warranties of
the Company contained in <B><U>&#8206;</U></B><U>Article 3</U> of this Agreement and the representations and warranties contained in any
Company Transaction Document, including the certificate contemplated by <U>Section 6.02(c)</U>. Buyer hereby acknowledges that there are
uncertainties inherent in attempting to develop estimates, projections, forecasts, business plans and other forward-looking information
with which Buyer is familiar, that Buyer is taking full responsibility for making its own evaluation of the adequacy and accuracy of all
estimates, projections, forecasts, business plans and other forward-looking information furnished to it (including the reasonableness
of the assumptions underlying such estimates, projections, forecasts, business plans and other forward-looking information) and, for the
avoidance of doubt, that Buyer will have no claim against the Company or any of its shareholders, directors, officers, employees, Affiliates,
advisors, agents or other Representatives with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 82; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->78<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(d)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>The Company agrees that, except for the representations and warranties contained in <B><U>&#8206;</U></B><U>Article 4</U> of this
Agreement and the representations and warranties of Buyer contained in any Buyer Transaction Document, including the certificate contemplated
by <U>Section 6.03(c)</U>, Buyer makes no other representations or warranties and hereby disclaims any other representations or warranties
made by itself or any of its Representatives, with respect to the execution and delivery of this Agreement or the transactions contemplated
by this Agreement, notwithstanding the delivery or disclosure to any other party or any other party&rsquo;s Representatives of any document
or other information with respect to any one or more of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.13</FONT> <I>Rules of Construction</I>. Each of the Parties acknowledges that it has been represented by counsel of its choice throughout
all negotiations that have preceded the execution of this Agreement and that it has executed the same with the advice of said independent
counsel. Each Party and its counsel cooperated and participated in the drafting and preparation of this Agreement and the documents referred
to herein, and any and all drafts relating thereto exchanged among the parties shall be deemed the work product of all of the Parties
and may not be construed against any Party by reason of its drafting or preparation. Accordingly, any rule of law or any legal decision
that would require interpretation of any ambiguities in this Agreement against any Party that drafted or prepared it is of no application
and is hereby expressly waived by each of the Parties, and any controversy over interpretations of this Agreement shall be decided without
regard to events of drafting or preparation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.14</FONT> <I>Counterparts; Effectiveness</I>. This Agreement may be signed in any number of counterparts, each of which shall be an
original, with the same effect as if the signatures thereto and hereto were upon the same instrument. This Agreement shall become effective
when each Party shall have received a counterpart hereof signed by the other Party. Until and unless each Party has received a counterpart
hereof signed by the other Party, this Agreement shall have no effect and no party shall have any right or obligation hereunder (whether
by virtue of any other oral or written agreement or other communication). Signatures to this Agreement transmitted by electronic mail
in PDF form, or by any other electronic means (including DocuSign) designed to preserve the original graphic and pictorial appearance
of a document, will be deemed to have the same effect as physical delivery of the paper document bearing the original signatures.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><FONT STYLE="font-style: normal; font-weight: normal">Section
8.15</FONT> <I>Certain Definitions</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(a)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>As used herein, the following terms have the following meanings:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Acceptable Confidentiality
Agreement</B>&rdquo; means a confidentiality agreement to which the Company or any of its Subsidiaries is a party containing terms not
less restrictive in any material respect in the aggregate to the counterparty thereto than the terms of the Confidentiality Agreement
(it being agreed that such confidentiality agreement need not contain any &ldquo;standstill&rdquo; or similar provisions or otherwise
prohibit the making, or amendment, of any Acquisition Proposal) and that was entered into in compliance with this Agreement and does not
contain terms that prohibit compliance in any respect with this Agreement; <U>provided</U>, <U>however</U>, that such confidentiality
agreement must contain provisions that permit the Company to comply with the provisions of <U>&#8206;Article 5</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 83; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->79<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Acquisition Proposal</B>&rdquo;
means any bona fide offer or proposal from any Third Party relating to any transaction or series of related transactions involving (i)
any acquisition or purchase by any Third Party, directly or indirectly, of 20% or more of any class of outstanding voting or equity securities
of the Company, or any tender offer or exchange offer that, if consummated, would result in any Third Party beneficially owning 20% or
more of any class of outstanding voting or equity securities of the Company, (ii) any merger, amalgamation, consolidation, share exchange,
business combination, joint venture or other similar transaction involving the Company or any of its Subsidiaries, the business of which
constitutes 20% or more of the net revenues, net income or assets of the Company and its Subsidiaries, taken as a whole, (iii) any liquidation,
dissolution, recapitalization, extraordinary dividend or other significant corporate reorganization of the Company or any of its Subsidiaries,
the business of which constitutes 20% or more of the net revenues, net income or assets of the Company and its Subsidiaries, taken as
a whole, (iv) any merger, consolidation, share exchange, business combination, joint venture, recapitalization, reorganization or other
similar transaction involving the Company, pursuant to which the shareholders of the Company immediately preceding such transaction hold
80% or less of the equity interests or voting power in the surviving or resulting entity of such transaction, (v) any acquisition (whether
by merger, consolidation, equity investment, joint venture or otherwise) which constitutes 20% or more of the consolidated assets (based
on fair market value) of the Company and its Subsidiaries, taken as a whole or (vi) any combination of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Affiliate</B>&rdquo;
means, with respect to any Person, any other Person directly or indirectly controlling, controlled by, or under common control with such
Person; provided, that in no event shall the Buyer or any of its Subsidiaries be considered an Affiliate of any portfolio company or investment
fund (excluding investment funds focused on private equity) affiliated with Wynnchurch, nor shall any portfolio company or investment
fund (excluding investment funds focused on private equity) affiliated with Wynnchurch be considered to be an Affiliate of the Buyer or
any of its Subsidiaries. As used in this definition, the term &ldquo;control&rdquo; (including the terms &ldquo;controlling,&rdquo; &ldquo;controlled
by&rdquo; and &ldquo;under common control with&rdquo;) means possession, directly or indirectly, of the power to direct or cause the direction
of the management or policies of a Person, whether through the ownership of voting securities, by contract or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Aggregate Transaction
Consideration</B>&rdquo; means the sum of the aggregate per share Consideration, plus the aggregate Option Cash Amounts, plus the aggregate
RSU Award Payments, plus the aggregate PSU Award Payments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Antitrust Laws</B>&rdquo;
means the Sherman Antitrust Act of 1890, the Clayton Antitrust Act, the HSR Act, the Federal Trade Commission Act of 1914 and all other
applicable federal, state, local or foreign antitrust, competition, premerger notification or trade regulation laws, regulations or Orders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Applicable Law</B>&rdquo;
means, with respect to any Person, any Law that is binding upon and applicable to such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Business Day</B>&rdquo;
means a day, other than Saturday, Sunday or other day on which commercial banks in New York, New York or London, England are authorized
or required by Applicable Law to close or, in the case of London, England, are customarily closed for normal banking business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 84; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->80<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Buyer Material Adverse
Effect</B>&rdquo; means any fact, circumstance, change, event, occurrence or effect that, individually or in the aggregate, materially
impairs, materially delays or prevents, or would reasonably be expected to materially impair, materially delay or prevent, Buyer&rsquo;s
ability to timely consummate the transactions contemplated hereby, including the Transaction, in each case, by the End Date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Buyer Termination
Payment</B>&rdquo; means an amount equal to $32,250,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Code</B>&rdquo;
means the U.S. Internal Revenue Code of 1986, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Companies Act</B>&rdquo;
means the United Kingdom Companies Act 2006, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Balance
Sheet</B>&rdquo; means the consolidated balance sheet of the Company and its Subsidiaries as of March 29, 2026 and the footnotes thereto
set forth in the Company&rsquo;s quarterly report on Form 10-Q for the quarterly period ended March 29, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Balance
Sheet Date</B>&rdquo; means March 30, 2026.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Board</B>&rdquo;
means the Board of Directors of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Credit Facilities</B>&rdquo;
means (a) the Multicurrency Revolving Facility Agreement, dated as of July 15, 2025 by and among the Company and the parties named therein,
and (b) that certain Amended and Restated Note Purchase Agreement and Private Shelf Agreement dated as of October 26, 2021 by and among
the Company and the parties named therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Disclosure
Schedule</B>&rdquo; means the disclosure schedule that has been prepared by the Company and delivered to Buyer prior to or simultaneously
with the execution of this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company EIP</B>&rdquo;
means the Company&rsquo;s Amended and Restated Non-Executive Directors Equity Incentive Plan (as amended and restated as of June 8, 2022).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Employee
Plan</B>&rdquo; means (i) each &ldquo;employee benefit plan,&rdquo; as defined in Section 3(3) of ERISA (whether or not subject to ERISA),
(ii) each employment, individual consulting, severance, change in control, retention, termination, or similar contract, plan, program,
arrangement, agreement or policy and (iii) each other plan, arrangement, contract, program, agreement or policy providing for compensation
(including variable cash compensation and sales commissions), bonuses, profit-sharing, share option or other share-related rights (including
restricted share units, restricted shares, and share purchase rights) or other forms of incentive or deferred compensation, insurance
(including any self-insured arrangements), health or medical benefits, employee assistance program, disability or sick leave benefits,
supplemental unemployment benefits, severance benefits and post-employment or retirement or other benefits (including compensation, pension,
health, medical or life insurance benefits), other than any such contract, plan, arrangement or policy that is terminable &ldquo;at will&rdquo;
(or following a notice period imposed by Applicable Law) without any contractual obligation on the part of the Company to make any severance,
termination, change in control, or similar payment, and other than any such contract, plan, arrangement or policy that is statutorily
mandated and maintained by a Governmental Authority, which, in each case of <U>clauses (i)</U> through <U>(iii)</U>, is maintained, sponsored,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 85; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->81<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">administered or contributed to by the Company or any of its Subsidiaries, including for the benefit of any current or former employees,
directors or consultants of the Company or any of its Subsidiaries, or with respect to which the Company or any of its Subsidiaries has
any liability (contingent or otherwise). For the avoidance of doubt, &ldquo;Company Employee Plan&rdquo; includes the UK DB Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company ESPP</B>&rdquo;
means the Company&rsquo;s Employee Stock Purchase Plan (as adopted as on March 27, 2014).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company GM</B>&rdquo;
means the general meeting of the Company Shareholders (and any adjournment or postponement thereof) to be convened in connection with
the Scheme of Arrangement, expected to be convened as promptly as reasonably practicable after the Scheme Meeting shall have been concluded
or adjourned or postponed (it being understood that if the Scheme Meeting is adjourned or postponed, the Company GM shall be correspondingly
adjourned or postponed).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Intellectual
Property</B>&rdquo; means all Intellectual Property owned or purported to be owned by the Company or any of its Subsidiaries (whether
or not it is used by the Company and its Subsidiaries in the business of the Company and its Subsidiaries as of the date hereof).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company LTIP</B>&rdquo;
means the Company&rsquo;s Long-Term Umbrella Incentive Plan (as amended and restated as of June 8, 2022).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Material
Adverse Effect</B>&rdquo; means any event, change, fact, condition, circumstance or occurrence that, when considered either individually
or in the aggregate together with all other events, changes, facts, conditions, circumstances or occurrences, has had, or would reasonably
be expected to have, a material adverse effect (i) on the business, financial condition or results of operations of the Company and its
Subsidiaries, taken as a whole, or (ii) individually or in the aggregate, materially impairs, materially delays or prevents, or would
reasonably be expected to materially impair, materially delay or prevent, the Company from consummating the Transaction by the End Date
(as the same may be extended hereunder); <U>provided</U>, <U>however</U>, that with respect to <U>clause (i)</U> none of the following
(alone or in combination) shall constitute or be taken into account in determining whether a Company Material Adverse Effect has occurred
or would reasonably be expected to occur:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(A)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the negotiation, execution, announcement or performance of this Agreement or the pendency or consummation of the transactions contemplated
by this Agreement (including the impact on the relationship of the Company and its Subsidiaries with their respective investors, contractors,
employees, lenders, customers, partners, suppliers, vendors, Governmental Authorities or other Third Parties resulting therefrom) (provided
that this clause (A) shall not apply to any representations and warranties set forth in <U>Section 3.03</U> or <U>Section 3.04</U> or
the conditions set forth in <U>&#8206;Section 6.02(a)</U> to the extent related thereto);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(B)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the identity of, or any facts or circumstances related to, Buyer or any of its Affiliates as the acquiror of the Company;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(C)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>changes in general economic, regulatory or political conditions, or the capital, credit, banking, debt, financial or currency markets,
in the United States or elsewhere in the world,</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 86; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->82<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">or changes therein, including changes in interest or exchange rates or any suspension
of trading in securities on any securities exchange or other market;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(D)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>changes in general conditions in any industry in which the Company and its Subsidiaries operate or in any specific jurisdiction
or geographical area in the United States or elsewhere in the world in which the Company and its Subsidiaries operate;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(E)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any changes in GAAP or other accounting standards (or any authoritative interpretation or enforcement thereof) after the date hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(F)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any changes in Applicable Law (or any authoritative interpretation or enforcement thereof) after the date hereof, including the
adoption, implementation, repeal, modification, or authoritative reinterpretation of any Applicable Law (or any authoritative interpretation
thereof) by any Governmental Authority, or any panel or advisory body empowered or appointed thereby;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(G)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any outbreak, continuation or escalation of acts of terrorism (including international trade related matters and matters related
to tariffs), hostilities, sabotage or war (whether or not declared and whether or not political in nature), hurricanes, volcanoes, tornados,
floods, earthquakes, tsunamis, mudslides, weather-related events, epidemics, pandemics, plagues, other outbreaks of illness or public
health events, fires or natural or man-made disaster or act of God, including any worsening of such conditions existing as of the date
hereof;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(H)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>the taking of any actions specifically required to be taken (other than the requirement that the Company and its Subsidiaries use
reasonable best efforts to operate in the ordinary course), or the failure to take any action, specifically restricted or prohibited by
this Agreement, or the taking of any action, or failure to take any action, by Buyer or any of its Affiliates, or as specifically directed
by Buyer or with its prior written consent;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(I)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any Transaction Litigation; or</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(J)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>any failure by the Company to meet, or changes to, internal or analysts&rsquo; estimates, projections, expectations, budgets or
forecasts of operating statistics, revenue, earnings, cash flow, cash position or any other financial or performance measures (whether
made by the Company or any Third Parties), any change in the Company&rsquo;s credit ratings, or any change in the price or trading volume
of Company Ordinary Shares (it being understood that the underlying causes of such failures or changes in this <U>clause (J)</U> may be
taken into account in determining whether a Company Material Adverse Effect has occurred, unless such underlying cause would otherwise
be excepted by this definition).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><U>provided</U> that in the case of <U>clauses
(C)</U>, <U>(D)</U>, <U>(E)</U>, <U>(F)</U> and <U>(G)</U>, such effect may be taken into account in determining whether or not there
has been a Company Material Adverse Effect to the extent such effect has a disproportionate adverse effect on the Company and its Subsidiaries,
taken as a whole, as compared to other participants in the industry in which the Company and its Subsidiaries operate, in which case only
the incremental disproportionate impact or impacts may be taken into account in determining whether or not there has been a Company Material
Adverse Effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Share Plan</B>&rdquo;
means the Company LTIP and the Company EIP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 87; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->83<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Shareholder</B>&rdquo;
means a holder of Company Ordinary Shares from time to time.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Shareholder
Approval</B>&rdquo; means (i) the approval of the Scheme of Arrangement by a resolution of a majority in number of the Company Shareholders
representing three-quarters (75%) or more of the votes cast by those Company Shareholders who (being entitled to do so) vote in person
or by proxy at the Scheme Meeting (or at any adjournment or postponement of such meeting) and (ii) the approval of the Company Shareholder
Resolutions by the requisite majority of the Company Shareholders at the Company GM (or at any adjournment or postponement of such meeting).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Shareholder
Resolutions</B>&rdquo; means the resolutions to alter the Company Articles of Association and such other matters as may be necessary to
facilitate the implementation of the Transaction and/or the Scheme of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company SIP</B>&rdquo;
means the Company&rsquo;s Share Incentive Plan, as amended.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Company Termination
Payment</B>&rdquo; means an amount equal to $18,000,000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Contract</B>&rdquo;
means any legally binding contract, agreement, note, bond, indenture, mortgage, guarantee, option, lease (or sublease), license, sales
or purchase order, warranty, commitment, offer or other instrument, obligation, arrangement or understanding of any kind.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Debt Financing Sources
Related Parties</B>&rdquo; means the Debt Financing Sources, together with their Affiliates and such lenders&rsquo; or Affiliates&rsquo;
former, current and future equityholders, officers, directors, employees, attorneys, partners (general or limited), trustees, controlling
parties, advisors, members, managers, accountants, consultants, investment bankers, agents, representatives and funding sources, in each
case, directly involved in the Debt Financing, and their respective successors and assigns.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Debt Financing Sources</B>&rdquo;
shall mean each Person (including, without limitation, each agent and arranger, but excluding Buyer and its Affiliates) that has committed
to provide the Debt Financing in connection with the transactions contemplated hereby.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Deutsche Bank</B>&rdquo;
means Deutsche Bank Securities Inc.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Environmental Law</B>&rdquo;
means any Applicable Law concerning pollution, protection of the environment, or public or worker health or safety (to the extent relating
to exposure to any Hazardous Substance), including any such Applicable Law relating to the manufacture, handling, transport, use, treatment,
storage, disposal or release of, or exposure to, any Hazardous Substance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Environmental Permits</B>&rdquo;
means any Governmental Authorizations issued under any Environmental Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA</B>&rdquo;
means the U.S. Employee Retirement Income Security Act of 1974, as amended, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 88; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->84<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>ERISA Affiliate</B>&rdquo;
of any entity means any other entity that, together with such entity, would be treated as a single employer within the meaning of Section
414(b), (c), (m) or (o) of the Code or Section 4001(b)(1) of ERISA.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Ex-Im Laws</B>&rdquo;
means applicable Laws, rules and regulations relating to export, re-export, transfer or import controls (including the Export Administration
Regulations administered by the U.S. Department of Commerce, and customs and import Laws administered by U.S. Customs and Border Protection).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Foreign Employee
Plan</B>&rdquo; means any Company Employee Plan that is maintained pursuant to or is subject to the laws of a country other than the United
States, excluding any benefit plan maintained by a Governmental Authority that is mandated or pursuant to which the Company or its Subsidiaries
is required to contribute, in either case, under Applicable Law. For the avoidance of doubt, &ldquo;Foreign Employee Plan&rdquo; includes
the UK DB Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Foreign Investment
Laws</B>&rdquo; means any Applicable Law intended to screen, prohibit or regulate foreign investments on public interest or national security
grounds.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>&ldquo;Fraud&rdquo; </B>means
with respect to any party, the making of a statement of fact in the express representations and warranties set forth in <U>Articles 3</U>
and <U>4</U> of this Agreement with the specific intent to deceive another party and requires (a) a false representation of material fact,
(b) actual knowledge that such representation is false, (c) the specific intention to induce the party to whom such representation is
made to act or refrain from acting in reliance upon it, (d) causing that party, in justifiable reliance upon such false representation
and without any knowledge of its falsity, to take or refrain from taking action and (e) causing such party to suffer damage by reason
of such reliance. For the avoidance of doubt, Fraud shall not include equitable fraud, promissory fraud, constructive fraud, or any other
tort (including fraud) based on negligence or recklessness.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>GAAP</B>&rdquo;
means generally accepted accounting principles in the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Government Bid</B>&rdquo;
means any quotation, offer, bid, or proposal made by the Company or any of its Subsidiaries that, if accepted or awarded, would result
in or lead to a Government Contract.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Government Contract</B>&rdquo;
means any Contract between the Company or any of its Subsidiaries, on the one hand, and (a) any Governmental Authority, (b) any Person
acting in the capacity of a prime contractor to a Governmental Authority, or (c) any higher-tier contractor with respect to any contract
described in <U>clause (a)</U> or <U>(b)</U>, on the other hand, in effect as of the Closing Date. Unless otherwise indicated, a task,
purchase, or delivery order, in each case, issued under a Government Contract shall not constitute a separate Government Contract for
purposes of this definition, but shall be part of the Government Contract under which it was issued.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental Authority</B>&rdquo;
means (i) any government or any state, department, local authority or other political subdivision thereof, or (ii) any governmental or
quasi-governmental body, agency, authority (including any central bank, Taxing Authority or trans-governmental or supranational entity
or authority), minister or instrumentality (including any court or tribunal or public or private arbitrator or arbitral body) exercising
executive, legislative, judicial, regulatory or administrative functions of or pertaining to government.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 89; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->85<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Governmental Authorizations</B>&rdquo;
means, with respect to any Person, all licenses, permits, certificates, registrations, waivers, consents, franchises (including similar
authorizations or permits), exemptions, variances, expirations and terminations of any waiting period requirements and other authorizations
and approvals issued to such Person by or obtained by such Person from any Governmental Authority, or of which such Person has the benefit
under any Applicable Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Hazardous Substance</B>&rdquo;
means any substance, material or waste that is listed, classified, characterized, defined or otherwise regulated under or pursuant to
any Environmental Law as &ldquo;hazardous,&rdquo; &ldquo;toxic,&rdquo; a &ldquo;pollutant,&rdquo; a &ldquo;contaminant,&rdquo; &ldquo;radioactive,&rdquo;
or words of similar meaning, for which liability or standards of conduct are imposed under Environmental Law, or the exposure to which
is prohibited, limited or otherwise regulated under Environmental Law, including petroleum and its by-products, petroleum-derived products,
asbestos or asbestos-containing materials, lead or lead-containing paint, toxic mold, radiation, per- or polyfluoroalkyl substances and
polychlorinated biphenyls.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Incidental License</B>&rdquo;
means, to the extent entered into in the ordinary course of business, a (i) Contract with a current or former employee or independent
contractor entered into in connection with the engagement of that Person, which Contract includes a license from that Person to use Intellectual
Property owned or sublicensable by that Person, (ii) Contract to the extent to which any Intellectual Property is non-exclusively licensed
to a contractor or vendor solely for the benefit of the licensor and its Affiliates, (iii) non-exclusive license granted in the ordinary
course of business in connection with the sale or provision of goods or services in connection with the use thereof, (iv) license of,
or subscription to, generally commercially available third party software (whether in object code, source code, or as software-as-a-service)
for an annual license fee of no more than $500,000, (v) Contract to the extent containing a non-exclusive license that is merely incidental
to the transaction contemplated in such Contract, the commercial purpose of which is primarily for something other than such license,
such as: (A) a sales or marketing Contract to the extent including such an incidental license to use the trademarks of either party thereto
for the purposes of advertising or marketing; (B) a Contract to purchase or lease equipment, such as a photocopier, computer, or mobile
phone, to the extent also containing such an Intellectual Property license; or (C) a nondisclosure Contract entered into in the ordinary
course of business to the extent containing such a license.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Indebtedness</B>&rdquo;
means, as to the Company and its Subsidiaries, without duplication, all (i) indebtedness of the Company or any of its Subsidiaries for
borrowed money (including the aggregate principal amount thereof and the aggregate amount of any accrued but unpaid interest thereon),
(ii) obligations of the Company or any of its Subsidiaries evidenced by bonds, notes or debentures, (iii) indebtedness of the Company
and its Subsidiaries evidenced by letters of credit to the extent drawn and not cash collateralized, (iv) obligations of the Company or
any of its Subsidiaries under leases required to be capitalized under GAAP (but excluding the effects of Financial Accounting Standards
Board Accounting Standard Codification 842), (v) obligations of the Company or any of its Subsidiaries in respect of interest rate, currency
obligation or commodity swaps and hedging arrangements, in each case, calculated as if the applicable swap or hedging arrangement was
terminated at the Effective Time, and (vi) obligations of the Company or any of its Subsidiaries to guarantee the types of payment obligations
set forth in <U>clauses (i)</U> through <U>(v)</U> above on behalf of any Person other than the Company or its Subsidiaries; <U>provided</U>
that, notwithstanding the foregoing or anything else to the contrary in this Agreement and for</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 90; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->86<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">clarification, Indebtedness shall not include
(A) any letters of credit to the extent not drawn (or otherwise cash collateralized), (B) surety bonds, performance bonds or other bonds
to the extent not drawn (or otherwise cash collateralized), (C) any intercompany indebtedness among the Company and its Subsidiaries (including
between Subsidiaries), (D) any prepaid amounts, customer deposits or deferred revenue, (E) trade payables or other current liabilities
in the ordinary course of business, (F) obligations under operating leases, (G) any fees, costs and expenses to the extent incurred by
or at the written direction of Buyer relating to Buyer&rsquo;s or any of its Affiliates&rsquo; financing (including, without limitation,
any Financing) for the transactions contemplated by this Agreement or any other liabilities or obligations incurred by Buyer or any of
its Affiliates in connection with the transactions contemplated by this Agreement or otherwise, (H) short-term deferred revenues, (I)
deferred rent arising in the ordinary course or (J) any fees, costs and expenses incurred pursuant to <U>Section 5.19</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Intellectual Property</B>&rdquo;
means all of the following and all rights therein and thereto: (a) patents and patent applications, and similar or equivalent rights in
inventions; (b) trademarks, trade names, service marks, trade dress and other designations of origin, together with the goodwill associated
therewith; (c) trade secrets, know-how, methods, processes, and techniques, and other confidential or proprietary business information,
in each case, including any that derive independent economic value, whether actual or potential, from not being known to other persons;
(d) copyrights and any other rights in works of authorship (including software) and any related rights of authors; (e) internet domain
names and social media accounts and handles; (f) computer programs, operating systems, applications, firmware and other code and software,
including all source code, object code, application programming interfaces, data files, databases, protocols, specifications, and other
documentation thereof; and (g) applications for, registrations of, and divisionals, continuations, continuations-in-part, reissuances,
renewals, extensions, restorations and reversions of any of the foregoing (as applicable); and (h) all other intellectual property rights
in any jurisdiction worldwide, in each case&nbsp;of&nbsp;<U>clauses (a)-(h)</U>, including as protectable by Applicable&nbsp;Law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Knowledge of Buyer</B>&rdquo;
means the actual knowledge after reasonable inquiry of direct reports of the individuals identified in <U>Section 8.15(a)</U> of the Company
Disclosure Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Knowledge of the
Company</B>&rdquo; means the actual knowledge after reasonable inquiry of direct reports of each of the individuals identified in <U>Section
8.15(b)</U> of the Company Disclosure Schedule.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Law</B>&rdquo; means
any international, federal, state, local or foreign law (including common law), act, code, statute, ordinance, rule, regulation, convention,
treaty, judgment, Order, directive, adjudication or agency requirement of any Governmental Authority.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Made Available</B>&rdquo;
means that such information, document or material was: (i) publicly available on the SEC EDGAR database prior to the execution of this
Agreement or (ii) made available at least twenty-four (24) hours prior to the execution of this Agreement for review by Buyer or Buyer&rsquo;s
Representatives in the virtual data room maintained by or on behalf of the Company via Datasite in connection with the transactions contemplated
by this Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 91; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->87<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Order</B>&rdquo;
means, with respect to any Person, any award, order, injunction, judgment, decree, ruling or other similar requirement enacted, adopted,
promulgated or applied by a Governmental Authority or arbitrator of competent jurisdiction or settlement or similar agreement with a Governmental
Authority that is binding upon or applicable to such Person or its property.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Permitted Liens</B>&rdquo;
means (i) Liens disclosed on the Company Balance Sheet, (ii) Liens for Taxes, assessments, utilities or other governmental charges or
levies that are (A) not yet due and payable (or are due and payable without penalty) or (B) being contested in good faith by appropriate
proceedings and, in each case, for which adequate reserves have been provided in accordance with GAAP, (iii) the interests of lessors
and sublessors of any leased properties and other statutory Liens in favor of lessors and sublessors, (iv) easements, rights of way and
other imperfections of title or encumbrances with respect to real property that do not materially interfere with the present use of, or
materially detract from the value of, the real property related thereto, (v) requirements and restrictions of zoning, building and other
laws which are not violated by the current use or occupancy of such property, (vi) Liens incurred or deposits or pledges made in connection
with, or to secure payment of, workers&rsquo; compensation, unemployment insurance, pension programs and similar obligations, (vii) mechanics&rsquo;,
carriers&rsquo;, workmen&rsquo;s, repairmen&rsquo;s or other like liens or other similar encumbrances arising or incurred in the ordinary
course of business that do not materially interfere with the present use of, or materially detract from the value of, the property related
thereto and do not reflect payments that are past due, (viii) nonexclusive licenses and sublicenses of Intellectual Property granted in
the ordinary course of business by the Company or any of its Subsidiaries, (ix) except with respect to Intellectual Property, Liens that
do not materially adversely affect the use of or impair the value of the asset or property subject to such Liens, (x) except with respect
to Intellectual Property, any Liens incurred in the ordinary course of business since the date of the Company Balance Sheet, (xi) Liens
that would be discharged or released at or prior to the Closing, (xii) any Lien securing capital lease obligations or purchase money debt,
and (xiii) Liens provided by operation of law for amounts not yet delinquent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Person</B>&rdquo;
means an individual, corporation, partnership, limited liability company, association, trust or other entity or organization or Governmental
Authority, including a government or political subdivision or an agency or instrumentality thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Personal Information</B>&rdquo;
means any information that identifies a natural Person or that is considered &ldquo;personally identifiable information,&rdquo; &ldquo;nonpublic
personal information,&rdquo; &ldquo;personal information,&rdquo; or &ldquo;personal data&rdquo; under applicable privacy or data protection
Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Privacy Requirement</B>&rdquo;
means collectively, all of the following to the extent relating to Processing of Personal Information or otherwise relating to data privacy,
data security, or security breach notification requirements: (i) the Company&rsquo;s or its Subsidiaries&rsquo; own published or public
rules, policies and procedures; (ii) Applicable Laws; (iii) binding industry standards applicable to the Company or any of its Subsidiaries,
including the Payment Card Industry Data Security Standard (PCI-DSS); and (iv) Contracts into which the Company or any of its Subsidiaries
has entered or by which it is otherwise legally bound.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Proceeding</B>&rdquo;
means any suit, claim, action, litigation, arbitration, proceeding (including any civil, criminal, administrative, investigative or appellate
proceeding), charge, complaint, hearing, audit, examination or investigation commenced, brought, conducted or heard by or before</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 92; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->88<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">any court,
tribunal or any other Governmental Authority or any public or private arbitrator or arbitration panel.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Processing</B>&rdquo;
means any operation performed on Personal Information, including the collection, recording, organization, structuring, storage, adaptation
or alteration, retrieval, consultation, use, disclosure by transmission, dissemination or otherwise making available, alignment or combination,
restriction, erasure or destruction of Personal Information.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Representatives</B>&rdquo;
means, with respect to any Person, the directors, officers, employees, advisors, financial advisors, attorneys, accountants, consultants,
agents and other authorized representatives of such Person, acting solely in such capacity.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Required Financial
Information</B>&rdquo; means all financial statements, financial data, audit reports and other information regarding the Company and its
Subsidiaries as may be reasonably requested by Buyer (or the Debt Financing Sources) to the extent that such information is required or
reasonably necessary in connection with the financing contemplated by the Debt Commitment Letter.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sanctioned Person</B>&rdquo;
means any Person who is the target of Sanctions, including by virtue of being (a) listed on any Sanctions-related list of designated or
blocked persons; (b) a Governmental Authority of, resident in, or organized under the Laws of a country or territory that is the target
of comprehensive Sanctions (as of the date of this Agreement, Cuba, Iran, North Korea, and the Crimea region and so-called Donetsk People&rsquo;s
Republic and Luhansk People&rsquo;s Republic (each a &ldquo;<B>Sanctioned Country</B>&rdquo;)); or (c) 50% or more owned or controlled
by any of the foregoing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sanctions</B>&rdquo;
means trade, economic and financial sanctions Laws, regulations, embargoes, and restrictive measures, including those administered, enacted
or enforced by (a) the United States (including the Department of Treasury, Office of Foreign Assets Control), (b) the European Union
and enforced by its member states, (c) the United Nations or (d) His Majesty&rsquo;s Treasury.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Sarbanes-Oxley Act</B>&rdquo;
means the Sarbanes-Oxley Act of 2002, and the rules and regulations promulgated thereunder.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Scheme Meeting</B>&rdquo;
means such meeting(s) of the Company Shareholders as the Court may direct in relation to the Scheme of Arrangement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Scheme of Arrangement</B>&rdquo;
means the proposed scheme of arrangement between the Company and the Company Shareholders under Part 26 of the Companies Act to effect
the Transaction pursuant to this Agreement in all material respects in the form set out in <U>Exhibit A</U>, subject to any amendment
thereof that the Parties agree in accordance with <U>&#8206;Section 5.04(d)</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Subsidiary</B>&rdquo;
means, with respect to any Person, any entity of which securities or other ownership interests having ordinary voting power to elect a
majority of the board of directors or other persons performing similar functions are directly or indirectly owned by such Person.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Superior Proposal</B>&rdquo;
means any unsolicited <I>bona fide </I>written Acquisition Proposal the Company Board or any duly authorized committee thereof determines
in good faith (after</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 93; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->89<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">consultation with the Company&rsquo;s financial advisor and outside legal counsel), taking into account such factors
the Company Board considers appropriate, among other things, all legal, financial, regulatory, and other aspects of the Acquisition Proposal
and the Third Party making the Acquisition Proposal, would, (a) if consummated in accordance with its terms, result in a transaction that
is more favorable from a financial point of view to the Company Shareholders than the Transaction (including any revisions to the terms
of this Agreement, the Guarantee and the Financing Commitment Letters proposed by Buyer in writing prior to the time of such determination),
(b) is fully financed or reasonably capable of being fully financed and (c) the conditions to the consummation of which are all reasonably
capable of being satisfied; <U>provided</U>, <U>however</U>, that, for purposes of this definition of &ldquo;Superior Proposal,&rdquo;
references in the term &ldquo;Acquisition Proposal&rdquo; to &ldquo;20% or more&rdquo; or &ldquo;less than 80%&rdquo; shall be deemed
to be references to &ldquo;more than 50%&rdquo; or &ldquo;50% or less&rdquo;, respectively.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax</B>&rdquo; means
any tax of any kind whatsoever, together with any interest, penalty, or addition to tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Tax Return</B>&rdquo;
means any report, return, or form, required to be filed with a Taxing Authority, including information returns and any document accompanying
payments of estimated Taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Taxing Authority</B>&rdquo;
means any Governmental Authority responsible for the collection, imposition or administration of any Tax.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Third Party</B>&rdquo;
means any Person or &ldquo;group&rdquo; (as defined under Section 13(d) of the Exchange Act) of Persons, other than Buyer or any of its
Affiliates or Representatives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Transaction Litigation</B>&rdquo;
means any claim, demand or Proceeding (including any class action or derivative litigation) asserted, commenced or threatened by, on behalf
of or in the name of, against or otherwise involving the Company, the Company Board or any committee thereof and/or any of the Company&rsquo;s
directors or officers relating directly or indirectly to this Agreement, the Transaction or any related transaction (including any such
claim, demand or Proceeding based on allegations that the Company&rsquo;s entry into this Agreement or the terms and conditions of this
Agreement or any related transaction constituted a breach of the fiduciary duties of any member of the Company Board, any member of the
board of directors of any of the Company&rsquo;s Subsidiaries or any officer of the Company or any of its Subsidiaries).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Treasury Regulations</B>&rdquo;
means the regulations promulgated under the Code by the United States Department of Treasury and the Internal Revenue Service.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>UK DB Plan</B>&rdquo;
means the Luxfer Group Pension Plan and the Luxfer Group Supplementary Pension Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>U</B>.<B>S</B>.
<B>Employee Plan</B>&rdquo; means any Company Employee Plan that is maintained pursuant to or is subject to the laws of the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>VAT</B>&rdquo; means
(i) within the UK, any value added tax imposed by Value Added Tax Act 1994 and any related secondaries legislation, (ii) within the European
Union, such taxation as may be levied in accordance with (but subject to derogations from) EU Directive 2006/112/EC, and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 94; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->90<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">(iii) any other
tax of a similar nature (including sales tax, use tax, consumption tax and goods and services tax), whether imposed in the UK or in a
member state of the European Union in substitution for, or levied in addition to, such tax referred to in <U>clauses (i)</U> or <U>(ii)</U>
above, or elsewhere.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>WARN Act</B>&rdquo;
means the Worker Adjustment and Retraining Notification Act of 1988, as amended, or any similar Applicable Laws.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<B>Willful and Material
Breach</B>&rdquo; means a material breach of this Agreement that is the consequence of an act or omission by the breaching party with
the actual knowledge that the taking of such act or failure to take such act, or the failure to cure such breach, would cause or constitute
such material breach.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">(b)<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">
</FONT>Each of the following terms is defined in the Section set forth opposite such term:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acceptable Confidentiality Agreement</FONT></TD>
    <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisition Proposal</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adverse Recommendation Change</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.03(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Affiliate</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Aggregate Transaction Consideration</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Alternative Financing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.15(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Anti-Corruption Laws</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.13(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Antitrust Laws</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Applicable Law</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Book-Entry Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.02(a)(ii)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Business Day</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Benefit Plans</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.07(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Expenses</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.04(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Liability Limit</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 7.02</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Material Adverse Effect</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Recovery Costs</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.04(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Related Parties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.04(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Termination Payment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Buyer Transaction Documents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.02</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Capitalization Date</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.05(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Certificates</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.02(a)(ii)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 1.02</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Closing Date</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 1.02</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Code</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Companies Act</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Articles of Association</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.01</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Balance Sheet</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Balance Sheet Date</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Board</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 95; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->91<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Credit Facilities</FONT></TD>
    <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Disclosure Schedule</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Employee Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Equity Awards</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(iv)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company EIP</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company ESPP</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company GM</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Intellectual Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Leased Real Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.21(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company LTIP</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Material Adverse Effect</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Ordinary Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.05(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company PSU Award</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(iv)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Recommendation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.02(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Recovery Costs</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.04(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Related Parties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;&lrm;Section 8.04(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company RSU Award</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(iii)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company SEC Documents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.07(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Securities</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.05(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Share Option</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(i)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Share Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Shareholder</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Shareholder Approval</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Shareholder Resolutions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company SIP</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Termination Payment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company Transaction Documents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.02(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidentiality Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.16</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Consideration</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 1.01</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Continuing Employee</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.07(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contracting Parties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.10(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Court</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 1.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Court Documentation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.04(a)(v)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Court Order</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 1.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit Facilities Termination</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current ESPP Offering Period</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current Premium</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.10(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Current SIP Accumulation Period</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(d)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Commitment Letter</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.08</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Financing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.08</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Financing Documents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Financing Sources Related Parties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Debt Financing Sources</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Delaware Courts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.08</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deutsche Bank</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 96; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->92<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Divestiture Action</FONT></TD>
    <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.11(d)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOJ</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.11(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earned RSUs</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(iv)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Earned Shares</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(ii)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective Time</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 1.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">End Date</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 7.01(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Enforceability Exceptions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.02(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental Law</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Environmental Permits</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Commitment Letter</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Financing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.08</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity Investor</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ERISA</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">ERISA Affiliate</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Act</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Agent</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.02(a)(i)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Agent Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.02(a)(i)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Exchange Fund</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.02(a)(i)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Excluded Benefits</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.07(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ex-Im Laws</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.08</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing Amounts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.08</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing Commitment Letters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.08</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Employee Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Foreign Investment Laws</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forms of Proxy</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.04(a)(v)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">FTC</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.11(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">GAAP</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government Bid</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Government Contract</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Authority</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Governmental Authorizations</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guarantee</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Guarantor</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Hazardous Substance</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">HSR Act</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Incidental License</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indebtedness</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnified Party</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.10(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Indemnified Party Proceeding</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.10(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Interested Party Transaction</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 3.14(a)(xi)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internal Controls</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.08(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intervening Event</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.03(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IT Systems</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.20(g)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Knowledge of Buyer</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 97; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->93<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Knowledge of the Company</FONT></TD>
    <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Labor Agreement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 3.17(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Law</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Lien</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.04</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Made Available</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Material Contract</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.14(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-Recourse Party</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.10(c)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Intervening Event</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.03(b)(iii)(A)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notice of Superior Proposal</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.03(b)(ii)(A)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">NYSE</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option Cash Amounts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(ii)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Order</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other Tail Premium</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.10(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Owned Real Property</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.21(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Parties</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payoff Letters</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.19</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PBGC</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 3.16(m)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Permitted Liens</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Person</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Personal Information</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Privacy Requirement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proceeding</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Processing</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proscribed Recipient</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.13(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Proxy Statement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.04(e)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">PSU Award Payments</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(iv)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recent SEC Reports</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Article 3</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Representatives</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Required Financial Information</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSU Award Payments</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(iii)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">RSUs</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(iii)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanctioned Person</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanctions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sanctioned Country</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sarbanes-Oxley Act</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scheme Document</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.04(a)(i)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scheme Meeting</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scheme of Arrangement</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Scheme Supplemental Document</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 5.04(a)(v)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities Act</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 3.03</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Solvent</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.09</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Specific Performance Conditions</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.10(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsidiary</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Superior Proposal</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tax Return</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<!-- Field: Page; Sequence: 98; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->94<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Taxing Authority</FONT></TD>
    <TD STYLE="text-align: right; width: 50%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Termination Payment</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.05(b)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Third Party</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time-Based Option Cash Amounts</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 2.03(a)(i)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfer Taxes</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.05(d)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction Documents</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 4.02</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transaction Litigation</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Treasury Regulations</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">U.S. Employee Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">UK DB Plan</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">VAT</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Voting Agreements</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recitals</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">WARN Act</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Willful and Material Breach</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&lrm;Section 8.15(a)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Wynnchurch</FONT></TD>
    <TD STYLE="text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section 5.16</FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.16 <I>Other Definitional
and Interpretative Provisions</I>. The words &ldquo;hereof,&rdquo; &ldquo;herein&rdquo; and &ldquo;hereunder&rdquo; and words of like
import used in this Agreement shall refer to this Agreement as a whole and not to any particular provision of this Agreement. The captions
herein are included for convenience of reference only and shall be ignored in the construction or interpretation hereof. References to
Articles, Sections, Exhibits and Schedules are to Articles, Sections, Exhibits and Schedules of this Agreement unless otherwise specified.
Any capitalized terms used in any Exhibit or Schedule but not otherwise defined therein shall have the meaning as defined in this Agreement.
Any singular term in this Agreement shall be deemed to include the plural, and any plural term the singular. Whenever the words &ldquo;include,&rdquo;
&ldquo;includes&rdquo; or &ldquo;including&rdquo; are used in this Agreement, they shall be deemed to be followed by the words &ldquo;without
limitation,&rdquo; whether or not they are in fact followed by those words or words of like import. &ldquo;Writing,&rdquo; &ldquo;written&rdquo;
and comparable terms refer to printing, typing and other means of reproducing words (including electronic media) in a visible form. References
to &ldquo;executive officer&rdquo; shall refer to such term as defined in Rule 3b-7 under the Exchange Act. References to any Person
include the successors and permitted assigns of that Person. References to any statute are to that statute and to the rules and regulations
promulgated thereunder, in each case as amended from time to time. References to &ldquo;$&rdquo; and &ldquo;dollars&rdquo; are to the
currency of the United States. References from or through any date shall mean, unless otherwise specified, from and including or through
and including, respectively. Accounting terms used, but not specifically defined, in this Agreement shall be construed in accordance
with GAAP as applied by the Company. The phrase &ldquo;ordinary course&rdquo; shall be deemed to be followed by the words &ldquo;consistent
with past practice.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">Section 8.17 <I>Debt Financing
Sources</I>. Notwithstanding anything herein to the contrary, the Company, on behalf of itself, its Subsidiaries and each of its controlled
Affiliates, hereby (i) agrees that no Debt Financing Sources Related Parties shall have any liability for any obligations or liabilities
of the parties hereto or for any action, cause of action, claim, cross-claim or third-party claim of any kind or description whether
in law or in equity, whether in tort, contract or otherwise, based on, in respect of, or by reason of, this Agreement, the Debt Financing,
the Debt Commitment Letter or any of the transactions contemplated hereby or thereby or the performance of any services thereunder (subject
to the last sentence of this <U>&#8206;Section 8.17</U>), (ii) agrees that any</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 99; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->95<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">Proceeding, whether in law or in equity,
whether in contract or in tort or otherwise, involving the Debt Financing Sources Related Parties, arising out of or relating to, this
Agreement, the Debt Financing or any of the agreements (including the Debt Commitment Letter) entered into in connection with the Debt
Financing or any of the transactions contemplated hereby or thereby or the performance of any services thereunder shall be subject to
the exclusive jurisdiction of any federal or state court in the Borough of Manhattan, New York, New York, so long as such forum is and
remains available, and any appellate court thereof and irrevocably submits itself and its property with respect to any such proceeding
to the exclusive jurisdiction of such court, and such proceeding (except to the extent relating to the interpretation of any provisions
in this Agreement (including any provision in the Debt Commitment Letter or in any definitive documentation related to the Debt Financing
that expressly specifies that the interpretation of such provisions shall be governed by and construed in accordance with the law of the
State of Delaware)) shall be governed by the laws of the State of New York (without giving effect to any conflicts of law principles that
would result in the application of the laws of another jurisdiction), (iii) agrees that service of process upon such party in any such
proceeding shall be effective if notice is given in accordance with this Agreement, (iv) irrevocably waives, to the fullest extent that
it may effectively do so, the defense of an inconvenient forum to the maintenance of such proceeding in any such court, (v) knowingly,
intentionally and voluntarily waives to the fullest extent permitted by applicable Law trial by jury in any proceeding brought against
the Debt Financing Sources Related Parties in any way arising out of or relating to this Agreement, the Debt Financing or any of the agreements
(including the Debt Commitment Letter) entered into in connection with the Debt Financing or any of the transactions contemplated hereby
or thereby or the performance of any services thereunder, (vi) agrees that Buyer may collaterally assign its rights and obligations hereunder
(while remaining liable for its obligations hereunder) to the Debt Financing Sources Related Parties pursuant to the terms of the Debt
Financing for purposes of creating a security interest herein or otherwise assigning as collateral in respect of the Debt Financing and
(vii) agrees that the Debt Financing Sources Related Parties are express third-party beneficiaries of, and may enforce, any of the provisions
in this Agreement reflecting the foregoing agreements in this <U>&#8206;Section 8.17</U> and such provisions and the definition of &ldquo;Debt
Financing Sources Related Parties&rdquo; shall not be amended in any way materially adverse to the Debt Financing Sources Related Parties
without the prior written consent of the Debt Financing Sources (such consent not to be unreasonably withheld, conditioned or delayed).
Notwithstanding the foregoing, nothing in this <U>&#8206;Section 8.17</U> shall in any way limit or modify the rights and obligations
of Buyer under this Agreement or any Debt Financing Sources Related Party&rsquo;s obligations under the Debt Commitment Letter, or any
rights of Buyer, the Company and their respective Subsidiaries available under the Debt Commitment Letter against the Debt Financing Sources
Related Parties with respect to the Debt Financing or any of the transactions contemplated thereby or any services thereunder following
the Closing Date. Notwithstanding anything to the contrary in this <U>&#8206;Section 8.17</U>, nothing herein shall limit or restrict
in any way the rights or remedies of the Company or any of its Subsidiaries under the Debt Commitment Letter against any Debt Financing
Sources Related Party in the event of fraud by such Debt Financing Sources Related Party.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 100; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->96<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the parties
hereto have caused this Agreement to be duly executed by their respective authorized officers as of the day and year first above written.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">LUXFER HOLDINGS PLC</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 60%">&nbsp;</TD>
    <TD STYLE="width: 5%"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 35%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Andrew Butcher</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</FONT></TD>
    <TD>Andrew Butcher</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>Chief Executive Officer</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD COLSPAN="2"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">DOUBLE EAGLE ACQUISITION BUYER, INC.</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</FONT></TD>
    <TD STYLE="border-bottom: Black 1.5pt solid">/s/ Brian Riordan</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&nbsp;</FONT></TD>
    <TD>Brian Riordan</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</FONT></TD>
    <TD>President</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">[<I>Signature Page to Transaction Agreement</I>]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 3.5in">&nbsp;</P>




<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 101 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">EXHIBIT A</P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Form of Scheme of Arrangement</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 102 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="text-align: center; margin-top: 0; margin-bottom: 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SCHEME OF ARRANGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IN THE HIGH COURT OF JUSTICE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BUSINESS AND PROPERTY COURTS OF ENGLAND AND WALES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPANIES COURT (ChD)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">Claim No. [&#9679;]</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IN THE MATTER OF LUXFER HOLDINGS PLC</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>-AND-</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IN THE MATTER OF THE COMPANIES ACT 2006</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEME OF ARRANGEMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(under Part 26 of the
Companies Act 2006)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>between</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LUXFER HOLDINGS PLC</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>and</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE SCHEME SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(as hereinafter defined)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: auto; margin-right: auto; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"><B>&nbsp;</B></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>PRELIMINARY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(A)</TD><TD STYLE="text-align: justify">In this Scheme, unless inconsistent with the subject or context, the following expressions have the following meanings:</TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1.75in">&ldquo;<B>Awards</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the share awards, restricted share units, conditional share awards, options, phantom options and/or phantom conditional awards granted under the Company Share Plans;</TD></TR>

<TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Book-Entry Shares</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">Scheme Shares represented by book-entry;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Business Day</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">any day (excluding any Saturday or Sunday or public or bank holiday) on which banks are generally open for normal banking business in New York, NY, United States and London, United Kingdom;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Buyer</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">Double Eagle Acquisition Buyer, Inc., a Delaware corporation;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Buyer&rsquo;s Group</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">Buyer and its subsidiaries;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 103 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1.75in">&ldquo;<B>Companies Act</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the Companies Act 2006, as amended from time to time;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Company</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">Luxfer Holdings PLC, a public limited company incorporated in England and Wales with company number 03690830;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Company Share Plans</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">each of the Luxfer Holdings PLC Long-Term Umbrella Incentive Plan (as amended and restated as of 8 June 2022), the Luxfer Holdings PLC Amended and Restated Non-Executive Directors Equity Incentive Plan (as amended and restated as of 8 June 2022), the Luxfer Share Incentive Plan (as amended);</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Company Shareholders</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">holders of issued Company Shares from time to time (excluding any treasury shares);</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Company Shares</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">ordinary shares of &pound;0.50 each in the capital of the Company;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Consideration</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">the cash consideration of $17.37 per Company Share payable by the Buyer to the Scheme Shareholders (as appearing on the register of members of the Company at the Scheme Record Time) on the proposed terms under which the Scheme Shares shall be transferred to the Buyer (and/or its nominee(s));</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Court</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">the High Court of Justice in England and Wales;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Court Meeting</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">such meeting(s) of the Scheme Shareholders (and any adjournment or postponement thereof) convened with the permission of the Court pursuant to section 896 of the Companies Act for the purpose of considering and, if thought fit, approving (with or without modification) the Scheme;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Court Order</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the order of the Court sanctioning this Scheme under section 899 of the Companies Act;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Effective Date</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the date on which this Scheme becomes effective in accordance with clause 6(a) of this Scheme; </TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Effective Time</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">has the meaning set out in clause 6(a) of this Scheme;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Encumbrances</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">any lien, pledge, hypothecation, charge, mortgage, security interest, encumbrance, rights of pre-emption, or other restriction of similar nature (including any restriction on the transfer of any security or other asset, or any restriction on the possession, exercise or transfer of any other attribute of ownership of any asset) or other third-party right of any nature;</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 104 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1.75in">&ldquo;<B>ESOP</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the Luxfer Group Employee Share Ownership Plan 1997;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Exchange Agent</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">has the meaning set out in clause 3(a) of this Scheme;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Exchange Fund</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">has the meaning set out in clause 3(b) of this Scheme;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Excluded Shares</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">(i) any Company Shares which are registered in the name of or beneficially owned by the Buyer or any member of the Buyer&rsquo;s Group and (ii) any Company Shares held in treasury by the Company;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>holder</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">registered holder and includes any person entitled by transmission;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Latest Practicable Date</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">5.00 p.m. (London time) on [&#9679;], being the latest practicable date before publication of the Scheme Document;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Permitted Dividend</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the Company&rsquo;s quarterly dividend of $0.13 per Company Share payable on 5 August 2026 to Company Shareholders of record as of the close of business on 17 July 2026;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Registrar</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">Computershare Investor Services PLC, the Company&rsquo;s share registrar;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Registrar of Companies</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the Registrar of Companies in England and Wales;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Scheme</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">this scheme of arrangement in its present form or with or subject to any modification, addition or condition which the Company and the Buyer agree and which is approved or imposed by the Court;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&ldquo;<B>Scheme Document</B>&rdquo;</TD>
    <TD STYLE="text-align: justify">the scheme circular or other similar document containing the terms of the Scheme and the appropriate explanatory statement in compliance with section 897 of the Companies Act, sent by the Company to Company Shareholders in connection with this Scheme;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Scheme Record Time</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">6.00 p.m. (London time) on the Business Day immediately prior to the Effective Date (or such other date and/or time that the Buyer and the Company may agree) and the Court may approve or impose;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Scheme Shareholder</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">a holder of Scheme Shares;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Scheme Shares</B>&rdquo;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">the Company Shares:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.75pt; text-align: justify; text-indent: -21.75pt">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;in
    issue at the date of the Scheme Document;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 21.75pt; text-align: justify; text-indent: -21.75pt">(ii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(if
    any) issued after the date of the Scheme Document but before the Voting Record Time; and</P>

</TD></TR>
</TABLE>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 105 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-indent: -0.375in; padding-left: 0.375in; vertical-align: bottom; text-align: justify">(iii)&nbsp;&nbsp;&nbsp;&nbsp;(if
    any) issued at or after the Voting Record Time and before the Scheme Record Time (including, for the avoidance of doubt, any Company Shares
    issued to satisfy the vesting of awards pursuant to existing incentive arrangements of the Company or any of its affiliates) on terms
    that the original or any subsequent holders shall be, or shall have agreed in writing by such time to be, bound by this Scheme,</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">in each case remaining in issue at the Scheme
    Record Time, but not including any Excluded Shares;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD STYLE="width: 0.5in">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 1.75in">&ldquo;<B>Transaction Agreement</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">the transaction agreement between the Company and the Buyer, dated July 26, 2026, setting out, <I>inter alia</I>, the proposed terms of the Scheme entered into by the Company and the Buyer (as such agreement may be amended from time to time); and</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">&nbsp;</TD></TR>
  <TR>
    <TD>&nbsp;</TD>
    <TD STYLE="vertical-align: top">&ldquo;<B>Voting Record Time</B>&rdquo;</TD>
    <TD STYLE="vertical-align: bottom; text-align: justify">6.30 p.m. (London time) on the date which is two Business Days prior to the Court Meeting or if the Court Meeting is adjourned 6.30 p.m. on the day which is two Business Days before the day of such adjourned meeting.</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">All references to clauses or paragraphs are to clauses or
paragraphs of this Scheme.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All references to &ldquo;<B>Dollars</B>&rdquo;
and &ldquo;<B>$</B>&rdquo; are to the lawful currency of the United States of America. &ldquo;<B>&pound;</B>&rdquo; means the lawful currency
of the United Kingdom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">All references to any statutory provision
or law or to any order or regulation shall be construed as a reference to that provision, law, order or regulation as extended, modified,
replaced or re-enacted from time to time and all statutory instruments, regulations and orders from time to time made thereunder or deriving
validity therefrom.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">Words importing the singular shall include
the plural and vice versa, and words importing the masculine gender shall include the feminine or neutral gender.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">A reference to &ldquo;<B>includes</B>&rdquo;
shall mean &ldquo;includes without limitation&rdquo;, and references to &ldquo;<B>including</B>&rdquo; and any other similar term shall
be interpreted accordingly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(B)</TD><TD STYLE="text-align: justify">As at the Latest Practicable Date, the entire issued share capital of the Company consisted of [&#9679;]
ordinary shares of par value &pound;0.50 each, all of which are credited as fully paid up and [&#9679;] of which were held in treasury.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(C)</TD><TD STYLE="text-align: justify">As at the Latest Practicable Date, Awards to acquire up to [&#9679;] Company Shares have been awarded
and remain outstanding pursuant to the Company Share Plans and the ESOP holds in aggregate [&#9679;] Company Shares that can be used to
satisfy outstanding Awards.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in"></P>

<!-- Field: Page; Sequence: 106 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(D)</TD><TD STYLE="text-align: justify">As at the date of the Scheme, neither the Buyer nor any member of the Buyer&rsquo;s Group beneficially
owns any Company Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(E)</TD><TD STYLE="text-align: justify">The Buyer has agreed to appear by counsel at the hearing to sanction this Scheme and to be bound by, and
undertake to the Court to be bound by, the terms of this Scheme and to execute and do, or procure to be executed and done, all such documents,
acts or things as may be necessary or desirable to be executed or done by or on behalf of the Buyer for the purpose of giving effect to
this Scheme.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in">(F)</TD><TD STYLE="text-align: justify">References to times are to the time in London, United Kingdom.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 107 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>THE SCHEME</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">1.</TD><TD STYLE="text-align: justify"><B>TRANSFER OF SCHEME SHARES</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">On and with effect from the Effective Time, the Buyer (and/or its nominee(s)) shall acquire all legal and beneficial title to all
of the Scheme Shares, fully paid-up, with full title guarantee, free from all Encumbrances (other than transfer restrictions arising under
applicable securities laws) and together with all rights as at the Effective Time or thereafter attaching or accruing thereto including,
without limitation, the rights to receive and retain in full all dividends and other distributions (if any) announced, authorised, declared,
made, becoming payable or paid, or any other return of capital or value (whether by reduction of share capital or share premium account
or otherwise) in respect of the Scheme Shares, made by reference to a record date after the Effective Date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">For such purposes, the Scheme Shares shall be transferred to the Buyer (and/or its nominee(s)) and such
transfer(s) shall be effected by means of a form or forms of transfer or other instrument(s) of transfer given or executed by any person
appointed by the Buyer. To give effect to such transfer(s) any person may be appointed by the Buyer as attorney and/or agent and/or otherwise
on behalf of each Scheme Shareholder, and shall be authorised as such attorney and/or agent and/or otherwise on behalf of each Scheme
Shareholder to execute and deliver as transferor one or more form(s) of transfer or other instrument(s) of transfer (whether as a deed
or otherwise) of, or otherwise give any instructions to transfer, all of the Scheme Shares and every form of transfer or other instrument
of transfer so given or executed shall be as effective as if it or they had been given or executed by the holder or holders of the Scheme
Shares thereby transferred. Such forms or instruments of transfer shall be deemed to be the principal instruments of transfer and the
equitable or beneficial interest in the Scheme Shares shall only be transferred to the Buyer (and/or its nominee(s)), together with the
legal interest in such Scheme Shares, pursuant to such forms or instruments of transfer.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">With effect from the Effective Date, each Scheme Shareholder shall cease to have any rights with respect
to the Scheme Shares, except the right to receive the Consideration, and the Buyer or its agents shall be entitled to direct the exercise
of any voting rights and any or all rights and privileges attaching to any Scheme Shares, and each Scheme Shareholder irrevocably:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">appoints the Buyer (and/or its nominee(s)) and/or each of their agents and directors as its attorney and/or
agent and/or delegate and/or otherwise to exercise or to direct the exercise on its behalf (in place of and to the exclusion of the relevant
Scheme Shareholder) of: (A) any voting rights attached to its Scheme Shares (including, without limitation, in relation to any proposal
to convert the Company to a private limited company); and (B) any or all rights and privileges attaching to its Scheme Shares (including,
without limitation, the right to receive any distribution or other benefit accruing or payable in respect thereof and the right to requisition
the</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 108 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: left">convening of a general meeting of the Company or any class of its shareholders);</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">appoints the Buyer (and/or its nominee(s)) and/or each of their agents and directors as its attorney and/or
agent and/or delegate and/or otherwise to sign on behalf of such Scheme Shareholders such documents, and do such things, as may in the
opinion of the Buyer (and/or its nominee(s)) and/or each of their respective agents and directors (in each case, acting reasonably) be
necessary or desirable in connection with the exercise of any voting rights and any or all rights and privileges attaching to such Scheme
Shares, including, without limitation, an authority to sign any consent to short notice of a general or separate class meeting and to
execute a form of proxy or other representative or similar document in respect of its Scheme Shares appointing any person nominated by
the Buyer to attend general and separate class meetings of the Company;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">authorises the Buyer (and/or its nominee(s)) to take such action as the Buyer or its nominee(s) sees fit
in relation to any dealings with or disposals of its Scheme Shares (or any interest in such Scheme Shares) and authorises the Company
and/or its agents to send to the Buyer (and/or its nominee(s)) at the Buyer&rsquo;s registered office any notice, circular, warrant or
other document or communication which may be required to be sent to it as a member of the Company; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iv)</TD><TD STYLE="text-align: justify">undertakes not to, without the consent of the Buyer: (A) exercise any vote or any other rights or privileges
attaching to the relevant Scheme Shares; or (B) appoint a proxy or representative for, or to attend, any general meeting or separate class
meeting of the Company,</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0in">such that from the Effective
Time, no Scheme Shareholder shall be entitled to exercise any voting rights attached to the Scheme Shares or any other rights or privileges
attaching to the Scheme Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">The authorities granted by each Scheme Shareholder pursuant to clauses 1(b) and 1(c) shall be treated
for all purposes as having been granted by deed.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">2.</TD><TD STYLE="text-align: justify"><B>CONSIDERATION FOR THE TRANSFER OF SCHEME SHARES</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">In consideration of the transfer of Scheme Shares to the Buyer and/or its nominee(s) as provided in clauses
1(a) and 1(b), the Buyer shall pay or procure that there shall be paid, to or for the account of each Scheme Shareholder (as appearing
in the register of members of the Company at the Scheme Record Time):</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; font: 10pt Times New Roman, Times, Serif; width: 100%">
<TR STYLE="vertical-align: top; text-align: left">
  <TD STYLE="text-align: right; width: 45%"><B>for each Scheme Share</B></TD>
  <TD STYLE="width: 10%">&nbsp;</TD>
  <TD STYLE="width: 45%"><B>$17.37 in cash</B></TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">If any dividend, distribution and/or return of capital is announced, declared, made or paid in respect
of any Scheme Share on or after the date of the Transaction Agreement and prior to the Effective Date, other than the Permitted Dividend,
the</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 109 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">Buyer shall be entitled to reduce the amount of the Consideration payable for each Scheme Share by the amount of all or part of any
such dividend, distribution or return of capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">If the Buyer exercises the right referred to in clause 2(b) to reduce the consideration payable by the
Buyer for each Scheme Share by all or part of the amount of a dividend, distribution or return of capital, then:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">the relevant Scheme Shareholders at the relevant Scheme Record Time shall be entitled to receive and retain
that dividend and/or distribution and/or return of capital (or relevant part of it) in respect of the Scheme Shares they held at such
Scheme Record Time, provided that if any Scheme Shareholder shall not be entitled to such dividend, distribution or return of capital
in respect of their Scheme Shares, then the Buyer shall pay the full amount of Consideration payable to such Scheme Shareholder pursuant
to clause 2(a);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">any reference in this Scheme to the Consideration payable under this Scheme shall be deemed a reference
to the Consideration as so reduced; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(iii)</TD><TD STYLE="text-align: justify">the exercise of such right shall not be regarded as constituting any revision or variation of the terms
of this Scheme. To the extent any such dividend, distribution and/or return of capital is transferred to the Buyer on a basis which entitles
the Buyer to receive and retain it, or is cancelled, the Consideration shall not be reduced in accordance with this clause.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">3.</TD><TD STYLE="text-align: justify"><B>SETTLEMENT</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">Prior to the Effective Time, the Buyer shall (A) select a nationally recognised bank or trust company
reasonably acceptable to the Company to act as exchange agent for the payment of the Consideration (the &ldquo;<B>Exchange Agent</B>&rdquo;)
and (B) enter into an exchange agent agreement (&ldquo;<B>Exchange Agent Agreement</B>&rdquo;), in form and substance reasonably acceptable
to the Company, with such Exchange Agent.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">On or prior to the Effective Date, the Buyer shall deposit (or cause to be deposited) with the Exchange
Agent, for the benefit of the Scheme Shareholders, cash in an amount equal to the aggregate Consideration. All cash deposited with the
Exchange Agent pursuant to this clause 3(b) shall hereinafter be referred to as the &ldquo;<B>Exchange Fund</B>&rdquo;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">In respect of the settlement of the Consideration pursuant to this clause 3, the Buyer shall cause the
Exchange Agent to, as soon as practicable after the Effective Time:</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(i)</TD><TD STYLE="text-align: justify">dispatch or procure to be dispatched to each holder of record of Company Shares a letter of transmittal,
which shall be in such form and have such other provisions as Buyer and the Exchange Agent may reasonably specify in accordance with the
provisions of clause 3(e), provided that the Exchange Agent Agreement shall require that each holder of Company Shares that have been
converted into the right to receive the Consideration shall be</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 110 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1.5in; text-align: justify">entitled to receive the aggregate Consideration payable to that person
pursuant to clause 2(a), in respect of: (x) the Scheme Shares which at the Scheme Record Time are in certificated form, as soon as practicable
following delivery to the Exchange Agent any and all outstanding certificates and of a duly completed and validly executed letter of transmittal;
and (y) Book-Entry Shares within two Business Days of receipt by the Exchange Agent of an &ldquo;agent&rsquo;s message&rdquo; and, in
each case, delivery to the Exchange Agent of such other documents as may be reasonably requested by the Exchange Agent, provided that
payments due from the Buyer to each Scheme Shareholder shall be made in accordance with the Exchange Agent&rsquo;s customary practices
and the Exchange Agent Agreement (including in respect of payments to any Scheme Shareholder who is recorded by the Registrar as &ldquo;gone
away&rdquo;), and the right of the Buyer to agree with any Scheme Shareholder to facilitate electronic payment of the consideration due
to such Scheme Shareholder in lieu of a cheque; and</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 1in"></TD><TD STYLE="width: 0.5in">(ii)</TD><TD STYLE="text-align: justify">in the case of Scheme Shares issued or transferred pursuant to the Company Share Plans after the making
of the Court Order and prior to the Scheme Record Time, pay, or procure the payment of, the amount due in respect of such Scheme Shares
to the relevant employer by such method as may be agreed with the Company, and the Company shall then procure that payments are made to
the relevant Scheme Shareholders via payroll (or in the case of Scheme Shareholders who are no longer employed by the Company or its subsidiaries,
into such account as they may specify) as soon as practicable, subject to the deduction of any applicable income taxes, national insurance
or social security contributions or any other required withholding in any relevant jurisdiction (for the avoidance of doubt, the payment
of the Consideration to the relevant Scheme Shareholder through payroll pursuant to this clause 3(c)(ii) shall be effected reasonably
promptly after the Effective Date but is not required to be effected within three Business Days of the Effective Date).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(d)</TD><TD STYLE="text-align: justify">Any portion of the Exchange Fund which has not been transferred to the Scheme Shareholder to which it
is due within twelve (12) months of the Effective Date shall be delivered to the Buyer or its designee(s) as soon as practicable after
such twelve (12) month period expires to be held by the Buyer or such person as the Buyer may nominate on behalf of such Scheme Shareholders
(subject to the legal requirements of any jurisdiction relevant to such Scheme Shareholders). The Exchange Agent or such other person
as the Buyer may nominate shall (subject to the legal requirements of any jurisdiction relevant to such Scheme Shareholders) hold the
consideration due to such Scheme Shareholders for a period of 12 years from the Effective Date, in a separate, interest-bearing UK bank
account established solely for that purpose, and such Scheme Shareholders may (subject to the legal requirements of any such jurisdiction
relevant to such Scheme Shareholders) claim the consideration due to them (excluding any interest accrued on such consideration) by written
notice to the Buyer in a form which the Buyer determines evidences their entitlement to such consideration at any time during the period
of</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 111 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify">12 years from the Effective Date. None of Buyer, the Company or the Exchange Agent or any of their respective affiliates or representatives
or agents shall be liable to any Person in respect of any Consideration (or dividends or distributions with respect thereto) from the
Exchange Fund delivered to a public official pursuant to any applicable abandoned property, escheat or similar law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(e)</TD><TD STYLE="text-align: justify">All deliveries of notices, certificates, statements of entitlement, letters of transmittal and/or cheques
required to be made under this Scheme shall be made by or on behalf of the Exchange Agent as provided for or in connection with the Transaction
Agreement, to the address appearing in the register of members of the Company at the Scheme Record Time or, in the case of joint holders,
to the address of the holder whose name stands first in such register in respect of the joint holding concerned at such time.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(f)</TD><TD STYLE="text-align: justify">All payments made in cash or by cheque shall be in Dollars and shall be made payable to the Scheme Shareholder
concerned, or in the case of joint holders, to that joint holder whose name stands first in the register of members of the Company in
respect of such joint holding at the Scheme Record Time by cheque or as the Exchange Agent shall otherwise determine and the encashment
of any such cheque shall be a complete discharge to the Buyer for the moneys represented thereby.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(g)</TD><TD STYLE="text-align: justify">None of the Company, the Buyer or their respective agents or nominees shall be responsible for any loss
or delay in the transmission of the statements of entitlement or cheques sent to Scheme Shareholders in accordance with this clause 3,
which shall be posted at the risk of the Scheme Shareholder concerned.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(h)</TD><TD STYLE="text-align: justify">The preceding paragraphs of this clause 3 shall take effect subject to any prohibition or condition imposed
by law.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">4.</TD><TD STYLE="text-align: justify"><B>CERTIFICATES IN RESPECT OF SCHEME SHARES</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">With effect from and including the Effective
Time:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">all certificates representing Scheme Shares shall cease to be valid as documents of title to the shares
represented thereby and every holder thereof shall be bound to deliver up such certificate(s) to the Exchange Agent;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">in the event that any certificate(s) representing Scheme Shares have been lost, stolen or destroyed, the
Exchange Agent shall pay in exchange for such lost, stolen or destroyed certificate(s), upon the making of an affidavit of that fact by
the holder thereof, the Consideration payable in respect thereof pursuant to clause 2(a); provided that the Buyer may, in its discretion
and as a condition precedent to such payment, require the owner of such lost, stolen or destroyed certificate to deliver a bond in such
reasonable and customary amount as the Buyer may direct as indemnity against any claim that may be made against the Buyer, its subsidiaries
or the Exchange Agent with respect to the certificate alleged to have been lost, stolen or destroyed; and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<!-- Field: Page; Sequence: 112 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(c)</TD><TD STYLE="text-align: justify">subject to the completion, delivery and, if applicable, stamping of any transfers, forms or instruments
of transfer as may be required in accordance with clause 1(b) and the payment of any stamp duty thereon, the Company shall make, or procure
to be made, the appropriate entries in the register of members of the Company to reflect the transfer of the Scheme Shares to the Buyer
and/or its nominees in accordance with clause 1.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">5.</TD><TD STYLE="text-align: justify"><B>MANDATES</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">All mandates relating to the payment of dividends
on any Scheme Shares and other instructions (including communications preferences) given to the Company by Scheme Shareholders in force
at the Scheme Record Time relating to Scheme Shares shall, as from the Effective Time, cease to be valid.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">6.</TD><TD STYLE="text-align: justify"><B>EFFECTIVE TIME</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(a)</TD><TD STYLE="text-align: justify">This Scheme shall become effective upon a copy of the Court Order being delivered to the Registrar of
Companies in England and Wales for registration (the &ldquo;<B>Effective Time</B>&rdquo;).</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 1in; text-align: justify; text-indent: -0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.5in">(b)</TD><TD STYLE="text-align: justify">Unless this Scheme has become effective on or before February 26, 2027 or such later date, if any, as
the Company and the Buyer may agree and the Court may allow, this Scheme shall never become effective.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">7.</TD><TD STYLE="text-align: justify"><B>MODIFICATION</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">The Company and the Buyer may jointly consent
on behalf of all persons concerned to any modification of or addition to this Scheme or to any condition which the Court may approve or
impose. For the avoidance of doubt, no modification may be made to the Scheme under this clause 7 once the Scheme has taken effect.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in; text-align: left">8.</TD><TD STYLE="text-align: justify"><B>GOVERNING LAW</B></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">This Scheme, and all rights and obligations arising
out of or in connection with it, are governed by the laws of England and Wales and are subject to the exclusive jurisdiction of the English
courts.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Dated: [&#9679;] 2026</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 113; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ea029929601ex99-1.htm
<DESCRIPTION>PRESS RELEASE OF LUXFER HOLDINGS PLC, DATED JULY 27, 2026
<TEXT>
<HTML>
<HEAD>
<TITLE></TITLE>
</HEAD>
<BODY>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><IMG SRC="ea029929601_ex99-1img1.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>LUXFER ENTERS INTO AGREEMENT TO BE ACQUIRED
FOR $17.37 PER SHARE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>IN ALL-CASH TRANSACTION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RIVERSIDE, CA, July 27, 2026 -- Luxfer Holdings PLC (NYSE: LXFR)</B>,
a global industrial company innovating niche applications in materials engineering, today announced that it has entered into a definitive
agreement to be acquired by affiliates of Wynnchurch Capital, L.P. (&ldquo;Wynnchurch&rdquo;) in an all-cash transaction.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #1B365D">
    <TD STYLE="width: 100%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 0.1in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: White"><B>Transaction
    Overview</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the terms of the agreement, which has been unanimously approved
by the directors in attendance at a meeting of Luxfer&rsquo;s Board of Directors, Luxfer shareholders will receive $17.37 per ordinary
share in cash.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The purchase price represents:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left">&#9679;<FONT STYLE="font-family: Symbol"></FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">~30.7%
premium to Luxfer&rsquo;s closing share price of $13.29 on April 28, 2026, the last trading day prior to Luxfer&rsquo;s first quarter
2026 earnings release, when Luxfer announced an active strategic review.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #1B365D">
    <TD STYLE="width: 100%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 0.1in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: White"><B>Management
    Comments</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&ldquo;Over the past several years, we have strengthened
Luxfer through disciplined operational execution, enhanced our positions in attractive end markets and invested in differentiated technologies.
These actions have improved profitability, created a stronger business and positioned Luxfer for long-term success.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">We believe this transaction delivers compelling value for
our shareholders while providing an excellent opportunity for our employees, customers and partners to continue building on Luxfer&rsquo;s
legacy of innovation.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><B>Andy Butcher, </B>Chief Executive
Officer - Luxfer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&ldquo;Luxfer is a differentiated advanced materials company
with leading technical capabilities, deep metallurgical expertise and mission-critical products serving attractive aerospace, defense
and demanding industrial end markets. We have tremendous respect for the business and management team and look forward to supporting the
Company with long-term capital, operational resources and sector expertise.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Greg Gleason,</B> Managing
Partner &ndash; Wynnchurch</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">&ldquo;We see meaningful opportunities to invest in innovation,
operational excellence, automation, capacity expansion and commercial growth across both of Luxfer&rsquo;s segments. We also believe the
Company is well positioned to pursue complementary acquisitions that can broaden its capabilities, product portfolio and geographic reach.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><B>Brian Riordan, </B>Managing
Director &ndash; Wynnchurch</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #1B365D">
    <TD STYLE="width: 100%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 0.1in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: White"><B>Transaction
    Information</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transaction is currently expected to be completed prior to the
end of 2026, subject to approval of Luxfer shareholders, receipt of regulatory approvals and customary closing conditions. The transaction
is not subject to financing conditions.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Until the transaction is completed, Luxfer will, subject to the terms
of the definitive agreement, continue to operate in the ordinary course of business, serving its customers, supporting its employees and
executing its strategic priorities.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Upon completion of the transaction, Luxfer will become a privately
held company, and its ordinary shares will no longer be listed on the New York Stock Exchange.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Deutsche Bank Securities Inc. is acting as exclusive financial advisor
to Luxfer, and Fried, Frank, Harris, Shriver &amp; Jacobson LLP is acting as legal advisor to Luxfer. Lazard is acting as exclusive financial
advisor to Wynnchurch, and Kirkland &amp; Ellis LLP is acting as legal advisor to Wynnchurch.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #1B365D">
    <TD STYLE="width: 100%; padding-top: 6pt; padding-bottom: 6pt; padding-left: 0.1in; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: White"><B>Second
    Quarter 2026 Financial Results Announcement</B></FONT></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Luxfer expects to report its second quarter 2026 financial results
on Tuesday, July 28, 2026, after the closing of the New York Stock Exchange.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In light of the pending transaction, Luxfer will not host an investor
conference call or webcast to discuss its second quarter 2026 financial results.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Luxfer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Luxfer is a global industrial company innovating niche applications
in materials engineering. Using its broad array of proprietary technologies, Luxfer focuses on value creation, customer satisfaction,
and demanding applications where technical know-how and manufacturing expertise combine to deliver a superior product. Luxfer&rsquo;s
high-performance materials, components, and high-pressure gas containment devices are used in defense and emergency response, clean energy,
healthcare, transportation, and specialty industrial applications. For more information, please visit www.luxfer.com. Luxfer is listed
on the New York Stock Exchange and its ordinary shares trade under the symbol LXFR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Wynnchurch Capital, L.P. (&ldquo;Wynnchurch&rdquo;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Wynnchurch Capital, L.P. is a leading middle-market private equity
investment firm that has been investing in industrial businesses for more than 25 years. Wynnchurch is currently investing out of its
sixth private equity fund and manages approximately $9.1 billion of assets under management. The firm&rsquo;s strategy is to partner with</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">middle-market companies that possess the potential for substantial growth and profit improvement. Wynnchurch specializes in recapitalizations,
growth capital, management buyouts, corporate carve-outs, and restructurings. Recent exits include the pending sale of FloWorks to Ferguson
Enterprises Inc. (NYSE: FERG) in a transaction valued at approximately $1.6 billion and sale of Labrie Environmental Group to Hiab Corporation
(Nasdaq Helsinki: HIAB) in a transaction valued at approximately $1.035 billion. Recent investments include MSHS Pacific Power Group,
Sterno, NABRICO Marine Products, Charter Industries, and Astro Shapes. For more information, please visit: www.wynnchurch.com or follow
on LinkedIn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B></B>&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Additional Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In connection with the proposed transaction between Luxfer and Wynnchurch,
Luxfer will file with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) a proxy statement on Schedule 14A. Additionally, Luxfer
may file other relevant materials with the SEC in connection with the proposed transaction. Investors and securityholders of Luxfer are
urged to read the proxy statement (which will include notices convening the scheme meeting and the general meeting of Luxfer&rsquo;s shareholders
to be convened in connection with the scheme of arrangement, and an explanatory statement in respect of the scheme of arrangement of Luxfer,
in accordance with the requirements of the U.K. Companies Act 2006) and any other relevant materials filed or that will be filed with
the SEC, as well as any amendments or supplements to these materials and documents incorporated by reference therein, carefully and in
their entirety when they become available because they contain or will contain important information about the proposed transaction and
related matters. The definitive version of the proxy statement will be mailed or otherwise made available to Luxfer&rsquo;s securityholders.
Investors and securityholders will be able to obtain a copy of the proxy statement (when it is available) as well as other filings containing
information about the proposed transaction that are filed by Luxfer with the SEC, free of charge on EDGAR at www.sec.gov, on the investor
relations page of Luxfer&rsquo;s website at https://www.luxfer.com/investors, or by contacting Luxfer&rsquo;s investor relations department
at Investor.Relations@Luxfer.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Participants in the Solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Luxfer and its directors and executive officers may be deemed to be
participants in the solicitation of proxies from Luxfer&rsquo;s shareholders in respect of the transaction. Information about Luxfer&rsquo;s
directors and executive officers is set forth in the proxy statement for Luxfer&rsquo;s 2026 Annual General Meeting, which was filed with
the SEC on April 30, 2026. Other information regarding the participants in the proxy solicitation and a description of their interests
will be contained in the proxy statement and other relevant materials to be filed with the SEC in respect of the proposed transaction
when they become available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This communication includes &ldquo;forward-looking statements&rdquo;
within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including with respect
to the proposed acquisition of Luxfer, and readers are cautioned not to place undue reliance on such statements. Such forward-looking
statements include, but are not limited to, the ability of Wynnchurch and Luxfer to complete the transactions contemplated by the transaction
agreement, including statements about the transaction, statements about the expected timetable for completing the transaction, Luxfer&rsquo;s
beliefs and expectations and statements about the benefits sought to be achieved in the proposed acquisition, and the potential effects
of the acquisition on Luxfer. These statements are based upon the current beliefs and expectations of Luxfer&rsquo;s management and are
subject to significant risks and uncertainties. There can be no guarantees that the conditions to the closing of the proposed transaction
will be satisfied on the expected timetable or at all. If underlying assumptions prove inaccurate or risks</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">or uncertainties materialize,
actual results may differ materially from those set forth in the forward-looking statements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Risks and uncertainties include, but are not limited to, uncertainties
as to the timing of the proposed transaction; the risk that competing offers or acquisition proposals will be made; the possibility that
various conditions to the consummation of the proposed transaction contained in the transaction agreement may not be satisfied or waived
(including, but not limited to, the failure to obtain shareholder approval and the failure to obtain the sanction of the High Court of
Justice in England and Wales); the occurrence of any event, change or other circumstances that could give rise to the termination of the
transaction agreement; the effects of disruption from the transactions contemplated by the transaction agreement and the impact of the
announcement and pendency of the transactions on Luxfer&rsquo;s business, including its ability to retain and hire key personnel and maintain
relationships with customers; the risk that any announcements relating to the transaction could have adverse effects on the market price
of Luxfer&rsquo;s ordinary shares; the risk of any unexpected costs or expenses resulting from the transaction; the risk that shareholder
litigation in connection with the transaction may result in significant costs of defense, indemnification and liability; and other risks
related to Luxfer&rsquo;s business.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Luxfer undertakes no obligation to publicly update any forward-looking
statement, whether as a result of new information, future events or otherwise, except to the extent required by law. Additional factors
that could cause results to differ materially from those described in the forward-looking statements can be found in Luxfer&rsquo;s Annual
Report on Form 10-K for the year ended December 31, 2025 and Luxfer&rsquo;s other filings with the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact Info:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Kevin Cornelius Grant</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Vice President of Investor Relations and Business Development</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Kevin.Grant@Luxfer.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 4; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>


</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>4
<FILENAME>ea029929601ex99-2.htm
<DESCRIPTION>PRESS RELEASE OF WYNNCHURCH CAPITAL, L.P., DATED JULY 27, 2026
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>Exhibit 99.2</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B><IMG SRC="ea029929601_ex99-2img1.jpg" ALT=""></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Wynnchurch Capital to Acquire Luxfer Holdings
PLC </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>in Take-Private Transaction </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Rosemont, IL &ndash; July 27, 2026 &ndash; Wynnchurch Capital, L.P.
(&ldquo;Wynnchurch&rdquo;) and Luxfer Holdings PLC (NYSE: LXFR) (&ldquo;Luxfer&rdquo; or the &ldquo;Company&rdquo;) today announced that
they have entered into a definitive agreement under which an affiliate of Wynnchurch will acquire Luxfer in an all-cash transaction. Upon
completion of the transaction, Luxfer will become a privately held company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Luxfer is a global manufacturer of highly engineered advanced materials
and components serving aerospace, defense and other mission-critical end markets. The Company operates through two market-leading segments,
Elektron and Gas Cylinders, and maintains longstanding relationships with a diversified, blue-chip customer base.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;This transaction delivers compelling and certain value to our
shareholders while positioning Luxfer for its next phase of growth,&rdquo; said Andy Butcher, Chief Executive Officer of Luxfer. &ldquo;Wynnchurch
understands technically complex industrial businesses and shares our commitment to Luxfer&rsquo;s employees, customers and long-term growth.
We look forward to partnering with the Wynnchurch team as we begin this next chapter as a private company.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Luxfer is a differentiated advanced materials company with leading
technical capabilities, deep metallurgical expertise and mission-critical products serving attractive aerospace, defense and demanding
industrial end markets,&rdquo; said Greg Gleason, Managing Partner at Wynnchurch. &ldquo;We have tremendous respect for the business and
management team and look forward to supporting the Company with long-term capital, operational resources and sector expertise.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Brian Riordan, Managing Director at Wynnchurch, added, &ldquo;We see
meaningful opportunities to invest in innovation, operational excellence, automation, capacity expansion and commercial growth across
both of Luxfer&rsquo;s segments. We also believe the Company is well positioned to pursue complementary acquisitions that can broaden
its capabilities, product portfolio and geographic reach.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The transaction is currently expected to be completed prior to the
end of 2026, subject to approval of Luxfer shareholders, receipt of regulatory approvals and customary closing conditions.</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lazard is acting as financial advisor to Wynnchurch, and Kirkland &amp;
Ellis LLP is acting as legal advisor to Wynnchurch. Deutsche Bank Securities Inc. is acting as exclusive financial advisor to Luxfer,
and Fried, Frank, Harris, Shriver &amp; Jacobson LLP is acting as legal advisor to Luxfer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Luxfer:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Luxfer is a global industrial company innovating niche applications
in materials engineering. Using its broad array of proprietary technologies, Luxfer focuses on value creation, customer satisfaction,
and demanding applications where technical know-how and manufacturing expertise combine to deliver a superior product. Luxfer&rsquo;s
high-performance materials, components, and high-pressure gas containment devices are used in defense and emergency response, clean energy,
healthcare, transportation, and specialty industrial applications. For more information, please visit www.luxfer.com. Luxfer is listed
on the New York Stock Exchange and its ordinary shares trade under the symbol LXFR.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Wynnchurch Capital:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Wynnchurch Capital, L.P. is a leading middle-market private equity investment firm that has been investing in industrial businesses
for more than 25 years. Wynnchurch is currently investing out of its sixth private equity fund and manages approximately $9.1 billion
of assets under management. The firm&rsquo;s strategy is to partner with middle-market companies that possess the potential for substantial
growth and profit improvement. Wynnchurch specializes in recapitalizations, growth capital, management buyouts, corporate carve-outs,
and restructurings. Recent exits include the pending sale of FloWorks to Ferguson Enterprises Inc. (NYSE: FERG) in a transaction valued
at approximately $1.6 billion and sale of Labrie Environmental Group to Hiab Corporation (Nasdaq Helsinki: HIAB) in a transaction valued
at approximately $1.035 billion. Recent investments include MSHS Pacific Power Group, Sterno, NABRICO Marine Products, Charter Industries,
and Astro Shapes. For more information, please visit: www.wynnchurch.com or follow us on LinkedIn.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Additional Information</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">In connection with the proposed transaction between
Luxfer and Wynnchurch, Luxfer will file with the Securities and Exchange Commission (&ldquo;SEC&rdquo;) a proxy statement on Schedule
14A. Additionally, Luxfer may file other relevant materials with the SEC in connection with the proposed transaction. INVESTORS AND SECURITYHOLDERS
OF LUXFER ARE URGED TO READ THE PROXY STATEMENT (WHICH WILL INCLUDE NOTICES CONVENING THE SCHEME MEETING AND THE GENERAL MEETING OF LUXFER&rsquo;S
SHAREHOLDERS TO BE CONVENED IN CONNECTION WITH THE SCHEME OF ARRANGEMENT, AND AN EXPLANATORY STATEMENT IN RESPECT OF THE SCHEME OF ARRANGEMENT
OF LUXFER, IN ACCORDANCE WITH THE REQUIREMENTS OF THE U.K. COMPANIES ACT 2006) AND ANY OTHER RELEVANT MATERIALS FILED OR THAT WILL BE
FILED WITH THE SEC, AS WELL AS ANY AMENDMENTS OR SUPPLEMENTS TO THESE MATERIALS AND DOCUMENTS INCORPORATED BY REFERENCE THEREIN, CAREFULLY
AND IN THEIR ENTIRETY WHEN THEY BECOME AVAILABLE BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION
AND RELATED MATTERS. The definitive version of the proxy statement will be mailed or otherwise made available to Luxfer&rsquo;s securityholders.
Investors and securityholders will be able to obtain a copy of the proxy statement (when it is available) as well as other filings containing
information about the proposed transaction that are filed by Luxfer with the SEC, free of charge on EDGAR at www.sec.gov, on the investor
relations page of Luxfer&rsquo;s website at https://www.luxfer.com/investors, or by contacting Luxfer&rsquo;s investor relations department
at Investor.Relations@Luxfer.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>Participants in the Solicitation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Luxfer and its directors and executive officers may be deemed to be
participants in the solicitation of proxies from Luxfer&rsquo;s shareholders in respect of the transaction. Information about Luxfer&rsquo;s
directors and executive officers is set forth in the proxy statement for Luxfer&rsquo;s 2026 Annual General Meeting, which was filed with
the SEC on April 30, 2026. Other information regarding the participants in the proxy solicitation and a description of their interests
will be contained in the proxy statement and other relevant materials to be filed with the SEC in respect of the proposed transaction
when they become available.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This release contains certain forward-looking statements that involve
risks and uncertainties that could cause actual results to differ materially from those projected in the forward-looking statements. Examples
of such forward-looking statements include but are not limited to: (i) statements regarding the Company&rsquo;s results of operations
and financial condition; (ii) statements of plans, objectives or goals of the Company or its management, including those related to financing,
products, or services; (iii) statements of future economic performance; and (iv) statements of assumptions underlying such statements.
Words such as &ldquo;believes,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;expects,&rdquo; &ldquo;intends,&rdquo; &ldquo;forecasts,&rdquo;
and &ldquo;plans,&rdquo; and similar expressions are intended to identify forward-looking statements but are not the exclusive means of
identifying such</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence -->&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0">statements. By their very nature, forward-looking statements involve inherent risks and uncertainties, both general and
specific, and risks exist that the predictions, forecasts, projections, and other forward-looking statements will not be achieved. The
Company cautions that several important factors could cause actual results to differ materially from the plans, objectives, expectations,
estimates, and intentions expressed in such forward-looking statements. These factors include but are not limited to: (i) demand conditions
in our end markets, including customer inventory cycles and regulatory developments; (ii) customer concentration and changes in purchasing
behavior; (iii) competitive pressures and pricing dynamics; (iv) global economic, geopolitical, trade and tax developments, including
tariffs, export controls and other trade measures; (v) supply chain disruption, raw material and energy cost volatility, and availability
of critical inputs; (vi) foreign currency fluctuations and hedging effectiveness; (vii) environmental, health and safety, climate-related
and other regulatory requirements; (viii) product liability, warranty, recall and litigation risks; (ix) cybersecurity threats, data protection
obligations and evolving disclosure requirements; (x) our ability to protect intellectual property and successfully innovate; (xi) pension
obligations and related regulatory requirements; (xii) operational disruptions, labor relations and workforce availability; (xiii) our
ability to successfully execute acquisitions and strategic initiatives; and (xiv) our level of indebtedness, financing arrangements and
covenant compliance. The Company cautions that the foregoing list of important factors are not exhaustive. These factors are more fully
discussed in the sections entitled &ldquo;Forward-Looking Statements&rdquo; and &ldquo;Risk Factors&rdquo; in its Annual Report on Form
10-K for the year ended December 31, 2025, which was filed with the U.S. Securities and Exchange Commission on February 24, 2026. When
relying on forward-looking statements to make decisions with respect to the Company, investors and others should carefully consider the
foregoing factors and other uncertainties and events. Forward-looking statements speak only as of the date on which they are made, and
the Company does not undertake any obligation to update or revise any such statement, whether because of new information, future events,
or otherwise.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>For new investment opportunities, please contact:</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">Mike Teplitsky &nbsp;</TD>
    <TD STYLE="width: 50%">Scott Fitch &nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">Partner </TD>
    <TD STYLE="font-size: 10pt">Partner</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="font-size: 10pt">mteplitsky@wynnchurch.com </TD>
    <TD STYLE="font-size: 10pt">sfitch@wynnchurch.com </TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">3</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><DIV STYLE="font-size: 1pt; border-top: Black 1.5pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>ea029929601_ex99-1img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea029929601_ex99-1img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !L * # 2(  A$! Q$!_\0
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M212QLKQR(S(Z,&4E2#4E?R<_\&YG_!6)OB]X4TO]@+]H3Q.\_P 5/A]H3_\
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M>*O"'BG1+EK35_#_ (BT.\BO]*U;3[A<[+BTNX8WV.KPSQ^9;W$<MO-+$_\
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)ML%%%%8FA__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>ea029929601_ex99-2img1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 ea029929601_ex99-2img1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0@)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !. >D# 2(  A$! Q$!_\0
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M&D2Z(=91;QM/5BIG%LQ QU/3I[U:A)JZ1#G%.S9TE%<T/'6C'0_[:!NO[/\
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M # %126=M*Y>2VA=SU9D!-344AC(XHXDV1QJB?W5&!38K6W@=FA@BC9OO%$
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M;_GWA_[X%344[L5D?'=%%%?3GS 4444 %%%% !1110 5L>$_^1OT?_K\B_\
M0A6/6QX3_P"1OT?_ *_(O_0A4S^%^A4/B7J?5E%%%?,GTP4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 ?
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>lxfr-20260727.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: /qpZs7xRiXgen8uBYXYsWa2HGaPtyJ1x6YkxuG9yfUnanywhTAaOsi9Kn//2sW0B -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2026" xmlns:us-gaap="http://fasb.org/us-gaap/2026" xmlns:srt="http://fasb.org/srt/2026" xmlns:srt-types="http://fasb.org/srt-types/2026" xmlns:LXFR="http://luxfer.com/20260727" elementFormDefault="qualified" targetNamespace="http://luxfer.com/20260727">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://luxfer.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="lxfr-20260727_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="lxfr-20260727_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2026" schemaLocation="https://xbrl.sec.gov/dei/2026/dei-2026.xsd" />
    <import namespace="http://fasb.org/us-gaap/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd" />
    <import namespace="http://fasb.org/us-types/2026" schemaLocation="https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2024-01-31" schemaLocation="https://www.xbrl.org/dtr/type/2024-01-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2026" schemaLocation="https://xbrl.sec.gov/country/2026/country-2026.xsd" />
    <import namespace="http://fasb.org/srt/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd" />
    <import namespace="http://fasb.org/srt-types/2026" schemaLocation="https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>lxfr-20260727_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>lxfr-20260727_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.5a -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="lxfr-20260727.xsd#Cover" roleURI="http://luxfer.com/role/Cover" />
    <link:presentationLink xlink:type="extended" xlink:role="http://luxfer.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2026/dei-2026.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.26.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Jul. 27, 2026</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Jul. 27,  2026<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-35370<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LUXFER HOLDINGS PLC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001096056<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1024030<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">X0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3016 Kansas Avenue<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Riverside<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92507<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">414<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">269-2419<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Ordinary Shares, nominal value &#163;0.50 each<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LXFR<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.26.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ea0299296-8k_luxfer.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://luxfer.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ea0299296-8k_luxfer.htm">ea0299296-8k_luxfer.htm</File>
    <File>lxfr-20260727.xsd</File>
    <File>lxfr-20260727_lab.xml</File>
    <File>lxfr-20260727_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2026</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ea0299296-8k_luxfer.htm": {
   "nsprefix": "LXFR",
   "nsuri": "http://luxfer.com/20260727",
   "dts": {
    "inline": {
     "local": [
      "ea0299296-8k_luxfer.htm"
     ]
    },
    "schema": {
     "local": [
      "lxfr-20260727.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd",
      "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd",
      "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd",
      "https://xbrl.sec.gov/country/2026/country-2026.xsd",
      "https://xbrl.sec.gov/dei/2026/dei-2026.xsd",
      "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "lxfr-20260727_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxfr-20260727_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2026": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2026": 22
   },
   "report": {
    "R1": {
     "role": "http://luxfer.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2026-07-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0299296-8k_luxfer.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2026-07-27",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ea0299296-8k_luxfer.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CityAreaCode",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CountryRegion",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentType",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Extension",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12bTitle",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "Security12gTitle",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "TradingSymbol",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2026",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://luxfer.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0002077096-26-000223-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0002077096-26-000223-xbrl.zip
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MD'HD[-Q \/?&(+BY<YPG]8V6'F=F<_(KQ<<]'J48=T0!W7I.> !?9/ E47W
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MV:4[@C?>B GK!B/NU^0/-9@_=/M(V(Y[HS]SW&CL\>D>\P-?X#/W=@^)5(1
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M7'Y)3RJ7E(, !&M[J[E3*5._S5E85:"1Z@N0,00-+:[S$+#NCKG'CF^%G<1
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M&D$14"LB*\.B@39%)A5G#  B'[ S0RIILJQ)4-9-$!.Z^OP&S&KDY)Z7I2\
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M61GF8TV1?/+KZLK 1=\$OLZX(60\91<)^9M#ZSP,0*QP[]?BJ!>9PF&+,.9
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MU=NU$OQ8&C]H-I>B!L_?-/]I&IZ[6[QGG5\DM\?+04U>D]>'9E2&T]=2+'4
M _=8<H%%_ BR2PHE9@HEZ12>$41*K0"=H;=6P)^0_2U+677>YB^/=+J86NX(
MI>IZTWD\D#A=E.G\JFX =74WPH7*!>2Y&GFFU2$@ND720:P:OW76:H0*S9RE
MEHII>9@>LKJ%.QVA+1 ! 4XC*^63F=5B""TIV;&T6XT23X2'X[3::XSNPHE4
M ))<U.I"'WG0S5%,-)"_,M+%"TY:$&-Q4QIJ3Y >KCR\KBNM80FXZ.HW96@G
M(N<E;DWF\G)D[#V_J9;YH?'N+Z2_=/*G/.,,5C5G0/5#,43)3^1AHQY8\YD#
M6Y8Y6(_)'!2\6BN2J'=E)NLL/S(UN<PX4SFVP' E(G+3KIH.R-0YD^7)J "8
M1%X&7[5_5AX^F9:![E;MF($%8_9RFAYG>E)]LU:D1+G).8665W'D)'<K.!9,
MCWDB ?O'1KO6WB(U1V>PF44^IH@W8:V<Z'YJCK6PFE,ARV?4'!.1]U1V+,G3
M(SI2BAQ_(>:#OE\XBC*,:Z1T'L/NQU/K8().^E_+[3NGC,PRE)-<R@ZF[&+.
M+Y$K3[.G\FG"-<6N!E1QI?.BZ9M0AVUFOWIP@\$?)=3V+0+,&[]CR3*6W/X=
M2UZ6P+-^.69_G&+_G(?URUELWZO;F% S$LOH%9)VQT$6MKY?]D2VYUQMK<D>
M&7?T&3DF]6RL]3I=Z5J5\C] ];)$SA83(\\"?U!'#8)=C8#</(];'1]/ [*[
M<P\4G@=Y><XN.^<SE5]4KA7E*AQ0@TA\L$-#FWJ2N*.1<# =&BR6G$,KSXO9
M*IFT%E\:0%D2()-@9L)HVLC"O"H "J!(?/GG6KH*,S_ 1],7P*KW."X"7RWF
MQ:%8LLA9B5Y#D%@).OO4!*MJD=32)4XGDP$<BBQB2 9]GYZG5'D*T."EL5G]
M(ATVA$>71F#UWP@;NZ35$:1X:@,"-&R4=-C(A4*98> DTO[4#B)4TZ.(X@JD
M2J?>1*,F GZ]T3EJLM003ZW>4=Q$8'=E51F6W )M[I9M3(UAWV 71I7%Z^2W
MP9GB ..9/EV@,*\ QMBDRDFL16F.-J.W1GX#;MLAQDA["6[7F+L. [X*2(%W
M4&&_X1[NY%BJY=FQ1(<"C"-&TN-M F690(&A#\_AI*0UKFNY"D>"(4-WS&]3
M3S507B/KOI.VWOE:-UC^6DR[?0^F749LBA517R:>OG%^<<5(P\^%%JG#]GQN
M9)5P(SAKE!<.W.(.?D2F5I[UD+&<,3O%K-3,,Z^:<UG&Z"9ESCEY-=D"4-4J
MY,H'5'U85KI0#/+(,(V*JW3%*/$5/[+HFK@X%J(0_(#90LRI&KH"BX<E:@+*
MQ$=KW%B**MJ(LI<S2\(TC&M9"'2&%16+_6"=8J3V0E36OF6N?]J(//?CK!^F
M^0^*:?O8/8['LOQ87G_A1@9$&,EU^!2F3T+M]35VQURT2I,FBB*K75#C0(<9
M#E.GT%P@YR;0_)$<HT)>%2$ALW*0%9DWP0<(D>'4&8AJC*[G $"<8)*&V7R\
MCCR*9?, 8[!(53[28'(?$< ,&[K\<ZF\&QXBG5:4;WX387WP\POK'!8EUE[<
M1ZI:]Y&J[!&E*C/9>EY<JU.#96* OKKL.E/ J^;5 _3S2#^O/[M%BC7G::C"
MD8'\PO*ENS0=X+?P_UK"?V,QX;]@^Z.L(CYU017=5.2:YQ/5HL:HC"3ZLA(?
M8PSW+O+N7EP5F5<A_K2D<4E67R'7(34X#V3M#!6(=&$EY W&FN+LDKVCM >/
M]'JR@D5:9D NJKP7%"5K,;--FIEL>3.SJS6[(L(S!:S,("P5)=8#10E;V.[+
M,Z19MFZ5JCP+6U\I4A;>O0K3RWHDT\N Z+?=]4.RWLU[V%TIPT1&MQC/6HZS
M6"EM+F&!/9BUG"_%6JS4[C$U[<5LM\Q,'8&EEH0/MJ(L:45]!2N0I5;@/".M
MH-ZF1IJ0&NJW,M*T$61]5R,MA<SZOD9:]H+LH;&DD78^J^5\)1/-D*O6?!/M
M+KE:H EC)5_=3#K_Z27@MPW6OR67W*79JZ@T/OUKA>S-'-4LK0<9E46V#&4+
M9FE \]*CY*$T\J,J3:D&V!8!)D+)7#Y,OHKR"7A9^YW2@DBC:T^6/Z12^[Y_
ML/WG"?IO_@[ZRZ#_QN^@_P]>0%Z=T8GW8'C2H<I!HY"])F0^D>+SCU+BDJ:F
M%WT^:?VI3(,D%0*_ZNDDYLJ*:\4C=:-#"XM L3!$*SUR6-5_K+09T3P37&L%
M4K7!]TI*8B6_7U5S]+"!2:;.4QMUK.2K86L//I6QK-3T$,ZOE._7F<W:S2=>
MYQO(%5TK.I,5>Z20QRB56Q5W%*M&T]G=Z%G=O41!X1*77V4?+G,&'2&?.L[,
MR?F^LQ4W/KVS%7=:'$X]>4-]8%1)BW8K&.J*/,AH<,B2.#BWR!=DNWNLJ%1=
M(]#:IZ7.;QW'XQB+6!R&L*)>'P&M4!$V:S=:-6U'JCL,A&/)/M-HJH2B+RA1
M\A>CD_(D:E0N91Z\QBB7U]XI;"K\HE](WJC$9,.F(%1-,LP^;D"(/'1T^0!)
MB@;KD&\*:<6\5%N/EI:Q6'WEA#$'Y#W-M&>JO:3;Q VU!$%6KZ4,8DRY5=2@
M6A9)HJKZ2L69+94<@+Z*G%"YH[!?5KDM;A:H_@]WU&%;$]@":7N0SQ_[0.A.
MV'<<DO2Y*D6UR2Z(Y G'KNO9T*#""C4X?M 3ONB[Q481UOR8$*X.>P=@"45F
MI]#5*ERYYV0740H9*6<8(H%\3MCK3/6C,#A/3^"_,[[1HUH@[&,)&.6>I<JO
M$A0KM!"] A-%H'$$V$1>^C!I.B2*T(VN88)X(E2_0S7_W- 7P 8BB).+%@-!
M/;P30Q%-A,B,8W4W !(TFG*!T:<&/C(;V.3=E17H8*HE)[9!U9(25E;X.#V6
M#>N U#9JL2J9ZOPV.[1G>#X=$=FAVQ/FP8EB523&^WAI0F00E:,*7*8&&6%E
M5FP<ZCCU,:=<(QI2:85L+XJ-! CW(QR8)I->'Y@#\==@KT&\8=B_EF,,@"90
M_]*F>YK<)/9EN#&W9*MDR5JUF*F'FT/BTLN8E:;E@,)! 0$:G52JTU?7W\D3
M;A7CBNKZ(8.*)1,I)ST#=30X4"'W0/>LD3--/=7TJ=^0/3 ^)7[6!(,8G'0X
ME+-OD^-FGI"[50=UIN>T>]6J7\K[+&K;5Q0_6$MVJ\\$R(K;:48<;*9O+ W:
M=SU1U?#C/A!;L[K2NX#.H\GJ0/H)O+HG,UP(G0 $7610#N((S9:L"TEV1RQ.
ME*JPY/RG%JK+=96_.#[\%5I]T[5F)[+K+S5)Q9 ),8^O?:W9CZ7;:2]EE#:,
M(?U-5E[U4_S8*7YT.V>\78N57ZY%I7$@#WHQJQYAYG8NO.I6]56F?A#,HUNQ
M*<]GQH(@&3,8(,^)Z8C;H!E$621',XHHZ8/BXM*L6:E_5DV8C5'(%2/>10&/
M*-=I "1#OF@R9<;BUI6!3L1P#[@#>2SX_;K+H7=#=B9WL!93GFUL)NTK9816
M8#T"HS)]R"@SS+9T2HI)*DB%KZEXSQ!(ULE.?67L-]AT*"1YF-/LC)Z"1@16
MWQLT"XTDA\B$(D]B5@8#/5@* HF,.U1U;9(40D,9).EX?TO>66TE%BF&@@_8
MLB2]4)>S0<(I)I>_/L@X4:3TIF_E G#::6=:!3/70;'5O.O!;.MLE;9UUI'Y
M^_9REO>6Z'2;M,>6'J^R5%EF,ZG)$8TCG_1Y'S, W%$/?9>R&#9_#%+V1>=,
MIJ+#Y*3$9SU]%KA:I%1A^:JT^LUD>E';^L7D.8@Q6<H;9UN?MCJQYILGDGZ$
M>=_H##;EJ%GT4.<O!BAGU94\N;.L7 /R&+DA7D?);90=P!I*^T5)5B$/+T>Q
M6!+@7.2^LY)KXF:3HW6#%M(7HF0LO9$%%"WE](3S>!/HIHYNU<4\D<D$2<VI
MN$]/0J4>%EO\&!>>&9>OL8(1<?KZP2?\1PEX?8N([M;OB*Z,Z&[^CNA^GXAN
M)>/O :D-*.FL;@=>$.ZAU1.+[%+R)W@IN82$DG6LXQMDWH]Y]_A]0?L^ G$.
M0.DEWSOZDF^36:9]@-$12-=T"NS)Q7T?AK+3)F+9M>_S4G1 6(S33N:Y ?$6
M$M-YI<-0N[N-ELZN-2-1N1 4DW*MP6:78ECC"ZW$>O!*6/5*V@NOY <BCT>E
M5SJ9!XY43;C'.J51JJ+.\1ZQ@CK."0#-.K'UB,=7_OL[YP&4>S'D]6W"L4Q\
MF(&6DA[FY?[<S%EZ?$@'(.\)AF%1H7(2>+6U>0#DG>Z0CGWH@C?TRM.0^J(V
M3]Q@0KT.QT3YN2K\,WIE^;!?)PUN4&-=Z=>=&E=<FH"@"R,)!S(,2A[Z,A_W
MJN$%DRJI4$W"(M7>6G.P"HTRTQFE6PI5?=!U*5_:F,C*UTY5ZZ]%JZ#"2%6>
MMC2(@[]=-5XU2JZ!7U. Z5A1R9;@ACGI]7[:)2A_-;<KYY"7CC_A.PJ(D,P"
M3\$DV:.,U*E9*+DDL!-ZP:IF<:D58G/LRNYE.?[20$B3&2;J K6IKF'@-]R5
MO>?A!]T5;ZJ#(+(YK^Q9)QT*([1B..U.&9LIHT+E>Y#6C(I"2E=8UK*180-M
MPR%6)#J-X!'7>,^:W%-X+UM'16.6 NW?=33TA'I(U4B5%X34S-$0OJ5N5]<
MK9D4D(_%**Q*Q^["Z)0WD(>:V@JE&YKX+"*^?BCK]6VPX@88IF?'1Z<'733?
M)I-) U;=& 0WZ17IJ7--M]:/2+TN'+$4IQ/1BUS,J8G9,(['T=[Z.H[J);=
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MU9)9I5J$GVBCKL&B.5@IV;UD/F^%PSBX;\:A1\C671V)S[WSH],_CS\.5SP
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MB=%LGK))HPIC*:2%"I<-Q+S90FQPQAEG9.Q-.9O"?-L[GBZV-Z-<C"I5&1>
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M[P=*F/(IX2[ ]?8V5K?92O8Z2\>E8NT/O%D8%E8S+'?O4X\M9JIOVO^:*&7
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M4.98HSC'0WO.V2/Z#:YZ$3V91%CR<!6J"\4NEK.>/ZPNO@-6<<$<Z@8:D[3
M(&@]TBV+P!P?=,ZC;DUT>'0E*5\PI53QC-!LWYN&$RK_PX,7^?YLPS$.KC=-
M45D!%B+JME?J$9>QSAS;@= G=LFQ81XL;RIC;D1]P1X*(SF4S7V3!9@V,EG:
M?3.X:K/$H%-,_^ QIJ]B^GN/,?V?B9JD%N.JQU"<$(O$'FL!-C!26*6PJK#5
MAKIF3LQVT5QC6I7A8?D[.EBG/UL:JJ._*8:O(W="]/IMK^9Q.:URO[@CR*:=
M@>O$F9@DT'<M;A(.D':G_3=*<2C"3,%<=^?ZW*HZRRZS)7D16 !\D3 O3$ R
MCE,!KH.)8* !JLYGR]=QR#;A:QL2KHJ_!PNY[*R-UT*7!A8 ;"'D+6>/!3'R
M>"4.Q4+,TW4,F7?["-2)2:6:$=D/-#WIANVD=:93;3]I80T T[C6O$P1L\ J
M/W"(1ZW^4_3;Q**'Q<@:RBI*C-#EHJ)7L:S E.VKK^-(L9^,%2^$7:U)'V:D
MRQ4%CWS35O[@.]4$U-=)\:0:=@I%7=H8*;.!E'1T./4&O$D?JP*^C^_YG'S/
MHT.PTZ@TUE1LGP79* "5\N33USB\X0+L1[?T+A7)66,C"U6/4]LU56BSVW^C
ML>V&M&G%Y@6^Z;+@&V0;Q6<L<BF[WX<4F6L"."E.K#(>2*\PFXN!&:1Y?&U#
M<TL=B>F#DX^I[M&!)8+(0ZU'T%*K@+=K)5%MY(^VXZ;VQ91MH7JVMB@_AO9;
M<P/57HPX UQPN& )O.85D(X%:KJJ(&][OC=M3Z[33!YJ,U#$GQ:? ]=3?=!1
MD1QV/0XGO#$"]?-ZDQDE.))G5XUGZ-!3#(^9(+B9+HI^8GC[Y$>C<(SXU5 U
MY1,.C$HXW4ERVKUAN#'FUQOK0[]R/C,?F[H_6I/F--#?SP(:CF^9R1BI0B/>
MP;S:^TIJ'R6]$,<U O+<9!HL3*QL)=F9BG/243]^7?FTGU\J>T]SQ4D8<4^"
MW#):[(7*4U%CV,]:5G]@=_  ==#XQH+7)16&%$Q:7W^+*-7JP7TROVPU)?^.
MJ:.JD9Z!U5((QUHF15:&1A;("'4[>9!*DEP28O0+56/J_LKJ?A9AG&'";:%G
MP1?6LY8,,@>6XLZ"7\>ZLAM7Q6H7HI++.K]QPW!H9N= JW 6Y> R<3M55U-S
ME3L=F#QU_U -;&I\D4G=DG?/ U3H]!*205(6?'*1\M%X%8&F40<C7*FYQ3#?
MU>]5 0$(ZM#T7$PM50AI*_U;>K%;[;,U: SOOC Q;(][TTZ$M:)G24$8K=2B
MX&AW$> U2D"$([?ME60SA6/5LMR:S2&WQUF_M\0V)/6":5OFS=*FFO$D*1AB
MFR;:/G,?K!U9(>D,5.M3KHWC'JERF*@?F!>6[YD"2L^87S->FE0SD=9:2I/R
MK(K_V!R&SBOY4JSC?$B30=J-0B;$]:2KF^084E._6=ND4W+E^6-R1257GCXF
M5WZFY$I=J[0Z<<LL SBYZXE<M!<X8 4J)5-.,CAO86:4I-*!-5L#E;\^U:\S
MM*L218Q#ASS>N)FXK=\;8]NV,+D0(P($,5=4[&0S"Z&=KQLBH?%N/$N8]X2'
M9%1J77&*@;; R.CW7.N(3Y VEV?3C)!U(L\:0T7UD-#M_*S82K"8S 6S@A,,
MC,@;!?MIL3>*B"-_Y(:MM15 ?8$!U/?*!((=HHV^5]XQGE")XI%*XT=@SQKH
MQH-R(FT#$[(L"&3<:(2C_)9)X^\I#1W-FJ_;LA,>5E$Q1VN(LSFD7(6DZ51H
M+V=7L$AK]4BZ"RZE*TR'0\_I>%QI8.GJWBU*/%Z%>L]3* "#CM2X68<%HLQ.
M:%I!K=QQ0/P.*@/^?_+$TAOH<914YU()U:@0##5VI,!O,_VK"NG47%N>-I4G
MDJ-%6A\[?7IU^JAIDN 8E_RL BK.LW >J&8"%9CK[\/A"?5_AD?64*KX;R,Z
MEFR(1: Z.;K%)#8>E[I9R]L.6/OB^F-3 VIRD-/+C8*<4N&Z: &NC]()Q@BN
M.&JP9=I4*!QQ,J%DH6D6;9)@+)1*#"EB2)."%6^2::-'^D0OCSA:SAU_XX/:
MA8DFU=IY_9[9<O,TCQKZ>G"84WJ$Z!WK9%JK<4P!)ZMP3)2YUW)U*EW#V7:N
MKJ/S+\@OO2FV<S4=L64)S-2HU]^RD,4)UH#ABZ)Q2*?I!/6BW?5:\Q#8<U45
M-4;3&%E;I)DVK>+_>[6NT%&0_";'3L*4A9>C?,Q'N8?6D;4HG.$A1 H(XR2<
M4J@5EO:4--_NT^#)[O[6E%-2N_L3^4LC4+!?K@EB#VQ^[@8KPDIQN3VH\Q+=
MCRCD6(LJ"M0_"(F.D$@G/=W!VV5B1A07 F8R/)Z"2H<EH:UF-:I!#8V'9HN&
ME;)A:3+%1P+F]+$%08FH<GP^%>'U>^2.I$G<V+C')8-NPV. ( 16EPC=+,1N
MW:#VFZY@*/&4IYHJUD>$*H!CIT4_Z8<)/,?"+RC]AQ42G%QHNJYQ_O@&(R2N
MH8[:PD\] >=NK,JH*%(6WXA_IRK1*%*>I$;Y7H?!%W0(I:XXAXU&3A\>IB&+
MRSA2)1=5](0,))CA44\(#UR8RIU!B>%&Y6;!<@=KZA?,5YZK7U1WF-+JBG@
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M@R-B@EB7B]"O36*3-MBT0^L[U<RT'EJ-$3#C:)W!IV)MP@V.OCXYGJF(6!U
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M2PI.,J$Y%8V&2:@JDZZIN]VUM%\5A#(H@;'4?I)FJOB[GY3Y=48;7RG/I?4
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M.\0R"F'-0I0KNMD\N%%!87C.;-/6;9WD9;=:-]R:EZ$P8U<6T=8\1EG4K\
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M;EW^0(*'</P:7?V,^0#)+? TV'UB^#&8W .O%R@Z'8J*/0P33APGR24$AZQ
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M5O=.JH6E/8Y_J4Q/(*T W7Y\)B0_T(>X/@1QJ" %)1:G4Z%' O\J=<-/XNE
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MH%*RCE;UW4#E!51;E)R9&2D/L.!I=-4U65TJHJ0YCK4AQA /N3'BE!2R8!Z
MB7%9FF:-"K^P&$.P]V+G]PU.)*^7C 14AVH8DJNEEN08)<XX%*&M/"T85BA!
M^!J0,RK/GR!M5.:&Z@<F@U6S*NLM5ZJT#5(!DN:1?=*&7\?(AL1U_ ZFXN7+
M*J1"E^-*HUX7A+'S<DCCV%3Q6B?U"$@7J(7+:!15J(Z6;/EG.P>X<,]VGC<C
MF%X^WZ\N,G>KP4^GT:0<(YM"OS<I-6B%;^+D1IL\]X9T3II5(QQ6&*=S:PI)
M(%F/T]1J66C3[!D0W"2$8R6GWA36U&V:?*Z5"6)%$)5&*EK.M@5-M/&+MO^8
M)KJO2$HMA4EE1C."K#&=9X+%YQF1(B+\S8;?57 .N\\<T:]8#JS,-TU&UL@V
M42W9:%$2[<C2%JRHK<\(7IK5,:B_<92'E&241+-R1CE_E!@*&P>(]JZ(Q].=
M"@9&A4XQF)(3<$9%D-U8<25.YHQ-QH,8PH9(;*T[+K."2W%#DDJ5!H5:N,/?
M,NW_[*G1^Y@_-2R43W>>3((;K B@4E\KU>)VAA-B<D??2Y-!"E[7AH3FC^5\
MTT5-N<:JF]_O+?;S50$&3KA&,R!T09(KDKE1A7?>[R58R4F!02;-'.%MF5[
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M_P-BWKD39 2DT>JEW=$195GNT9WV$I)[^IV/( E6P2(!#@!6B?/K;YXU3R8
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M<Y1'&)41QR]A;'L5V9G)VV-2'<^?7%(=DNKXXI+J^&SW\L,V6?^]; ?FW?"
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MKF3L0.;_II@5U'[P"/>5.?7<,#Q;C!D02=ACW. S$VJ?;*]8B/"/5?F(TM,
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M_F1PR@)N:><B#&C;JM12S'VS[5$.,))%G=V5WAGBW;I=%/+O9E[0EN:]C<D
MWI\IUO[0ZK2^_MY#=VCSIC(#I ^T"/&]6#&I]BF5(0$B(H@XR*#X#S>JADIR
M<%B,+K/Q!ST[B'NQUJU52R2?G=M(V20L@9$B0_I4"*H(3JF3Z40+]!3"%5U*
M,TJFZN-==6;6Q#&9B9>7S(1D)IY>,A-_J,Q$5I>"-=OF"<D7FZ_N:N$N5G"?
M6 8OBL-MX:7 E["EPM,>A-<^':R!:E1-/2HZLV2EI'Y*IPGG67,#.A@\T+[
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M)YDD/_ VW.FS#R>^/]!(+<\'EM9G\H[P1 ;WHR:>&G>@FZ7$KI>1NX?"+=R
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M$4X^4 W&@;J*)"JK"  97 N?,!ICLIN:4'&WY"!"O&@]T;QR \RDJ,M(F)"
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M.9-N,MH[@(1JM4IG^Z61MJ]L(CF,\OF=*1AA:/_BWH9(O[C*<YVO9YX,)TZ
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M+;@CA/52C["G643L=;Z8ILPC$V9_(!)0K B L \8CP_FKC8X!NH8*XPX'<T
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MI7$+=V)"]F1N!(@? @B=D.K'_69H8FE2QR-P04TV'Y6-7/^3A(_>$0(TBL3
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MPC]4L!$@UBD;B80TN:W>1_1BOV0?DGR5,W>9#Y('%[S-VVU=ZJW@>_C86L)
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MRJI<U"9/][D938L'-)JL_D7,A3A 6O3AT6-DO_.G 7DG!/]2#FAKU8CY%9'
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M.W_T#'#Z;BAOVGSMYN4I_(W(V+?Y]9:+7']X=(7DHMO5-789\UWJ7TNI_!4
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MC#Z!GL38MHAE4&BJUT:*,_)",L;9T/GX=TT@ZA&9J"&Z9Q#4UCDS3:+))F\
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MPX2'LQ8E,7DU[=!.]>29HIPG$:?321F// 9O'_3-.X"- 8,,@U3=V+Z;(H^
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M*T /0?Z^V\Z:8E$X@4OU7'*>BE8,YJ*6687C1HCIJL9OP<2J=GF.\0B3E0\
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MG=*L85[OQ2U#/R3&O*_3+U9J!\AQN"D6&&L_X<Q)T-HMQZ/YJD!G_JZJW\/
MB4E6T"11;0]5(D-HW!GV[FS"#UH^/)-"J+FY?XU%+MNMC"/CC(//BM";H\LO
M086"SA7XFKVNL.D$KP04TIDG"L:.1S8:"X>I$VTYXF"1*=89!W0#A\3,EN+
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M; /=*5? M;\BCJZ//%966R@2$^^Y@^Z8>F,[)YB :!Y.98Y'0<@*52;<\VC
MKC?.]JU1SSS"DY0)$ _[X5F T!*W@)0X/$?.,X$L/,(D#?S(1](A]D[H?PI*
M-JG/\VYN=HT3 2LG-#*1N!*(4?.PLRD#FEB. X'2O [1!!8X3$)O:*942/;L
M*(^+<8I0]],BW^1X;IO(IO7U'TR4>#]S0F4)=DY4I%*J"*&])K6$G\X \H)+
M)I8^97]J8CG#S=DK^_U&&)J6\>@.D\6Z%D@%WJ,O;NA$WN1"N#97RR-<1\'.
M=M>GP]Z-N/R;Z@Y,)?R; V6QO>C\R!JQ #VJ2<23;AUF!6H"*],DA+0,AY<L
MC(.GAR@ *1'"E0:>N+>MJ]4W@N.=AO'J/OFV?R\2KQPI73%-Y]4C;E/"N\A-
MXM8-:0:$56A,:HG$"HHQ:A*(5#U!O)Y&]3.1!'PWZ!3*.C?[5G@\"HX@?(?Y
MQ!VC]^WI]:\ YIN,'LVO;?NH6C[:5//W.3#.?RC6VW4H!0X>?4HVV\?9B8@W
MCS_;D*]%ID",ST9N2Y_-18=OT.H:CV!$YV;N/&2_AP[ [S!+)[:E2B06Y8LN
M8H!76_T)%>+U-D,ZGMQF?_CH8<- 3L.U3,CB% *1C^&>8RDSZ(5UD((Q9X#R
MM] 6#=)RH8GD0SO?<(. IG7;L&AN4G,7H<[$'_<<%_=]K\) LXA2\^&+G==N
M/BHK\/*2%9"LP--+5N SW,OPW*AZ"(AX+6@S;"[=E\0>AGZ&M-**UT]9\H#8
M4WE$K!TD@**X@).N-K25,HH5,%A45V@"1E&\",'QE/\,>M/NCX*9MV]]VI_R
M^RHSR>+!CB;6 18,@9:R,@RKT\MEN*BNIQN5)V^=W]!T"/6VX5T_DN(+;Q:6
M8?8BY#NZDDU9=R9IO<8C; #94.0,/()PNR !'E0W/R((&$W3'($1],NIP-48
MLPI>3D9DE\.%GMWY09Q:6/-ID*[4EDN,^Q#3(J9SGSN8& K3S,W2#*I7NV:"
MP6IW[,OX1QYFXTS*HN8X)9X*C8_Y=;1L O&=]BTP;=1P@<],.W\RD.TK V3[
M15@?W40R+/<-&5T<$6/OCCDM#?5E*B4Z?.$2FLHZ+VN>Q]^L*[<;JKK8KGU5
M#P,?$\CX/5+JR:B 6@)@%?;A]*51LV C]O+]2DNROO+?N.X7TJC[ZW[=+QAB
M']?4!J55H96+M -X*+_3E@9<80_&MG8!14)C]FJQOP^7YWK"*W)MP[MGV_:F
MPN*4C*@L/'^OT 6?6I+-4E<%.B28HS82MG<$LYB0)#IP:PRO>Z0K1<#JW#NU
M^_8!!#J[ZZW$#)?S?^+Y_]J<__^J6BZ.1KIA%@&64>"V@I ZF"V4!L7C!Q\N
M4E8O9&C\5"^H*Q/=R&M$"/]6=Z7R[HM;V:FA <&/ "WT^_!@B W&3/E1VT&,
MZQS?]N6R44[;*$^?F(TB,@PG_2<B*TW^5K"/?,$_WS_^N2D^)),OIAB_LP#G
M$+T;Y'6",[K."@'_"[DLHZ-P#97<7CY<R6+ZND9,,=FFF7, /.5U71%!?L6X
MU8:K7# 7$)11A$ACM#H1T*0IGPU9QUR(@]"?/G)]7Y_YL>^B/"TEJZPNE23'
MT-$A(3)%!HXF!C>* '3 'Z$$HW>@.P]R3W9H?@[G CCO%<230RY,#<<" _+A
MF.#3)\(/%//%#!!*(F!YXWP?9[<1?.X#$58ND^=/GOP?>4&>* C!:V,9GR:L
M;68"7V %0./EUCUZ6320(,(XO0:;_7)-0DS&*Z[4^IE&%&#&L19WJ;DJ'/%X
MU'-/RBI9_G)X*??6]HVB)['U=\0IT]I@T&S^""F#$]Y" 8H]M)0>Z0_CD#R
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MB6+B+A^ Y[+LTOC7;_C]P8W#)&7@88O1+,=H7F$C68*X,H#,S)OMA 3&+;,
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M'RHL:H:WJ?+9.3<>$ EC0C&/:?33#J=\US;'U3UO#FUYD8)M,!-GY8TOB)+
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MQ@F/H<CD?&OQ,V"KS;."X0K4^E_);1S%#SX(=YD\9M?6_3Y/F5/+BH6&T$/
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M8X7 )T<<?@.F0!VR"-1+[+GGK)V+K7G*+R$$8'8!#YH?,@5\((#2S1&Y?N]
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M@H$X; :#T\?V$CLF#K+!-OG S\$S&6'=Z.*/K9?_YK*U5>#[U3[PK8'OY_O
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MZ6 >DA'5YO(+#W$*SEXU$@_+QY XRFK"Q@Q2JH@0BLX5Q)6+V74Y(=Z2@V+
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M\Y*,K78RCV#)%9CDI(YL;^71.(CAC0,%2&R,;M!CHR0Q,Y?L"6%E'/3_FVP
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M;P,R@8))%/$)F]*=-9>P HV%X_3:%5"7M $7Z&&"BD3Q"]22A>6' 0OH:12
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M/B(5#B*OE0:68L#I&=(2$+EZ?;)-A=]7X! _3R5W8[Z3N7FIPFB2%7%)IMF
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MY^C\Y$_B0;]=O7T#__C_4$L#!!0    ( /MC^USK]_1\)14  #]9   5
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M7IZ/T ><^?O.\^]V]FX&F[/%;)S&&\NP4"^PEL(OA*Z-E__W=+/WW3_:+<C
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MWBF@#52&]]K)+EC)!-O3VPJ!*NAQ@OQ6+;$)1*%>X.\0/D'\/K@IF;8"=
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M3+LY)1Y8</JN=%=!S&Y^;&^W=7KG3],,TN0M^,))LLH'0_X=M=C)E&LJ;"+
M[XXUU6;6&!H<1P;&F5E.$N!DLKK>Q'F1V$WI@F[L+S!L'^1OI$/%G,R5C2%
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MQ&R?05BFY ^'=6/QU=^M$3D^;8+Y(W!HV .FH!A\TP@T8:JFC[\!4$L#!!0
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MS-)$#6"]D+2ESD\W +.M4P]#%Q0G@#GXE*32^R5E_D@H5;<#,.L?4&QBU[3
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MH+P6V^^7US==RT]RL]XD_UKBE,@M_P502P,$%     @ ^V/[7*&1!JI8!P
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M,CDY,CDV,#%E>#DY+3(N:'1M4$L! A0#%     @ ^V/[7()2M1 E P  W L
M !$              ( !IA@" &QX9G(M,C R-C W,C<N>'-D4$L! A0#%
M  @ ^V/[7-?P#?3]"@  ?X8  !4              ( !^AL" &QX9G(M,C R
M-C W,C=?;&%B+GAM;%!+ 0(4 Q0    ( /MC^URAD0:J6 <  -!7   5
M          "  2HG @!L>&9R+3(P,C8P-S(W7W!R92YX;6Q02P4&      <
,!P#2 0  M2X"

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>ea0299296-8k_luxfer_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2026"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxfr-20260727.xsd" xlink:type="simple"/>
    <context id="AsOf2026-07-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001096056</identifier>
        </entity>
        <period>
            <startDate>2026-07-27</startDate>
            <endDate>2026-07-27</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="AsOf2026-07-27" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2026-07-27" id="Fact000004">0001096056</dei:EntityCentralIndexKey>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2026-07-27" id="xdx2ixbrl0012">X0</dei:EntityIncorporationStateCountryCode>
    <dei:DocumentType contextRef="AsOf2026-07-27" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2026-07-27" id="Fact000010">2026-07-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2026-07-27" id="Fact000011">LUXFER HOLDINGS PLC</dei:EntityRegistrantName>
    <dei:EntityFileNumber contextRef="AsOf2026-07-27" id="Fact000013">001-35370</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2026-07-27" id="Fact000014">98-1024030</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2026-07-27" id="Fact000015">3016 Kansas Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="AsOf2026-07-27" id="Fact000016">Riverside</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2026-07-27" id="Fact000017">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2026-07-27" id="Fact000018">92507</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2026-07-27" id="Fact000019">414</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2026-07-27" id="Fact000020">269-2419</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="AsOf2026-07-27" id="Fact000021">Ordinary Shares, nominal value &#xa3;0.50 each</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2026-07-27" id="Fact000022">LXFR</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2026-07-27" id="Fact000023">NYSE</dei:SecurityExchangeName>
    <dei:WrittenCommunications contextRef="AsOf2026-07-27" id="Fact000024">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2026-07-27" id="Fact000025">true</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2026-07-27" id="Fact000026">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2026-07-27" id="Fact000027">false</dei:PreCommencementIssuerTenderOffer>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2026-07-27" id="Fact000028">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
